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Dr Hannah Brindle: The Epidemiology of and Risk factors for Central Nervous 
System Infections in Vietnam 
In Vietnam, central nervous system (CNS) infections due to acute encephalitis 
syndrome (AES) and meningitis are caused by multiple aetiologies. Despite 
implementation of vaccination, the most common cause in children is Japanese 
encephalitis virus (JEV), and in adults, Streptococcus suis. In at least half of the 
cases, the cause is unknown however, there are peaks in incidence of acute 
encephalitis syndrome (AES) in the summer months in northern Vietnam. 
This thesis is composed of four results chapters with the following main objectives: 1) 
to understand the spatio-temporal distribution and risk factors of CNS infections in 
Vietnam; 2) to assess the feasibility and acceptability of conducting a case control 
study which aims to determine the risk factors for CNS infections; 3) to evaluate 
human movement and contact patterns in relation to risk factors for CNS infections 
and 4) to determine whether there are associations between the seroprevalence of 
JEV in pigs and incidence of AES and Japanese encephalitis (JE) in humans. 
The first results chapter uses monthly national surveillance data of the incidence of 
AES and meningitis at the provincial level from 1998 to 2016. The incidence of AES 
was highest in provinces bordering Lao PDR and seasonal patterns corresponded 
closely with those of JE. Negative binomial Integrated Nested Laplace Approximation 
(INLA) multivariate models showed a positive correlation of the number of cases of 
AES and meningitis with temperature and absolute humidity, and AES with the 
Normalised Difference Vegetation Index (NDVI) at a lag of one month. This might 
suggest that many cases of CNS infections are due to vector-borne diseases. 
In the second results chapter, many of the participants with AES had a bacterial 
meningitis due to the poor specificity of the case definition for AES, the predominantly 
adult patient population and the season of recruitment. The recruitment of matched 
controls who were relatives of hospital in-patients was also insufficient. Therefore, 
adaptations to the methods would be required for a future, larger case control study 
to evaluate risk factors for AES. 
The third results chapter showed that it was feasible to determine human movement 
patterns using global positioning system (GPS) tracking devices and contact patterns 
using diaries over the period of a year. Urban adults travelled the most and all 
participants spent the most time in areas of medium to high NDVI. Contact patterns 
occurred most frequently between children and adults. These findings may have 
implications for the transmission dynamics of pathogens causing CNS infections with 
larger studies recommended.  
The final results chapter showed that nearly two-third of pigs were seropositive to JEV 
at slaughter however, the specificity of the complement enzyme-linked 
immunosorbent assay (cELISA) was 57.4%. Multivariate analysis showed no 
evidence of an association between incidence of human JE and AES and 
seroprevalence of JEV in pigs. However, human-pig studies at the individual level are 
needed to determine whether this absence of risk is true. 
There is evidence that many CNS infections may be due to undiagnosed JE however, 
this requires further investigation before any changes to public health policy are made. 
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INTRODUCTION  
This Wellcome Trust Clinical PhD Fellowship was originally designed to be a multi-
centre case-control study conducted in Nepal. Over a period of approximately two 
years, cases of acute encephalitis syndrome (AES) were to be recruited from at least 
three tertiary hospital sites; Kanti Children’s Hospital in Kathmandu, BP Koirala 
Institute of Health Sciences (BPKIHS), Dharan and Lumbini Zonal Hospital, Butwal 
with community controls from locations within the hospital catchment areas. 
Diagnostics were to be performed by a collaborative study, conducted by the Ministry 
of Health of Nepal with the University of Liverpool and the World Health Organization. 
An additional study whereby healthy community members were to participate in a 
human movement and contact pattern study in the Kathmandu (urban) and Sunsari 
(rural) districts was also to be conducted.  
 
However, on 25 April 2015, there was a major earthquake of magnitude 7.8 with a 
depth of 15km and an epicentre 81km northwest of Kathmandu (World Health 
Organization, 2018a). A second earthquake of magnitude 7.3 with an epicentre 76 km 
northeast of Kathmandu occurred on 12 May 2015 (United Nations Office for the 
Coordination of Humanitarian Affairs, 2015). There were 8,659 deaths, 21,924 injuries 
and 88,482 people displaced (World Health Organization Country Office for Nepal, 
2015).  
 
I conducted a situation report with my local supervisor and drafted an adaptation to 
the PhD to account for undertaking work in a humanitarian crisis. However, following 
discussion with the Wellcome Trust Centre for Global Health Research, Liverpool, it 
was decided that the research in Nepal should be closed and the work transferred to 
Hanoi, Vietnam, in collaboration with the Oxford University Clinical Research Unit 
(OUCRU). As a result of this, the programme of work was altered particularly with 
regard to differences in research governance between Vietnam and Nepal. Whilst the 
aim of the work to evaluate risk factors associated with CNS infections through a case 
control study was the same, the proposed geographical distribution of the recruitment 
was much more limited in Vietnam. It was intended to recruit cases of AES from the 
National Hospital for Tropical Diseases (NHTD) and the National Hospital of 
Pediatrics (NHP) in Hanoi. As NHP was already included in a multicentre study of 
AES in southeast Asia led by Institute Pasteur, the possibility of collaborative work 
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was explored but was ultimately not feasible. Recruitment of paediatric cases from 
other hospitals within the Red River Delta region of northern Vietnam were explored 
but not possible to set-up within the timeframe of the grant.  Without the collaboration 
with the WHO, diagnostics were required to be funded through the clinical PhD 
fellowship. The geographical area in which the movement and contact pattern work 
was also restricted to one province in northern Vietnam.  
 
This thesis therefore evaluates the epidemiology and risk factors of central nervous 
system infections (CNS) in Vietnam. Following a literature review of the epidemiology 
of CNS infections in south, southeast and east Asia there are four results chapters. 
The first results chapter is an ecological study which uses national surveillance data 
of notifiable diseases and syndromes to understand the spatio-temporal distribution 
and risk factors for CNS infections and make suggestions as to the possible cause 
given that many cases are of unknown aetiology. The second results chapter is a pilot 
case control study which aims to determine the feasibility of the recruitment of cases 
and controls and the feasibility and acceptability of conducting home visits to 
understand participants’ risk factors for AES in northern Vietnam. The third results 
chapter evaluates the human movement and contact patterns amongst a healthy 
cohort of participants living in Ha Nam province to determine their risk of CNS 
infections. The final results chapter examines the associations between the 
seroprevalence of Japanese encephalitis virus (JEV) in pigs and incidence of 
Japanese encephalitis (JE) and AES in humans.  
 
VIETNAM 
Vietnam is located in southeast Asia and is bordered by China to the north, Lao 
Peoples’ Democratic Republic (Lao PDR) and Cambodia to the west and the “East 
sea” to the east (figure a). It stretches from approximately 8.5°N to 23°N (Nguyen-Le, 
Matsumoto and Ngo-Duc, 2014).   
 
The geography varies from the low-lying Red River Delta in northern Vietnam and the 
Mekong Delta in southern Vietnam, to mountainous areas (up to 3,000 m elevation) 
in the northwest and the Central Highlands. Northern Vietnam has four seasons 
(Trang et al., 2016) with a cool and humid winter and a warm, wet summer whereas 
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southern Vietnam has a tropical climate (Kelly-Hope et al., 2007) with a wet and dry 
season (Lin et al., 2000). The total area of the country is 331,235.7 km2 (General 
Statistics Office of Viet Nam, 2019).  
 













The population of Vietnam is 97 million with 70% of the population aged under 35 
years (The World Bank, 2020a). The capital city, Hanoi, in northern Vietnam, has a 
population of 8 million within the municipality and the largest city, HCMC (HCMC) in 
southern Vietnam, a population of 9 million within the municipality (General Statistics 
Office of Viet Nam, 2019). 
 
From 111 BC to 905 AD, Vietnam was under Chinese colonial rule however, it 
alternated between being independent and under Chinese rule until 1427 (Adger, 
1999). Vietnam was colonised by France from 1867 until the end of Franco-
Vietnamese War in 1954. Following this, the country was divided into the communist 
North and non-communist South under the Geneva Accord (Adger, 1999; Tucker-
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Jones, 2014). Ongoing conflict led to the Vietnam War between 1965 and 1975 with 
the south being supported by the United States. Following victory by the north, the 
country was reunified in 1976 however, economic growth was hindered (Asselin, 
2018). During the 1980s Vietnam suffered from food shortages despite three-quarters 
of the Vietnamese labour force being employed in agriculture. As a result of this, the 
country was reliant on foreign aid until the economic reform in 1986 ‘Doi Moi’ which 
increased the workforce in the modern sector and integrated Vietnam into the world 
markets with a rise in exports. As a result of this, the Vietnamese economy grew 
rapidly with a decline in the ratio of those living in poverty (Tran, 2013).  In 2019 the 
growth of the gross domestic product (GDP) was one fastest in the world at 7% (The 
World Bank, 2020a). However, there are still economic discrepancies with 86% of 
those who remain poor, being from ethnic minorities. Despite this, 70% of those living 
in rural areas and 95% of those in urban areas have access to clean water and 99% 
use electricity for lighting (The World Bank, 2020a).  
 
As economic growth increased and living standards improved, health outcomes also 
improved with a reduction in infant mortality rate from 32.6 per 1000 live births in 1993 
to 16.7 per 1000 live births in 2017 and an increase in life expectancy from 70.5 years 
in 1990 to 76.3 years in 2016 (The World Bank, 2020a).     
 
The healthcare system in Vietnam consists of both private and public facilities. Public 
hospitals are divided into central level hospitals, provincial level hospitals and district 
level hospitals with most people visiting hospital as their first point of care (World 
Health Organization, 2020g).  However, hospital autonomy reforms initiated in the 
1990s allow the public sector to charge user fees to mobilise finance from the private 
sector and individuals (World Health Organization, 2020g; The World Bank, 2012). 
This has led to increases in total hospital revenues with improved salaries of hospital 
staff and an expansion of healthcare services. However, it appears that central 
hospitals and those in large cities have benefited more than those in rural areas (The 





THE ROLES AND RESPONSIBILITIES OF THE WORK 
The work for this thesis was designed by myself with support of my supervisors and 
collaborators. 
 
The analysis of the data was undertaken by me and reviewed by my supervisors. I 
sought advice from Dr Marc Choisy (OUCRU) and Dr Leo Bastos (London School of 
Hygiene and Tropical Medicine) regarding the choice of spatio-temporal models for 
chapters two (“The spatio-temporal distribution of and risk factors associated with 
Acute Encephalitis Syndrome and meningitis in Vietnam: an ecological study”) and 
five (“The seroprevalence of Japanese encephalitis virus in pigs in northern 
Vietnam”). I co-supervised Maria Malik, an intern from Princeton University who 
performed an initial descriptive analysis of the surveillance of AES in Vietnam. 
However, none of her work was included in the thesis. Dr Marc Choisy (supervisor in 
Vietnam) provided the interpolated data for climatic variables from the weather 
stations and due to the size of computation required, the NDVI for the provinces in 
chapter two.  
 
Data cleaning was undertaken by myself with support of the OUCRU Clinical Trials 
Unit for chapter three (“A pilot case-control study to assess the risk factors for Acute 
Encephalitis Syndrome (AES) in patients admitted to the National Hospital for Tropical 
Diseases from the Red River Delta region in northern Vietnam”) and staff from the 
National Institute of Hygiene and Epidemiology (NIHE) for chapter four (“Evaluation 
of the daily activities and contact patterns of healthy adults and children in rural and 
urban settings in Ha Nam province, Vietnam to explore potential risk factors for acute 
encephalitis syndrome”) where required. The national surveillance data used for 
chapter two was already cleaned and made available as an R package prior to my 
use for analysis.   
 
Laboratory work for chapter three was undertaken by staff at OUCRU and for chapter 
five by staff at OUCRU, the National Institute for Veterinary Research (NIVR), Hanoi, 
and Mahidol University, Bangkok. The results were checked by me. 
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Consent in Vietnamese was undertaken by study staff from the National Hospital for 
Tropical Diseases (NHTD), and the Preventive Medicine Center (PMC) Ha Nam for 
chapters three and four, respectively. Primary data collection was undertaken in 
Vietnamese by local staff. For chapter three, clinical data collection was performed by 
the staff from NHTD with support of OUCRU staff where required and at the homes 
of participants by field staff employed by OUCRU. For chapter four, the contact pattern 
diaries were completed by staff from the PMC. Data entry into the electronic data 
system CliRes was undertaken by OUCRU staff. The focus group discussions and 
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1.1 AN INTRODUCTION TO CENTRAL NERVOUS SYSTEM (CNS) 
INFECTIONS 
The central nervous system (CNS) is composed of the brain and spinal cord. This 
differs from the peripheral nervous system which is composed of the nerves which 
branch off the spinal cord. CNS infections typically include encephalitis, meningitis 
and meningo-encephalitis (Sigfrid et al., 2019) but can also include brain and spinal 
epidural abscesses, ventriculitis and subdural empyemas (Ziai and Lewin, 2008). For 
the purpose of this thesis, CNS infections refers to encephalitis, meningitis and 
meningo-encephalitis.  
 
THE CASE DEFINITIONS OF CNS INFECTIONS 
 
THE CASE DEFINITION OF ENCEPHALITIS 
Encephalitis is defined as inflammation of the brain parenchyma (tissue) leading to 
dysfunction of the neurological system (Johnson, 1996; Venkatesan et al., 2013; 
Sejvar et al., 2007). Confirmed diagnosis would be based on evidence of oedema, 
inflammation and the death of neuronal cells (neurophagia) however, performing pre-
mortem biopsies is challenging and not often undertaken (Sejvar et al., 2007; 
Venkatesan et al., 2013). Diagnosis may therefore be based on a clinical definition 
alone however, where resources are available neuroimaging, laboratory diagnosis 
and electroencephalography (EEG) may also be used (Venkatesan et al., 2013; 
Granerod et al., 2010a). However, no standard case definitions exist for encephalitis 
(Granerod and Crowcroft, 2007) and often vary between research studies (Hills et al., 
2009; Jmor et al., 2008). Additionally, studies may use the World Health Organization 
(WHO) International Classification of Disease (ICD) codes (Jmor et al., 2008). 
 
In 2006, the World Health Organization (WHO) provided a clinical definition for an 
‘acute encephalitis syndrome’ as part of the surveillance standards for the pathogen 
Japanese encephalitis (JE) (Solomon et al., 2008; Hills et al., 2009). AES is defined 
as ‘a person of any age, at any time of year, with the acute onset of fever and a change 
in mental status (including symptoms such as confusion, disorientation, coma, or 
inability to talk) AND/OR new onset of seizures (excluding simple febrile seizures). 
Other early clinical findings can include an increase in irritability, somnolence or 
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abnormal behaviour greater than that seen with usual febrile illness’ (World Health 
Organization, 2006). However, the specificity of detecting cases with Japanese 
encephalitis virus (JEV) was only found to be 39% (95%CI 30-48%) in those admitted 
to the Centre for Tropical Disease, HCMC, Vietnam (Solomon et al., 2008). Examples 
of the use of the WHO AES case definition as an inclusion criteria includes studies in 
Nepal (Rayamajhi et al., 2011) and India (Goel et al., 2017).  
 
The case definition for AES developed by the Brighton Collaboration Encephalitis 
Working Group has been one of the most widely used (Venkatesan et al., 2013). 
However, this uses criteria based on varying levels of diagnostic certainty to aid the 
standardisation of encephalitis as an adverse event following immunisation. Level 1 
of diagnostic certainty includes the confirmation of inflammation by histopathology; 
and levels 2 and 3, the presence of an encephalopathy e.g. a reduction in the level of 
consciousness, lethargy or a change in personality lasting more than 24 hours with 
additional specific symptoms and signs of encephalitis in combination with a number 
of the following: fever, raised white cell count in the cerebrospinal fluid (CSF 
pleocytosis), EEG findings consistent with encephalitis or neuroimaging consistent 
with encephalitis. Neuroimaging should show evidence of parenchymal inflammation 
on computerised tomography (CT) or magnetic resonance imaging (MRI) (Sejvar et 
al., 2007). 
 
In March 2012, the International Encephalitis Consortium in the United States stated 
that the sensitivity and specificity of the case definition produced by the Brighton 
Collaboration Encephalitis Working Group was unknown and they had concerns 
about the overlap between the definitions of encephalitis and encephalopathy which 
refer to altered mental status but without inflammation of the brain tissue. The 
consortium therefore developed diagnostic criteria to capture both encephalitis and 
encephalopathy with major criteria including a change in consciousness and minor 
criteria including the presence of fever, seizures, new focal neurology, a CSF 
pleocytosis, abnormalities of the brain parenchyma on neuroimaging or a EEG 
consistent with encephalitis. Confirmation of encephalitis required one of 1) brain 
inflammation on pathology, 2) evidence of acute infection e.g. by microbiology, 
pathology or serology or 3) evidence of an autoimmune condition known to be strongly 
associated with encephalitis as provided by laboratory diagnosis (Venkatesan et al., 
2013). An overlap of the WHO case definition for AES has also been seen with 
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encephalopathy, meningitis and other neurological manifestations including a myelitis 
(inflammation of the spinal cord), abscesses, febrile convulsions and non-infectious 
causes (Solomon et al., 2008).  
 
A study of the causes of encephalitis in the United Kingdom (UK) from 2005 to 2006 
amongst 203 patients found that the most common clinical symptoms and signs were 
fever (72%, 95%CI 66-78); headache (60%, 95%CI 53-67%), a change in personality 
or behaviour (64%, 95%CI 57-71%), lethargy (55%, 95%CI 48-62%) and seizures 
(52%, 95%CI 45-59%). 80% (95%CI 74-86%) had a CSF pleocytosis, 60% (95%CI 
53-68%) changes on MRI and 83% (95%CI 75-89%) an EEG suggestive of 
encephalitis. The case definition included “any person of any age admitted to hospital 
with encephalopathy (altered consciousness that persisted for longer than 24 hours, 
including lethargy, irritability or a change in personality and behaviour) and with two 
or more of the following: fever or history of fever (≥38°C) during the presenting illness; 
seizures and/or focal neurological findings (with evidence of brain parenchyma 
involvement); CSF pleocytosis (more than four white blood cells per µL); 
electroencephalographic (EEG) findings indicative of encephalitis; and abnormal 
results of neuroimaging (CT or MRI) suggestive of encephalitis” (Granerod et al., 
2010a). 
 
THE CASE DEFINITION OF MENINGITIS 
Where encephalitis is due to inflammation of the brain parenchyma, meningitis is 
caused by inflammation of the meninges which surround the brain and spinal cord 
and the subarachnoid space which contains the CSF. However, inflammation of 
the brain parenchyma and cortex (a layer which surrounds the brain) can also 
occur. When the meninges become inflamed this can lead to symptoms and signs 
of fever, headache and neck stiffness and a CSF pleocytosis. Although meningitis 
can be caused by a variety of agents (bacterial, viral, fungal etc), the WHO 
provide a case classification for bacterial meningitis only due the severity of the 




The WHO case classification for bacterial meningitis is as follows  
Suspected Any person with sudden onset of fever (> 38.5 °C rectal or 38.0 °C 
axillary) and one of the following signs: neck stiffness, altered consciousness or 
other meningeal sign. 
Probable A suspected case with CSF examination showing at least one of the 
following:- turbid appearance;- leukocytosis (> 100 cells/mm3);- leukocytosis 
(10-100 cells/ mm3) AND either an elevated protein (> 100 mg/dl) or decreased 
glucose (< 40 mg/dl).
Confirmed A case that is laboratory-confirmed by growing (i.e. culturing) or 
identifying (i.e. by Gram stain or antigen detection methods) a bacterial pathogen 
(Hib, pneumococcus or meningococcus) in the CSF or from the blood in a child with 
a clinical syndrome consistent with bacterial meningitis. 
 
An aseptic meningitis is defined as a CSF pleocytosis without a positive Gram stain 
or culture (Shukla et al., 2017).  
 
THE CASE DEFINITION OF MENINGOENCEPHALITIS 
Commonly, both inflammation of the meninges and brain parenchyma occur thereby 
eliciting symptoms and signs of encephalitis with meningitis. In these cases, the term 
‘meningoencephalitis’ is used (Tunkel et al., 2008).  
 
THE GLOBAL BURDEN AND AETIOLOGY OF CNS INFECTIONS 
In 2016, the Global Burden of Diseases, Injuries and Risk Factors Study (GBD) 
conducted a systematic analysis of estimate the global, regional and national burden 
of neurological disorders. In addition to CNS infections this analysis included 
malignancy, stroke, trauma and dementia and other manifestations of neurological 
disorders from 1990 to 2016 (G. B. D. Neurology Collaborators, 2019). Case 
definitions for the neurological disorders were based on ICD criteria as provided in 
the 2015 systematic analysis (G. B. D. Neurological Disorders Collaborator Group, 
2017) with modelling used to estimate prevalence, incidence and mortality (G. B. D. 
Neurology Collaborators, 2019). However, the authors noted that due to the various 
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iterations of the ICD classifications, comparison of the data sources required 
extensive effort and all sources of measurement bias could not be accounted for. In 
2016, encephalitis accounted for 653.4 million cases (95% confidence interval (CI) 
595.7-716.5 million), 103,000 deaths (95% CI 84,000-138,000), 670.4 million 
Disability-Adjusted Life Years (DALYS) (95%CI 546.9-857.4 million). Although the 
total number of cases of meningitis in 2016 was lower at 2.821 million (95% CI 2.464-
3.310 million) the number of deaths was higher with a total of 318,000 (95%CI 
265,000-409,000) and the number of DALYS much higher at 2.19 billion (95%CI 1.82-
2.83 billion) total (G. B. D. Neurology Collaborators, 2019). However, from 1990 to 
2016, there was an increase in the incidence of meningitis globally from 2.5 million 
(95% uncertainty interval 2.19-2.91) to 2.82 million (2.46-3.31) but with a 21% 
reduction in deaths. The meningitis belt which includes countries in sub-Saharan 
Africa which are peri-Sahelian e.g. border the Sahara from Ethiopia to Senegal saw 
the highest age-standardised incidence. However, some countries outside of this 
region also experienced some of the highest mortality rates including Afghanistan, 




The infectious aetiologies of encephalitis include viruses, bacteria, rickettsia, 
parasites and fungi. Non-infectious aetiologies include immune-mediated or toxic 
causes (Granerod et al., 2010a). A systematic review of forty-one studies from 1950 
to 2002 found that in twenty-six studies the proportion of cases of AES of unknown 
aetiology was 50% or greater (Granerod et al., 2010b) and worldwide it is estimated 
that up to 85% of cases may be due to unknown causes (Granerod et al., 2010a). 
However, both the incidence of AES and the proportion of cases in which no cause is 
found is dependent on the number of pathogens tested for and the methods used in 
addition to the case definition (Granerod et al., 2010b). Similarly, the breadth of 
aetiologies detected is dependent on the type of testing undertaken with studies 
conducted in high-resourced settings more likely to detect more pathogens. This 
potentially leads to reporting biases between studies.  
 
The risk of encephalitis varies by age, geographic region and seasonality (Granerod 
and Crowcroft, 2007). For example, in the United Kingdom, encephalitis is most 
commonly caused by herpes simplex virus (HSV) (Granerod et al., 2010a; Ambrose 
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et al., 2011). HSV is also a common cause of encephalitis in Asian countries however, 
Japanese encephalitis virus (JEV) which is unique to the continent accounts for the 
majority of cases in many countries, particularly in children (Tan le et al., 2014; 
Rayamajhi et al., 2011; Tarantola et al., 2014). There is also strong evidence for a 
seasonal pattern of JEV, peaking in incidence in the warmer months or during the 
monsoon (Kumar Pant et al., 2017; Robertson et al., 2013). Table 1 outlines a 





















Table 1: Pathogens causing encephalitis by category (Granerod et al., 2010a; Ludlow 
et al., 2016b; Morfopoulou et al., 2016; Moriguchi et al., 2020; Arabi et al., 2015; 
Glaser et al., 2003; Tunkel et al., 2008; Dittrich et al., 2015; Granerod and Crowcroft, 
2007; Lewthwaite et al., 2010; Marinho et al., 2019). 
Category Family/classification Pathogens 
Virus Herpesviridae 
Herpes simplex virus 1 and 2 (HSV 1 and 
HSV 2) 
Varicella zoster (VZV) 
Cytomegalovirus (CMV) 
Epstein-Barr virus (EBV) 
Human herpesvirus-6/7 (HHV-6/7) 
B virus 
Epstein-Barr virus (EBV) 
Virus Flaviviridae 
Japanese encephalitis virus (JEV) 
Dengue virus (DENV) 
West Nile virus (WNV) 
St. Louis encephalitis virus (SLEV) 
Tick-borne encephalitis virus (TBEV) 
Zika virus 
Murray Valley encephalitis virus (MVEV) 
Powassan virus 
Yellow Fever virus (YFV) 
Virus Picornaviridae 












Category Family/classification Pathogens 
Virus Togoviridae 
Chikungunya virus (CHIKV) 
Eastern equine encephalitis virus (EEEV) 
Venezuelan equine encephalitis virus 
(VEEV) 
Western equine encephalitis (WEEV) 
Rubella virus 
Virus Bunyaviridae 
La Crosse virus (LACV) 
Rift Valley fever virus (RVFV) 
Toscana virus (TOSV) 
Virus Orthomyxoviridae Influenza A and B viruses 
Virus Rhabdoviridae 
Rabies virus (RABV) 




Rift Valley Fever 
Virus Arenaviridae 
Lymphocytic choriomeningitis virus 
(LCMV) 
Virus Retroviridae Human Immunodeficiency Virus (HIV) 
Virus Polyomaviridae Human polyomavirus 2/JC virus 
Virus Orthocoronaviridae Human coronavirus OC43 (HCoV-43) 
Severe acute respiratory syndrome 
Coronavirus 2 (SARS-CoV-2) 
Middle-East respiratory syndrome 
coronavirus (MERS-CoV) 
Virus Adenoviridae Adenovirus 
Virus Reoviridae Banna virus 
Bacteria Gram positive cocci Streptococcus pneumoniae 
Enterococcus faecium 
Group A streptococci 
Bacteria Gram positive bacilli Listeria monocytogenes 
Tropheryma whipplei 
Bacteria Gram negative cocci Neisseria meningitidis 
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Category Family/classification Pathogens 
Bacteria Gram negative bacilli Brucella species 
Pseudomonas species 
Bacteria Gram negative cocco-
bacilli 
Haemophilus influenzae 














Bacteria Mollicutes Mycoplasma pneumoniae 
Bacteria Spirochetes Treponema pallidum 
Leptospira species 
Borrelia burgdorferi  
Bacteria Rickettsiaceae Orientia tsutsugamushi 
Rickettsia species 
Parasite Obligate intracellular Toxoplasma gondii 
Parasite Protozoa Plasmodium falciparum 
Parasite Kinetoplastid Trypanosoma brucei gambiense 
Trypanosoma brucei rhodesiense 
 Nematode Gnanthostoma species 
Baylisascaris procyonis 
 Cestode Taenia solium 




Category Family/classification Pathogens 
Amoeba  Acanthamoeba species 
Naegleria fowleri 
Prions 




 Acute disseminated encephalomyelitis 
Anti-N-methyl D-aspartate receptor (anti-
NMDAR)  






Meningitis can also be caused by a number of pathogens, with causes of community-
acquired meningitis differing in incidence according to the age of those infected and 
the geographical region (van de Beek et al., 2016). Globally, the most common 
causes of bacterial meningitis are S. pneumoniae, N. meningitidis and Haemophilus 
influenzae type b (Hib) (McIntyre et al., 2012). However, incidence of these pathogens 
has reduced due to the introduction of vaccines, particularly Hib (van de Beek et al., 
2016). The incidence of these pathogens also differs by age with S. pneumoniae more 
common amongst those aged less than five years and the elderly, N. meningitidis 
amongst older children and young adults and Hib in those less than 12 months (van 
de Beek et al., 2016). However, in southeast Asian countries where pigs are farmed, 
the Streptococcus suis is an important cause in adults (van Samkar et al., 2015; 
Wertheim et al., 2009b). Table 2 outlines a selection of the pathogens more frequently 











Table 2: Pathogens causing meningitis by category (McGill et al., 2016; Molyneux et 
al., 2009; Jarvis et al., 2010; Federspiel, Skovmand and Skarphedinsson, 2020). 
Category Family/classification Pathogens 
Virus Picornaviridae Enteroviruses 




Virus Paramyxoviridae Measles virus 
Mumps virus 








Bacteria Gram positive bacilli L. monocytogenes 
Bacteria Gram negative cocci N. meningitidis 
 
Bacteria Gram negative cocco-
bacilli 
H.  influenza type b 






Bacteria Mycobacteria M. tuberculosis 
Bacteria Mollicutes M. pneumoniae 
Bacteria Spirochetes T. pallidum 
Leptospira species 
Fungi  C. neoformans 




1.2 THE EPIDEMIOLOGY AND AETIOLOGY OF CNS INFECTIONS 
IN SOUTHEAST ASIA 
 
Table 3, develop by myself, shows examples of studies evaluating the aetiology of 
CNS infections in southeast and south Asia. In summary, the most common cause of 
CNS infections amongst adults in Vietnam is S. suis and in children, JEV (Tan le et 
al., 2014; Le et al., 2010; Ho Dang Trung et al., 2012; Taylor et al., 2012).  
 
The aetiology was unknown in 44.9-72.7% of cases. In addition to infectious causes 
and not shown in table 3, autoimmune and toxic causes of AES have been identified 
in Vietnam. Of ninety-nine patients admitted with encephalitis to the Hospital for 
Tropical Diseases in HCMC, Vietnam, 9.1% (n=9) had antibodies to NMDA receptors 
(Nguyen Thi Hoang et al., 2017). In Bac Giang province in northern Vietnam, a 
retrospective analysis of data from 2004-2009 showed an association between the 
proportion of land covered by lychee plantations and the incidence rate ratio of acute 
encephalitis in children (Paireau et al., 2012b). A later case control study conducted 
in northern India found that consumption of lychees was associated with an 
encephalopathy in children (odds ratio (OR) 9.6, 95%CI 3.6-24) (Shrivastava et al., 
2017).  
 
JEV was the most common cause identified in a study of paediatric patients in 
Cambodia (Horwood et al., 2017). In other paediatric studies in Cambodia and in 
China enterovirus was identified as the most common cause (Turner et al., 2017; Ai 
et al., 2017). The remaining studies did not differentiate the aetiology between adults 
and children however, in Lao PDR the median age of those with JEV was 13 years 
with an interquartile range of 8-20 years compared to the Cryptococcus species, the 
second most common pathogen with a median age of 33 years and an interquartile 
range of 27-41 years (Rattanavong et al., 2020). In Nepal, the median age of those 
with enterovirus, the most common pathogen was 39 years with an interquartile range 
of 33-53 years and JEV, 42 years with an interquartile range of 27-67 years (Giri et 
al., 2013). In the study in Lucknow, the age distribution was only given for those with 
JEV and DENV with 59.2% of those with JEV and 57.7% of those with DENV being 
less than 15 years and 57.7% (Jain et al., 2017).  
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Many studies categorised a CNS infection as either probable for example, based on 
clinical judgement with or without abnormalities in the CSF or WHO criteria; or 
confirmed based on a laboratory diagnosis of a pathogen (Tan le et al., 2014; Le et 
al., 2010; Taylor et al., 2012; Ho Dang Trung et al., 2012; Turner et al., 2017; Horwood 

































































































































































(Tan le et al., 
2014) 
HCMC 1996-2008 Adults 291 NA NA NA NA NA 12.4 6.5 6.5 2.7 NA 22.7 68.0 
Vietnam (Le et al., 2010) HCMC 2004 Children 194 0 3.1 NA 3.1 0 25.8 0.5 4.6 9.3 NA 8.7 44.9 
Vietnam 
(Taylor et al., 
2012) 
Hanoi 2007-2008 Adults 352 13.6 2.0 2.6   0 0.6 NA 3.4 NA 0.6 NA 4.5 72.7 
Vietnam 
(Ho Dang Trung 
et al., 2012) 
Multiple 2007-2010 Adults 617 23.8 5.7 5.5 0 0.7 1.8 3.6 3.7 3.2 NA 4.2 47.8 
Vietnam 
(Ho Dang Trung 
et al., 2012) 
Multiple 2007-2010 Children 624 0 5.9 1.8 6.3 1.0 22.8 2.2 2.2 5.8 NA 3.0 49.0 
Cambodia 





2010-2013 Children 1160 0 1.6 0 0.7 0.2 24.5 0.9 4.6 3.5 4.7 3.3 55.8 
Cambodia 
(Turner et al., 
2017) 




Vientiane 2003-2011 Both 1065 ? 2.1 1.9 ? ? 8.8 ? 2.5 ? 2.9 ?** ? 
China (Ai et al., 2017) Multiple 2009-2012 Children 546 NA NA NA NA NA 0.34 10.8 2.9 15.4 NA 18.0*** 47.4 
Nepal 
(Giri et al., 
2013) 
Kathmandu 2009-2011 Adults 87 0 3.5  0 5.8 8.1 2.3 0 10.3 NA 5.8 63.2 
India 
(Rathore et al., 
2014) 
Odisha 2011-2012 Both 526 NA NA NA NA NA 1.3 4.0 0.2 0 NA 16.2 78.3 
India 
(Jain et al., 
2017) 
Lucknow 2014-2016 Both 4092 NA 0.94 NA 0.97 0 8.3 0.8 7.8 0.4 31.8 1.5 47.5 
? = it is unknown whether the pathogen was tested for 
NA = the pathogen was not tested for 
 
	
* This can also include probable diagnoses 
** 6.8% of the total were due to Cryptococcus species 
*** 1.8% of the total were due to TBEV 
	
	 30 
As demonstrated in tables 1 and 2, the aetiology of CNS infections globally is very 
broad. However, given that this thesis aims to explore the epidemiology and risk 
factors of CNS infections in Vietnam, only those infections which are common in 
Vietnam and its neighbouring countries will be discussed in detail including JEV, 
DENV, O. tsutsugamushi, HSV, enterovirus 71 and S. suis. For each of these 
pathogens an overview is given of the epidemiology and transmission; clinical 
symptoms, signs, and prognosis; diagnostics; treatments and control and surveillance 
on a global level with a focus on Asia. A separate section on the epidemiology of the 
pathogen in Vietnam is also given.  
 
Other pathogens which are known to be important but less common causes of CNS 
infections in Vietnam and its neighbouring countries or are not found in Vietnam but 
are important globally are discussed in less detail including VZV, measles virus, 
mumps virus, rubella virus, influenza virus, CMV, EBV, CHIKV, Nipah virus, rabies 
virus, S. pneumoniae, N. meninigitidis, H. influenzae, M. tuberculosis, Leptospira 
species, R. typhi, WNV, Zika virus and TBEV. For each of these pathogens an 
overview of their epidemiology, neurological manifestations and control is given with 
a focus on Vietnam. 
 
In addition to infectious, autoimmune and toxic causes will be mentioned briefly. This 
list is based on a list of pathogens causing encephalitis in the countries of the Mekong 










1.3 COMMON PATHOGENS CAUSING CNS INFECTIONS IN 
VIETNAM AND ITS NEIGHBOURING COUNTRIES 
 
JAPANESE ENCEPHALITIS VIRUS (JEV) 
 
TRANSMISSION AND EPIDEMIOLOGY 
JEV, is a single-stranded positive-sense ribonucleic acid (RNA) virus with five 
genotypes, based on the nucleotide sequence of the viral envelope (E) gene (Li et al., 
2011). JEV is transmitted in an enzootic cycle between Culex mosquitoes, animals 
such as wild birds and pigs and humans (Solomon et al., 2000b; Scherer et al., 1959a; 
Buescher et al., 1959; Scherer et al., 1959b). The replication of the virus in both the 
vertebrate and non-vertebrate hosts makes this an arbovirus (Rosen, 1986).  JEV is 
predominantly transmitted by Culex tritaeniorhynchus Giles, 1901 mosquitoes of the 
order Dipetra and family Culicidae however, it can also be transmitted by other 
species of Culex including Culex gelidus, Culex fuscocephala and Culex annulirostris 
(van den Hurk, Ritchie and Mackenzie, 2009; Longbottom et al., 2017; Reuben et al., 
1994). JEV has an extrinsic incubation period (EIP) (the time taken for the virus to be 
transmitted by a mosquito after a blood meal) (Ye et al., 2016) of 7-14 days in the 
mosquito (van den Hurk, Ritchie and Mackenzie, 2009).  
 
Cx. tritaeniorhynchus is found across east, south and southeast Asia, northern 
Australia, the Middle East, Africa and Greece (Longbottom et al., 2017; Reisen, 
Aslamkhan and Basio, 1976; Sallam et al., 2013; Lytra and Emmanouel, 2014; Samy 
et al., 2018). The mosquito larvae mainly breed in irrigated rice fields but also pools 
of water which may be temporary or semi-permanent including swamps and marshes 
(Keiser et al., 2005; Longbottom et al., 2017; Self et al., 1973). However, the vector 
can also be found in urban areas (Murthy et al., 2002). Climatic factors including 
rainfall and temperature, and altitude also influence the abundance of the larval 
breeding sites and habitats for adult mosquitoes (Keiser et al., 2005). A reduction in 
rainfall can result in fewer breeding sites as the eggs will not survive dessication. If 
rainfall is too heavy, breeding sites can be flooded (Reisen, Aslamkhan and Basio, 
1976; Longbottom et al., 2017). However, this flooding is not necessarily detrimental 
as populations of Cx. tritaeniorhynchus have been shown to remain high even during 
these periods (Gould et al., 1974). Higher temperatures are associated with longevity 
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of the mosquitoes (Niaz and Reisen, 1981). However, temperatures which are too 
high can negatively impact both the activity and survival of the mosquitoes (Liu et al., 
2018). Higher altitudes may also result in fewer mosquitoes, due to cooler 
temperatures and absence of suitable breeding grounds. In Yunnan, China, there was 
an absence of Cx. tritaeniorhynchus above 3000m (Sun et al., 2009). However, more 
recently Cx. tritaeniorhynchus infected with JEV were found in Tibet at elevations of 
3100m (Zhang et al., 2017a). Cx. tritaeniorhynchus is an exophagic (biting outdoors) 
mosquito with biting times after sunset and the middle of the night (Longbottom et al., 
2017; Rohani, Zhong and King, 2010; Reisen and Aslamkhan, 1978). Figure 1.1 
shows the predicted environmental suitability for Cx. tritaeniorhynchus within areas 
where there is a risk of transmission of JEV based on models including covariates 
such as land surface temperature, tasselled cap wetness, elevation and vegetation 
cover (Longbottom et al., 2017). This model should be interpreted with some caution 
as the authors acknowledge that countries such as Malaysia and Indonesia show low 
suitability for Culex yet are areas of known JEV transmission. This effect is also seen 
in areas of Vietnam, particularly the northwest. 
Figure 1.1 The predicted environmental suitability for Cx. tritaeniorhynchus within 
areas where there is a risk of transmission of JEV. High suitability is shown in red and 




Infected mosquitoes feed on and transmit the virus to a number of amplifying and 
dead-end hosts. Wading birds such as herons and egrets of the family Ardeidae and 
wild and domestic swine are the most commonly implicated amplifying hosts (Scherer 
et al., 1959b; Buescher et al., 1959; Scherer and Buescher, 1959; Soman et al., 
1977). Amongst swine, clinical disease is only seen is pregnant sows where fetal 
abortion and stillbirth may occur (Salmon, 1984; Lindahl et al., 2012a). Antibodies 
against JEV have been found in other animals such as ducks (Kalaiyarasu et al., 
2016; Pant, 2006; Ayu Mirah Adi et al., 2016), chickens (Ayu Mirah Adi et al., 2016), 
cats (Kumar et al., 2018), dogs (Ohno et al., 2009) and cattle (Kumar et al., 2018) 
amongst other animals (van den Hurk, Ritchie and Mackenzie, 2009). However, it has 
been shown that cattle do not produce a viraemia sufficient to act as amplifying hosts 
and are therefore ‘dead-end’ (Ilkal et al., 1988) and although other mammals are not 
thought to be implicated in the transmission cycle of JEV (van den Hurk, Ritchie and 
Mackenzie, 2009) the role of domestic birds is unknown (Lord, Gurley and Pulliam, 
2015). Humans, infected when bitten by a mosquito carrying the virus, are a dead-
end host (Solomon et al., 2000a).  
 
A case control study conducted in Bali, Indonesia identified living close to rice fields 
as a risk factors for JE in humans (Odds ratio (OR) 2.93, 95% confidence interval (CI) 
1.57-5.45) (Liu et al., 2010). The percentage of irrigated land was also positively 
associated with incidence of JE at the district level in a study in Nepal (Impoinvil et 
al., 2011). However, an ecological study conducted in northern Vietnam found a 
negative association between the proportion of land covered by rice and the incidence 
rate ratio of acute encephalitis (Paireau et al., 2012b) and a further study in Nepal 
found that the amount of irrigated land was not associated with a risk of JE possibly 
due to the increased number of cases in the Kathmandu Valley and mountainous 
regions (Robertson et al., 2013).  
 
In Uttar Pradesh, northern India, an association was found between an absence of 
indoor residual spraying (IRS) of insecticides within the past year and JE (OR 0.31, 
95%CI 0.19-0.50) (Kakkar et al., 2017) and in Assam, northern India, the use of 
insecticide-treated mosquito nets (ITMNs) was associated with a risk ratio of JE in 
humans of 0.28 (95% CI 0.16-0.49) (Dutta et al., 2011). However, this association 
was not seen by Liu et al, 2010 in Bali. Similarly, the risk of JE from living close to 
pigs remains a matter of debate. Liu et al., 2010 found that the rearing of pigs by the 
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family or neighbours was associated with an increased risk (OR 1.96, 95%CI 1.07-
3.56) and in Nepal, the rearing of pigs at home was also associated with JE (OR 6.12, 
95%CI 2.14-17.94) (Rayamajhi et al., 2007). The relocation of domestic pigs to more 
than 5 km from human habitation has therefore been proposed, whilst it was 
acknowledged that the benefit remained unknown (Solomon, 2006). However, on the 
Torres Strait islands, Australia it was found that the removal of pigs did not eliminate 
the presence of mosquitoes infected with JEV (van-den-Hurk et al., 2008).  
 
The first notification of a case of JE occurred in 1871 in Japan followed by an outbreak 
in 1924 (World Health Organization, 2019f; Solomon, 2006) and the virus is currently 
endemic in twenty-four countries in Asia-Pacific (Campbell et al., 2011; Quan et al., 
2020; World Health Organization, 2019f). Figure 2 shows the distribution of areas with 
and without a risk of JEV (Centers for Disease Control and Prevention, 2019). 
 
Figure 1.2 Distribution of Japanese encephalitis virus (Centers for Disease Control 




In 2015, it was estimated that there were 100,308 (95%CI 61,720-157,522) cases of 
JE globally with 25,125 (95%CI 14,550-46,031) deaths (Quan et al., 2020). This is 
higher than the estimate in 2011 (approximately 67,900 cases annually) (Campbell et 
al., 2011) however, the authors attribute it to accounting for under-reporting, 
differences in the quality of surveillance data and changes in the population and 
vaccination programmes over time (Quan et al., 2020).  Incidence of JE has reduced 
over time in countries such as Japan, the Republic of Korea and Taiwan (China) due 
to the implementation of vaccination programmes. Many other countries rolled 
vaccination out more slowly and incidence rates between countries is variable 
(Campbell et al., 2011) with annual incidence varying from 0.003 per 100,000 in Japan 
and the Republic of Korea to 3.7 per 100,000 in Malaysia, Cambodia and Indonesia 
(Campbell et al., 2011; Turtle and Solomon, 2018). There are reports of incidences of 
greater than 10 per 100,000 per year during outbreaks (World Health Organization, 
2019f).  
 
Two epidemiological patterns exist; in tropical regions such as southern Thailand and 
Vietnam and Indonesia, the virus is endemic with cases of JE occurring throughout 
the year but with a peak after the start of the wet season. In more temperate regions 
such as northern Thailand and Vietnam, Nepal and China epidemics occur during the 
summer months (Solomon et al., 2000a; Vaughn and Hoke, 1992). Major outbreaks 
are seen every 2-15 years in temperate regions and can be difficult to predict (World 
Health Organization, 2019f; Lindquist, 2018). The mechanism for persistence of JEV 
during cooler winter months when mosquitoes are unable to survive remains unknown 
(Turtle and Solomon, 2018). Transmission of the virus between pigs via respiratory 
secretions has been shown (Ricklin et al., 2016). Additionally, it has been 
hypothesised that the virus could be reintroduced to the area by migratory birds or 
persist in other animals such as lizards or snakes or even in mosquitoes (van den 
Hurk, Ritchie and Mackenzie, 2009).  
 
JE is seen mostly commonly in children as adults tend to acquire natural immunity. 
However, JE may also be seen in adults, especially those who have no pre-existing 
immunity for example, countries which have experienced epidemics more recently 
including Nepal, India and Sri Lanka (Solomon et al., 2000a).   
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CLINICAL SYMPTOMS AND SIGNS AND PROGNOSIS 
Less than 1% of those infected with JEV develop symptoms (Campbell, 2011) which 
may range from a mild flu-like illness with headache and fever to encephalitis with 
reduced consciousness (Solomon, 2000a), seizures (Kumar et al., 2006), an acute 
flaccid paralysis (Solomon et al., 1998), a focal neurological deficit such as a 
hemiparesis (Rayamajhi et al., 2007) or extrapyramidal features such as tremor, 
rigidity, hypokinesia and masking of the face (Misra and Kalita, 2002). Mortality has 
been reported in up to 44% of cases and as many as 91% can suffer long term 
neurological sequelae (Turtle and Solomon, 2018). A study in Nepal found that 68% 
of children hospitalised with JE had a neurological impairment at follow-up, most 
commonly difficulties with language and lower limb function (Griffiths et al., 2013). A 
report in 2002, showed JE to cause 709,000 DALYs on an annual basis (Mathers, 
Ezzati and Lopez, 2007).  
 
DIAGNOSTICS 
The WHO recommend that confirmation of infection with JEV is based on the 
presence of an IgM antibody against the virus in either CSF, the preferred method to 
reduce the risk of a false positive result due to prior vaccination or infection, or blood 
(World Health Organization, 2019f). A second sample should be tested at 
approximately the tenth day of the onset of illness as it can take this time to develop 
IgM (World Health Organization, 2007b). A study in Lao PDR found that the use of 
dried CSF spots on pre-cut filter paper might be useful where laboratory access is 
limited (Bharucha et al., 2016). Serological cross-reactivity with other flavivirus 
antibodies can present challenges (Dubot-Peres et al., 2015) and although 
polymerase chain reaction (PCR) and cell culture are more specific, the virus is often 
not present in either blood or CSF when symptoms manifest. Additionally, these tests 
are expensive and require greater technical expertise and facilities to perform (Moore 
et al., 2012).   
 
TREATMENTS 
There are currently no licensed treatments for JE and management is supportive 
(World Health Organization, 2019f). This includes careful fluid balance 
(Tiroumourougane et al., 2003), the management of seizures using anti-epileptics 
(Misra and Kalita, 2001) and prevention of malnutrition, bed sores and contractures 
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through nursing care and physiotherapy (Solomon and Vaughn, 2002). There have 
been a number of trials of therapeutics, none of which have shown a detected benefit 
on the clinical outcome of patients with JE (Turtle and Solomon, 2018). Treatments 
which have been trialled include dexamethasone (Hoke et al., 1992), interferon-alpha 
(Solomon et al., 2003), ribavarin (Kumar et al., 2009), intravenous immunoglobulin 
(Rayamajhi et al., 2015) and minocycline (Kumar Singh et al., 2016). There are a 
number of other potential treatments which have proved to be successful in animal 
models or in vitro which are awaiting trials in humans (Turtle and Solomon, 2018).  
 
CONTROL AND SURVEILLANCE 
Control of JE exists primarily through human vaccination programmes which have 
been established in a number of countries. Vaccines against JEV have been in use 
since the 1950s with mouse brain-derived inactivated vaccines used for over fifty 
years (Hegde and Gore, 2017). However, a suspension of the recommendation for 
the use of this vaccine was implemented in 2005 for safety reasons following rare 
cases of ADEM despite no causal link (Ferguson et al., 2007).  The live-attenuated 
SA-14-14-2 vaccine was licensed in China in 1988 and is recommended for children 
aged 1-2 years with a booster dose the following year (Hegde and Gore, 2017). In 
Nepal, vaccine efficacy after a single dose was shown to be 99.26% (Bista et al., 
2001), 98.5% one year later (Ohrr et al., 2005) and 96.2% five years later (Tandan et 
al., 2007). Lower seroprotection rates were seen in India (Indian Academy of 
Pediatrics et al., 2013). Most inactivated vaccines are not sold internationally with the 
exception of the inactivated adjuvanted SA-14-14-2 vaccine which is  now is licensed 
in Europe, North America and other countries as IXIARO (Turtle and Solomon, 2018). 
The first recombinant vaccine to be licensed is ‘Imojev’ which uses the premembrane 
and envelope genes of the SA-14-14-2 vaccine with a yellow fever 17D vaccine. 
Vaccination was first introduced in 1954 in Japan (Campbell et al., 2011), however, 
in Lao PDR it was only introduced in 2015 (WHO, 2017), and Myanmar in 2017 
(Gudmastad, 2017). Despite this approximately 81% of cases still occur in countries 
where there is a well-established or developing vaccination programme including 
China and India (Campbell et al., 2011). Suggested reasons for this include a lack of 
vaccine coverage, waning immunity where transmission is intermittent, poor vaccine 
effectiveness or cold chain issues (Turtle and Solomon, 2018). 
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In addition to vaccination, the intermittent irrigation of rice paddy fields (alternate dry-
west irrigation (ADWI) (Howell, Shrestha and Dodd, 2015)) to reduce the mosquito 
burden (Keiser et al., 2005), use of larvivorous fish (Keiser et al., 2005), insecticide 
treated bed-nets (Dutta et al., 2011) and vaccination of pigs (Sasaki et al., 1982) and 
possibly relocating pigs (Solomon, 2006) may provide some benefit to the control of 
JEV.  
 
The WHO recommend various types of surveillance for JE in order to understand the 
geographic distribution and at-risk populations and to inform vaccine policy and 
evaluate vaccine effectiveness. These range from minimal surveillance such as 
sentinel hospital surveillance with laboratory confirmation to enhanced surveillance 
such as using national data on AES with laboratory confirmation of JE. The case 
definition of AES is used to identify a suspected case of JE.  However, in the absence 
of laboratory testing a definition of ‘probable JE’ is only provided if there is a 
geographic or temporal link to a laboratory-confirmed case of JE during an outbreak, 
otherwise the case is classified as ‘AES unknown’ (World Health Organization, 
2018b). A study conducted in Nepal showed that seasonal peaks of incidence of JE 
coincided with those of AES therefore the authors proposed that the patterns of AES 
could act as an early-warning tool for JE (Robertson et al., 2013). 
 
JEV IN VIETNAM 
JEV was first isolated in Vietnam in 1951 with a continued high incidence of JE in 
northern Vietnam between 1969 and 1974 (Okuno, 1978). Between 1978 and 1980, 
epidemics were reported in northern Vietnam with 93% of cases occurring from May-
July with a peak in June (Le, 1986). Reports from 1985 to 1993 in northern Vietnam 
showed incidence of AES, reported as JE to be highest in the provinces of the Red 
River Delta (Yen et al., 2010). Reports from 1976-1992 documented year-round cases 
of AES in southern Vietnam with JEV being isolated from human sera and 
mosquitoes. The highest incidence occurred in the Mekong Delta (Do, 1995). A 
number of studies of the vectors which transmit JEV have been conducted in Vietnam. 
In 2003 a study found Culex to be the predominant species of mosquito in Ha Tay 
province, northern Vietnam and in a later study, found Cx. tritaeniorhynchus to be 
positive for JEV (Hasegawa et al., 2008; Kuwata et al., 2013; Nguyen-Tien, Lundkvist 
and Lindahl, 2019). A study in Can Tho city in southern Vietnam found that there was 
a positive association between the number of Cx. tritaeniorhynchus and pigs in close 
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vicinity (Lindahl et al., 2012b). This finding is supported by the presence of anti-JEV 
antibodies in 100% of pigs sampled inside the city (Lindahl et al., 2013).  
 
A study of patients with AES admitted to Bach Mai Hospital, Hanoi, northern Vietnam 
from June to August 1995 found that 31 of 46 paediatric patients (67%) and 2 of 33 
adults patients (6%) had JE. The median age of the paediatric patients was 6 years 
(range 6 months to 16 years) and adults, 33 years (range 19-58 years). It was also 
noted that 15% of paediatric patients without AES had evidence of past JEV infection 
as measured by anti-IgG compared to 40% of adults (Lowry et al., 1998). A seaparate 
study conducted at the provincial level found that in five provinces: Bac Giang, Hai 
Duong, Hai Phong, Thai Binh and Thanh Hoa, 52% of the cases of AES tested for 
JEV were IgM were positive. This proportion was highest in Thai Binh (71%) and 
lowest in Bac Giang (17%) and highest in the age group 11-15 years (65%). The 
authors recommended expansion of JE testing and collection of further information to 
better understand the epidemiology of JE (Yen et al., 2010).  
 
‘Viral encephalitis’ is a notifiable disease in Vietnam (Binh et al., 2013) with JE 
notificable since 2017 (personal communication, Pham Thai Quang). Since 1997, a 
domestically produced inactivated mouse brain-devired vaccine against JEV has 
been included in the Expanded Programme on Immunization (EPI). Vaccination 
commenced in twelve high-risk districts in northern Vietnam before being rolled-out to 
other districts (Yen et al., 2010). By 2015, all districts except Cao Bang were receiving 
the vaccine as part of the EPI but with varying degrees of coverage (data from the 
National Institute of Hygiene and Epidemiology, Hanoi). Children aged 1-5 years 
receive two doses of vaccine 1-2 weeks apart followed by a booster dose the following 
year (Yen et al., 2010). Despite a reduction in the proportion of cases of AES which 
are due to JE from approximately 60% of cases in children aged over 5 years prior to 
1999 to less than 27% since 2002 (Van Tu et al., 2007) concerns about the 
immunisation programme remain. A study conducted in Ha Tay province in northern 
Vietnam showed that incidence remained high, especially amongst children aged 5-9 
years and therefore trialled a model immunization programme compared to the EPI 
which showed a significant reduction in the risk of JE (Yen et al., 2015).    
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DENGUE VIRUS (DENV) 
 
TRANSMISSION AND EPIDEMIOLOGY 
 
Dengue virus (DENV) is a single-stranded positive-sense RNA virus of which there 
are four seroptypes (DENV1-4) (Simmons et al., 2012). It is transmitted by the bite of 
an infected Aedes aegypti mosquito, the primary vector or Aedes albopictus 
mosquitoes, considered to be secondary vectors (Brady et al., 2013) with female 
mosquitoes having a preference for feeding on humans (Ferreira-de-Lima and Lima-
Camara, 2018; Harrington, Edman and Scott, 2001). Ae. aegypti tends to be 
distributed only in tropical and subtropical climates however, the eggs of Ae. 
albopictus can survive in more temperate regions (Brady et al., 2013). Outbreaks have 
also been attributed to other species including Aedes polynesiensis and those of the 
Aedes scutellaris complex (World Health Organization, 2020c). The EIP of DENV is 
8 to 12 days and is faster than higher temperatures (Gubler, 1998; Guzman et al., 
2010; Watts et al., 1987).  
 
Both Ae. aegypti and Ae. albopictus originated in forests with the former in Africa and 
the latter in South Asia (Tedjou et al., 2019). The Ae. aegypti mosquito has adapted 
to live in urban areas and often breeds in water storage containers (Schmidt et al., 
2011; Simmons et al., 2012). Ae. albopictus can also inhabit urban areas but less 
frequently than Ae. aegypti and in further proximity to humans (Brady et al., 2013). 
Ae. aegypti feeds only on humans whereas Ae. albopictus feeds on humans and 
animals (Kraemer et al., 2015). However, unlike JEV, humans are not a dead-end 
host and mosquitoes become infected after biting viraemic people (Duong et al., 
2015).  Given the short flight distance of Aedes of just over 500m (Harrington et al., 
2005) the population density and contact patterns between humans play an important 
role in the transmission of the virus (Padmanabha et al., 2012; Simmons et al., 2012). 
In forested areas in Southeast Asia and Africa, DENV may also have a sylvatic lineage 
and can be transmitted between non-human primates, with humans rarely becoming 
infected (Cardosa et al., 2009; Brady and Hay, 2020). The Aedes mosquitoes are 
mostly active during daylight hours, often with peaks of activity in the early morning 
and late afternoon (Reinhold, Lazzari and Lahondere, 2018). The timing of the peaks 
of activity depends on the season (Yasuno and Tonn, 1970). Similar to Culex, the 
activity of Aedes mosquitoes is dependent on many climatic factors. Development of 
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the immature stages of Ae. aegypti from egg, to larvae and pupae occurs between 
16°C and 34°C (Reinhold, Lazzari and Lahondere, 2018) and Ae. albopictus occurs 
at a wider range of 10.4°C to 29.7°C (Delatte et al., 2009). Flight times of Ae. aegypti 
are reduced at temperatures lower than 10°C and higher than 35°C (Rowley and 
Graham, 1968) however, the impact of temperature on the flight activity of Ae. 
albopictus is less well known (Reinhold, Lazzari and Lahondere, 2018). In addition to 
temperature, humidity is correlated with the propagation of DENV within Ae. aegypti, 
with a preferred humidity of over 60% (Thu, Aye and Thein, 1998) and a reduced 
longevity of adult Ae. albopictus mosquito at lower humidities (Waldock et al., 2013). 
However, the effect of dessication has been shown to be higher on the mortality of 
Ae. albopictus eggs compared to Ae. aegypti eggs (Juliano et al., 2002). Although 
adequate rainfall is required to provide suitable environments for breeding and 
development of the larvae, heavy rainfall can risk the larvae being washed away 
(Koenraadt and Harrington, 2008; Seidahmed and Eltahir, 2016). The geographical 
distribution of both vectors has expanded due to the impact of climate change and 
increasing travel patterns of humans  (Ebi and Nealon, 2016). Nepal saw the 
introduction of cases of dengue fever more recently, thought to be due to the 
movement of viraemic people from northern India (Dumre et al., 2013), and now has 
evidence of the presence of vectors in high mountain regions (Dhimal et al., 2015). 
Figure 1.3 shows the predicted distribution of Ae. aegypti and figure 1.4, the 
predicated distribution of Ae. albopictus based on records of the occurrence of these 






















Globally, there are an estimated 390 million infections of DENV annually with 
approximately 100 million developing symptoms and 10,000 dying. The majority of 
cases occur in Asia and the Americas with fewer in Africa, although this estimate is 
thought to be an under-estimation and very few in Oceania (Bhatt et al., 2013). 
Autochthonous cases are now also seen in a number of countries in Europe 
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(Tomasello and Schlagenhauf, 2013). Figure 1.5 shows the probability of the 
occurrence of cases based on records of the occurrence of dengue (Bhatt et al., 
2013). Studies from southeast Asia showed that up to 20% of those admitted to 
hospital with an encephalitis-like illness had dengue (Chokephaibulkit et al., 2001; 
Kankirawatana et al., 2000; Srey et al., 2002). This percentage was higher in south 
America with 26% in Puerto-Rico (Garcia-Rivera, Vorndam and Rigau-Perez, 2009)  
and 47% in Brazil (Soares et al., 2011).  
 





The risk of dengue is associated with a number of factors. In terms of climate, a high 
level of rainfall and a temperature suitable for transmission of the virus are associated 
with an increased risk (Bhatt et al., 2013). A number of countries therefore see 
seasonal peaks in cases of dengue fever in the warm, wet months (Morales et al., 
2016; Phanitchat et al., 2019; Zhang et al., 2019; Lowe et al., 2011) with the effect of 
the El Niño Southern Oscillation (ENSO) predicting the epidemiology in  Ecuador 
(Stewart-Ibarra et al., 2014; Petrova et al., 2019) and India (Kakarla et al., 2019) 
amongst others (Gagnon, Bush and Smoyer-Tomic, 2001). However, in addition to 
climate the behaviour and travel patterns of humans should also be taken into account 
when understanding seasonality (Sippy et al., 2019). In addition to annual seasonal 
peaks of cases of dengue fever, epidemics occur where the incidence is higher than 
that seen over previous years which may be due to climatic factors (Vincenti-Gonzalez 
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et al., 2018; Stewart-Ibarra and Lowe, 2013; Kanakaratne et al., 2009; Descloux et 
al., 2012) but also human movements (Wesolowski et al., 2015b). 
 
Ae. aegypti is both an endophilic (shelters within homes) and endophagic (feeds 
inside houses) vector. However, it also moves between inside and outside. Ae. 
albopictus however, is considered to be exophagic (bites outside) but can also be 
endophilic (Reinhold, Lazzari and Lahondere, 2018). Low-income urban and peri-
urban areas (Bhatt et al., 2013) and those which are densely populated are at 
particular risk (Koyadun, Butraporn and Kittayapong, 2012). However, there is a 
suggestion that the risk may also be high in rural areas where there is lack of piped 
water supply (Schmidt et al., 2011). Living in proximity to breeding sites including 
unclean swamps or sewage have also been shown to be risk factors for disease 
(Swain et al., 2020; Toan et al., 2015).  
 
Figure 1.6 shows the environmental suitability for dengue based on temperature, 
precipitation, minimum relative humidity, gross domestic product (GDP) per capita, 
human population density and the environmental suitability for Ae. aegypti and Ae. 
albopictus (Messina et al., 2019).  
 






CLINICAL SYMPTOMS AND SIGNS AND PROGNOSIS 
A diagnosis of dengue fever is suspected based on the presence of a high fever 
(40°C) with at least two of the symptoms of a severe headache, retro-orbital pain, 
myalgia and arthralgia, nausea, vomiting, rash and swollen glands (World Health 
Organization, 2020b). Most patients will have mild, self-terminating disease which 
doesn't require hospital admission. A minority will develop severe dengue. Severe 
dengue normally occurs 3-7 days after the onset of symptoms, often coincident with 
a decrease in fever. Symptoms and signs of severe dengue include persistent 
vomiting, breathlessness, severe abdominal pain, fatigue, haematemesis, bleeding 
gums and restlessness (World Health Organization, 2020b). The WHO classify 
severe dengue as any of 1) plasma leakage which causes dengue shock syndrome 
or respiratory distress, 2) severe bleeding or 3) severe organ impairment (World 
Health Organization, 2009; Wilder-Smith et al., 2019b). In areas which have high rates 
of endemicity for the virus, initial exposure usually occurs during childhood and 
therefore symptomatic dengue is seen most commonly in older children and young 
adults.  Where endemicity rates are lower, it is seen more commonly in adults than 
children including in the elderly (Wilder-Smith et al., 2019b; Rowe et al., 2014).Severe 
dengue has been associated in some instances with a second infection with a 
heterologous serotype leading to antibody dependent enhancement (ADE) (Halstead, 
2007). ADE causes in increases in the number of cells infected with the virus and 
later, increases in the number cytokines which cause vascular permeability, possible 
leading to shock and death (Guzman, Alvarez and Halstead, 2013).  
 
DENV can cause a wide range of CNS manifestations and in the case of CNS 
infections, an encephalitis, meningitis or meningoencephalitis as a result of the virus 
or an immune-mediated syndrome including an ADEM. Those with a meningitis or 
meningoencephalitis may present with a reduction in the conscious level, headache, 
seizures, disorientation, dizziness and changes in behaviour (Carod-Artal et al., 2013; 
Araujo et al., 2012; Domingues et al., 2008). 30% of those with neurological 
involvement in a study in Pakistan died (Wasay et al., 2008) and in Vietnam, 29% had 






A diagnosis of DENV in the first few days of infection can be made via detection of 
the NS1 antigen using a rapid diagnostic test. Alternatively, RNA can be detected in 
the blood using reverse transcriptase PCR (RT-PCR). ELISA can be used to detect 
IgM antibodies from approximately 4-7 days after the onset of symptoms until three 
months (World Health Organization, 2020b; Wilder-Smith et al., 2019b). As for JEV 
there is a risk of cross-reactivity of the antibodies with other flaviviruses giving a false 
positive result (Nunes et al., 2011). The presence of the NS1 antigen, DENV RNA or 
anti-DENV IgM in the CSF can be used to make a diagnosis of a CNS infection caused 
by DENV however, compared to the serum, the sensitivity of these tests is low (Carod-
Artal et al., 2013; Soares et al., 2006).  
 
TREATMENTS 
There are no treatments for dengue virus and management is supportive with the use 
of analgesia such as paracetamol (World Health Organization, 2020b). Severe 
dengue should be managed with careful fluid resuscitation (Wilder-Smith et al., 
2019b). A number of randomised trials have been conducted to evaluate the effect of 
drugs with antiviral properties including chloroquine, balapiravir, celgosivir and 
lovastatin however, there has been no evidence of a benefit (Tricou et al., 2010; 
Nguyen et al., 2013; Low et al., 2014; Sung et al., 2016; Whitehorn et al., 2016). 
Additionally, no benefit was seen in a randomised of oral prednisolone, an 
immunosuppressant (Tam et al., 2012).  
 
CONTROL  
Prevention of DENV can be achieved by eliminating mosquito breeding sites and the 
WHO advocate for integrated vector management (World Health Organization, 2009). 
Environmental measures might include covering or emptying water storage 
containers, disposing of waste which can hold water and adding screens to windows; 
chemical measures using mosquito repellents, residual spraying with insecticides, 
larvacides, or biological methods such as using larvivorous fish and copepods to 
eliminate larvae (Wilder-Smith et al., 2019b; World Health Organization, 2020b). New 
approaches to the control of Ae. aegypti include the use of Wolbachia, an 
endosymbiotic bacteria which can render infected mosquitoes incompetent (Dorigatti 
et al., 2018) or the Release of Insects carrying Dominant Lethal genes (RIDL) (Wilder-
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Smith et al., 2019b). A vaccine against dengue ‘Dengvaxia’ was licensed in 2015 
(Wilder-Smith et al., 2016) however, safety data released in 2018 showed an 
increased risk of severe dengue in recipients who were seronegative at the time of 
vaccination (Sridhar et al., 2018). As a result of this, it was recommended that the 
vaccine only be given to those who were dengue-seropositive (Wilder-Smith et al., 
2019a).     
 
DENV IN VIETNAM 
DENV-1 and DENV-2 are the predominant circulating serotypes in Vietnam, with 
detection of DENV-3 and DENV-4 occurring more recently (Do et al., 2014, (Ha and 
Ninh, 2000). Cases of dengue fever occur across the country however, there are 
regional differences in the seasonality. Transmission occurs throughout the year in 
southern Vietnam but with a peak during the rainy season from July to September. In 
northern Vietnam and the central highlands, there are few cases in the winter with 
Hanoi seeing most cases occurring in the autumn months (Do et al., 2014). Major 
outbreaks occur almost every 10 years including in 1987 (Tran et al., 2010; Lee et al., 
2017a), 1998 (Ha et al., 2000; Lee et al., 2017a), 2009  (Minh An and Rocklov, 2014; 
Lee et al., 2017a) and most recently, 2017 (Sun et al., 2017). The outbreaks of 1987, 
1998 and 2010 are thought to have coincided with increased activity of El Niño and 
La Niña (Minh An and Rocklov, 2014). Ae. aegypti predominates in urban areas 
whereas Ae. albopictus is found urban and suburban areas at a lower density 
(Nguyen-Tien, Lundkvist and Lindahl, 2019). DENV has been detected by PCR in 
female Ae. aegypti in both Hanoi and HCMC (Kim Lien et al., 2015; Anders et al., 
2015). 
 
DENV was the second most common viral aetiology after JEV in a study of adults with 
CNS infections admitted to the Hospital for Tropical Diseases (HTD) in HCMC, 
southern Vietnam, accounting for 6.5% of cases (Tan le et al., 2014) and the third 
most common viral aetiology amongst children with encephalitis admitted to 
Children’s Hospital Number One (CH1) in HCMC, accounting for 4.6% of cases (Le 
et al., 2010). In a multicentre study of CNS infections across Vietnam, DENV was the 
most common viral aetiology with HSV in adult patients (4%) but the third most 
common in children with HSV (2%) (Ho Dang Trung et al., 2012). In 1995, a study of 
the neurological manifestations of dengue infection amongst patients admitted to the 
Centre for Tropical Diseases in HCMC with suspected CNS infections found that 4.6% 
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had evidence of DENV with over half having an encephalitis and 44% a neurological 
manifestation which coincided with severe dengue (Solomon et al., 2000b). 
 
Dengue is a notifiable disease in Vietnam with control of the disease organized by the 
Vietnam National Dengue Control Program established in the late 1990s (Quyen et 
al., 2018; Lee et al., 2017a; Pham et al., 2011). The programme was established with 
the aim of focusing on vector control such as reducing mosquito breeding sites, 
spraying insecticide and treating symptomatic cases (Lee et al., 2017a; Quyen et al., 
2018).  
 
The Dengvaxia vaccine was trialed in Vietnam but has not been locally licensed 
(Quyen et al., 2018). The burden of disease is high with dengue and severe dengue 
leading causes of hospitalisation, morbidity and (Pham et al., 2011; Lee et al., 2017a; 
Do et al., 2014) however, case fatality rates have declined (Anders et al., 2011; Lam 
et al., 2013).  
 
ORIENTIA TSUTSUGAMUSHI (SCRUB TYPHUS) 
 
TRANSMISSION AND EPIDEMIOLOGY 
Scrub typhus is caused by O. tsutsugamushi, a gram-negative obligate intracytosolic 
bacterium (Paris et al., 2013; Xu et al., 2017). O. tsutsugamushi, is transmitted by the 
bite of an infected trombiculid or Leptotrombidium delicense mite (chigger) during its 
larval stage (Traub and Wisseman, 1974; Xu et al., 2017; Lv, Guo and Jin, 2018). The 
mite lives in wild, overgrown areas such as jungle or scrub in damp soil or detritus 
(Seong, Choi and Kim, 2001) and feeds on vertebrates such as rodents and also 
humans (Paris et al., 2013; Lin et al., 2014). Humans are a dead-end host for the 
bacteria and it is thought that rodents are too given that only a small proportion of 
mites become infected after feeding on the animals (Paris et al., 2013; Frances et al., 
2000).   
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L. delicense is mainly distributed in tropical, subtropical and temperature zones in 
Asia and the Pacific. As with mosquitoes, the development of the chigger mite is 
dependent on climatic factors. Studies have shown the optimum temperature for 
development and reproduction was 18-28°C and 18-30°C for transmission of disease. 
A relative humidity of 95-100% was most suitable for development and reproduction 
(Lv, Guo and Jin, 2018; Traub and Wisseman, 1974; Xu and Chen, 1960). The mite 
therefore tends to be found at lower altitudes (Lv, Guo and Jin, 2018). Figure 1.7 
shows the distribution of L. delicense (Lv, Guo and Jin, 2018).   
 





One billion people are at risk of scrub typhus with one million becoming ill each year 
Determining the incidence of scrub typhus is challenging as established surveillance 
system exist only in five countries: Japan, Thailand, the Republic of Korea, China and 
Bhutan (Bonell et al., 2017; Xu et al., 2017). In these countries, the estimated annual 
incidence ranged from 1.22/100,000 in China (Wu et al., 2016) to 17.7 in the Republic 
of Korea (Park et al., 2015). However, within-country differences in incidence over 
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time were seen in China and the Republic of Korea (Park et al., 2015; Wei et al., 2014; 
Yang et al., 2015b). Separate seroprevalence studies showed an estimated 
seroprevalence ranging from 9.3% in Indonesia (Richards et al., 2003) to 27.9% in 
Papua New Guinea (Spicer, Taufa and Benjamin, 2007).  
 
Cases of scrub typhus are generally found within the “tsutsugamushi triange” region 
from northern Japan and eastern Russia to northern Australia and Pakistan and 
Afghanistan (Lv, Guo and Jin, 2018; Xu et al., 2017). However, cases have also been 
reported outside of the triangle in the United Arab Emirates (UAE), Chile and a 
number of countries in Africa (Xu et al., 2017; Izzard et al., 2010; Balcells et al., 2011; 
Thiga et al., 2015; Ghorbani et al., 1997; Osuga et al., 1991; Horton et al., 2016; 
Groen et al., 1999). Figure 1.8 shows the countries with reported cases of scrub 
typhus (Xu et al., 2017).  
 
Figure 1.8 The countries reporting cases of scrub typhus (Xu et al., 2017). 




Studies have shown neurological complications in up to 15% of patients (Silpapojakul 
et al., 1991; Mahajan et al., 2010). A more recent study in Lao PDR diagnosed O. 
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tsutsugamushi in 12% of CSF samples taken from patients with suspected CNS 
infection (Dittrich et al., 2015) and another in India, showed that 31.8% of cases were 
positive for anti-IgM against scrub typhus (Jain et al., 2017). Studies demonstrating a 
meningitis, encephalitis or meningoencephalitis have been described in a number of 
locations including India (Jamil et al., 2015; Misra, Kalita and Mani, 2015), the 
Republic of Korea (Kim et al., 2011), Thailand (Silpapojakul et al., 1991) and Nepal 
(Adhikari et al., 2018). 
 
The incidence of scrub typhus is seasonal, the months which see the highest number 
of cases depending on the climate of the country. For example, in China, most cases 
are seen in June and July, whereas in Japan and the Republic of Korea, most cases 
occur in November and October and November respectively. In India the peak is seen 
between August and October (Xu et al., 2017).  
 
Those working outside, particularly in rural areas are at higher risk of scrub typhus 
(Kweon et al., 2009; Suputtamongkol et al., 2009) with risk of infection often highest 
amongst middle-aged and older adults (Bonell et al., 2017; Xu et al., 2017). Those 
working in farming are at increased risk as demonstrated in a number of studies 
(Bonell et al., 2017; George et al., 2018). In some studies males have been shown to 
be at increased risk yet, in others the risk for females is higher (Bonell et al., 2017). A 
study in the Republic of Korea hypothesised that the squatting position adopted by 
female farmers increases their risk of infection (Kweon et al., 2009). Studies in Lao 
PDR and Nepal showed that those living in rural or peri-urban areas were at increased 
risk of infection (Vallee et al., 2010; Gautam, Parajuli and Sherchand, 2019). 
Increased risk of infection has also been described in northern India with storing 
firewood indoors and handling cattle fodder (Thangaraj et al., 2018),  and in southern 
India with living in proximity to other homes (Trowbridge et al., 2017), having a water 
body or bushes close to the house or cooking outside the house (Rose et al., 2019).  
 
CLINICAL SYMPTOMS AND SIGNS AND PROGNOSIS 
The clinical presentation of scrub typhus can range from a mild illness to severe and 
even fatal illness. Patients initially develop an eschar, which is an area of necrosis of 
the skin found at the site of the bite of the chigger mite and is accompanied by regional 
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lymphadenopathy. This is followed by a range of symptoms including fever, myalgia, 
cough, rash, gastrointestinal symptoms, headache, transient hearing loss and 
generalised lymphadenopathy (Paris et al., 2013; Vallee et al., 2010; Xu et al., 2017; 
Premaratna et al., 2006). In severe cases, multi-organ failure may develop with acute 
respiratory failure, gastrointestinal bleeding, acute renal failure, coagulopathy and 
shock (Paris et al., 2013; Wang et al., 2007). 
 
In a case series of 37 patients admitted to a tertiary care teaching hospital in North 
India and referred to the neurology service with a febrile illness which was attributed 
to scrub typhus 84% had a change in consciousness and 24%, seizures (Misra, Kalita 
and Mani, 2015).  The case fatality rate from meningitis/meningoencephalitis in a 
study in India was 5.8% (Abhilash et al., 2015) and in Lao PDR, 14% (Dittrich et al., 
2015). A separate study in India demonstrated that 11% of those with a neurological 
manifestation of scrub typhus had a disability on discharge but all recovered. Those 
with significant disability were of older age and had a prolonged stay in hospital (Misra, 
Kalita and Mani, 2015). In addition to meningitis, encephalitis and 
meningoencephalitis other clinical manifestations of scrub typhus have been 
described including a cerebellitis, cranial nerve pathology, Guillain-Barré syndrome, 
peripheral neuropathy, transverse myelitis and cerebrovascular accidents amongst 
others (Mahajan and Mahajan, 2017). 
 
DIAGNOSTICS 
The indirect immunofluorescence assay (IFA) is the gold standard for scrub typhus 
diagnosis however, it is expensive, complicated to perform and doesn’t detect 
antibodies in the early stages of infection (Xu et al., 2017). In resource-limited settings, 
ELISA and immunochromatographic tests are therefore more commonly used 
(Gautam et al., 2020). Other serological tests for scrub typhus include the Weil-Felix 
agglutination test and the indirect immunoperoxidase assay (IIP) (Xu et al., 2017). 
Finally, PCR can be used to detect the DNA of O. tsutsugamushi (Tantibhedhyangkul 






The standard treatment for scrub typhus is the antibiotic doxycycline however, 
rifampicin can be used in those who do not respond well to doxycycline (Xu et al., 
2017; Watt et al., 2000).  
Chloramphenicol or azithromycin are recommended in pregnant women and children 
where doxycycline is contraindicated (Xu et al., 2017; Lee et al., 2017b).  
 
CONTROL  
Despite attempts to develop a vaccine against O. tsutsugamushi no current vaccine 
exists (Chattopadhyay and Richards, 2007). Control is therefore centred around other 
measures to prevent infection. Those working outdoors are advised to wear long-
sleeved clothing to prevent bites, avoid lying on the ground and removing the clothes 
and washing on returning home. Controlling rodents by for example, poisoning or 
trapping and improving sanitation and clearing vegetation helps to remove the habitat 
for the chigger mites (Xu et al., 2017).   
 
O. TSUTSUGAMUSHI IN VIETNAM 
Case reports of scrub typhus in Vietnam date back to the 1960s and 1970s, with many 
American military personnel infected (Berman and Kundin, 1973). However, recent 
studies in northern Vietnam found a low seroprevalence amongst the general 
population (1.1%) (Trung et al., 2017) and 3.5% (n=251) of hospital admissions over 
a two-year period with either fever with an eschar, lymphadenopathy and rash, or 
fever and no signs of another infection. 55.7% of those with scrub typhus were farmers 
and incidence was highest in the summer months when rice farming was more 
common (Nadjm et al., 2014). However, Nadjm et al. 2014 noted that microbiological 
confirmation of the pathogen was challenging. A separate study, also conducted in 
northern Vietnam found that the majority of patients with scrub typhus were from rural 
areas. Although fever and headache were commonly reported, the authors do not 
mention whether any had evidence of CNS infection (Trung et al., 2019). Similarly, 
studies of the aetiology of CNS infections in Vietnam did not report any cases of scrub 
typhus however, it is possible that the diagnostics used were insufficient to detect this 
(Ho Dang Trung et al., 2012; Taylor et al., 2012).  
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HERPES SIMPLEX VIRUS (HSV) 
 
TRANSMISSION AND EPIDEMIOLOGY 
HSV belongs to family Herpesviridae and is a double-stranded DNA virus (Ludlow et 
al., 2016b). There are two types of herpes simplex virus, herpes simplex virus type 1 
(HSV-1) and type 2 (HSV-2). HSV-1 is typically acquired during childhood causing a 
lifelong infection (World Health Organization, 2020f).  It is transmitted via oral 
secretions such as saliva or orolabial ulcers with both symptomatic and asymptomatic 
transmission occurring (Pebody et al., 2004; World Health Organization, 2020f). Most 
commonly, the virus is transmitted via oral to oral contact however, oral to genital 
transmission contact can occur and rarely, vertical transmission during labour 
(Pebody et al., 2004; World Health Organization, 2020f; Lafferty et al., 2000; Corey 
and Wald, 2009). HSV-2 is normally transmitted via the genital route (Whitley, 2006) 
with prevalence increasing with age and incidence highest amongst adolescents 
(World Health Organization, 2020f). Data from 2016, estimated that 67% of the global 
population had an HSV-1 infection with prevalence being highest in Africa (88%) and 
lowest in the Americas (45%). Globally, 13% of those aged 15-49 years were living 
with HSV-2, with prevalence highest in Africa (44% in women compared to 25% men) 
(World Health Organization, 2020f).  
 
Herpes viruses can become latent with certain cell types (Ludlow et al., 2016b). HSV-
1 is neurotropic, becoming latent in sensory neurones and following replication in oral 
or genital mucosa (Nicoll, Proenca and Efstathiou, 2012) where HSV-2 is thought to 
become latent in the sacral ganglia (Berger and Houff, 2008). Despite many people 
being infected with HSV-1, only a small proportion will develop encephalitis (Xu et al., 
2006). Encephalitis caused by HSV occurs either as a consequence of primary 
infection or reactivation of the latent virus with HSV-1 causing up to 90% of Herpes 
Simplex encephalitis (HSE) and HSV-2 being more likely to cause a meningitis 
(Ludlow et al., 2016b, (Berger and Houff, 2008). Initial studies suggested that in the 
majority of patients, encephalitis occurred in those where there was reactivation of a 
latent virus compared to a primary infection (Nahmias et al., 1982). A study of the 
clinical manifestations of genital HSV infection found that 13% of men and 36% of 
women with primary genital HSV-2 infection had symptoms of meningitis (Corey et 
al., 1983). 
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Herpes simplex encephalitis is the most common cause of viral encephalitis in high-
income countries with an annual incidence of 1 in 250,000 to 500,000 (Whitley, 2006) 
also the virus is also a known cause of encephalitis in low and middle-income 
countries including in south and southeast Asia (Kalita et al., 2016; Rathore et al., 
2014).  
 
Unlike the vector-borne diseases, HSE is not thought to have a seasonal pattern 
(Kalita et al., 2016). Individual risk factors for developing HSE include immune-
compromising diseases, diabetes mellitus and malignancy (Ludlow et al., 2016b) with 
the majority of cases occurring in those aged 50 years and over with a higher 
incidence in those less than 3 years of age and males and females being equally 
affected (Bradshaw and Venkatesan, 2016).  
 
CLINICAL SYMPTOMS AND SIGNS AND PROGNOSIS 
Patients with HSE develop a prodromal phase of fever, malaise and headache and 
less frequently, nausea and vomiting. At the same time, a change in consciousness 
includes behavioural changes and confusion may occur (Sabah, Mulcahy and Zeman, 
2012). Seizures are particularly common as the virus affects the temporal lobes 
(Ludlow et al., 2016b). In some cases, patients develop focal neurological signs such 
as unilateral weakness (Sabah, Mulcahy and Zeman, 2012). Without treatment, over 
70% of those with HSE may die and of those who survive many have neurological 
sequelae such as seizures, memory impairment, personality change and motor 
impairment (Ludlow et al., 2016b; Khandaker et al., 2016). Mortality rate of up to 15% 
are seen in those who are treated and of those who survive, the majority suffer 
disability and are unable to return to work (Martinez-Torres et al., 2008).  
 
Those with HSV meningitis develop fever, headache, nausea and vomiting and 
meningeal signs and symptoms such as neck stiffness and photophobia and in some, 
additional symptoms associated with primary genital infection (Logan and MacMahon, 
2008; Mommeja-Marin et al., 2003). One-third of cases develop a sacral 
radiculomyelitis with constipation, paraesthesia and urinary retention (Corey et al., 
1983; Logan and MacMahon, 2008). Unlike HSE, mortality rates are lower and most 
infections are self-limited (Mommeja-Marin et al., 2003). However, 20-50% of cases 
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may develop a recurrence of meningitis which is more common in women with a 
primary infection (Logan and MacMahon, 2008).    
 
DIAGNOSTICS 
Diagnosis of both encephalitis and meningitis is confirmed by PCR of the CSF for viral 
DNA (Solomon et al., 2012; Mommeja-Marin et al., 2003). It should be noted that PCR 
might be negative during the initial period of illness but should be positive on a second 
sample take 3-7 days later (Solomon et al., 2012). Changes to the medial temporal 
lobe and cingulate gyrus seen on magnetic resonance imaging (MRI) of the brain are 
seen in approximately 90% of patients with HSE within 48 hours of hospital admission 
(Solomon et al., 2012).  
 
TREATMENTS 
Intravenous aciclovir (an antiviral) is used to treat HSE and should be started 
empirically if HSE is suspected. If the patient has renal impairment, the dose should 
be reduced (Solomon et al., 2012). Compared to an alternative antiviral, vidarabine, 
treatment with aciclovir is associated with lower mortality and improved outcome in 
survivors in randomised controlled trials (Skoldenberg et al., 1984; Whitley et al., 
1986). The benefit of using steroids for the treatment of HSE is unknown. There is 
currently a trial conducted by the University Hospital, Grenoble and the University of 
Liverpool to look at outcome of HSE following four days of dexamethasone compared 
to no dexamethasone (ClinicalTrials.gov, 2018). There is variation in the treatment of 
HSV-2 meningitis with clinicians using antivirals and others not (McGill, Zuckerman 
and Solomon, 2015). However, no trial has been conducted to evaluate the efficacy 
of aciclovir in this condition (McGill, Zuckerman and Solomon, 2015; Logan and 
MacMahon, 2008). Early treatment with aciclovir however, results in a much lower 
death rate, with 15% being recorded in a multicentre study (Raschilas et al., 2002).  
 
CONTROL  
To prevent transmission, those with oral or genital herpes, should avoid oral and 
genital contact, respectively. Condoms can reduce the risk of infection of genital 
herpes but not prevent it (World Health Organization, 2020f). Vaccine candidates are 
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currently being studied as is the use of topical microbicides (World Health 
Organization, 2020f; Awasthi and Friedman, 2014; Kizima et al., 2014).  
 
HSV AND ITS NEUROLOGICAL MANIFESTATIONS IN VIETNAM 
A study conducted in multiple countries amongst women aged 15 years and older to 
determine the performance of ELISA found that 100% of those in Hanoi and 98% of 
those in HCMC had antibodies to HSV-1 (Ashley-Morrow et al., 2004). A meta-
analysis of reports of HSV-1 reports in Asia showed a pooled mean seroprevalence 
of 76.5% in adults (Khadr et al., 2019) compared to a study in Europe which showed 
the seroprevalence in England and Wales amongst those more than 39 years old to 
be 23% (Pebody et al., 2004). 
 
A cross-sectional study conducted amongst ever married women found that 
seroprevalence of HSV-2 was 30.8% in those from HCMC compared to 8.8% in those 
from Hanoi (Le et al., 2009). A separate study found HSV-2 antibodies in 27.7% of 
female sex workers from border provinces in Vietnam. Prevalence was higher in 
southern and central provinces compared to those in northern Vietnam (O'Farrell et 
al., 2006).  
4% (n=22) of adults and 2% (n=14) of children had CNS infections due to HSV in a 
multi-centre study conducted between 2007 and 2010 (Ho Dang Trung et al., 2012) 
and 3% (n=12) adults in a study in Hanoi from 2007 to 2008 (Taylor et al., 2012).  
 
ENTEROVIRUSES (ENTEROVIRUS 71) 
 
TRANSMISSION AND EPIDEMIOLOGY 
Enteroviruses are single-stranded non-enveloped RNA viruses belonging to the 
Picornaviridae family (Ludlow et al., 2016b; Pons-Salort, Parker and Grassly, 2015). 
Enteroviruses are primarily transmitted via the shedding of the virus via the faecal-
oral route and also via the respiratory route between humans (Li et al., 2013a; Ludlow 
et al., 2016a; Pons-Salort, Parker and Grassly, 2015). However, transmission via 
contact with infected surfaces or fomites can also occur (Solomon et al., 2010). The 
virus replicates in the respiratory and gastrointestinal tract before disseminating to 
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other organs via the bloodstream (Ludlow et al., 2016b). There are over 100 serotypes 
of human enteroviruses which were originally classified into coxsackieviruses A and 
B, echoviruses and polioviruses but are now numbered instead (Solomon et al., 
2010). Enteroviruses exhibit seasonal changes in incidence, predominantly in 
temperate climates with peaks in the summer and early autumn (Pons-Salort, Parker 
and Grassly, 2015).  
 
A number of different enteroviruses can cause an aseptic meningitis or encephalitis 
following compromise of the blood brain barrier facilitating entry to the CNS (Chen et 
al., 2020). However, only enterovirus 71 will be described in detail given its ability to 
cause severe neurological manifestations and hence a public health threat in the Asia-
Pacific region (Chen et al., 2020).  
 
Enterovirus A71 (EV-A71) was first isolated in 1969 in the United States of America 
(USA), though it was likely circulating prior to this (Solomon et al., 2010). The virus is 
found in a number of countries however, it causes cyclical major outbreaks of hand, 
foot and mouth disease (HFMD) in the Asia-Pacific region (Cardosa et al., 2003; 
Solomon et al., 2010; Sabanathan et al., 2014). A number of countries are 
implementing national surveillance and making the pathogen a notifiable disease 
(Solomon et al., 2010). In Japan and Malaysia, outbreaks tend to occur every 2-3 
years which is thought to be due to the presence of a sufficient population of children 
susceptible to infection to sustain transmission (Sabanathan et al., 2014). More 
frequent (annual) epidemics have been seen in China (Xing et al., 2014). 
Seroprevalence of EV-A71 is high amongst neonates however, declines after 
maternal antibody wanes. It then increases with age with a systematic review and 
meta-analysis in China showed that 70% of those at 5 years of age had antibodies 
(Yang et al., 2015a). Similar trends were seen in a study in Thailand with 80% of those 
aged over 6 years having antibodies (Linsuwanon et al., 2014).  
 
Children and infants are most commonly affected with transmission often occurring in 
crowded settings and outbreaks associated with nurseries and primary schools 
(Sabanathan et al., 2014). However, household transmission is also frequent but with 
adults less frequently infected (Chang et al., 2004). The incidence of EV-A71 has 
been shown to correlate with temperature with a study in Taiwan showing an increase 
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in infections at temperatures above 13°C but a decrease at temperatures greater than 
26°C and an increase in incidence with relative humidity (Chang et al., 2012). Similar 
patterns were also seen in the Republic of Korea (Kim et al., 2016).  
 
CLINICAL SYMPTOMS AND SIGNS AND PROGNOSIS 
Those infected with EV-A71 may have a self-limiting illness, may be asymptomatic, 
or may be severely affected and even die (Sabanathan et al., 2014; Solomon et al., 
2010). HFMD is generally a brief and mild illness characterised by fever, oral ulcers 
and papulovesicular rash on the palms and soles (Ooi et al., 2010). A range of 
neurological manifestations can occur with an aseptic meningitis, encephalitis, acute 
flaccid paralysis and encephalomyelitis occurring most commonly. A study conducted 
in Sarawak, Malaysia conducted over several epidemics showed that 10-30% of 
children admitted to hospital with HFMD developed a neurological manifestation with 
62% developing an encephalitis and 36% an aseptic meningitis (Ooi et al., 2010).   
Brainstem encephalitis is the most common neurological complication in children 
(Wang et al., 1999). Those with brainstem involvement tend to develop myoclonic 
jerks however, prolonged and recurrent seizures are less common than in other viral 
encephalitides (Ooi et al., 2010). They may also develop autonomic dysregulation 
with hypertension and tachycardia with some developing pulmonary oedema which is 
thought to be neurogenic (Ooi et al., 2010; Sabanathan et al., 2014). A study from 
Malaysia found that in addition to mouth ulcers and fever, younger age, vomiting, 
breathless, poor urine output and cold limbs were risk factors for CNS manifestations 
(Ooi et al., 2007). A study conducted in Taiwan found that 14.3% of children who had 
brainstem encephalitis had a residual deficit including both cognitive and motor 
defects with cerebellar dysfunction being most common in the latter (Huang et al., 
2006). A separate study also conducted in Taiwan found that at a median follow-up 
of 2.9 years, all patients with an aseptic meningitis made a complete recovery 
however, 20% of those with encephalomyelitis and 64% of those with 
cardiopulmonary failure had unilateral limb weakness and atrophy.  
 
DIAGNOSTICS 
A diagnosis of EV-A71 is confirmed by PCR of a sample from an ulcer, throat or rectal 
swab, serum, urine, vesicular fluid. Virus is detected in only 0-5% of CSF samples in 
those with neurological manifestations. Detection of IgG and IgM antibodies by ELISA 
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is complicated due to cross-reactivity with other enteroviruses, particularly in older 
children (Ooi et al., 2010).  
 
TREATMENTS 
There are no known antivirals which are effective against EV-A71. Intravenous 
immunoglobulin (IVIG) is often used as a treatment of severe EV-A71 and is part of 
the national treatment guidelines in Taiwan and widely used in Vietnam. However, 
trials are needed to determine its efficacy (Ooi et al., 2010; Sabanathan et al., 2014).  
A study with historical controls in Taiwan and one small randomised control trial in 
Vietnam have shown a reduction in mortality of children with pulmonary oedema in 
those treated with the cyclic nucleotide phosphodiesterase inhibitor milrinone 
compared to standard care (Wang et al., 2005; Chi et al., 2013).  
 
CONTROL  
During outbreaks, public health education messages including frequent hand 
washing, disinfecting surfaces and disposal soiled nappies are often implemented 
(Sabanathan et al., 2014). Additionally, social distancing measures such as closing 
school and childcare facilities may be implemented (Sabanathan et al., 2014; Ang et 
al., 2009). Inactivated vaccines have been licensed in China (Mao et al., 2016; Lin, 
Kung and Shih, 2019). Despite a vaccination campaign in 2016-2017 in Beijing, the 
vaccine is not included in the EPI as post-licensure effectiveness is still to be 
determined (Wang et al., 2019) and has not been implemented outside of China 
(Nhan et al., 2018). Vaccine trials have also been undertaken in Taiwan and 
Singapore (Lin, Kung and Shih, 2019).  
 
ENTEROVIRUS 71 AND ITS NEUROLOGICAL MANIFESTATIONS IN 
VIETNAM 
EV-A71 was first isolated in Vietnam in 2003. Prior to this, an increase in viral 
encephalitis amongst those aged less than 4 years and a reduction in cases due to 
JEV was noticed (Van Tu et al., 2007). However, severe epidemics were not seen 
until after 2011. HFMD is a notifiable disease, with hospitals reporting cases on a 
weekly basis (Thao et al., 2017) and a clinical grading system implemented by the 
Ministry of Health used to guide management (Khanh et al., 2012). The outbreak in 
2011 resulted in 113,121 cases and 170 deaths with the majority of both cases and 
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deaths occurring in the southern provinces and deaths in boys aged 3 years or 
younger (Nguyen et al., 2014). Although the virus circulates all year in Vietnam, 
seasonality is seen with peaks from March to May and September to December. 
There are approximately 50,000 to 100,000 cases annually with over 60% occurring 
in southern Vietnam (World health Organization, 2020e). A study conducted in HCMC 
found that 9.3% (n=18) children admitted with encephalitis had an enterovirus of 
whom six had confirmed or probable EV-A71 with a 50% mortality rate. All patients 





TRANSMISSION AND EPIDEMIOLOGY 
S. suis is a gram-positive bacterium and zoonotic pathogen with a natural habitat in 
the gastro-intestinal, respiratory and genital tract of pigs (Nghia et al., 2011).  Humans 
become infected following the consumption of undercooked pig blood or intestine, 
occupational exposure to raw pig products and the preparation of raw pork in the 
presence of skin lesions (Nghia et al., 2011; Huong et al., 2015). Additional risk factors 
for acquisition of the bacteria include being male or consuming excessive amounts of 
alcohol (Nghia et al., 2011; Wertheim et al., 2009b). In pigs, Porcine Respiratory and 
Reproductive Syndrome (PRRS) is associated with secondary bacterial infections 
such as S. suis (Wertheim et al., 2009b). Therefore, living in or adjacent to an area 
with PRRS is also a risk factor for S. suis (Huong et al., 2015). 
 
The prevalence of S. suis is highest in east and southeast Asia with the first reports 
of the pathogen coming from Hong Kong in 1984 (Kay, Cheng and Tse, 1995). 
Awareness of the pathogen increased after an outbreak in China in 2005 (Horby et 
al., 2010; Yu et al., 2006). Although cases are seen in Europe and North America, the 
prevalence is lower and mainly confined to butchers, pig breeders and those working 
in abattoirs (Huong et al., 2014a). There is no clear estimate of the global burden of 
S. suis infection in humans, however a systematic review of 177 publications found 
the cumulative prevalence rate to be highest in Thailand (8.21 cases/million 
population) followed by Vietnam (5.40/million). The pooled mean age of the cases 
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was 51.4 years (95%CI 49.5-53.2%, 8.0% (4.6-13.7%) had diabetes mellitus, and 
meningitis was the main clinical syndrome with a pooled rate of 68.0% (95%CI 58.9%-
75.8%) (Huong et al., 2014a). Again, the global burden of S. suis meningitis is 
unknown however, a separate systematic review and meta-analysis of twenty-four 
studies between 1980 and 2015 identified 913 cases from studies performed in 
Thailand, Vietnam, Hong Kong, the Netherlands, China and Japan. Risk factors for 
meningitis were same as those for acquisition of infection with pathogen (van Samkar 
et al., 2015).  
 
Some studies have suggested a possible temporal pattern of infection of S. suis. 
Higher numbers of patients were admitted to hospitals in China and Thailand during 
the rainy season from June to September  (Wertheim et al., 2009a). In northern 
Vietnam, the incidence has been shown to peak between May and July (Wertheim et 
al., 2009b) However, in southern Vietnam there was no clear effect of seasonality with 
cases occurring throughout the year (Nghia et al., 2011). A further study conducted 
in northern Vietnam suggested that a possible cluster of infections between March 
and August 2010 corresponded with the peak of a PRRS outbreak (Huong et al., 
2016). 
 
CLINICAL SYMPTOMS AND SIGNS AND PROGNOSIS 
After meningitis, the most common clinical syndromes associated with S. suis are 
sepsis, arthritis, endocarditis, and endophthalmitis (Huong et al., 2014).  31% of 
patients have dermatological manifestations including petechiae, purpura and 
ecchymoses, skin necrosis, haemorrhagic bullae and gangrene of the peripheries 
(Wertheim et al., 2009a). A systematic review and meta-analysis of S. suis meningitis 
reported that the most common presentations included fever (97%), headache (95%), 
neck stiffness (93%) and nausea or vomiting (65%). 31% had altered consciousness, 
2.9% died and 64% were left with sequelae with the most common being hearing loss 
(53%)  (van Samkar et al., 2015). This mortality rate is lower than the pooled case-
fatality rate (CFR) from a separate systematic review of all S. suis infections which 
was 12.8% and showed a negative correlation between the CFR and meningitis 
(Huong et al., 2014). Hearing loss is a known outcome of infection with S. suis with 
reported rates varying between 6 and 100% (Huong et al., 2014). A case-control study 
conducted at the National Hospital for Tropical Diseases (NHTD) in Hanoi found 
significantly increased rates of hearing loss and vestibular dysfunction amongst 
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meningitis cases compared to controls at hospital discharge, with an improvement in 
occurring only within the first three months after discharge and vestibular dysfunction 
showing little recovery (Huong et al., 2018). 
 
DIAGNOSTICS 
The pathogen can be cultured from CSF or blood but is often mis-reported as 
alternative Streptococcal species, Enterococcus faecalis or Aerococcus viridans 
(Wertheim et al., 2009a; Donsakul, Dejthevaporn and Witoonpanich, 2003). As 
cultures can be negative if antibiotics have been used prior to admission PCR may 
be a preferable method of diagnosis (Wertheim et al., 2009a). 
 
TREATMENTS 
Empirical treatment of bacterial meningitis with the antibiotic ceftriaxone will 
adequately treat S. suis. Penicillin G has also been used successfully to treat S. suis 
(Wertheim et al., 2009a). Dexamethasone is given to adult patients in southern 
Vietnam who have a short disease onset following a randomised controlled trial which 
found a significant reduction in mortality in those with bacterial meningitis and a lower 
rates of hearing loss in those with S. suis meningitis who were given dexamethasone 
compared to a placebo (Wertheim et al., 2009a).  
 
CONTROL  
There is no vaccine available against S. suis in humans (Wertheim et al., 2009a; 
Hopkins et al., 2019). Autogenous vaccines may be used but the effectiveness is 
unknown (Hopkins et al., 2019; Prufer et al., 2019). Preventative measures therefore 
include hand-washing after or wearing gloves during the handling of raw pork meat. 
It is also advised that pork is cooked thoroughly (Wertheim et al., 2009a).  
 
S. SUIS AND ITS NEUROLOGICAL MANIFESTATIONS IN VIETNAM 
S. suis was detected in Vietnam in 1997. However, national guidelines for diagnosis 
and treatment of the disease were not implemented until 2007 following a report 
identifying S. suis as the most common cause of bacterial meningitis at the National 
Hospital for Tropical Diseases, Hanoi (Horby et al., 2010). Since 2011, S. suis has 
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been a notifiable communicable disease in Vietnam with health facilities required to 
report culture confirmed S. suis within twenty-four hours.  By 2015, over five-hundred 
cases of S. suis had been reported in Vietnam however, this number is likely to be an 
under-estimate of the true burden potentially due to the absence of or underutilisation 
of microbiology in hospital or use of antibiotics prior to admission (Huong et al., 2019). 
Based on modelling approaches, the annual incidence in Vietnam in 2014 was 
estimated to be 0.249 per 100,000 population with a DALY of 1401 (Huong et al., 
2019).  A study conducted in HCMC found that S. suis was the most common 
pathogen causing bacterial meningitis accounting for 33.6% (n=151) of cases 
however, mortality was lower than for other pathogens (CFR=2.6%). There was no 
evidence of clustering of cases in time and place (Mai et al., 2008).  
1.4 PATHOGENS WHICH ARE FOUND IN VIETNAM AND ITS 
NEIGHBOURING COUNTRIES BUT ARE LESS COMMON CAUSES 




VARICELLA ZOSTER VIRUS (VZV) 
Primary disease with VZV causes chickenpox, a disease characterized by fluid-filled 
blisters, fever, fatigue, headache and loss of appetite. The virus transmitted by 
respiratory droplets or direct contact with the blisters of an infected person or if the 
virus particle from the blister becomes airborne (Centers for Disease Control and 
Prevention, 2016). In temperate countries, children are most commonly affected 
whereas in tropical regions infection is less common and may occur at a later age. 
Incidence in temperate climates peaks in the winter, whereas in tropical climates this 
may differ by country. For example, in India, Sri Lanka and Thailand outbreaks are 
more common in the cooler months. However, in Singapore there appears to be no 
seasonal effect (Lee, 1998). Neurological manifestations including a varicella 
cerebellitis may occur with chickenpox, but this is rare. Reactivation of the virus which 
has become latent in the sensory ganglia is known as herpes zoster or shingles and 
is more likely to cause neurological manifestations including meningitis and 
particularly in those who are immunocompromised, encephalitis (Ludlow et al., 
2016b). Studies of adults admitted to hospitals in HCMC and Hanoi with a CNS 
infection, found that 1.7% (n=5) and 1.4% (n=5) had VZV (Tan le et al., 2014; Taylor 
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et al., 2012). A vaccine against VZV has been available since 1974 (World Health 
Organization, 2015c) however, it is recommended mainly higher-income countries 
(Gabutti et al., 2019) and is not part of the EPI in Vietnam (Binh et al., 2013).     
 
CYTOMEGALOVIRUS (CMV) 
CMV is transmitted via bodily fluids with many people becoming infected as children. 
The virus then becomes latent with an ability to reactivate later in life  (Centers for 
Disease Control and Prevention, 2020). A study in Beijing showed no evidence of 
seasonality of acute infection (Chen et al., 2019). Most healthy people have no 
symptoms or only mild symptoms (Centers for Disease Control and Prevention, 2020; 
Pass, 1985; Krishna, Wills and Sinclair, 2019). However, primary infection or 
reactivation during pregnancy can result in congenital CMV which can result in 
neurological sequelae (Lim and Lyall, 2017). Alternatively, CMV-induced neurological 
disorders, including an encephalitis amongst others are most commonly seen in 
immunosuppressed patients as a result of reactivation of the virus (Ludlow et al., 
2016b). In studies conducted in patients with CNS infections in HCMC, only one adult 
and one child had CMV (Tan le et al., 2014).  
 
EPSTEIN-BARR VIRUS (EBV) 
EBV is transmitted via contact with oral secretions. Infants and children are normally 
asymptomatic or have nonspecific symptoms however, adolescents and adults can 
develop an infectious mononucleosis with fever, lymphadenopathy and pharyngitis 
(Cohen, 2000). Studies in the United States have shown no clear evidence of 
seasonality of infection. (Odumade, Hogquist and Balfour, 2011). Neurological 
manifestations of can occur as a result of primary infection, reactivation of the virus 
or a chronic infection and can include a meningitis or encephalitis amongst others 
(Ludlow et al., 2016b). Despite evidence of past infection of EBV in a study of 24 
adults with CNS infection, none had an acute infection (Tan le et al., 2014). There is 
no vaccine against EBV and prevention is through avoiding sharing contact with the 







Measles virus is transmitted between humans via respiratory droplets and is highly 
contagious. Patients have a fever and erythematous maculopapular rash. Since the 
introduction of vaccination there has been a reduction in deaths from measles 
however, cases still remain in countries where vaccine coverage is lower. Despite a 
reduction in cases in Vietnam, outbreaks still occur  (Choisy et al., 2019; Nmor, Thanh 
and Goto, 2011). Annual seasonal peaks are seen in the winter and early spring in 
temperate climates with more irregular cycles seen in tropical regions (Moss, 2017). 
One in 1000 develop an acute demyelinating encephalitis (ADEM) and one in 1700 to 
one in 3300 of those under 5 years of age develop a subacute sclerosing 
panencephalitis (SSPE) 4-10 years after infection (Ludlow et al., 2016a). Cases of 
acute measles encephalitis (AME) have been described during an outbreak of 
measles in 2008 in northern Vietnam (Fox et al., 2013).    
 
MUMPS VIRUS 
Mumps virus is transmitted by respiratory droplets, direct contact  or contaminated 
fomites (Hviid, Rubin and Muhlemann, 2008). Mumps has also been shown to be 
seasonal with the highest incidence in the spring and summertime in Taiwan (Liu et 
al., 1998; Ho et al., 2015). Initial symptoms include fever, malaise, headache and 
parotitis with 1-10% developing a meningitis and 0-1%, an encephalitis (Hviid, Rubin 
and Muhlemann, 2008) Vaccines against mumps exist as monovalent, bivalent (with 
measles) and trivalent (with measles and rubella (MMR)) however, mumps vaccine is 
not part of the EPI in Vietnam (Jit et al., 2015). Mumps virus accounted for 0.7% (n=2) 




Nipah virus is an emerging pathogen which caused an outbreak of severe encephalitis 
in Malaysia from 1998-1999, with many cases occurring in those who had had 
exposure to pigs (Chua et al., 2000). The virus was later isolated in Pteropus bats 
which were found to be a natural host for the pathogen (Chua et al., 2002). During 
outbreaks in Bangladesh, the consumption of date palm sap which had been 
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contaminated with bat excreta was suggested as a potential source of transmission 
of the virus (Islam et al., 2016; Rahman et al., 2012). Seasonality of cases was evident 
with illness onset occurring from December to May coinciding with the harvesting of 
date palm sap (Luby et al., 2009). Evidence of person to person transmission has also 
been shown in outbreaks in West Bengal, India (Chadha et al., 2006); Bangladesh 
(Gurley et al., 2007; Homaira et al., 2010) and Kerala, India  (Chatterjee, 2018). A 
study looking at the seroprevalence of Nipah virus in Vietnam found henipavirus 
antibody in 49.1% of bats specimens from Hoa Binh province in northern Vietnam. 
However, it was thought that ‘Nipah-like’ viruses rather than Nipah or Hendra viruses 
may be circulating in these bat populations given that there were no increases in 
reports of encephalitis where the bats were captured (Hasebe et al., 2012). Nipah 
virus has been found in bats in Cambodia (Cappelle et al., 2020). There are no known 
published reports of Nipah virus in humans in Vietnam. A study conducted in Hanoi, 
tested eighty patients with CNS infections for the virus but none were positive (Taylor 





Rubella is transmitted by respiratory droplets normally affecting children and young 
adults (World Health Organization, 2020i). A mild, self-limiting disease occurs in most 
cases of infection of rubella virus with adults being more likely to develop fever and a 
rash compared to children (Lambert et al., 2015; Banatvala and Brown, 2004). 
However, infection during pregnancy, this can result in miscarriage or congenital 
rubella syndrome (Lambert et al., 2015). A SSPE can occur in those with congenital 
rubella syndrome (Weil et al., 1975; Banatvala and Brown, 2004) and rarely, a 
progressive rubella panencephalitis is seen in older children with congenital rubella 
syndrome or those infected post-natally (Frey, 1997). However, a 
meningoencephalitis can also be seen in young adults (Aguado et al., 1993).  
Outbreaks of rubella were seen frequently in Vietnam however, since 2014, 
vaccination has been included in the routine immunisation programme (Vynnycky et 
al., 2016). A study in Mexico showed evidence of regional differences in seasonality 
however, the effect of seasonality on the virus in Vietnam is unknown (Vynnycky et 
al., 2016; Metcalf et al., 2011). In a study conducted in HCMC between 1996 and 
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2008, 2% of adults (n=6) had a CNS infection due to rubella. However, the authors 
only tested those with a rash and therefore this number is likely to be an 
underestimate (Tan le et al., 2014). Rubella virus was not tested for in other studies 
of the aetiology of CNS infections in Vietnam (Le et al., 2010; Taylor et al., 2012; Ho 




INFLUENZA VIRUS  
Influenza virus typically affects the respiratory system. CNS involvement is the most 
common extra-respiratory complication including encephalitis and meningitis (Ludlow 
et al., 2016b). A study in Japan described most cases being associated with Influenza 
A (Morishima et al., 2002) and in a study of children admitted to a hospital in HCMC, 
Vietnam, there was one case of encephalitis caused by influenza A which was the 
highly pathogenic influenza A (H5N1) (Le et al., 2010; de Jong et al., 2005). A study 
of adults admitted to a hospital in HCMC with CNS infections found that none were 
caused by Influenza A or B (Tan le et al., 2014). Influenza A peaks in the winter in 
temperate regions when there is a reduction in absolute humidity (Shaman and Kohn, 
2009). However, in tropical climates such as Vietnam, influenza-like illness and 
absolute humidity are positively correlated (Thai et al., 2015). A seasonal influenza 
vaccine against the strain A/H1N1, A/H3N2 and B was licensed in Vietnam in 2019 




ZIKA VIRUS (ZIKV) 
ZIKV is transmitted via the bite of infected Aedes mosquitoes however, humans can 
be infected via other routes (Petersen, Jamieson and Honein, 2016). These include 
vertical transmission during pregnancy (Calvet et al., 2016), sexual transmission 
(Davidson et al., 2016; Moreira et al., 2017) and through the transfusion of blood 
products or organ transplantation (Motta et al., 2016; Williamson et al., 2017; 
Nogueira et al., 2017). 
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The first confirmed human infection occurred in 1962 in Uganda with a few cases 
occurring Sub-Saharan Africa and Southeast Asia since (Baud et al., 2017) and 
outbreaks in the western Pacific in 2007 (Duffy et al., 2009) and 2013 (Musso, Nilles 
and Cao-Lormeau, 2014). An epidemic in Brazil in 2015 spread through Latin America 
and the Caribbean with outbreaks also occurring in Cape Verde, Singapore and 
Florida (Baud et al., 2017).  Modelling has suggested that the transmission of the virus 
is driven by the climatic conditions caused by El Niño and that seasonality depends 
on the region in world. For example in South America, peaks in the reproduction ratio 
are seen in the winter and spring and in Asia, the summer and autumn (Caminade et 
al., 2017). 
An association between infection during pregnancy, particularly during the first 
trimester, and subsequent microcephaly in infants, has been shown in Brazil and 
French Polynesia where ZIKV outbreaks coincided with an increase in congenital 
CNS malformations (Cauchemez et al., 2016; de Araujo et al., 2016; Kleber de 
Oliveira et al., 2016). There have also been case reports of encephalitis in adults 
which are secondary to ZIKV (Soares et al., 2016; Ugarte et al., 2017; Mehta et al., 
2018). Since 2016, cases of ZIKV have been were reported in central and southern 
Vietnam and in travellers returning from Vietnam (Bui et al., 2018; Chu, Ngoc and 
Tao, 2017; Hashimoto et al., 2017). One case of microcephaly occurred in Dack Lak 
province in the Central Highlands  (Moi et al., 2017). However, serological evidence 
suggests that ZIKV was circulating at very low levels in southern Vietnam in 2013 
(Quyen et al., 2017) and neutralising antibodies against ZIKV were found in northern 
Vietnam in 1954 (Pond, 1963). There are no known published reports of Zika 





Rabies virus is normally transmitted via the saliva of an infected animal through 
contamination of a wound (e.g. bite or scratch) or mucus membrane. The virus can 
be carried either by a carnivore (known as terrestrial rabies) or bat (bat rabies) and 
95% of cases occur in Asia and Africa (World Health Organization, 2018d). A study 
in in Lao PDR showed that the number of cases of rabies in dogs was higher during 
the dry season which corresponded with other studies showing increases in the 
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number of cases in the spring to coincide with increased contact between animals 
(Douangngeun et al., 2017). 
 
80% of cases of rabies present in an encephalitic form including autonomic 
dysfunction, hydrophobia, hyperexcitability and aerophobia (Leung, Davies and Hon, 
2007). Pre and/or post-exposure vaccination and post exposure immunoglobulin are 
used to prevent rabies in humans (World Health Organization, 2018e) however, 
without these the disease is fatal (Jackson et al., 2003). Post-exposure prophylaxis is 
available in Vietnam (Nguyen et al., 2018) however, the virus still kills more than 





S. pneumoniae, a Gram-positive bacterium asymptomatically colonises the upper 
respiratory tract. It can result in an acute otitis media or pneumonia if it infects the 
middle-ear space and terminal airways respectively. It is transmitted between humans 
via contact with infected secretions with strains carried for weeks to months before 
being cleared (Kadioglu et al., 2008). A study conducted on the Thailand-Myanmar 
border found that transmissibility of the virus in infants was highest during the cool 
and dry months (Numminen et al., 2015). Those at highest risk of invasive disease 
include young children and those aged over 50 years, those with underlying medical 
conditions and use of drugs which compromise the immune system or those with 
damage to the naso and oropharyngeal mucosae for example due to a viral infection 
or local pneumococcal infection (Mook-Kanamori et al., 2011). A prospective case 
series of adults with pneumococcal meningitis in the Netherlands found that 84% had 
a headache, 81% neck stiffness, 84% a fever and 85%, an altered mental state with 
a 30% CRF (Weisfelt et al., 2006). Since 2009, polysaccharide-protein conjugate 
vaccines have been on the market and the WHO recommend the use of 
pneumococcal vaccines (PCV) in childhood immunisation programmes globally  
(World Health Organization, 2019g). The PCV has not yet been introduced in Vietnam 
(Le Polain De Waroux et al., 2018). S. pneumoniae accounted for 6% (n=35) of CNS 
infections in adults and 6% (n=37) of children in a multi-centre study in Vietnam (Ho 
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N. meningitidis is a Gram-negative bacteria which is a commensal in the nasopharynx 
of humans and is transmitted by aerosol or secretions (Rosenstein et al., 2001) 
particularly during mass gatherings (World Health Organization, 2018c). Meningitis 
occurs when the bacteria spread to the CNS with young children and young adults 
most commonly affected (World Health Organization, 2018c). Symptoms include 
headache, fever and neck stiffness, with nausea, vomiting, photophobia and altered 
mental status occurring on occasion and in some cases, a meningococcal 
septicaemia with a petechial or purpuric rash  (Rosenstein et al., 2001). There are 
twelve serogroups of which six cause epidemics (A, B, C, W, X and Y). The largest 
burden of disease occurs in the meningitis belt in sub-Saharan Africa during the dry 
season from December to June. CFR in treated patients is 8-15%, rising to 50% in 
those untreated. Vaccines against serogroups A, C, W and Y are available and used 
both as part of routine immunisation schedules and during outbreaks with conjugate 
vaccines used in the former and polysaccharide in the latter. Vaccination against 
serogroup B is generally used during outbreaks. Antibiotics chemoprophylaxis may 
also be given to close contacts of cases (World Health Organization, 2018c). In 
Vietnam which has suffered a number of epidemics of meningococcal disease there 
is a requirement to notify all cases however, only a polysaccharide vaccine is available 
(Phan et al., 2019). N. meningitidis was the cause of CNS infections in 0.6% (n=4) of 
adults and 1% of (n=6) children in the study by Ho Dang Trung et al., 2012 and 0.6% 
of adults (n=2) in the study by Taylor et al., 2012.  
 
HAEMOPHILUS INFLUENZAE TYPE B 
H. influenzae type b (Hib) is a Gram-negative bacterium (Robbins et al., 1973). It is 
transmitted via oral and respiratory secretions (Murphy et al., 1989) with invasive 
disease including meningitis mainly occurring in children. A study in Taiwan found that 
most cases of Hib meningitis occurred during the winter months (Shao et al., 2004). 
Incidence has reduced globally greatly since the introduction of vaccination (World 
Health Organization, 2020d). The Hib vaccine was initiated in 2010 in Vietnam (Le et 
al., 2015). Despite this, in the study by Ho Dang Trung et al. 2012 Hib was the most 
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common pathogen in children less than one year old (n=27, 41%) and accounted for 
6% (n=39) of all infections in children. No infections were seen in adults. 
 
MYCOBACTERIUM TUBERCULOSIS (MTB) 
MTB is an intracellular bacteria transmitted via aerosolised droplets which can affect 
many organ but is primarily causes a pulmonary disease (tuberculosis (TB)) (Smith, 
2003). Millions of people are infected with MTB every year with the highest burden in 
Asia and Africa (World Health Organization, 2020j). Peaks in incidence of TB are seen 
in northern Vietnam in the summer months with an association between sunlight and 
TB incidence at a lag of 6 months which has been seen in other countries (Bonell et 
al., 2020).  
 
1% of cases are tuberculous meningitis (TBM), with patients often presenting with a 
subacute meningitis starting with a low-grade fever and headache (Thwaites, van 
Toorn and Schoeman, 2013). TBM is thought to account for more than 100,000 new 
cases per year globally with a CFR of nearly 50% (Wilkinson et al., 2017). The Bacillus 
Calmette-Guérin (BCG) vaccine has been shown to be efficacious in preventing 
childhood MTB (Trunz, Fine and Dye, 2006). The use of the BCG vaccine in the 
prevention of MTB in adults in unknown (Brancusi, Farrar and Heemskerk, 2012).  In 
the study by Ho Dang Trung et al, 2012 MTB accounted for 5% (n=34) cases of CNS 
infections in adults and 2% (n=11) in children. In the study by Taylor et al., 2012 it 
accounted for 3% of the cases (n=9).  
 
LEPTOSPIRA SPECIES 
Leptospirosis, caused by the spirochaete Leptospira is a zoonotic disease. The 
pathogen is transmitted to humans via the urine of infected mammals, particularly 
rodents (Adler and de la Pena Moctezuma, 2010). The geographical distribution of 
leptospirosis is broad (Costa et al., 2015) however, it has more recently emerged in 
Thailand (Wuthiekanun et al., 2007) and Sri Lanka (Agampodi, Peacock and 
Thevanesam, 2009). Those who are resource-poor, including farmers from tropical 
regions are particularly at risk as are those who come into contact with animal 
reservoirs or contaminated environments (Costa et al., 2015). However, epidemics 
are also reported in urban slums which provide environmental conditions for rodents 
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(Felzemburgh et al., 2014; Ko et al., 1999). Leptospirosis case numbers have been 
shown to positively correlate with rainfall in Thailand (Chadsuthi et al., 2012) however, 
this is not always the case, as was demonstrated in Lao PDR (Dittrich et al., 2015). 
The clinical manifestations of leptospirosis typically include fever, headache, myalgia, 
conjunctivitis and occasionally, a rash. Severe cases may result in renal failure which 
may be accompanied by hepatic failure and/or pulmonary haemorrhage (Adler and 
de la Pena Moctezuma, 2010; Costa et al., 2015). CNS manifestations of leptospirosis 
have been reported in studies in Brazil and the Philippines (Romero, Blanco and 
Yasuda, 2010; Watt, Manaloto and Hayes, 1989) and accounted for 12% of adults 
and children in Lao PDR in whom a lumbar puncture was taken (Dittrich et al., 2015). 
Of these patients, 45% had a meningoencephalitis, 23% meningitis without AES and 
7% AES without meningitis (Dittrich et al., 2015). A study in southern Vietnam found 
a seroprevalence of leptospirosis in 12.8% of children (Thai et al., 2006) and a study 
in the Mekong Delta found a seroprevalence of 18.8% in those aged 15-60 years (Van 
et al., 1998). However, the contribution of leptospirosis to CNS infections in Vietnam 
is unknown possibly because the pathogen is not frequently tested for. 
 
RICKETTSIA TYPHI 
Murine typhus caused by R. typhi, is transmitted through the faeces of infected fleas, 
either through bites to or an abrasion of the skin or via mucous membranes or he 
conjunctiva  (Azad, 1990; Gasem et al., 2009). The rodents, on which the fleas live, 
provide a reservoir (Azad, 1990).  Although many patients present with fever, murine 
typhus can also cause a meningoencephalitis and contributed to up to 11% of cases 
of suspected CNS infection in a study in Laos (Dittrich et al., 2015). Unlike scrub 
typhus, cases of murine typhus normally occur in urban areas (Vallee et al., 2010; 
Hamaguchi et al., 2015a) and a study in Lao PDR showed no effect of seasonality 
(Dittrich et al., 2015). A study conducted in northern Vietnam found evidence of 
murine typhus in one-third (n=193) of patients with suspected rickettsiosis with 52.9% 
living in Hanoi and 72% being male (Hamaguchi et al., 2015a). The contribution of R. 





1.5 PATHOGENS WHICH ARE NOT KNOWN TO BE FOUND IN 
VIETNAM OR ITS NEIGHBOURING COUNTRIES BUT ARE 
PARTICULARLY IMPORTANT CAUSES OF CNS INFECTIONS 
GLOBALLY 
	
CHIKUNGUNYA VIRUS (CHIKV) 
CHIKV is an alphavirus of the family Togoviridae. It is transmitted to human by the 
bites of infected Aedes mosquitoes (Pialoux et al., 2007). The first outbreak was 
reported in Tanzania from 1952-1953 (Robinson, 1955) followed by a large outbreak 
in India in 1964 (Myers et al., 1965) and Thailand (Halstead et al., 1969). However, 
since 2004 there has been an ongoing global epidemic in tropical and sub-tropical 
areas (Petersen and Powers, 2016). CHIKV also shares similar symptoms and signs 
with DENV including fever, myalgia, headache and rash. However, those with CHIKV 
are more likely to suffer from arthralgia (Staples, Breiman and Powers, 2009). Despite 
usually being a self-limiting illness, severe infection can occur with multi-system 
complications (Tandale et al., 2009). Cases of CHIKV encephalitis have been 
described from La Réunion Island (Gerardin et al., 2016), Tonga (Nelson et al., 2014) 
and Brazil (Pereira et al., 2017). A recent seroprevalence study conducted in Vietnam 
showed evidence of previous CHIKV transmission in central and southern Vietnam 
but no evidence of sustained transmission (Quan et al., 2018). In a similar way to 
DENV, CHIKV also shows seasonality with transmission rates increasing in warmer 
and wetter weather (Johansson, 2015). 
 
TICK-BORNE ENCEPHALITIS VIRUS (TBEV) 
TBEV, a flavivirus is found throughout Asia and Europe and is maintained in an 
enzootic cycle between wild mammalian hosts such as rodents and Ixodid ticks 
(Charrel et al., 2004; Ludlow et al., 2016a; Wengler, Wengler and Gross, 1978; Mandl 
et al., 1997). The infected tick transmits the virus whilst feeding on the host (Mansfield 
et al., 2009) with the rodent host acting as a reservoir for the virus but also amplifying 
it (Suss, 2003) whereas humans and larger mammals such as deer and horses are a 
dead-end hosts (Mansfield et al., 2009; Gritsun, Lashkevich and Gould, 2003). In 
addition to being infected via the bite of a tick, humans can also become infected via 
consumption of unpasteurized milk (Dumpis, Crook and Oksi, 1999; Ludlow et al., 
2016a). An increase in the number of cases of tick-borne encephalitis in Europe and 
Russia is thought to be due to a combination of climate change with the ticks moving 
to higher altitudes and latitudes and socio-political changes (Suss, 2008; Suss, 2011). 
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In Europe tick activity peaks from April until July (Randolph et al., 2000) with cases of 
tick-borne encephalitis (TBE) seen in the summer months (Rezza et al., 2015). 70% 
of infections are asymptomatic with a few developing a flu-like illness and of these, 
some progressing to a meningitis, encephalitis or meningoencephalitis (Ludlow et al., 
2016b). 
 
WEST NILE VIRUS (WNV) 
West Nile virus (WNV) is a flavivirus transmitted in an enzootic cycle between birds 
by Culex mosquitoes, transmitted to and other mammals through mosquito bites 
(Petersen, Brault and Nasci, 2013). The first described case occurred in Uganda in 
1937 (Hayes, 2001). Epidemics of WNV which occurred in north America are thought 
to be influenced by the accumulation of ground water which provided breeding sites 
for the mosquitoes (Shaman, Day and Komar, 2010). 1 in 140 develop an encephalitis 
or meningitis with incidence higher in the elderly population (Ludlow et al., 2016b). 
 
1.6 NON-INFECTIOUS CAUSES OF CNS INFECTIONS 
	
AUTOIMMUNE 
A multicentre study in England found that 21% of patient with encephalitis (n=42) had 
an acute immune-mediated encephalitis. Of these, twenty-three had an ADEM, nine 
had antibodies against the N-Methyl D-Aspartate (NMDA) receptor, seven antibodies 
against voltage-gated potassium channels (VGKC) and the remaining were 
secondary to systemic vasculitis, multiple sclerosis or paraneoplastic (Granerod et al., 
2010a). ADEM normally occurs following a viral infection or vaccination, more 
commonly in children, which results in demyelination involving the brain and spinal 
cord (Tenembaum, 2013). A study in the US showed that more cases occurred in the 
winter and spring (Murthy et al., 2002).  
Patients with anti-NMDA receptor encephalitis typically present with headache, fever 
and psychiatric symptoms such as agitation, paranoia and hallucinations. A number 
also develop seizures and a reduction in conscious level (Dalmau et al., 2008). 
Women account for approximately 80% of cases of whom around half have an 
underlying tumour which is frequently an ovarian teratoma (Kayser and Dalmau, 
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2011). A study in the US found that 78% of paediatric cases of anti-NMDA receptor 
encephalitis occurred from April-September.  
Anti-VGKC encephalitis has since been divided in three categories. Those with 
leucine-rich glioma-inactivated1 (LGI1) antibodies often present with a limbic 
encephalitis with hyponatraemia and seizures whereas those with contactin-
associated protein like 2 (Caspr2) may also have a limbic encephalitis but 
hyponatremia is rare. In both cases, patients are more likely to be male and of and 
older age. However, in the third group which are LGI1 and Caspr2 negative, half are 
male, all ages are affected, and presentation may include psychiatric symptoms, pain 
syndrome and cognitive decline (van Sonderen et al., 2016).  
In a study conducted in the Hospital for Tropical Diseases, HCMC over a period of 
eighteen months, twenty-four patients met the inclusion criteria for autoimmune 
encephalitis out of ninety-nine admitted with all-cause encephalitis. Nine patients 
tested positive for anti-NMDA receptor encephalitis. The median age of patients was 
28 and 55.6% were female. All had prior admission to a mental health hospital, two 
had fever and seven had seizures. The authors suggested that this was an important 
differential diagnosis in patients admitted to hospital with encephalitis in Vietnam (Yen 
et al., 2010) .  
 
LYCHEE TOXICITY 
Encephalitis thought to be related to harvesting lychees in May-July has been 
described in children in northern Vietnam where incidence of AES was independently 
associated with the proportion of lychee plantation surface (Paireau et al., 2012b). A 
case-control study was conducted in northern India where an increased incidence of 
a neurological syndrome coincided with the lychee harvesting season. The study 
found that those who had eaten lychees were at higher odds of having an 
encephalopathy compared to those who had not and this effect was increased in 
those who had not consumed an evening meal. The encephalopathy was thought to 
be due to the effect of the hypoglycin A or methylenecyclopropylglycine (MCPG) 




1.7 SUMMARY  
There are multiple causes of CNS infections globally which are both infectious and 
non-infectious. This review gives an overview of the most common causes in Vietnam 
and neighbouring countries including Cambodia, Thailand and Lao PDR. Although 
clinical symptoms and signs may overlap, the epidemiology of the aetiologies differs 
greatly. Some pathogens are transmitted by mosquitoes and other arthropod vectors, 
with incidence showing seasonal patterns, some have a zoonotic reservoir and others 
are transmitting only from human to human. There is variation in the age distribution 
of cases and risk factors for acquisition of the pathogen. The aetiology remains 
unknown in many cases however, by understanding this epidemiology, we can start 
to consider the potential pathogens which may contribute to these cases which will 
















CHAPTER 2 THE SPATIO-TEMPORAL DISTRIBUTION 
OF AND RISK FACTORS ASSOCIATED WITH AES AND 


























Spatial epidemiology is defined as “the description and analysis of geographic 
variations in disease with respect to demographic, environmental, behavioural, 
socioeconomic, genetic and infectious risk factors” (Elliott and Wartenberg, 2004). In 
addition to considering place, the epidemiology of diseases also often considers time, 
referred to as spatio-temporal epidemiology (Waller and Gotway, 2004; Meliker and 
Sloan, 2011). Spatial statistics uses Tobler’s First Law of geography “everything is 
related to everything else, but near things are more related than distant things'' 
(Tobler, 1970). This defines ‘spatial autocorrelation’ where pairs of spatially close 
observations are more similar than those which are far apart. The presence of spatial 
correlation in the residual of a model is a risk for the under-estimation of standard 
errors and too narrow CIs, thereby giving misleading results (Mohebbi, Wolfe and 
Jolley, 2011; Saas and Gosselin, 2014).	
 
SPATIAL SCALES 
Spatial models may use data from different scales (Meliker and Sloan, 2011). This 
might include data which are aggregated into units such as administrative zones 
(Bivand, Pebesma and Gómez-Rubio, 2013; Meliker and Sloan, 2011). The 
components of spatial data which have distinct properties and locations are referred 
to as ‘features’ where an administrative zone would be an ‘area’, the geographic 
location of a house, a ‘point’ and roads, a ‘line’ (Waller and Gotway, 2004). Where 
data is missing, the value may be obtained using measurements from surrounding 
locations, a process known as interpolation. A number of methods exist for 
interpolation with the most common including inverse-distance interpolation and 







SOURCES OF SPATIAL DATA 
Spatial data may be obtained from a variety of sources. Health data may come from 
notifiable disease surveillance systems, disease registries, death certificates and 
health surveys (Waller and Gotway, 2004). However, to predict where and when 
disease, or the potential for disease may occur, we may need to include explanatory 
variables such as environmental factors including temperature, precipitation or land 
use which may influence the survival of, for example, mosquito vectors (Ostfeld, Glass 
and Keesing, 2005; Keiser et al., 2005). These may include remotely sensed data 
from satellite images, environmental and natural resource data such as air and water 
quality and climate and census data relating to counts of the population and housing 
(Waller and Gotway, 2004).  
 
SPATIO-TEMPORAL DYNAMICS 
Dynamic maps can be used to describe spatial patterns of disease over time, for 
example, how the incidence of disease changes within regions and where there may 
be disease hotspots (Meliker and Sloan, 2011). However, analytical methods may be 
used to investigate the spread of infection, known as “spatio-temporal dynamics” 
which can help to guide disease control interventions (Bayles et al., 2017). Whilst not 
specific to spatio-temporal dynamics, these might be divided into statistical models, 
mathematical or mechanistic models and empirical or machine learning-based 
models. Statistical models might include regression (frequentist and Bayesian) and 
time series (Siettos and Russo, 2013, Lessler et al., 2016, Aswi et al., 2018, 
Raghavan et al., 2014).	Wavelet analysis is one form of time series analysis used to 
characterise the periodicity of non-stationary epidemiological time series	 (Grenfell, 
Bjornstad and Kappey, 2001) allowing it to detect sudden changes in periodic patterns 
of time series (Cazelles, Cazelles and Chavez, 2014). Examples of wavelet analysis 
include the evaluation of change in the periodicity of incidence of DENV in time and 
space and also	 its relationship with climate and the El Niño-Southern Oscillation 
(ENSO) (Thai et al., 2010); the seasonality of influenza in Uganda (Yang et al., 2018) 
and Brazil (Alonso et al., 2007) and the movement of measles epidemics from urban 
to rural areas in United Kingdom in the 1950s and 60s areas (Grenfell, Bjornstad and 
Kappey, 2001). Mathematical models commonly include the deterministic or 
stochastic susceptible-infectious-recovered (SIR) model or other variations of it such 
as the susceptible-exposed-infectious-recovered (SEIR) model. Examples of these 
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models have been used to predict the transmission of, most recently, SARS-CoV-2  
(Kucharski et al., 2020) but also severe acute respiratory syndrome (SARS) (Riley et 
al., 2003) and measles (Becker et al., 2016). Other mathematical models include 
individual-based models (IBMs) such as agent-based models (ABMs) which have 
been used to look at the effect of social mixing patterns and mobility on vaccine-
preventable diseases and how those might, for example, affect vaccination 
programmes (Willem et al., 2017). Other examples of mathematical models used in 
infectious disease dynamics include complex networks and stochastic Markov Chain 
(Siettos and Russo, 2013). Finally, machine learning-based models might include 
web-based data mining or surveillance networks (Siettos and Russo, 2013). An 
example of a machine learning method includes the use of search queries on the 
Google platform to detect symptoms of influenza to detect an early epidemic 
(Ginsberg et al., 2009).   
   
REGRESSION MODELS   
Regression models which are used for non-spatial data such as logistic, linear and 
Poisson regression can be applied to spatial analysis provided these take into account 
spatial autocorrelation if this demonstrated in the residuals. As health data normally 
includes counts, or the presence or absence of a disease, Poisson or negative 
binomial or logistic regression may be used respectively. In a paper by Saas and 
Gosselin (2014) which compared regression methods for spatially autocorrelated 
count data found that non-spatial Poisson generalised linear models (GLMs) 
performed the worst with generalised linear mixed models (GLMMs) and generalised 
additive mixed models (GAMMs) with independent location-specific random effects 
and quasi-Poisson non-spatial GLMs showing a better fit however, the optimal models 
are those which had spatially-structured location-specific random effects. The spatial 
dependencies in these models included neighbourhood-based correlated random 
effects or distance-based random effects (Saas and Gosselin, 2014). The GLMM and 
GAMM can include Gaussian random effects however, these may not allow for 
hierarchical structure (Waller and Gotway, 2004). Instead, methods used in Bayesian 
statistics can be applied such as Markov chain Monte Carlo (MCMC) algorithms and 
Integrated Nested Laplace Approximation (INLA) with the latter being computationally 





The analysis of spatial point patterns is used to identify locations where there may be 
clusters of e.g. cases with a particular disease (Waller and Gotway, 2004). This is 
particularly important in detecting outbreaks (Unkel et al., 2012) but also used to 
understand the spatio-temporal transmission of disease (Ruiz-Moreno et al., 2010). A 
common method for determining clusters is the kernel density estimation which either 
estimates a ‘density function’ (the probability of observing an event at a location) or   
the probability of the number of events expected per unit area at a location (the 
‘intensity function’). Other methods for detecting clusters include Poisson cluster 
processes, Cox processes and contagion/inhibition processes (Waller and Gotway, 
2004).  
 
THE SPATIO-TEMPORAL MODELLING OF CNS INFECTIONS 
The spatio-temporal modelling of CNS infections can be used to help guide where 
and when to implement disease prevention strategies and allocate public health and 
diagnostic resources. Examples of these studies are given below. 
 
Data from JE cases in Nepal, confirmed using an anti-JE IgM antibody capture ELISA 
was obtained from the AES surveillance unit of the WHO Programme for 
Immunization Preventable Disease (IPD). This was used to determine the temporal 
pattern and geographic distribution of cases including where there was evidence of 
clustering. Spatial interpolation of the incidence of JE in each district was performed 
using an inverse distance weighing (IDW) method. The IDW method creates a 
smoothed surface which gives increased weighting to closer locations. Spatial 
autocorrelation was assessed using Moran’s Index with maps showing clusters of 
high and low incidence of JE based on Local Indicators of Spatial Autocorrelation 
(LISA). High-high incidence clusters (where the surrounding areas had a similarly high 
incidence) and were found in the Terai region, southern Nepal with low-low incidence 
clusters (those where the surrounding areas also had a low incidence) in the 
mountainous districts in the northwest (Kumar Pant et al., 2017). A separate study, 
also conducted in Nepal, used surveillance data to compare the spatio-temporal 
dynamics of non-JE AES, JE and an unknown viral encephalopathy. In addition to 
comparing the spatial and temporal patterns of the groups, geographically weighted 
regression models were used to show associations of JE and AES with landscape 
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variables. Irrigated land was positively associated with JE and AES and forest, 
negatively (Robertson et al., 2013).  
 
Many of the spatio-temporal studies of meningitis originate in sub-Saharan Africa. A 
study conducted in Niger evaluated spatial and spatio-temporal clustering of 
meningococcal meningitis from 2002 to 2009. The authors initially looked for the 
presence of geographical clusters occurring within the same year. The Anselin’s Local 
Moran’s I test was used to determine spatial autocorrelation between each health 
centre catchment area (HCCA) and its neighbours which were classified as high-high 
(high incidence HCCA surrounded by high incidence rate HCCAs) and high-low (high 
incidence HCCA surround by low incidence rate HCCAs).   
 
The Kulldorff’s spatial scan statistic using the SaTScan software was then used to 
detect clusters of cases of meningococcal meningitis situated together in space and 
time whilst using the alert threshold for epidemic detection based on the number of 
cases per 100,000 inhabitants. It was found that most clusters occurred the in the 
southern districts with epidemics occurring in different HCCAs each year (Paireau et 
al., 2012a). In a separate study of meningococcal meningitis conducted in Nigeria and 
Niger between 2013 and 2017, the Global Moran’s I statistic and Anselin’s local 
Moran’s I to locate clusters to inform the vaccination policy used to manage outbreaks. 
There was evidence clustering of high incidence of meningococcal meningitis in 
different districts each year but the authors suggested that there was no need to 
change their response methods to epidemics for example by lowering the incidence 
threshold for reporting or vaccinating neighbouring districts (Cooper et al., 2019). 
 
A number of epidemiological studies have been conducted which describe the spatio-
temporal distribution of CNS infections in Vietnam. Yen et al., 2010 analysed national 
surveillance data from 1998 to 2007. Temporal differences were seen between 
different regions with evidence of seasonality in northern but not southern Vietnam 
with peaks in incidence in the summer months in northern Vietnam. Mean annual 
incidence of AES was highest in the provinces of Lai Chau, Son La, Dien Bien, Bac 
Giang and Lang Son in northern Vietnam and Binh Duong and Bac Lieu in southern 
Vietnam. In 2004-2005, five provinces in northern Vietnam: Bac Giang, Hai Duong, 
Hai Phong, Thai Binh and Thanh Hoa also conducted testing for anti-JEV IgM in sixty 
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percent of cases. It was unknown how these cases were selected however, 52% were 
positive for JEV ranging from 17% in Bac Giang to 71% in Thai Binh. 
 
A study conducted in three central hospitals in HCMC from 2005-2015 found used 
GAMM to examine the spatio-temporal distribution and risk factors for paediatric CNS 
infections excluding TBM as defined by ICD-10 criteria. Data from 9469 cases showed 
that the highest incidences of both presumed bacterial and non-bacterial infection (BI 
and non-BI, respectively) were seen in the urban districts close to the hospitals but 
also some districts further away. Incidence of bacterial infections was highest in the 
dry season from December to April with a relatively strong positive association with a 
one-month lag in temperature (RR=1.73, 95%CI 1.22-2.45 and RR=2.83, 95%CI 
1.77-4.53, respectively). However, positive associations were also seen between BI 
and the average monthly rainfall (RR=1.04, 95%CI 1.01-1.06) and between non-BI 
and rainfall at lags of 1 and 3 months (RR=1.05, 95%CI 1.02-1.09 and RR=0.96, 
95%CI 0.93-0.99, respectively). The authors suggested that the findings may explain 
the smaller peak of BI during the later months of the rainy season but do not comment 
on the non-BI (Ho et al., 2017). 
 
THE SURVEILLANCE OF COMMUNICABLE DISEASES 
Public health surveillance is defined as the ‘ongoing systematic collection, collation, 
analysis and interpretation of data and dissemination in order for action to be taken’. 
It is serves as an early warning system to identify public health emergencies, to guide 
public health policy and to understand the impact of an intervention towards public 
health goals (World Health Organization, 2019d). Different types of surveillance 
include national active surveillance (accelerated disease control), passive 
surveillance and sentinel surveillance (World Health Organization, 2019a). Visiting 
health facilities to review medical records and talk to health-care providers is defined 
as active surveillance and is normally used when a disease is a target for elimination 
or eradication (World Health Organization, 2019b). The notification of cases from 
healthcare providers including healthcare centres and laboratories to a higher 
administrative level is passive surveillance (World Health Organization, 2019c). 
Sentinel surveillance requires selected units to report cases of specific diseases 
which may not be detected using the WHO passive system. This requires a high-
quality diagnostic laboratory (World Health Organization, 2019e). 
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THE SURVEILLANCE OF COMMUNICABLE DISEASES IN VIETNAM 
The General Department of Preventive Medicine (GDPM), a department of the 
Ministry of Health (MoH), Vietnam conducts a number of activities including the 
prevention and control of communicable diseases and diseases of unknown cause 
(Ministry of Health Viet Nam, 2018). The surveillance system for notifiable diseases 
was set up in 1979 and became web-based in 2009 (personal communication, Marc 
Choisy). There are currently fifty-seven notifiable diseases (Vietnam General 
Department of Preventive Medicine, 2016) which hospitals and clinics need to be 
report within twenty-four hours to the provincial preventive medicine centres (PMCs). 
The PMCs then report these on either a daily, weekly or monthly basis to the GDPM 
depending on the disease  (Binh et al., 2013; Phung et al., 2018). In addition to the 
known pathogens, severe viral respiratory infections and dangerous emerging 
diseases of unknown cause must also be reported (Binh et al., 2013). Sentinel site 
surveillance is undertaken for pathogens including rotavirus (Van Man et al., 2005); 
influenza virus (Nguyen et al., 2009) and JEV (Yen et al., 2010).  
 
THE SURVEILLANCE OF AES IN VIETNAM 
AES is one of the notifiable diseases in Vietnam and for reporting purposes, is called 
‘viral encephalitis’. It is defined clinically as “Fever great than 38°C and a change in 
mental status, seizures, abnormal movements, tremor or spastic paralysis”. The 
district health centres reported the number of cases and deaths of AES on a weekly 
basis to the provincial health authorities who then report these to the regional 
surveillance centres (northern, central, central highlands and southern) on a monthly 
basis. The regional surveillance centres then report cases and deaths to the National 
Institute of Hygiene and Epidemiology (NIHE) and the GPDM annually (Yen et al., 
2010). The GDPM reports to do not include the aetiology of AES however, sentinel 
site surveillance for meningoencephalitis in children aged 15 years and younger exists 
at two hospitals: the National Children’s Hospital in Hanoi and the Children’s Hospital 
No.1 in Ho Chi Minh City. The case definition for suspected meningoencephalitis (ME) 
includes: a sudden onset of fever (≥38ºC), headache, seizures, vomiting, altered 
consciousness, a change in behaviour, neck stiffness, a bulging fontanel (in infants 
less than 12 months of age) and also atypical signs in infants such as “poor sucking” 
and “not doing well” (WHO, personal communication). Cases of suspected ME are 
tested for anti-JEV IgM using enzyme-linked immunosorbent assays.  
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THE SURVEILLANCE OF MENINGITIS IN VIETNAM 
The case definition for meningococcal meningitis in Vietnam is “the sudden onset of 
high fever, severe headache, nausea and vomiting and a stiff neck with possible 
haemorrhagic lesions” and viral meningitis “a sudden onset of high fever (39-40ºC), 
headache, disorderly movement and confusion (Binh et al., 2013). The sentinel site 
surveillance for meningoencephalitis defines cases of probable bacterial meningitis 
as children less than 5 years old with more than one of the following cerebrospinal 
fluid findings: appearance turbid or cloudy; white blood cell count >100/mm3; white 
blood cell count 10-100/mm3 and protein>100mg/dl; WBC 10-100/mm3 and 
Glucose<40mg/dl. Confirmed bacterial meningitis is defined as a case of probable 
bacterial meningitis with the following laboratory findings: H. influenzae, S. 
pneumoniae, or N. meningitidis isolated in the CSF by bacterial culture, latex 
agglutination or PCR; or S. pneumoniae positive by the Binax immuno-
chromatographic test for the presence of the antigen. 
 
THE SPATIO-TEMPORAL DISTRIBUTION OF CNS INFECTIONS IN 
VIETNAM 
 
JUSTIFICATION FOR THE RESEARCH AND QUESTIONS TO BE 
ADDRESSED 
A number of studies describe the spatio-temporal distribution of CNS infections in 
Vietnam however, none have used the most recent national surveillance data. 
Additionally, although clinical studies showed that Japanese encephalitis virus (JEV) 
is the most common cause of CNS infections in children in Vietnam (Ho Dang Trung 
et al., 2012; Le et al., 2010) and Streptococcus suis, the most common cause in adults 
(Ho Dang Trung et al., 2012; Taylor et al., 2012); the cause remained unknown in half 
of the cases or more (Ho Dang Trung et al., 2012; Le et al., 2010; Tan le et al., 2014; 
Taylor et al., 2012).  
 
This study aims to continue the work by Yen et al., 2010 using more recent 
surveillance data for AES but also to combine this with surveillance data for meningitis 
and sentinel site data for JE to provide a full spatio-temporal analysis of CNS 
infections in Vietnam. Additionally, the work uses explanatory variables and 
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surveillance data from other pathogens or syndromes which have the potential to 
cause CNS infections to suggest possible causes of CNS infections of unknown 
aetiology in Vietnam using multivariate mixed models.  
 
The objectives to be addressed are as follows: 
1. To compare and contrast the spatio-temporal distribution of AES and meningitis in 
Vietnam with other syndromes and pathogens. 
2. To estimate population level risk factors for AES and meningitis in Vietnam.  
3. To determine the potential effect of the JE vaccine on the incidence of AES and 
meningitis in Vietnam. 
4. To use the results from questions 1, 2 and 3 to estimate the aetiology of AES and 







Data on monthly incidence of AES and meningitis (using the case definition for 
meningococcal meningitis) at the provincial level was obtained from the GDPM. The 
R package ‘gdpm’ (Choisy and Contamin, 2019b) contains monthly data of selected 
notifiable diseases at the provincial level from 1st January 1980 to 31st December 







Table 2.1 The list of diseases in the GDPM 
Adenovirus Amoebiasis Anthrax 
Chickenpox Cholera Dengue 
Diarrhoea Diphtheria Dysentery 
Encephalitis H5N1 influenza Hepatitis 





Malaria Measles Meningitis 
Mumps Neonatal tetanus Pertussis 
Plague Polio Rabies 
Rubella Shigella S. suis 
Tetanus Typhoid  
 
In addition to surveillance data for encephalitis and meningitis, surveillance data for 
pathogens and syndromes which were known causes of CNS infection in Vietnam or 
countries within the region and may exhibit some evidence of seasonality which could 
be compared to cases of AES were also obtained from the GDPM. These included: 
dengue (Le et al., 2010; Tan le et al., 2014; Ho Dang Trung et al., 2012; Thai et al., 
2010), influenza-like-illness (ILI) as a proxy for influenza  (Morishima et al., 2002; Thai 
et al., 2015), S. suis (Mai et al., 2008; Wertheim et al., 2009b), measles (Fox et al., 
2013; Moss, 2017), leptospirosis (Dittrich et al., 2015; Chadsuthi et al., 2012) and 
hand, food and mouth disease (enterovirus 71) (HFMD) (Le et al., 2010; Chang et al., 
2012; Kim et al., 2016). Other pathogens within the list also have the potential to 
cause CNS manifestations however, have either been reported less widely as 
aetiologies in Vietnam or the region or were unlikely to have a seasonal pattern of 








The case definitions for the each of the pathogens are given below (Binh et al., 2013). 
S. suis is reported based on the confirmation of culture (Huong et al., 2019).  
 
Dengue A high fever above 38ºC for 2-7 days; headache, muscle and joint pain, 
periorbital pain, congestion, skin rash, signs of bleeding or signs of shock; influenza 
as a sudden onset of fever (39-40 ºC), severe headache, body, muscle and joint pain, 
runny nose, sore throat or coughing.  
 
ILI A measured fever of ≥38°C and cough; with the onset within the last 10 days 
(World Health Organization, 2014).. 
 
Suspected measles Fever with a least one of the following symptoms: coughing, 
runny nose, conjunctivitis or rash. 
 
Leptospirosis A sudden onset of high fever, headache, chills, malaise, myalgia 
(especially in the calves and thighs), conjunctival effusion, renal failure, arrhythmias, 
jaundice or rash. 
 
HFMD A brief febrile illness in children accompanied by a typical skin rash, with or 
without mouth ulcers. The rash is papulo-vesicular occurring on the palms or soles of 
the feet, or both. In young children or infants, the rash may be maculo-papular without 
vesicles and may also involve the buttocks, knees or elbows (Nguyen et al., 2014). 
 
Due to missing data in the earlier years, it was decided to include from 1998 onwards. 
Data was available from 1998 until 2016 for all pathogens/syndromes with the 
exception of HFMD and S. suis where data was available from 2011 only.  Sentinel 
site data for JE and PBM were provided by the Expanded Programme for 
Immunization, WHO, Hanoi from June 2011 to August 2017. The month and year of 
onset, the province of the home of the patient, the hospital site and the diagnosis (JE 
or PBM) were the only data used for the analysis. 
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THE PROVINCES IN VIETNAM 
The R package ‘gadmVN’ (Choisy and Contamin, 2019a) was used to obtain the maps 
of the provinces of Vietnam. As provinces have merged and split over time, the maps 
used include the provinces in 1998 with Hanoi merged with Ha Tay (figure 2.1). The 
economic regions of Vietnam are shown in figure 2.2. 
 




















An Giang 1 Kon Tum 31 
Ba Ria - Vung Tau 2 Lai Chau 32 
Bac Giang 3 Lam Dong 33 
Bac Kan 4 Lang Son 34 
Bac Lieu 5 Lao Cai 35 
Bac Ninh 6 Long An 36 
Ben Tre 7 Nam Dinh 37 
Binh Dinh 8 Nghe An 38 
Binh Duong 9 Ninh Binh 39 
Binh Phuoc 10 Ninh Thuan 40 
Binh Thuan 11 Phu Tho 41 
Ca Mau 12 Phu Yen 42 
Can Tho 13 Quang Binh 43 
Cao Bang 14 Quang Nam 44 
Da Nang 15 Quang Ngai 45 
Dak Lak 16 Quang Ninh 46 
Dong Nai 17 Quang Tri 47 
Dong Thap 18 Soc Trang 48 
Gia Lai 19 Son La 49 
Ha Giang 20 Tay Ninh 50 
Ha Nam 21 Thai Binh 51 
Ha Noi 22 Thai Nguyen 52 
Ha Tinh 23 Thanh Hoa 53 
Hai Duong 24 Thua Thien Hue 54 
Hai Phong 25 Tien Giang 55 
Ho Chi Minh 26 Tra Vinh 56 
Hoa Binh 27 Tuyen Quang 57 
Hung Yen 28 Vinh Long 58 
Khanh Hoa 29 Vinh Phuc 59 































































































Climatic variables have been shown to be correlated with the incidence of Japanese 
encephalitis in humans with positive correlations seen between JE and temperature 
and relative and absolute humidity (Lin et al., 2017; Tian et al., 2015). The association 
with rainfall varies with a study in China showing a positive association of rainfall with 
the number of JE cases (Tian et al., 2015) however, during an epidemic in Nepal and 
a different study in China, JE cases were negatively associated with rainfall (Impoinvil 
et al., 2011; Bai et al., 2014). Similarly, climatic variables have been shown to be 
correlated with the incidence of other pathogens and syndromes which have the 
potential to cause CNS infections including dengue (Do et al. 2014), leptospirosis 
(Sumi et al., 2017) and ILI (Thai et al., 2015). In the case of JE and DENV, this is 
likely to be due to the dependence of the mosquito vectors on temperature and 
humidity and rainfall for their development and survival (Reisen et al., 2008). The 
transmission of leptospirosis is associated with flooding as human behaviour such as 
walking barefoot in stagnant water may increase the risk of exposure to the bacteria 
(Kawaguchi et al., 2008). ILI in Vietnam is positively associated with absolute humidity 
(Thai et al., 2015) however, in temperate climates, influenza incidence peaks in the 
winter possibly due to indoor crowding (Tamerius et al., 2011).  
 
Climatic data was obtained from sixty-seven weather stations situated in Vietnam 
including monthly means for daily absolute (g/L) and relative (%) humidity, daily 
minimum and maximum and average temperatures (ºC) and cumulative precipitation 
(mm) and hours of sunlight (Bonell et al., 2020). In this study, the data from the 
weather stations was used to impute missing values on a 10,000-cell regular grid 
using the method of interpolated called Kriging. Kriging, developed by DG Krige in the 
1950s is a Gaussian process where interpolation is used to predict unknown values 
(van Beers and Kleijnen, 2003). The interpolations are weighted averages of 
neighbouring measures (Bonell et al., 2020). The method for Kriging utilises a 
variogram, a diagram which shows the variation between two locations in terms of the 
difference between their measurements (van Beers and Kleijnen, 2003). In this study, 
Kriging used the function autoKrige() from the R package ‘automap’ which 
automatically tunes the hyperparameters of the estimation  (Hiemstra et al., 2008). As 
demonstrated in a previous study, this Kriging process, performs well with the 
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exception of the rainfall data which produces some extreme outliers, most likely due 
to variation of this variable in space. As a result of this, any climatic variables which 
were extreme outliers were removed from the dataset.  
  
In order to compute climatic variables which were representative of the distribution of 
the population within the provinces (polygons), weighted averages of the population 
density were taken for each grid whereby the magnitude of population density was 
directly proportion to the climatic variable. The population densities were computed 
from the WorldPop project 2009 raster file which has a resolution of 100m (Lloyd, 
Sorichetta and Tatem, 2017) using the R packages ‘sptools’ (Choisy and Contamin, 
2019e), ‘magrittr’ (Milton Bache and Wickham, 2014), ‘purrr’ (Henry and Wickham, 
2019) and ‘raster’ (Hijmans, 2019b). Computed versions of the climatic variables were 
all lagged by one and two months, and rainfall by three months based on the 
possibility that preceding climatic conditions can influence a later peak in transmission 
of pathogens (Hsu, Yen and Chen, 2008; Bai et al., 2014). Lag times beyond three 
months are deemed not biologically plausible for infections caused by vectors (Jacups 
et al., 2008).  
 
Normalised difference vegetation index (NDVI) 
NDVI is used to estimate the density of land which is green. It is calculated from the 
light reflected by vegetation including visible (VIS) and near-infrared (NIR) (NDVI = 
(NIR-VIS)/(NIR+VIS) where chlorophyll strongly absorbs VIS and the cell structure of 
the leaves strongly reflects NIR  (NASA: Earth Observatory, 2000). The NDVI ranges 
from -1 to +1 where the higher the value, the more biomass of photosynthetically 
active vegetation exists. Negative values refer to non-biomass e.g. clouds, water or 
snow (Helbich, 2019). The NDVI of rice paddy has been shown be a positively related 
to both mosquito density and the number of Japanese encephalitis cases in China 
(Tian et al., 2015). 
 
The NDVI rasters for each month over the analysis time period were obtained from 
the National Centers for Environmental Information (NOAA) (NOAA: National Centers 
for Environmental Information, n.d.). The NDVI for each province for each month was 
extracted and weighted by population density as explained for the climatic variables.  
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JE Vaccination coverage 
Data of coverage of three doses of vaccination against JEV by province and year was 
provided by the National Institute of Hygiene and Epidemiology (NIHE). Vaccination 
campaigns provide two doses of the domestically produced, inactivated mouse brain-
derived JE vaccine as part of the expanded programme on immunisation (EPI) 1-2 
weeks apart followed by a booster dose one year later (Yen et al., 2010).  
Poverty, hospitals and number of pigs 
Data of the poverty rate, number of hospitals and number of pigs per province, per 
year was provided by the General Statistical Office of Vietnam (General Statistics 
Office of Viet Nam, 2010) and extracted using the R packages ‘gso’ (Choisy and 
Contamin, 2019c) and ‘gdpm’ (Choisy and Contamin, 2019b). For the purpose of 
analysis, missing data was imputed using the R package ‘mice’ (van Buuren and 
Groothuis-Oudshoorn, 2011) which imputes the missing data based on the values in 
the other columns (Multivariate Imputation by Chained Equations) (RDocumentation, 
n.d.-a); the number of hospitals was given per 1000 km2 to provide a proxy measure 
of accessibility to healthcare and the number of pigs per 100,000 human population 
to provide a proxy measure of proximity between humans and pigs which may be 
associated with the risk of JE (Liu et al., 2010). 
 
Elevation 
The elevation data for each province was obtained from the National Aeronautics and 
Space Administration (NASA) Shuttle Radar Topographic Mission (SRTM) digital 
elevation models (DEM) available from the Consortium of International Agricultural 
Research Centres Consortium for Spatial Information (CGIAR-CSI) GeoPortal 
(CGIAR-CSI, 2018). The R package ‘srtmVN’ contains a raster file of the DEM for 
Vietnam at a resolution of 90m (Choisy and Contamin, 2019f). The mean elevation 





Table 2.2 The datasets used, their unit of time and source. 
Dataset Unit of time Spatial 
unit 
Source Year Resolution 
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Population  Yearly Province GSO 1998-2016 NA 




























All analysis was conducted using R statistical programming software version 3.6.1.  
 
DESCRIPTIVE ANALYSIS 
Time series plots showing the national monthly incidence of each of the 
syndromes/pathogens including AES, meningitis, dengue, ILI, S. suis, measles, 
leptospirosis and hand foot and mouth diseases were plotted using the R functions 
ts() and plot(). The function ts() is used to create time-series objects for example from 
a vector (RDocumentation, n.d.-f) and plot() is used for plotting objects to create 
graphics (RDocumentation, n.d.-b). The times series were decomposed using the 
function stl() with the features of decomposition extracted using the function feat_stl(). 
The stl() function decomposes a time series into seasonal, trend and irregular 
components. This is done using Loess (RDocumentation, n.d.-d). Loess is a locally 
weighted regression which is based on moving averages for time series (Cleveland 
and Devlin, 1988). The feat_stl() function extracts the features of the time series 
including the strength of the trend and the seasonality (RDocumentation, n.d.-e). The 
strength of both the trend and seasonality are given on a scale of 0 to 1 with zero 
exhibiting almost no seasonality or trend (Hyndman and Athanasopoulos, 2018).  
 
Given the difference in acquisition of data for JE, a time series plot of the combined 
incidence of JE at the hospital sites was compared with the incidence of AES for cases 
arising from the same provinces from 2012 until 2016. 
 
Choropleth maps of the mean monthly incidence of each of the syndromes/pathogens 
and heatmaps of the mean monthly and yearly incidences by province were 
constructed using the R packages ‘ggplot2’ (Wickham, 2016), ‘viridis’ (Garnier, 2018), 








Separate negative binomial generalised linear models (GLM) with log population fitted 
as an offset were constructed to determine the association between time fitted as a 
linear continuous predicator (months 1 to 288); month as a categorical covariate and 
year also as a categorical covariate with the number of cases of AES and meningitis 
nationally using the R package ‘MASS’ (Venables and Ripley, 2002).  
 
The same models were run to determine the effect of seasonality on the number of a 
cases of AES and meningitis using annual, bi-annual and quarterly harmonic terms 
as covariates including: sin(2*pi*month/12)), sin(4*pi*month/12)) and 
sin(8*pi*month/12)) respectively.  
 
Spatial autocorrelation amongst the residuals from the models was tested determined 
using the Monte-Carlo simulation of Moran I using 1000 iterations to allow for 
convergence using the R package ‘spdep’ (Bivand, Pebesma and Gomez-Rubio, 
2013). The association between year and the number of cases of AES and 
seasonality and the number of cases at the level of province were shown as 
choropleth maps where the p value of the estimate was <0.05. 
 
Negative binomial GAM models, again with log population fitted as on offset were then 
constructed to determine the association of each of the covariates with the number of 
cases (incidence) of AES and meningitis per month as follows: mean maximum and 
minimum temperatures (°C), mean absolute and relative humidities (g/m3 and %, 
respectively); mean rainfall (mm), mean sunshine (hours) and mean NDVI with a lag 
of one and two months and in the case of rainfall, three months; mean elevation (m), 
number of pigs per 100,000 human population, number of hospitals per km2, poverty 
rate (%) and coverage with three doses of JE vaccination (%); in addition to the 
incidence per 100,000 population of meningitis, dengue, S. suis, measles, ILI, 
leptospirosis and HFMD. Month and year (as linear predictors) were fitted as 
smoothed terms using the ‘s’ function in the R package ‘mgcv’ to account for non-
linearity of these covariates. The ‘mgcv’ package is used to create GAMs and GAM 
mixed models (GAMMs) using multiple smoothing parameter estimations (Wood, 
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2019). The ‘s’ function is a thin plate regression spline which does not have ‘knots’ 
and is the default smoothing function as it is optimal for any given basis 
dimension/rank (Wood, 2003; R Documentation, n.d.).  
 
Given the evidence for significant spatial autocorrelation amongst the residuals in 
each of the univariate GAM models, the analysis was repeated using Integrated 
Nested Laplace Approximation (INLA) negative binomial models. INLA uses a 
Bayesian approach whereby the probability of an event is based on prior and current 
data to derive the posterior distribution (Blangiardo et al., 2013). Linear regression 
models such as generalised linear mixed models (GLMMs) and GAMMs can be used 
to produce spatial models which account for spatially autocorrelated data (Waller and 
Gotway, 2004). These frequentist approaches can do this by for example, using 
distance-based or neighbourhood-based correlated random effects (Saas and 
Gosselin, 2014). However, adding these to the model can be a complex process. The 
R package ‘R-INLA’ (Rue, Martino and Chopin, 2009) eliminates some of this 
complexity by allowing the construction of spatial neighbourhood matrices (Moraga, 
2019). In addition to INLA, Markov Chain Monte Carlo (MCMC) methods can be used 
to compute spatial Bayesian models where a Markov chain (a sequence of random 
values) is used to compute the posterior distribution (Waller and Gotway, 2004; Diggle 
and Ribeiro 2007). However, unlike INLA, MCMC methods can be computationally 
intensive to perform (Saas and Gosselin, 2014). A study performed by Saas and 
Gosselin, 2014 compared regression methods for spatially autocorrelated data. They 
found that Bayesian methods (MCMC and INLA) performed better than the frequentist 
methods (GLMM and GAMM).     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
Markov Chain Monte Carlo (MCMC) methods are commonly used to compute 
Bayesian models however, these can be computationally intensive. INLA which uses 
a latent Gaussian approach is more efficient (Blangiardo et al., 2013). The formula for 
the linear predictor included the incidence of AES and meningitis as outcomes and 
the covariates as described above. To take into account spatial autocorrelation, the 
neighbouring province was fitted as a random effect using the f() function, the first 
argument of which is an index vector for which the random effect is applied to each 
observation and the second is the name of the model (Moraga, 2019) using a Besag-
York-Mollie (bym) model (Besag, York and Mollie, 1991). The bym model accounts 
for over-dispersion by considering both unstructured and structured spatial 
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components (Riebler et al., 2016). To account for temporal autocorrelation, year and 
month were added as random effects using the model ‘Random Walk of order 1’. The 
inla() function was then used to fit the model using the family “nbinomial” (negative 
binomial). The outputs of the model were plotted using the function Efxplot() from the 
R package ‘ggregplot’ (Albery, n.d.). These show the estimate (mean) for each 
covariate with the posterior standard deviation and 2.5% and 97.5% quantiles (the 
credible interval) (Mtambo, Masangwi and Kazembe, 2015). Those estimates which 
did not cross zero were deemed to be significant at p<0.05.  
 
MULTIVARIATE ANALYSIS 
Given the evidence for spatial autocorrelation in the univariate analysis, multivariate 
models were constructed using only the INLA method described above. Separate 
correlation matrices were developed to compare the covariance between each of the 
climatic covariates and between the incidence per 100,000 population of each of the 
different pathogens/syndromes determined using Pearson’s correlation coefficient 
function rcorr() from the ‘Hmisc’ package (Harrell Jr, 2019). These were plotted using 
the function corrplot() from the ‘corrplot’ package (Wei and Simko, 2017) which 
creates a correlogram of the correlation matrix where the magnitude of the correlation 
is determined by the size and colour of a dot. 
 
Based on the results of this different models with an outcome of AES or meningitis 
were fitted using a combination of covariates. Climatic variables with a correlation 
coefficient of 0.80 or greater were not included in the same models to reduce the 
effect of multicollinearity. Incidence of meningitis and S. suis were the only 
syndromes/pathogens included in models with an outcome of the number of cases of 
AES and incidence of HFMD with an outcome of the number of cases of meningitis 
as these were the only pathogens/syndromes showing a strong association with the 
outcomes respectively, in the univariate analyses. Twelve models were therefore 





Table 2.3 Construction of the multivariate models. The boxes shaded indicate the 










Outcome = number of cases of 
encephalitis 
Outcome = number of cases of 
meningitis 
Covariates             
Maximum temperature (°C) 
 
            
Maximum temperature at a lag of 
minus one (°C) 
            
Maximum temperature at a lag of 
minus two (°C) 
            
Minimum temperature (°C) 
 
            
Minimum temperature at a lag of 
minus one (°C) 
            
Minimum temperature at a lag of 
minus two (°C) 
            
Relative humidity (%) 
 
            
Relative humidity at a lag of minus 
one (%) 
            
Relative humidity at a lag of minus 
two (%) 
            
Absolute humidity (g/m3) 
 
            
Absolute humidity at a lag of minus 
one (g/m3) 
            
Absolute humidity at a lag of minus 
two (g/m3) 
            
Rainfall (mm) 
 
            
Rainfall at a lag of minus one (mm) 
 
            
Rainfall at a lag of minus two (mm) 
 
            
Rainfall at a lag of minus three (mm)             
Sunshine (hours) 
 
            
Sunshine at a lag of minus one 
(hours) 
 
            
Sunshine at a lag of minus two 
(hours) 
 
            
NDVI 
 
            
NDVI at a lag of minus one 
 
            
NDVI at a lag of minus two 
 
            
Elevation (m) 
 
            
Number of pigs per 100,000 human 
population 
            
Poverty rate (%) 
 
            
Number of hospitals per 1000km2 
 
            
JE vaccination coverage with three 
doses 
            
Incidence of meningitis per 100,000 
population 
            
Incidence of S. suis per 100,000 
population 
            
Incidence of HFMD per 100,000 
population 
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As for the univariate analysis, the outputs of the model were plotted using the function 
Efxplot() from the R package ‘ggregplot’. Additionally, the Deviance Information 
Criterion (DIC) and Watanabe-Akaike information criterion (WAIC) were given to 
assess the fit of the models. A choropleth map of the estimate of number was 
constructed for each of the models. Due to the absence of data for S. suis prior to 




DESCRIPTIVE ANALYSIS: PATHOGENS AND SYNDROMES 
 
THE DESCRIPTION OF THE INCIDENCE OF AES IN SPACE AND TIME 
Figures 2.3 (below) and A2.1, appendix 2.1) show an initial increase national monthly 
incidence of AES in the earlier years of the study and then a decline after a peak in 
incidence seen in June 2004 (0.80 cases per 100,000 population). The annual 
incidence of AES reduced from 3.01 cases per 100,000 population in 1998 to 1.06 
cases per 100,000 population in 2016 with strong evidence for a negative correlation 
of incidence of AES with time, particularly after 2005 with a non-linear trend (tables 
A2.1 and A2.2, appendix 2.1). However, in eight provinces, an increase in incidence 
over was seen over time. This was highest in the provinces of Son La and Lao Cai in 
the Northern Midlands and Mountains (an increase of 5.64 cases per 100,000 
population and 4.26 cases per 100,000 population, respectively) and Gia Lai in the 
Central Highlands (4.45 cases per 100,000 population) (figure 2.4).  
 
Decomposition of the time series showed a trend strength of 0.604 and seasonal 
strength of 0.766 (figure A2.1, appendix 2.1). The mean national monthly incidence 
was highest in June (0.35 cases (standard deviation (SD)=0.21) per 100,000 
population) and lowest in February (0.08 cases (SD=0.04) per 100,000 population). 
May to September were positively correlated with the number of cases of AES 
compared to January (table A2.3, appendix 2.1).   
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The mean monthly incidence of AES was highest in Son La (0.77 (SD=0.89) cases 
per 100,000 population) and lowest in Phu Yen on the Central Coast (0.01 (SD=0.05) 
cases per 100,000 population). However, the highest incidence was seen in January 
2002 in Kon Tum in the Central Highlands (69.10 cases per 100,000 population). 
Nationally, there was evidence of annual seasonality (table A2.4, appendix 2.1) which 





















Figure 2.3 Time series plots showing the national incidence of AES, meningitis, 















































































































































































































































































































































































































































(1) The mean monthly 
incidence by province 
	
(2) The mean incidence/year 
by province (ordered by 
latitude)*  
 
(3) The mean incidence/month 
by province (ordered by 
latitude)* 
* The outlying cases in Kom 
Tum in January 2002 have 
been removed to improve the 
visualisation of the remaining 
data 
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Figure 2.5 Estimates from negative binomial GLMs with an outcome of number of 
































THE DESCRIPTION OF THE INCIDENCE OF MENINGITIS IN SPACE AND 
TIME 
The annual incidence of meningitis reduced from 1.85 cases/100,000 in 1998 to 
0.05/100,000 in 2016 with a sharp decline since 2010 (figures 2.3 (above) and A2.1, 
appendix 2.1; and tables A2.5 and A2.6, appendix 2.1). Decomposition of the time 
series showed a trend strength of 0.823 and a seasonal strength of 0.417 (figure A2.1, 
appendix 2.1). The mean national monthly incidence was highest in July (0.08 
(SD=0.06) cases per 100,000 population) and lowest in December (0.04 (SD=0.04) 
per 100,000 population). March to October were positively correlated with the 
incidence of meningitis compared to January (table A2.7, appendix 2.1).   
 
The mean monthly incidence of meningitis was highest in Son La (0.40 (SD=0.73) 
cases per 100,000 population) and lowest in Thua Thien Hue on the Central Coast 
(3.25x10-3 (SD=0.02) per 100,000 population) with strong evidence for a difference 
between the two (p<0.001). However, the highest incidence was seen in Dak Lak 
province in the Central Highlands in April 2008 (5.53 cases per 100,000 population). 
Despite a national decline in annual incidence there was an increase in incidence 
between 1998 and 2016 in three provinces, with the highest increase in Hoa Binh in 
the Northern Midlands and Mountains (0.32 cases per 100,000 population) (figure 
2.6). Nationally, there was evidence of annual and quarterly seasonality (table A2.8, 
appendix 2.1) with seasonality greatest in Northern Midlands and Mountains and the 


























































































































































































































































(1) The mean monthly 
incidence 
 by province 
	
(2) The mean incidence/year 
by province (ordered by 
latitude) 
 
(3) The mean incidence/month 




Figure 2.7 Estimates from negative binomial GLMs with an outcome of number of 






























THE DESCRIPTION OF THE INCIDENCE OF DENGUE VIRUS IN SPACE 
AND TIME 
Unlike AES and meningitis, there has not been a general decrease in incidence of 
dengue (figures 2.3 and A2.1, appendix 2.1). The highest annual incidence was seen 
in 2010 with 148.03 cases per 100,000 population however, peaks were also seen in 
1998 (311.33 cases per 100,000 population) and 2016 (136.07 cases per 100,000 
population). The decomposition of the time series gave a trend strength of 0.646, a 
seasonal strength of 0.584 (figure A2.1, appendix 2.1). The mean national monthly 
incidence was highest in October (13.3 (SD=9.76) cases per 100,000 population) and 
lowest in February and March (2.85 (SD=1.66) cases per 100,000 population) and 2.8 
(SD=1.39 cases) per 100,000 population, respectively) (figure 2.8). 
 
The mean monthly incidence of dengue was highest in Ben Tre in the Mekong Delta 
(25.56 (SD=53.94) cases per 100,000 population) and the lowest in Tuyen Quang in 
the Northern Midlands and Highlands (1.16x10-3 (SD=12.39x10-3 cases per 100,000 
population). However, the highest incidence was seen in Quang Tri on the Central 


































































































































































































































































(1) The mean monthly 
incidence by province 
	
(2) The mean incidence/year 
by province (ordered by 
latitude) 
 
(3) The mean incidence/month 




THE DESCRIPTION OF THE INCIDENCE OF INFLUENZA-LIKE-ILLNESS 
(ILI) IN SPACE AND TIME 
Over the study time period, the incidence of ILI increased and then decreased with a 
peak incidence in 2005 of 2163.04 cases per 100,000 population. In 2016 the 
incidence was 883.37 cases per 100,000 population (figures 2.3 andA2.1, appendix 
2.1). Decomposition of the time series gave a trend strength of 0.92 and seasonal 
strength of 0.64 (figure A2.1, appendix 2.1). The mean national monthly incidence 
was highest in September (160.46 (SD=40.70) cases per 100,000 population) and 
lowest in January (120.20 (SD=22.94) cases per 100,000 population) (figure 2.9).  
The mean monthly incidence of ILI was highest in Lai Chau in the Northern Midlands 
and Mountains (667.30 cases (SD=347.42) per 100,000 population) and lowest in Ho 



















































































































































































































































































(1) The mean monthly 
incidence by province 
	
(2) The mean incidence/year 
by province (ordered by 
latitude) 
 
(3) The mean incidence/month 
by province (ordered by 
latitude) 
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THE DESCRIPTION OF THE INCIDENCE OF S. SUIS IN SPACE AND TIME 
Data from 2011 showed the highest incidence of S. suis in 2012 (0.15 cases per 
100,000 population) and lowest in 2014 (0.08 cases per 100,000 population) (figures 
2.3 and 2.4). Decomposition of the time series showed a trend strength of 0.21 and 
seasonal strength of 0.42 (figure A2.1, appendix 2.1). The mean national monthly 
incidence was highest in May (1.49x10-2 (SD= SD=8.78x10-3) cases per 100,000 
population) and lowest in January (4.64x10-3/100,000, SD=2.62x10-3/100,000) (figure 
2.10). The mean monthly incidence of S. suis was highest in Thua Thien Hue on the 
Central Coast (2.17x10-2/100,000, SD=3.05x10-2/100,000) and lowest in Dack Lak in 








































































































































































































































(1) The mean monthly 
incidence by province 
	
(2) The mean incidence/year 
by province (ordered by 
latitude) 
 
(3) The mean incidence/month 
by province (ordered by 
latitude) 
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THE DESCRIPTION OF THE INCIDENCE OF MEASLES IN SPACE AND 
TIME 
Yearly incidence of measles generally declined since 2001 however, there were 
peaks in in 2009 (22.43 cases per 100,000 population) and 2014 (37.35 cases per 
100,000 population) (figures 2.3 and A2.1, appendix 2.1). Decomposition of the time 
series gave a trend strength of 0.56 and seasonal strength of 0.39 (figure A2.1, 
appendix 2.1). The mean monthly incidence was greatest in April (1.80 (SD=2.23) 
cases per 100,000) and lowest in September (0.30 (SD=0.34) cases per 100,000 
population) (figure 2.12). The mean monthly incidence was highest in Ha Giang in the 
Northern Midlands and Mountains (4.47 (SD=19.02) cases per 100,000 population) 
and lowest in Ninh Binh in the Red River Delta (0.19 (SD=0.85) cases per 100,000 





































































































































































































































































3 (1) The mean monthly 
incidence by province 
	
(2) The mean incidence/year 
by province (ordered by 
latitude) 
 
(3) The mean incidence/month 




THE DESCRIPTION OF THE INCIDENCE OF LEPTOSPIROSIS IN SPACE 
AND TIME 
Incidence of leptospirosis remained relatively stable until 2004 when a peak was seen 
(0.25 cases per 100,000 population). However, by 2016 the incidence had decreased 
to 9.7x10-3 cases per 100,000 population in 2016 (figures 2.3 and A2.1, appendix 2.1). 
The decomposition of the time series showed a trend strength of 0.25 and seasonal 
strength of 0.22 with a seasonal peak at month 8 and trough at month 2 (figure A2.1, 
appendix 2.1). The mean national monthly incidence was highest in August (8.99x10-
3 (SD=2.83x10-2) cases per 100,000 population) and lowest in February (6.22x10-4 
(SD=8.20x10-4) per 100,000 population) (figure 2.13). The mean monthly incidence 
was highest in Lai Chau in the Northern Midlands and Mountains (3.59x10-2 
(SD=0.28) per 100,000 population). In sixteen provinces, no cases were reported 



































































































































































































































































(1) The mean monthly 
incidence by province 
	
(2) The mean incidence/year 
by province (ordered by 
latitude) 
 
(3) The mean incidence/month 
by province (ordered by 
latitude) 
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THE DESCRIPTION OF THE INCIDENCE OF HFMD IN SPACE AND TIME 
 
Data from 2011 showed incidence to be highest in 2012 (177.22 cases per 100,000 
population) and decreased to 51.17 cases per 100,000 population in 2016 (figures 
2.3 and 2.4). Decomposition of the time series showed a trend strength of 0.74 and 
seasonal strength of 0.68 (figure A2.1, appendix 2.1). Mean incidence was highest in 
October (14.23 (SD=7.14) cases per 100,000 population) and lowest in February 
(3.28 (SD=2.52) cases per 100,000 population) (figure 2.13). The mean monthly 
incidence was highest in Bac Kan in the Northern Midlands and Mountains (12.20 
(SD=11.98) cases per 100,000 population) and lowest in Ha Noi in the Red River 








































































































































































































































(1) The mean monthly 
incidence by province 
	
(2) The mean incidence/year 
by province (ordered by 
latitude) 
 
(3) The mean incidence/month 




THE DESCRIPTION OF THE INCIDENCE OF JE IN SPACE AND TIME 
 
Data for JE was available from 2012 to 2016 from two hospital sites in Hanoi in the 
Red River Delta and Ho Chi Minh City in the Southeast with the highest number of 
cases in 2014 (n=97). The number of cases was highest in June (total=179) and 
lowest in January and February when no cases were seen. The temporal pattern 
corresponded with that of AES (figure 2.14). The total number of cases was highest 
in Ha Nam province (n=50) (figure 2.15).  
 
Figure 2.14 Time series plot of the monthly number of cases JE admitted to the 
National Children Hospital in Hanoi and Children’s Hospital No.1 in Ho Chi Minh City 
(the red line), compared to the number of cases of AES from national surveillance 




























Figure 2.15 The total number of cases JE admitted to the National Children Hospital 
in Hanoi and Children’s Hospital No.1 in Ho Chi Minh City from national surveillance 




















DESCRIPTIVE ANALYSIS: COVARIATES 
 
DESCRIPTION OF THE CLIMATIC VARIABLES IN SPACE AND TIME 
The mean temperatures for the study period were higher in southern compared to 
northern Vietnam. In the Mekong Delta and the Southeast, the temperatures 
remained relatively constant throughout the year whereas the northern part of the 
Central Coast, the Red River Delta and the Northern Midlands and Mountains 
experienced warmer summers and cooler winters (figure 2.16). The relative humidity 
remained relatively constant throughout the year in northern Vietnam however, in 
southern Vietnam and the Central Highlands it was highest in the summer months. In 
the Central Coastal provinces, it was high throughout the year except in June to 
August. The absolute humidity remained high throughout the year in southern 
Vietnam whereas in the Central Coastal provinces and northern Vietnam it was 
highest in the summer months, with the exception of provinces at higher elevation 
including Lai Chau and Son La where it remained lower throughout the year with a 
mild increase in the summer months (figure 2.17). Throughout the country rainfall was 
greatest in the summer and autumn months with the exception of the provinces on 
the Central Coast Vietnam when it was highest in the autumn. In northern and Central 
Coastal Vietnam, there was a marked difference between the hours of sunshine 
throughout the year with these being greatest in the summer months. In southern 
Vietnam, there was less of a difference however, the number of hours was greater in 




































































































































































































































































(1) The mean monthly maximum temperature by province 
 (2) The mean maximum temperature/month by province 
 (3) The mean monthly minimum temperature by province 
 (4) The mean minimum temperature/month by province 
 
* Provinces are shown in increasing order of latitude 
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(1) The mean monthly relative humidity by province 
 (2) The mean maximum relative humidity/month by province 
 (3) The mean monthly absolute humidity by province 
 (4) The mean minimum absolute humidity by province 
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(1) The mean monthly rainfall by province 
(2) The mean maximum rainfall/month by province 
(3) The mean monthly hours of sunshine by province 
(4) The mean minimum hours of sunshine by province 
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The mean elevation was highest in the provinces in the Northern Midlands and 
Mountains and the Central Highlands with Lam Duong in the Central Highlands having 
the highest elevation weighted by population density (1046.16m). The mean elevation 
was lowest in Bac Lieu in the Mekong Delta (1.89m) (figure 2.19). The NDVI was 
highest in the Northern Midlands and Mountains and the Central Highlands and lowest 
in the coastal provinces of the Red River Delta, Da Nang on the Central Coast and 
the provinces in the Mekong Delta, southern Vietnam. The mean NDVI was highest 
in Binh Phuoc province in the Southeast (0.26, SD=0.16) and lowest in Ca Mau in the 
Mekong Delta (0.08, SD=0.06) (figure 2.21). Nationally, the NDVI was highest in May 
(mean=0.21, SD=0.15) and lowest in January (mean=0.13, SD=0.15).  
 
The mean number of pigs per 100,000 human population was highest in northern 
Vietnam and lowest in the Mekong Delta and southern provinces of the Central Coast 
with the highest number in Bac Giang in the Northern Midlands and Mountains 
(64039.52, SD=10965.80) and lowest in Ho Chi Minh (3936.55, SD=340.65). The 
mean poverty rate was highest in Lai Chau (87.63%, SD=14.41%) and lowest in Binh 
Duong in the Southeast (5.07%, SD=5.14%). Nationally, there has been a decrease 
in the poverty rate from 30.11% in 1998 to 8.17% in 2016. The mean number of 
hospitals per 1000km2 was highest in Ho Chi Minh (23.30, SD= 3.68) and lowest in 
Quang Binh on the Central Coast (0.87, SD=0.21) (figure 2.20).  
 
In 1998, ten provinces in northern Vietnam received the JE vaccine with a mean 
coverage of three doses of 93.23%. In 2015, all provinces except Cao Bang in the 
Northern Midlands and Mountains received the vaccine with a mean coverage of 
93.13%. Where vaccination was rolled-out annual coverage ranged from 4.74 in Ho 











































Mean elevation weighted by population density
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Figure 2.20 The mean NDVI, number of pigs per 100,000 population; poverty rate 

























































































































































UNIVARIATE ANALYSES: OUTCOME OF THE NUMBER OF CASES OF 
AES 
In all negative binomial GAMs there was evidence of spatial autocorrelation of the 
residuals (p<0.001) (table A2.9, appendix 2.1). Univariate INLA  models showed a 
positive association of maximum and minimum temperature with the number of cases 
of AES (posterior mean=0.094, 95% credible interval=0.081-0.108; and posterior 
mean=0.063, 95% credible interval=0.051-0.076, respectively) including at a lag of 
one month (posterior mean=0.039, 95% credible interval=0.029-0.050; and posterior 
mean=0.050, 95% credible interval=0.039-0.061); and absolute humidity including 
with a lag of one and two months (posterior mean=0.089, 95% credible 
interval=0.078-0.099, posterior mean=0.055, 95% credible interval=0.044-0.065). 
Relative humidity was positively associated at a lag of one month (posterior 
mean=0.008, 95% credible interval=0.003-0.012) and rainfall showed no association 
with the number of cases. Sunshine was positively associated with the number of 
cases (posterior mean=0.003, 95% credible interval=0.002-0.003) including at a lag 
of one month (posterior mean=0.001, 95% credible interval=0.001-0.002) but 
negatively associated at a lag of two months (posterior mean= -0.002, 95% credible 
interval= -0.002- (-0.001). NDVI was positively associated with the number of cases 
(posterior mean=0.513, 95% credible interval=0.286-0.740) but showed no 
association at a lag of one month and was negatively associated with a lag of two 
months (posterior mean = -0.253, 95% credible interval= -0.475 – (-0.030). Elevation, 
the number of pigs per 100,000 population and the number of hospitals per 1000km2 
showed no association with the number of cases but JE vaccination coverage showed 
a positive association. Incidence of meningitis and S. suis were the only 
syndromes/pathogens to show a positive association with the number of cases of AES 








Figure 2.22 The posterior means of the INLA univariate models by each covariate with 
an outcome of number of cases of AES. The dot represents the posterior mean value 
and bars represent the 95% credible intervals. The presence of an asterix (*) indicates 















*Sunshine at a lag of minus two (hours)
Sunshine at a lag of minus one (hours)
Sunshine (hours)
Rainfall at a lag of minus three (mm)
Rainfall at a lag of minus two (mm)
Rainfall at a lag of minus one (mm)
Rainfall (mm)
Relative humidity at a lag of minus two (%)
Relative humidity at a lag of minus one (%)
Relative humidity (%)
Absolute humidity at a lag of minus two (g/m3)
Absolute humidity at a lag of minus one (g/m3)
Absolute humidity (g/m3)
Minimum temperature at a lag of minus two (degree Celsius)
Minimum temperature at a lag of minus one (degree Celsius)
Minimum temperature (degree Celsius)
Maximum temperature at a lag of minus two (degree Celsius)
Maximum temperature at a lag of minus one (degree Celsius)



















*JE vaccination coverage with three doses (%)
Number of hospitals per 1000km2
Poverty rate (%)
Number of pigs per 100,000 human population
Elevation (m)
NDVI at a lag of minus two

















Incidence of HFMD per 100,000 population
Incidence of leptospirosis per 100,000 population
Incidence of S. suis per 100,000 population
Incidence of measles per 100,000 population
Incidence of ILI per 100,000 population
Incidence of dengue per 100,000 population
Incidence of meningitis per 100,000 population









CORRELATION BETWEEN THE COVARIATES  
The greatest correlation between climatic covariates was seen between the absolute 
humidity and maximum temperature (0.90); the absolute humidity and minimum 
temperature (0.88) and the maximum and minimum temperatures (0.85) (figure 2.23). 
There was no evidence of a strong correlation between any of the 
pathogens/syndromes however, he greatest correlation between 
pathogens/syndromes was seen between HFDM and ILI (0.17); AES and ILI (0.12) 
and dengue and ILI (-0.10) (figure 2.24). 
 
Figure 2.23 Matrix of correlation coefficients between different climatic covariates 
using Pearson’s correlation coefficients. The size of the dot corresponds to the 






































































Figure 2.24 Matrix of correlation coefficients between different pathogens and 
syndromes using Pearson’s correlation coefficients. The size of the dot corresponds 

































































MULTIVARIATE ANALYSES: OUTCOME OF THE NUMBER OF CASES OF 
AES 
In the multivariate analysis, maximum temperature, minimum temperature and 
absolute humidity were positively associated with the number of cases of AES in all 
four models. Minimum temperature and absolute humidity were also positively 
associated at a lag of one month. Relative humidity was positively associated but only 
in models 1, 2 and 4 and there was no effect of rainfall on the number of cases. 
Sunshine was positively associated with the number of cases of AES in models 2, 3, 
5 and 6 and positively associated at a lag of minus two months in all models (figure 
2.25).  
 
NDVI at a lag of one month was positively associated with the number of cases of 
AES in models 1, 3 and 6 and a lag of two months, negatively associated with the 
number of cases of AES in all models. Poverty rate was negatively associated and JE 
vaccination coverage positively associated with the number of cases of AES in all 
models but elevation, the number of pigs per 100,000 population and the number of 
hospitals per 1000km2 showed no association in any models. The incidence of 
meningitis and S. suis were positively associated with the number of cases of AES in 
models 4, 5 and 6 (figure 2.25 and tables A2.11-A2.16, appendix 2.1). The model with 
the lowest DIC and WAIC was 4, (43917.46 and 44049.91, respectively) and highest, 
2 (44047.71 and 44180.42, respectively) (table 2.4). In all models, the estimate of risk 
was highest in the provinces of Lai Chau in the Northern Midlands and Mountains 
(ranging from a posterior mean of 1.85 in model 3 to 1.97 in model 5) and Son La also 
in the Northern Midlands and Mountains (ranging from a posterior mean of 1.81 in 
model 5 to 1.94 in model 1), both of which are in northern Vietnam bordering Lao 
PDR. The estimate of risk was lowest in Phu Yen on the Central Coast, ranging from 
a posterior mean of -1.97 in model 4 to -2.17 in model 2 and Bac Kan in the Northern 
Midlands and Mountains ranging from a posterior mean of -1.38 in model 6 to -1.48 





Figure 2.25 The posterior means of the INLA multivariate models by incidence of 
pathogens/syndromes with an outcome of number of cases of AES.  The dot 












JE vaccination coverage with three doses (%)
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Model DIC WAIC 
1 44023.26 44155.75 
2 44047.71 44180.42 
3 44026.70 44158.98 
4 43917.46 44049.91 
5 43939.64 44072.36 
6 43920.87 44053.27 
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Figure 2.26 The predicted posterior mean from each of the models by province. Only 


































UNIVARIATE ANALYSES: OUTCOME OF THE NUMBER OF CASES OF 
MENINGITIS 
In all GAM models, there was evidence of spatial autocorrelation of the residuals with 
a p<0.001 (table A2.11, appendix 2.1). Using INLA, there was evidence of a positive 
association of maximum and minimum temperature (posterior mean=0.061, 95% 
credible interval=0.049-0.073; and posterior mean= =0.065, 95% credible 
interval=0.051-0.078) with the number of cases of meningitis including at a lag of one 
month (posterior mean=0.031, 95% credible interval=0.019-0.043; and posterior 
mean=0.042, 95% credible interval=0.028-0.056, respectively); and absolute humidity 
(posterior mean=0.05, 95% credible interval=0.04-0.06) including at a lag of one 
month (posterior mean=0.034, credible interval=0.023-0.046). Other climatic 
variables did not show any correlation with the number of cases. NDVI was positively 
associated with the number of cases of meningitis (posterior mean=0.451, 95% 
credible interval=0.129-0.774) but showed no association at a lag of one or two 
months. Elevation, the number of pigs per 100,000 population, the number of 
hospitals per 1000km2 and JE vaccination showed no association with the number of 
cases. HFMD was the only pathogen to show an association with the number of cases 
















0.012 – (-0.003) with the other syndromes/pathogens showing no association (figure 
























Figure 2.27 The posterior means of the INLA univariate models by each covariate with 
an outcome of number of cases of meningitis. The dot represents the posterior mean 
value and bars represent the 95% credible intervals. The presence of an asterix (*) 
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MULTIVARIATE ANALYSES: OUTCOME OF THE NUMBER OF CASES OF 
MENINGITIS 
In the multivariate analysis, maximum temperature and minimum temperatures and 
absolute humidity including at a lag of one month were positively associated with the 
number of cases of meningitis and at a lag of two months, negatively associated. 
Relative humidity was negatively associated at a lag of one month. Rainfall and 
sunshine showed no correlation with the number of cases and there was no 
association between other covariates and the cases of meningitis with the exception 
of the incidence of HFMD which was negatively associated (figure 2.28 and tables 
A2.17-A2.22, appendix 2.1). The DIC and WAIC ranged from 23733.78 and 23814.86, 
respectively in model 4 to 23745.28 and 23825.56 in model 2 (table 2.5). In all models, 
the estimate of risk was highest in the provinces of Son La, in the Northern Midlands 
and Mountains (ranging from a posterior mean of 2.24 in model 6 to 2.30 in model 1) 
and Thai Binh in the Red River Delta (ranging from a posterior mean of 1.99 in model 
2 to 2.01 in model 4). The estimate of risk was lowest in Bac Kan in the Northern 
Midlands and Mountains ranging from a posterior mean of –2.23 in model 2 to -2.28 
in model 4 and Thua Thien Hue on the Central Coast ranging from a posterior mean 













Figure 2.28 The mean posterior estimates of the INLA multivariate models by 
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Table 2.5 The DIC and WAIC of multivariate models in figure 2.28 with an outcome 
of the number of cases of meningitis. 
Model DIC WAIC 
1 23740.83 23821.04 
2 23745.28 23825.56 
3 23741.23 23822.74 
4 23733.78 23814.86 
5 23738.95 23820.30 



















Figure 2.29 Choropleth maps to show the predictions from the models in figure 2.29 



































































A number of studies have been conducted in Vietnam, and regionally, exploring the 
aetiology, and on occasion, the spatio-temporal distribution of CNS infections. 
However, the majority of these have been cross-sectional studies conducted at a few 
sites. This is the first known study in Vietnam to explore the spatio-temporal 
distribution of both AES and meningitis at the national level using surveillance data 
over decades. Whilst other studies have utilised national surveillance data to explore 
the spatio-temporal distribution of pathogens causing CNS infections, none have 
explored the differences between these. This was therefore the first objective of this 
study. 
 
OBJECTIVE 1: TO COMPARE AND CONTRAST THE SPATIO-TEMPORAL 
DISTRIBUTION OF AES AND MENINGITIS IN VIETNAM WITH OTHER 
SYNDROMES AND PATHOGENS 
A decline in both the national incidence of AES and meningitis was seen over time. In 
the case of AES this becomes particularly apparent from 2005 onwards. However, 
increases in incidence of AES were seen in provinces in northern Vietnam which 
border Lao PDR and those in the central highlands with the mean incidence of AES 
and meningitis over the study period highest in Son La province. A clear effect of 
seasonality with peaks of incidence of AES in the summer months of June and July 
was seen in the northern but not southern provinces of Vietnam. A higher incidence 
of meningitis is seen in Son La and Yen Bai in northern Vietnam in the summer months 
but there was no clear difference in seasonality by latitude. If we compare the spatio-
temporal distribution of AES and meningitis with other pathogens, it is difficult to find 
any clear similarities with the exception of JE and AES which both peak in the 
summer. The incidence of dengue was strongly seasonal yet the peaked occurred 
slightly later than AES in July and August and there were very few cases in northern 
Vietnam. Furthermore, unlike AES and meningitis there is not a decline in cases of 
dengue over time but instead, there was evidences of epidemics in 1998, 2010 and 
2016. Although the spatial pattern of ILI showed similarities with AES and meningitis 
with the highest incidence in northern Vietnam and the central highlands, the peaks 
tended to be later than those of AES. The incidence of measles was also highest in 
the northern provinces bordering Lao PDR however, peaks in incidence were seen 
from March to May. Overall, the incidence of HFMD was is highest in southern 
Vietnam with peaks in the months of September to November. The incidence of 
	 151 
leptospirosis was higher in northern Vietnam with more cases in the summer months 
however, the number of cases was comparatively lower making it more difficult to 
draw comparisons. Similarly, due to the lower number of cases of S. suis, possibly 
due to under-reporting it was difficult to compare this pathogen (Huong et al., 2019).  
 
Given the evidence for spatial autocorrelation in the GAM models, Bayesian modelling 
was used in the form of INLA with neighbouring province added as a random effect. 
Results from these models showed that S. suis and meningitis were the only 
pathogens/syndromes positively associated with the number of cases of AES in the 
univariate analysis and remained so in the multivariate models. This is possibly due 
to the specificity of the case definition of AES which is discussed further in the next 
chapter (Venkatesan et al., 2013) whereby clinicians are reporting some cases of 
meningitis as AES and vice versa. As the positive association between HFMD and 
meningitis present in the univariate analysis when adjusting for other covariates was 
reversed in the multivariate analysis, it can be concluded that there was no 
association between any of the pathogens/syndromes (with the exception of AES) 
and meningitis. 
 
OBJECTIVE 2: TO ESTIMATE POPULATION LEVEL RISK FACTORS FOR 
AES AND MENINGITIS IN VIETNAM 
The second objective of this research was to estimate the population level risk factors 
for AES and meningitis in Vietnam. In the multivariate analysis, there is a correlation 
between temperature and absolute humidity and with the exception of two models, 
relative humidity and the number of cases of AES, and between temperature and 
absolute humidity and the number of cases of meningitis. In the descriptive analysis, 
it is evident that the seasonal pattern of temperature and absolute humidity 
corresponds with the spatio-temporal distribution of incidence of AES.  
 
Climatic factors affect the transmission dynamics of a number of pathogens (Metcalf 
et al., 2017). As described in chapter one, of the potential pathogens causing AES, 
vector-borne diseases are particularly influenced by climate as the breeding and 
survival of mosquitoes and other vectors such as chiggers is dependent on 
temperature and humidity (Keiser et al., 2005; Niaz and Reisen, 1981; Liu et al., 2018; 
	 152 
Reinhold, Lazzari and Lahondere, 2018; Delatte et al., 2009; Lv, Guo and Jin, 2018; 
Xu and Chen, 1960; Traub and Wisseman, 1974). As a result, there is evidence of 
seasonality of diseases such as JE, dengue and scrub typhus corresponding with the 
climatic factors (Solomon et al., 2000a; Lowe et al., 2011; Xu et al., 2017). Other 
pathogens causing CNS infections also show seasonality such as enterovirus 71, 
causing HFMD, S. suis and influenza virus (Chang et al., 2012; Wertheim et al., 
2009a; Wertheim et al., 2009b; Thai et al., 2015). Like the vector-borne diseases, 
influenza has been shown to be positively associated with absolute humidity (Thai et 
al., 2015) and HFMD with temperature and relative humidity (Chang et al., 2012). In 
Vietnam, the incidence of S. suis also corresponds spatio-temporally with that of AES 
(Wertheim et al., 2009b; Nghia et al., 2011). However, whether the climate has a direct 
impact on these pathogens or whether it is due to human behaviour remains to be 
determined. In some of the multivariate models there is evidence of a positive 
association between temperature and humidity at a lag of one month and the number 
of cases of AES or meningitis. In the case of vector-borne diseases, this is likely to 
be accounted for by the time taken for the vector to complete its life-cycle and 
subsequently transmit the pathogen to humans as was demonstrated in a study of JE 
in Nepal (Impoinvil et al., 2011). Interestingly, in this study there was no evidence of 
an association between rainfall and the number of cases of AES and meningitis 
despite studies showing evidence of an association between this climatic factor and 
the survival of mosquitoes (Reisen, Aslamkhan and Basio, 1976; Longbottom et al., 
2017; Koenraadt and Harrington, 2008; Seidahmed and Eltahir, 2016) and in some 
situations the number of cases of leptospirosis (Chadsuthi et al., 2012; Triampo et al., 
2007). 
 
Of the non-climatic variables, NDVI was positively associated with the number of 
cases of AES with a lag of one or two months in selected multivariate models whereas 
no association was seen with the number of cases of meningitis. Other work has 
shown NDVI to be positively associated with cases of JE in China (Tian et al., 2015) 
although this association is not necessarily linear and the risk may reverse over a 
particular threshold of greenness (Wang et al., 2014). NDVI has also been shown to 
be positively associated with the incidence of scrub typhus in Taiwan (Kuo et al., 
2011) and WNV in the United States (Chuang and Wimberly, 2012). However, a 
negative association was seen between DENV and NDVI in Taiwan possibly due to 
the role of population density in transmission (Huang et al., 2018). The lag of one or 
two months between NDVI and number of cases of AES in this study, might therefore 
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suggest that vector breeding and development may occur prior to transmission of the 
pathogen.  
 
There was no association between the number of cases of AES or meningitis and 
elevation in any of the multivariate models. This is in keeping with the univariate 
analysis which also showed no association and the descriptive analysis which 
demonstrated that incidence of AES and meningitis was highest in provinces in the 
northwest of Vietnam and the Central Highlands which are at a higher altitude. Despite 
JE and S. suis being the most common pathogens causing CNS infections in children 
and adults respectively in Vietnam there was an absence of an association of pigs 
with cases of AES and meningitis in this study (Le et al., 2010). However, although 
there is a potential risk of acquiring JEV from being in close proximity to pigs, this 
remains undetermined (Liu et al., 2010; van den Hurk, Ritchie and Mackenzie, 2009). 
The greatest risk of S. suis is most likely to come from the consumption of or 
occupational exposure to raw pig blood or viscera (Huong et al., 2014b; Nghia et al., 
2011). It is therefore possible that these activities are more frequent in provinces with 
higher numbers of pigs however, further work would be needed to evaluate this. There 
is a spatio-temporal association with PPRS and S. suis (Huong et al., 2016) but it is 
unknown whether there is any relationship with the number of pigs per province at the 
national level. The poverty rate showed no association with either AES or meningitis 
despite highest incidence in provinces in northwest Vietnam and the Central 
Highlands which are poorer. It is possible that this is either not the driving force behind 
the cases or the difference in poverty rate for many provinces was quite similar, with 
Lai Chau being an outlier. Alternatively, there may be under-representation of those 
with CNS infections who are poorer as they are less likely to access healthcare. The 
inclusion of the number of hospitals per km2 was to account for access to healthcare 
which may bias the results. Although we might have expected a negative association 
given the higher number of cases in rural areas, no association was seen in the 
multivariate analysis. This might suggest that cases are being under-reported in these 





OBJECTIVE 3: TO DETERMINE THE POTENTIAL EFFECT OF THE JE 
VACCINE ON THE INCIDENCE OF AES AND MENINGITIS IN VIETNAM 
The third objective of this work aimed to determine the potential effect of the JE 
vaccine on the incidence of AES and meningitis. In 1998 vaccination against JE was 
taking place in ten provinces. By 2015 this had expanded to all provinces except Cao 
Bang. In the multivariate models, vaccination coverage was positively associated with 
the number of cases of AES and showed no association with the number of cases of 
meningitis. Although a negative association might have been expected as has been 
shown in Nepal (Upreti et al., 2017), this result is possibly due to the presence of 
vaccination campaigns which tend to take place in response to outbreaks of JE.  
 
OBJECTIVE 4: TO USE THE RESULTS FROM QUESTIONS 1, 2 AND 3 TO 
ESTIMATE THE AETIOLOGY OF AES AND MENINGITIS IN VIETNAM 
In summary, this study suggests of the potential pathogens causing a CNS infections, 
the spatio-temporal distribution of JE most closely resembles that of AES. However, 
it is unknown whether all of the cases are in fact due to JEV without diagnostic 
information. It is therefore possible that other pathogens contribute towards the cases. 
Leptospirosis has a similar distribution to AES and meningitis however, as the 
numbers are relatively small further investigation would be recommended. The 
seasonality of ILI and measles do not correspond with that of AES but it is interesting 
that the incidence of these pathogens is also highest in the provinces bordering Lao 
PDR and the central highlands and it is possible that they may contribute to some of 
the cases. Additionally, is possible that O. tsutsugamushi which is a common cause 
of CNS infections in neighbouring countries (Dittrich et al., 2015) and is also seasonal, 
contributes to some of these cases. Other pathogens known to cause CNS infections 
which are transmitted by mosquitoes and therefore influenced by the temperature and 
absolute humidity include WNV, ZIKV and CHIKV. Interestingly, there is no evidence 
that these are currently circulating widely in Vietnam despite suitable climatic 
conditions. The reasons for this are unknown however, it is possible that the 
circulation of both JEV and DENV may provide some immunity against other 
flaviviruses including WNV and ZIKV (Slon Campos, Mongkolsapaya and Screaton, 
2018). Finally, we should continue to consider novel pathogens as a potential 
aetiology as was proposed by Vietnam Initiative on Zoonotic Infections (VIZIONS) 
(Rabaa et al., 2015). 
	 155 
In the case of JE, we might wonder why incidence remains high despite good 
vaccination coverage. As JEV is zoonotic, it is not possible to obtain herd immunity 
through vaccination of the human population (World Health Organization, 2010). 
Therefore, ‘pockets’ of non-vaccinated individuals could continue to contribute to the 
relatively higher incidence of the disease in selected provinces. The reasons for a 
lower vaccination uptake amongst these populations could be wide ranging including 
vaccine hesitancy which has been shown to be associated with lower socioeconomic 
status (Larson et al., 2014), poor access to locations where vaccination is taking place 
or inability to afford vaccines. Additionally, a porous border exists between Lao PDR 
and Vietnam (Okello et al., 2015). Given that the JE vaccine was only introduced into 
the EPI in Lao PDR in 2015 (World Health Organization, 2015a) it would be worth 
exploring whether cases of JE in border provinces are occurring amongst Laotians.  
 
LIMITATIONS AND FURTHER WORK 
Ecological studies are observational studies where the unit of analysis is the 
population rather than the individual (Sedgwick, 2014). These types of study are often 
inexpensive and quick to undertake as data can often be obtained from surveys, 
registries or similar (Morgenstern, 1995). As data can be obtained from wide ranges 
in space and time ecological studies they are ideal for conducting spatio-temporal 
analysis (Meliker and Sloan, 2011) and may also be necessary if it is difficult to 
measure the exposure at the individual level, for example analyzing the effect of a 
population intervention (Morgenstern, 1995). However, as a result of aggregating the 
data, the studies are subject to ecological fallacy whereby the associations derived 
from the analysis are assumed to apply at the individual level (Sedgwick, 2014). 
Furthermore, adjustments for covariates at the population level may not provide a 
sufficient means of controlling for confounding (Morgenstern, 1995) particularly if the 
distribution of exposures and potential confounders within the groups studied is 
unknown (Guthrie, 2001). As a result of this, ecological studies may be better at 
generating rather than testing hypotheses (Morgenstern, 1995).  
 
Given that this study is conducted at the provincial level it is subject to ecological 
fallacy (Piantadosi, Byar and Green, 1988). Therefore, we cannot make any 
assumptions about individual risk of CNS infections. Additionally, it should be 
acknowledged that surveillance data in particular is often subject to reporting biases 
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(Lee et al., 2018) with potential differences in the interpretation of case definitions 
between medical staff and healthcare centres. Reporting rates may also have differed 
over time as the country grew economically, healthcare improved and the capacity for 
diagnostics increased. However, it is possible that a proportion of the population were 
missed either because they could not afford or did not have access to healthcare or, 
their symptoms were too mild to seek healthcare leading to selection biases.  
 
In addition to the potential biases with the surveillance data, I did not have evidence 
about the accuracy of the covariates and whether this data was validated. For 
example, I did not know how the number of pigs per province were counted, how the 
measurements used to determine poverty rate were determined and the quality of the 
recordings obtained from the weather stations. As data did not exist for many 
covariates for each year, this was imputed. Although imputation can reduce biases 
associated with missing data, there are caveats, particularly if the data was not 
missing at random as was the case for this study. In such situations the imputation 
itself may lead to additional biases (Sterne et al., 2009). For many of these covariates, 
it would be difficult to obtain data outside of the General Statistics Office for Vietnam. 
However, an alternative to using interpolated data from weather stations, climatic data 
can be obtained from satellite imagery such as land surface temperature (LST) (Li et 
al., 2013b) but given the computational complexities with obtaining monthly provincial 
level data over this time period this was not utilized.  
 
The accuracy of vaccination data can be particularly challenging as reported data 
often shows a higher coverage than is true (Murray et al., 2003). It should also be 
noted that vaccination coverage acts only as a proxy for immunity to JEV. To better 
understand the effect of immunity we would need to take into account the age 
distribution of those vaccinated in each province, the vaccine efficacy and duration of 
protection, and the likelihood of natural immunity based on the force of infection.  
 
Despite including data on the incidence of many pathogens, surveillance data was 
not available for a number of key pathogens causing CNS infections either in Vietnam 
or neighbouring countries including O. tsutsugamushi (Dittrich et al., 2015), TBM  
(Thwaites and Tran, 2005) and Herpes Simplex encephalitis (Tan le et al., 2014).  
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Based on the results and limitation of this the following recommendations would be 
made for future work: 
1.To conduct a cross-sectional study to ascertain the aetiology in provinces with a 
high incidence of CNS infections such as Son La and Lai Chau. This would help guide 
public health measures such as vaccination against pathogens such JEV, measles 
virus or influenza virus; or the provision of education about the prevention of bites 
from vectors or the consumption and handling of raw pig blood and viscera as 
required.  
2. To consider comparing models using: 
- tasselled cap wetness and brightness with those using NDVI. These 
variables were used by Longbottom et al. 2017 for their predictions of the 
suitability of Culex tritaeniorhynchus and take into account aridity which can 
affect mosquito dessication.  
- LST with those using temperature interpolated from weather station data.  
3. To compare the results from the INLA models with other methods such as MCMC, 
potentially with the aim of improving the fit of the model.  
4. To evaluate the reasons for the increase in incidence of AES in provinces in 
northwest Vietnam bordering Lao PDR. This might include looking at the migration 
across the border and JE vaccination status. 
 
CONCLUSION 
This work provides an insight into the risk factors associated with CNS infections in 
Vietnam based on surveillance data. The spatio-temporal patterns of AES correlated 
most strongly with JE however, other pathogens or syndromes showing similar 
patterns such as leptospirosis or ILI cannot be excluded. To understand this better, 
we would need to either expand diagnostic testing as part of surveillance or conduct 





CHAPTER 3 A PILOT CASE-CONTROL STUDY TO 
ASSESS THE RISK FACTORS FOR ACUTE 
ENCEPHALITIS SYNDROME IN PATIENTS 
ADMITTED TO THE NATIONAL HOSPITAL FOR 
TROPICAL DISEASES FROM THE RED RIVER DELTA 



























EPIDEMIOLOGICAL STUDIES  
Epidemiological studies can be divided into descriptive and analytical. Analytical 
studies aim to infer causality by allowing associations between outcomes and 
exposures to be measured (Carneiro, 2017b). These studies are divided into 
ecological studies, cross-sectional studies, cohort studies and case-control studies. 
This thesis has so far, used ecological data to explore the epidemiology of CNS 
infections in Vietnam. Ecological and cross-sectional studies are advantageous in that 
they are cheap and quick to undertake. However, they are often subject to biases and 
confounding. Cohort studies, whereby a population who have been exposed are 
followed-up over time to determine if they develop the outcome have fewer problems 
with bias and confounding however, are expensive and can be take a long time to 
conduct. Despite case control studies being subject to selection bias which may lead 
to the association between the exposure and outcome differing in the study population 
compared to the target population (Geneletti, Richardson and Best, 2009) and 
information bias which may result from inaccurate reporting of the exposures, 
potentially due to recall bias (Shapiro, 2004) and possible confounding if this is not 
taken into account in the study design or analysis (Smith and Day, 1984). They offer 
a more efficient approach to ascertain association whereby cases with the outcome 
are recruited and exposures measured at the same time (Carneiro, 2017a).  
 
CASE CONTROL STUDIES ADDRESSING RISK FACTORS FOR CNS 
INFECTIONS 
A number of cross sectional studies have been conducted in Vietnam to determine 
the aetiology of CNS infections (Tan le et al., 2014; Le et al., 2010; Ho Dang Trung et 
al., 2012; Taylor et al., 2012) however, case control studies to understand the risk 
factors for infection have mainly focussed on single pathogens, in particular S. suis.  
A study conducted at the Hospital for Tropical Diseases, Ho Chi Minh City between 
2006 and 2009 recruited 101 patients with S. suis meningitis, 303 unmatched hospital 
controls and 300 community controls matched on residency and age. Participants 
were interviewed by staff who completed a questionnaire to ascertain their risk factors 
for S. suis (Nghia et al., 2011). In Hanoi, a case control study was conducted to 
understand the association between S. suis and porcine reproductive and respiratory 
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syndrome (PRRS) recruiting cases with confirmed S. suis and hospital controls with 
sepsis not due to S. suis from the National Hospital for Tropical Diseases. Cases and 
controls were compared with outbreaks of PRRS both in space and time (Huong et 
al., 2016).  
 
In 1998, case control studies were conducted in northern Vietnam comparing risk 
factors for adults with AES compared to adults without AES and children with JE 
compared to children without AES. Epidemiological information was collected about 
the home environment including mosquito prevention measures, proximity to animals 
and JE vaccination status however, it was unclear whether the study staff visited the 
home of the participants to obtain this (Lowry et al., 1998). There is also no evidence 
that a similar study has been conducted since in Vietnam although a more recent 
study was undertaken in northern India in 2016 which recruited paediatric patients 
with AES and community controls. Field staff visited the homes of both cases and 
controls to obtain information on mosquito prevention measures, water and sanitation, 
proximity of vegetation to the house and presence of livestock. The data was collected 
electronically using tablets (Singh et al., 2016).  
 
Chapter two of this thesis showed that AES was seasonal in northern Vietnam and 
positive correlated with temperature, humidity and normalised difference vegetation 
index which may suggest that many cases were due to by vector-borne diseases. 
However, this analysis was subject to ecological fallacy with covariates provided at 
the level of province.  
 
To better understand the risk factors for AES in northern Vietnam a multi-centre case-
control study was therefore planned with the following objectives: 
1. to describe the spatial and temporal distribution of cases hospitalised with AES 
who reside in the Red River Delta region, northern Vietnam 
2. to compare the socio-demographic, environmental, entomological and zoonotic 
risk factors between AES cases and healthy controls. 
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Nested within this study two cross-sectional studies were to be performed to compare 
by aetiological agent: 
3. the clinical features on admission with outcome at hospital discharge and 
community follow-up  
4. the socio-demographic, environmental, entomological and zoonotic risk factors 
associated with AES. 
 
A pilot study was designed to help ensure the methods proposed for the case-control 
study were achievable and acceptable in this setting with the following objectives: 
1. to assess the recruitment rate of cases and controls 
 
2. to determine the feasibility of visiting participants within four weeks of hospital 
discharge  
 
3. to understand the practicality of undertaking participant questionnaires and the 
acceptability of photographing the local environment and housing during the 
community visits.  
 
Unfortunately, for logistical reasons, it was not possible to proceed to the full case 
control study. Therefore, the results of the pilot study are presented here. In addition 
to the objectives for the pilot study, the results of the clinical features, outcome and 
risk factors within the home environment are presented and discussed to provide 
suggestions for the development of the CRF and questionnaire for the future case 









The pilot study was conducted at the National Hospital for Tropical Diseases (NHTD) 
in Hanoi from 16th December 2016 to 15th June 2017. NHTD is a tertiary referral 
hospital for tropical and infectious diseases for the region with 634 in-patient beds 
(personal communication, OUCRU, Hanoi). The study flow chart for cases and 
controls are shown in figures 3.1 and 3.2 respectively.  
 







Patients screened on a daily basis for eligiblity criteria
Case (or relative) consented for the study
Case followed up throughout hospital stay and CRF completed by study staff
Case discharged from hospital (or died)
Phone call to case (or relative) at home to complete disability score
Arrange home visit with case/relative 4 weeks after discharge to complete a 
questionnaire about risk factors
3 months post-discharge - phone call to case (or relative) at home to 
complete disability score 
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Cases and controls were screened and recruited to the study in parallel. Patients 
admitted to the emergency department, intensive care unit (ICU), paediatric ward or 
general medical ward with suspected AES were screened by the study doctors for 
eligibility. Those who consented to be in the study, were followed through their 
hospital admission until discharge or death with their clinical details completed using 
a case report form (CRF). At the time of discharge and three months following 
discharge, the participant or their relative was contacted by telephone to complete an 
outcome score. Additionally, the cases or their relatives were contacted to arrange a 
home visit within four weeks of discharge to complete a questionnaire about risk 
factors for AES (figure 3.1).  
 
A list of potential controls was compiled by study nurses for their respective wards on 
a daily basis. These potential controls were matched to cases by the clinical trials 
team and consented by the study nurses. A home visit to complete a questionnaire 
about risk factors for AES was arranged within a four-week window period of 
undertaking a home visit to the matched case (figure 3.2). 
 
Nursing staff provided with a list of patients on their wards without  AES and 
likely to remain in hospital for 72 hours
Nursing staff added the age, gender, province of home and whether they lived 
with the patient to the list
Potential controls matched to cases 
Matched controls consented for the study
Arrange a home visit within 4 weeks of the home visit of the matched case to 





Cases were patients hospitalised with AES according to the WHO clinical criteria: “a 
person of any age, at any time of year with an acute onset of fever (before or after 10 
days of admission to the initial hospital/clinic) and either a change in mental status 
(including symptoms such as confusion, disorientation, coma or inability to talk) or a 
new onset of seizures (excluding simple febrile seizures) or other early clinical findings 
including an increase in irritability (in paediatric cases), somnolence or abnormal 
behaviour as well as focal neurological signs (World Health Organization, 2016).” 
 
Cases were also required to be living in one of the provinces in the Red River Delta 
region of northern Vietnam including Bac Ninh, Ha Nam, Hai Duong, Hung Yen, Nam 
Dinh, Ninh Binh, Thai Binh, Vinh Phuc or the municipalities of Hanoi and Haiphong 
and were required to provide signed informed consent with permission to visit the 
home or if they lacked capacity, informed consent could be provided by a relative or 
guardian. 
 
Cases were excluded from the study if they had evidence of an encephalopathy due 
to non-infectious cause (e.g. cerebrovascular accident, brain tumour, electrolyte 
imbalance (where not a complication of an underlying encephalitis or meningo-
encephalitis); encephalopathy due to an infectious cause other than a central nervous 
system infection e.g. sepsis secondary to pneumonia or a post-surgical 
meningitis/encephalitis. Cases could only be recruited once into the study. 
 
Cases were recruited from emergency department, intensive care unit (ICU), 
paediatric ward and general infection ward. Written informed consent was obtained 
from the case whilst in hospital or if the case lacked capacity, their relative or if a child 
aged under sixteen years, their parent or guardian. If during the home visit, the case 
had re-gained capacity, they were re-consented. Children aged twelve to fifteen years 




Controls were relatives and living in the same house of a patient with diagnosis of 
infection other than AES, and a likely length of hospital stay of 72 hours or more were 
to be recruited at a ratio of three controls to one case. Controls were matched to cases 
on province of home, gender, and age. Age was matched as follows: +/- one year in 
those aged under 3 years; +/- 2.5 years in the case of children aged 3-21 years; +/- 5 
years in those aged 22-49 years and +/-10 years (in those aged over 50 years. 
Controls were required to provide written informed consent or in the the case of 
children. Where relatives of cases were required to answer questions as proxy 
respondents (for example, if the case was too unwell to do so), it was aimed for an 
equal number of proxy respondents for controls to reduce the effect of response bias. 
 
Controls were excluded if they fulfilled the criteria for AES or had a past medical 
history of AES; lived in the house of someone with symptoms of AES or a past medical 
history of AES; had previously participated in the study. Controls could only be 
recruited once into the study. 
 
Where more than one suitable control existed, staff were instructed to assign numbers 
to each, and select one randomly using a random number table or random number 
generator. If a control declined participation, a subsequent control was then 
approached where available. 
 
Written informed consent was obtained from controls during their hospital visit. 
However, assent from children aged 12-15 years could be obtained at their home if 











ADMISSIONS TO NHTD 
A list of patient admissions over the study time period was provided by NHTD. Data 
on those with meningitis or meningo-encephalitis (Vietnamese: viêm não or viêm não 
màng não), the month and ward of admission of home province were extracted and 
to be used as baseline numbers of potential cases.  
 
SCREENING TOOLS 
Study doctors were asked to complete a screening log of all potential cases of AES 
who were not successfully recruited into the study and the reasons why. This was 
collected on a weekly basis (appendix 3.3). Nursing staff were originally asked to 
actively find controls who matched the cases however, it was noticed that there was 
very scanty recruitment of controls and therefore from 27th March onwards, additional 
support for recruitment was provided directly by OUCRU. The nursing staff were 
provided with lists of the patients on their wards and then asked to list the age, gender 
and province of their relatives and whether they lived with the patient. CTU staff then 
matched these with cases. The original feedback form is provided in appendix 3.4 
however as this was not completed by nursing staff, staff from CTU used their own 
system as a screening log. 
 
CASE REPORT FORMS (CRFS) 
Paper CRFs were completed by the study doctors for all cases. These included 
clinical details, medication, laboratory results and diagnosis (appendix 3.5). The 
covariates included the screening criteria for eligibility to understand which signs and 
symptoms of AES were seen most commonly and provinces from which the 
participants were recruited; the demographics of the participants to determine if there 
was any difference between the age and gender by aetiology; the duration of 
symptoms prior to seeking medical care and the duration of time before transfer to 
NHTD to understand the process of medical care in this setting; the Glasgow Coma 
Score, admission to ICU and intubation status as a marker of severity of illness; 
information on the past medical history to understand whether there may be any 
predisposing factors associated with AES; and the medications taken prior to 
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admission to understand whether prior antibiotic usage may be the cause of partially-
treated bacterial meningitis in cases with a negative CSF and blood cultures (Pandit 
et al., 2005) and steroids in the case of afebrile AES (Ward, Levin and Phillips, 2001). 
The results of the CSF were used to determine whether those in whom a pathogen 
was not detected were more likely to have a bacterial or viral aetiology. Any missing 
information was added by the CTU staff using the patients’ medical records.  
 
The Liverpool Outcome Score (LOS) was completed for children (University of 
Liverpool, 2006) and the Extended Glasgow Outcome Scale (GOS) for adults 
(Medaille and Usinger, 2019) (appendix 3.5) at discharge and three months after 
discharge as feasible. This was undertaken by telephone interview with the case or if 
the case had died, lacked capacity or was a child, by the parent, guardian or relative. 
For the purpose of this study, the same LOS and Glasgow Outcome Scale were used 
at discharge and three months post-discharge.  
 
FOCUS GROUP DISCUSSIONS (FGDS) 
FGDs were undertaken to determine the understanding of vector-borne diseases and 
prevention measures, animal contact and acceptability of home visits. It was 
anticipated that these would include a total of twenty relatives (five men from urban 
areas; five women from urban areas; five men from rural areas and five women from 
rural areas) of those with AES or an infection for which the duration of hospital 
admission was likely to be 72 hours or more. The decision to define the home location 
as rural or urban was at the discretion of the study nurse and the communities could 
include those outside the Red River Delta. These discussions aimed to help identify 
environmental and behavioural risk factors of vector borne diseases reported by the 
local community with questions being ordered in terms of priority in case some 
participants may have wished to leave the FGD early (appendix 3.6). It was 
anticipated that the information obtained could be used to refine the questionnaire 
conducted at the home of the participants. Informed written consent was obtained 





QUESTIONNAIRES AT THE HOME 
Cases and controls were interviewed by field staff within their homes about their 
environmental, socio-demographic and zoonotic risk factors for AES during the month 
prior to becoming unwell for cases, and within the previous two months for controls 
(appendix 3.8). A verification form of the risk factors was completed by the field staff. 
This included recording observations around the home (including taking photos) and 
obtaining global positioning system (GPS) (appendix 3.8). The covariates were 
selected based on the risk factors for pathogens which were common causes of CNS 
infections in Vietnam or the neighbouring countries as outlined in chapter one.  
If the case had died, following agreement with family members, the home was visited 
and a proxy respondent was interviewed. Similarly, if a case lacked capacity to answer 
questions or was a child aged under sixteen years, the questionnaire was completed 
by a relative, parent or guardian of their behalf. The questionnaire was conducted 
using the application ‘ODK Collect’ which is part of the electronic data capture 
software Open Data Kit (ODK) (Open Data Kit, 2020) using Samsung Galaxy Android 
smartphones. At the time of the home visit, the study participants also received an 
education leaflet about potential causes of AES (appendix 3.9). 
 
DIAGNOSTICS 
A lumbar puncture was undertaken in patients with AES at the discretion of the 
treating doctor as part of routine medical care and where no contraindications existed. 
At NHTD, the routine tests for AES include a CSF cell count and biochemistry; CSF 
and blood culture; Ziehl Nielsen staining, PCR and GeneXpert for M. tuberculosis 
(MTB); PCR for S. suis; ELISA (IgM) for Japanese encephalitis virus; NS1 and 
serology (IgM) for dengue virus (DENV) and PCR for herpes simplex virus (HSV). 
Other tests which are available include a Cryptococcal antigen, malaria film and 
antigen, PCR for enterovirus, PCR and serology (IgG) for rickettsia, serology for 
toxoplasma and serology for certain helminth infections. All tests are performed at the 
discretion of the treating doctor or medical team. The results of tests performed during 
hospital admission were documented in the CRF (appendix 3.5).  
 
All CSF samples underwent repeated tested by OUCRU Hanoi for a panel of 
pathogens with the exception of those which already had a confirmed diagnosis of S. 
suis. In this case, the pathogen was not tested for again. The choice of pathogens 
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was decided based on previous literature of the causes of CNS infections in Vietnam 
and neighbouring countries (Le et al., 2010; Taylor et al., 2012; Ho Dang Trung et al., 
2012; Dittrich et al., 2015; Turner et al., 2017). The pathogens and testing methods 
are outlined in table 3.1. Fast Track Diagnostics (FTD) multiplex PCR kits for viral 
meningitis, bacterial meningitis and tropical fever core have been used for other 
aetiology studies of encephalitis in similar settings (Turner et al., 2017; Goel et al., 
2017) and less expensive than using in-house methods. The multiplex PCRs were 
performed in accordance with the manufacturers’ guidelines (appendix 3.10). 
However, for pathogens including S. suis, O. tsutsugamushi, measles virus and 
rubella virus which were not included in the FTD multiplex PCR, an in-house PCR 
was used (appendix 3.11). JEV and DENV were tested in accordance with the 
standard operating procedure from the Lao-Oxford-Mahosot Hospital Wellcome Trust 
Research Unit (LOMWRU) (appendix 3.12 and appendix 3.13) using the InBios JE 
Detect IgM Antibody Capture ELISA and Panbio® Dengue IgM Capture, in addition 
to the PCR for DENV. The pathogens and the methods by which they were tested are 















Table 3.1 The pathogens tested for and methods of diagnosis.  
Pathogens Diagnostic test 
HSV 1 and 2 FTD (FTlyo viral meningitis) multiplex PCR 
Enterovirus FTD (FTlyo viral meningitis) multiplex PCR 
VZV FTD (FTlyo viral meningitis) multiplex PCR 
Mumps virus FTD (FTlyo viral meningitis) multiplex PCR 
N. meningitidis FTD (FTlyo bacterial meningitis) multiplex PCR 
S. pneumoniae FTD (FTlyo bacterial meningitis) multiplex PCR 
H. influenzae FTD (FTlyo bacterial meningitis) PCR multiplex 
DENV FTD tropical fever core multiplex PCR 
Rickettsia species FTD tropical fever core PCR multiplex PCR 
Salmonella species FTD tropical fever core multiplex PCR 
WNV FTD tropical fever core multiplex PCR 
Leptospira species FTD tropical fever core multiplex PCR 
CHIKV FTD tropical fever core multiplex PCR 
S. suis In-house PCR 
Measles virus In-house PCR 
Rubella virus In-house PCR 
O. tsutsugamushi In-house PCR 
JEV InBios JE Detect IgM Antibody Capture ELISA 
DENV PanBio Dengue IgM Capture ELISA 
 
STUDY CONDUCT ASSESSMENTS 
In addition to the screening tools for cases and controls group discussions took place 
at three and five months after the start of recruitment with hospital staff to obtain their 
views on any problems with the study in terms of recruitment and performing the 
questionnaire at the homes of the participants (appendix 3.14). Field staff were asked 
to provide feedback for each home visit including the time taken to reach the home 
and any problems with data collection (appendix 3.15). Group discussions also took 
place with the field staff at three and five months to identify any further issues 





Data from the paper CRFs and feedback forms was entered into the OUCRU 
electronic database ‘CliRes’ and downloaded as Microsoft Excel files for analysis. 
Data entered into the ODK application on the tablets was sent to an ODK Aggregate 
server hosted at the University of Liverpool. The data was downloaded as .csv files 
and .jpeg files for images for analysis. The data was cleaned using R statistical 
software with any queries referred back to the CTU for clarification. Any results which 
were still outside the range were removed from the analysis. A recruitment log of the 
participants was kept as a Microsoft Excel file by the CTU to record the participant 
details, their discharge date, follow-up and matched controls. Laboratory results were 
entered directly into Microsoft Excel. 
 
The discussions with the study staff as part of the study conduct assessment were 
recorded using dictaphones. The recordings were transcribed into Vietnamese and 
then translated into English.  
 
SAMPLE SIZE 
As this was a pilot study, no formal sample size estimation was undertaken. Within 
six months we estimated that fifty cases and one-hundred and fifty controls could be 





The number of admissions to NHTD with meningitis or meningo-encephalitis were 
totalled by month, ward and province and where available, the number of patients 
screened for eligibility as either a case or control. Using the screening logs for 
controls, the ratio of availability of potential controls by province, gender, age and 
whether they were living with the patient (relative) were calculated to ascertain where 
difficulties in recruitment may lie as a result of the matching.  
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The final aetiology for cases of AES was based on a combination of the diagnosis 
made NHTD and the laboratory results from OUCRU. In the absence of laboratory 
confirmation, a final diagnosis of S. suis or MTB was provided, based on clinical 
judgement alone. Two cases with laboratory confirmed JEV by NHTD were given a 
final diagnosis of JEV despite no pathogen being detected by OUCRU. This is due to 
the possibility of sample degradation during storage (Khalakdina et al., 2010). 
R statistical software was used for all quantitative analysis. Given the small numbers 
with individual pathogens, clinical data was summarised for all cases rather than 
individual aetiologies. The number and percentage were given for categorical 
covariates, and median and range for continuous covariates. The completion of the 
Glasgow Outcome Score did not appear consistent with the guidelines in many cases. 
Therefore, a judgement was made as to the final score which best fitted the 
guidelines.   
 
Conditional logistic regression was attempted to compare the risk factors ascertained 
from the questionnaires conducted at the home between cases and controls. 
However, due to the small number of matched controls to cases, the model was 
unable to converge. As a result of this, an unconditional logistic regression was used 
however, to account for the small sample size, Firth’s bias reduction method was 
applied using the R package ‘logistf’ (Ploner, 2018). If the number of events in a 
database is too low for example, lower than the number of risk factors, overfitting can 
occur whereby the predictions made by the models may be inaccurate and the model 
can fail to converge. A number of methods can be used to overcome this. Compared 
to other methods, Firth’s penalized method can introduce bias however, it is a less 
challenging approach (Rahman and Sultana, 2017). 
 
QUALITATIVE 
For each of the pre-defined questions in the FGDs, a list of words and frequency with 
which they were appeared in the transcript was constructed using the R package 
‘tidytext’ to produce a codebook (appendix 3.17). Words which appeared twice or 
more by either group were used to summarise the findings, referring back to the 
transcript to confirm the context in which they were discussed. If a word appeared 
once but the context in which it was provided was considered to be a useful finding 
this was also included in the summary. As unique identifiers were not provided and 
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consent was not obtained from participants to show individual quotes, the comments 
in the summaries may refer to one or more of the participants. Data was only available 
for the rural men and women.  
 
Study conduct assessments took place at three and five months with hospital and 
field study staff to obtain their views about any problems with study in terms of 
recruitment and performing the questionnaire. The study conduct assessments were 
semi-structured, using a set of pre-defined questions with the facilitator using prompts 
where required to explore topics in more depth. The assessments were recorded 
using dictaphones, transcribed into Vietnamese and translated into English.  
 
For each of the groups: field staff, nursing staff and doctors, the assessments at three 
and five months were combined. Key themes were constructed which aimed to 
address the study objectives with summaries of the text provided for each.   
 
ETHICS 
The study was approved by the Oxford Tropical Research Ethics Committee	
(OxTREC) (reference 42-15), the University of Liverpool ethics committee 
(RETH001070), the University of Liverpool Sponsorship (UoL001172) and the 






















During the study recruitment period, three hundred and fifty-five patients were 
admitted to NHTD with a diagnosis of meningitis or meningo-encephalitis (viêm não 
or viêm não màng não). Tables 3.3-3.5 show the distribution of these admissions by 
month and ward of admission and province in which they live. The number of patients 
admitted was higher during the spring compared to winter months, with the June 
predicted to be the month with highest number of admissions (n=45 until 15th). Most 
patients were admitted to the emergency department and the general infection ward 
(86%) and were from the Red River Delta (69.6%).  
 
Table 3.3 Month of admission of patients admitted to NHTD over the study recruitment 
period with an initial diagnosis of AES or meningo-encephalitis according to hospital 
data. 



















Table 3.4 Ward of admission of patients admitted to NHTD over the study recruitment 
period with an initial diagnosis of AES or meningo-encephalitis according to hospital 
data. 





























Table 3.5 Province of patients admitted to NHTD over the study recruitment period 
with an initial diagnosis of AES of meningo-encephalitis according to hospital data. 
Province Number of patients 


























































Study conduct assessments 
Recruitment of cases took place from 16th December 2016 until 1st June 2017. During 
this time, fifty cases were consented for the study, however, twelve were later 
identified to be ineligible for the study, leaving thirty-eight for analysis. 
Feedback was provided by doctors for twenty-eight patients who were not 
successfully recruited into the study for either one or more reasons. Thirteen patients 
lived outside of the Red River Delta, eight did not have impaired consciousness or 
seizures, seven had a post-operative meningitis or encephalitis and one did not have 
a fever.  
 
Themes from the discussion groups 
Four key themes emerged from the discussion groups with the doctors including 1) 
the study recruitment numbers and catchment area; 2) the process of informed 
consent; 3) the inclusion and exclusion criteria and 4) the transfer of cases to Dong 
Anh hospital and other departments. 
 
1. Study recruitment numbers and catchment area 
Despite there being many adult patients with AES, the doctors felt that the study 
catchment area was too small as many patients who fulfilled the inclusion for AES 
lived in provinces outside of the Red River Delta including Nghe An, Thanh Hoa, Bac 
Giang, Lang Son and Son La. Furthermore, they thought it more likely that patients 
with S. suis and MTB would be recruited if the catchment area was limited to the Red 
River Delta. They therefore suggested that the area be increased to include these 
areas. The lack of paediatric patients was thought to be due to a seasonal effect as 
most are normally admitted during the summer months.  
 
2. Informed consent 
Some doctors felt that the length of the ICF, including the need to verify consent by 
ticking boxes, was inconvenient. They commented that given the study collaboration 
with the UK, some participants may have believed that their homes would visited by 
foreign investigators, potentially causing anxiety. 
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3. Inclusion and exclusion criteria 
Some study doctors found the inclusion and exclusion criteria difficult to understand, 
particularly when cases were enrolled on the basis of the clinical criteria but were later 
found to have a normal CSF result. This was a particular problem in those with a 
reduction in conscious level of unknown cause. 
 
4. Transfer of cases to Dong Anh hospital and other departments 
Due to cases being from NHTD to Dong Anh hospital (a second tropical diseases 
hospital which opened in 2016) and to other departments, study doctors found it 
difficult to know whether to recruit cases with an anticipated transfer and if so, how to 
manage their follow-up in the study.  
 
Clinical results of cases recruited 
The final aetiologies of the cases of AES were as follows: S. suis (n=7 (18.4%); TBM 
(n=7 (18.4%)); JEV (n=2 (5.3%)); S. pneumoniae (n=1 (0.3%)); mixed pathogens (n=4 
(1.1%)) and no pathogen detected (n=17 (4.8%)). The mixed pathogens included one 
case with S. suis and S. pneumoniae, one case with S. suis and DENV, one case with 
MTB and VZV and one case with HSV and S. pneumoniae.  
 
With regard to the inclusion criteria, cases were recruited from all provinces in the 
Red River Delta with the exception of Van Phuc. The highest number of cases were 
from Hanoi (n=10, 26.3%) (table A3.1, appendix 3.18). Following a change in 
conscious level, the most common neurological presentation was seizures (n=10, 
26.3%) with very few or no cases having other signs or symptoms (table A3.2, 
appendix 3.18). The majority of cases were men (n=27, 71.1%), the median age was 
60 years with a range of 9-85 years) (table A3.3, appendix 3.18). 23.7% (n=9) of 
patients were admitted to ICU and the median GCS on admission to the initial hospital 
was 11 (tables A3.4 and A3.5, appendix 3.18). The most common medications given 
prior to admission were the antibiotics, ceftriaxone (26.3%, n=10) followed by 
ampicillin (13.2%, n=5) (tables A3.6, appendix 3.18) with over half of the cases having 
a lumbar puncture prior to admission to NHTD (51.4%, n=19) (table A3.7, appendix 
3.18). The median CSF white cell count was 310 cells/μl with a range of 3 – 15634 
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cells/μl with a median percentage of neutrophils of 70% (range 2-97%) and 
lymphoctyes 10% (1-96%) (table A3.8, appendix 3.18). The median length of hospital 
stay was 21 days, with 52.6% (n=20) discharged home and 7.9% (n=3) discharged to 
die (table A3.9, appendix 3.18). The Glasgow Outcome Score was completed for 
twelve cases at a median time of 27 days after discharge from NHTD with the majority 
of cases having an upper or lower severe disability (75%, n=9) (table A3.10, appendix 
3.18). The score was completed again for thirteen cases at a median time of 108 days 
post discharge where the percentage of those with an upper or lower severe disability 
had reduced to 53.9% (n=7) (table A3.11, appendix 3.18). The Liverpool Outcome 
Score was completed for one child. This was a score of two (“Severe sequelae, 
impairing function sufficient to make patient dependent”) at discharge and three 
(“Moderate sequelae mildly affecting function, probably compatible with independent 





Data was available from for a total of 1311 potential controls whose relatives were 
from the Red River Delta. Of these:  
• nine individuals who met the matching criteria refused participation in the study 
and four were discharged before consent. 
• 102 patients had no relative visiting so matching could not take place. 
• 182 patients had already been discharged and 14 transferred to Dong Anh 
hospital so could not be matched 
The first control was recruited on 24th January 2017. By 15th June 2017, twenty-one 
controls were recruited, matching with twelve cases. Eight controls were 
inappropriately recruited as three did not match the case on location and five did not 
fulfil the inclusion criteria (or there was missing data with regard to eligibility). One 
control was recruited despite not fully completing the consent form. Table A3.12, 
appendix 3.18 shows the feasibility of recruiting potential controls if the matching 
criteria had been altered based on the province of the home. Matching only on gender, 
sufficient numbers of females would have been recruited however, the number of men 
would have been insufficient for many provinces. However, once age and living with 
the patient were included as matching criteria, insufficient numbers would have been 
recruited from every province except Hanoi.  
 
Study conduct assessments 
 
Themes from the discussion groups  
Two key themes were found from the discussion groups with the nursing staff: 1) the 






1. Recruitment of controls 
Nurses experienced difficultly finding appropriately matched controls. The recruitment 
of male controls was particularly difficult as most of the visiting relatives were female. 
Additionally, it was challenging to find matches of an older age as relatives tended to 
be young. The nurses emphasised that they believed the age bands for matching 
were too narrow. In situations where the nursing staff found a control who matched 
on age, gender and province, they may not have lived in the same house as the 
patient as sometimes family members visit patients because they work in Hanoi but 
do not live with them. Furthermore, the relatives sometimes hire a helper who is of no 
relation to the patient and therefore ineligible for the study. In addition to the difficulty 
with age-matching, it was challenging to find relatives who came from outside of 
Hanoi. 
 
Although the nurses often carried out work in shifts, they did not consider this to affect 
the recruitment controls as they felt they could work more closely with relatives outside 
of the working hours, particularly with those visiting patients in ICU.  
 
When consenting controls, the nurses felt that as the relatives were healthy, there 
was some reluctance to participate in the study. Additionally, some participants 
appeared uncomfortable with the prospect of people visiting their homes to take 
photos. There were different opinions regarding reimbursement for the participants. 
Some nurses believed that the controls should receive a higher payment for 
participation. However, other nurses didn’t think that reimbursement influenced a 
control’s decision to participate and if they wished to be in the study they would.  
 
2. Follow-up of patients after discharge to complete the disability scores 
The nurses claimed that there was some difficulty following up patients after 
discharge, especially when transferred to another hospital. The nurses emphasised 
that it could be challenging to contact patients at certain times of the day. They also 




During FGDs at five months after the start of recruitment, the nurses again explained 
the difficulty with recruiting controls who were reluctant to agree to the study. 
According to the nursing staff the relatives of patients were afraid of having ‘troubles’ 
and ‘did not like anything related to the patients and hospital’.  
 
OBJECTIVE 2: TO DETERMINE THE FEASIBILITY OF VISITING 
PARTICIPANTS WITHIN FOUR WEEKS OF HOSPITAL DISCHARGE  
Thirty-seven cases received a home visit. Of these, data was available for twenty-
seven after excluding those who were ineligible. Fifteen controls received a home visit 
with data available for six after excluding those recruited in error or who did not fully 
complete the consent form. The median time between discharge and home visit was 
39 days with a range of 15 to 98 days using data available from 25 cases. The median 
time between the visits to the homes of cases and controls was 20 days with a range 
of -5 days to 71 days.  
 
Feedback from field staff was not fully completed. Therefore, accurate information on 
the date the distances travelled and time taken to reach the house is missing. How 
key themes from the discussion group at three months since the start of the study are 
shown below under objective 3.  
 
OBJECTIVE 3: TO UNDERSTAND THE PRACTICALITY OF UNDERTAKING 
PARTICIPANT QUESTIONNAIRES AND THE ACCEPTABILITY OF 
PHOTOGRAPHING THE LOCAL ENVIRONMENT AND HOUSING DURING 
THE COMMUNITY VISITS  
 
THE DISCUSSION GROUPS WITH THE FIELD STAFF  
Two main themes emerged from the discussion groups with the field staff: 1) the 





1. Acceptability of the questionnaire 
Generally, cases were happy to complete the questionnaire and taking photos of the 
home environment was acceptable. However, field staff occasionally experienced 
some reluctance from other family members in the home. There were also some 
difficulties finding a suitable proxy respondent, particularly as this participant was not 
informed of the study beforehand. On one occasion, the participant’s neighbours were 
suspicious of the field staff but after showing identification and explaining the study, 
the issue was resolved. Most questions were easy for staff to follow however, some 
participants would be inconsistent with their answers, for example, declaring the use 
of treated water and then changing it to rain water.  
 
2. Using the ODK Collect application 
In general, there were few problems with the Android or the ODK application. 
However, the battery on the Android could run out quickly. During the group 
discussion at five months following the start of recruitment, field staff advised that the 
maximum travel time was a return trip totalling six hours. There were some difficulties 
if the participants’ homes were in remote areas where public transport was 
unavailable and could not be located using GPS. Additional challenges occurred 
when the incorrect phone number for the participant was provided. Despite the staff 
being flexible with regard to arranging home, visits, they found it difficult to enquire 
persistently about discharge dates which may have led to some withdrawing from the 
study. Additionally, only one out of four relatives of patients who died accepted a home 
visit.  
 
FGDS WITH RURAL PARTICIPANTS 
The responses to the questions for the FGD which are outlined in appendix 3.6 are 
shown below.  
 
1. In the area where you live are there places where you think you would be 
bitten by mosquitoes? What time of day? 
Both women and men talked about the presence of vegetation such as plants and 
trees around the house which attract mosquitoes. Both rural women and men also 
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identified water storage as a place where there are mosquitoes with rural women 
discussing rubber tyres and rural men discussing water storage tanks. The rural 
groups discussed natural water sources as sites for mosquitoes including rivers and 
ponds with the men also discussing rice fields. Rural women discussed their keeping 
of animals, with a reference to the abundance of excreta and mosquitoes whereas 
some of the urban women believed that the presence or absence of mosquitoes 
around their homes was dependent on the presence of livestock kept by neighbours 
with some urban women claiming not to see any mosquitoes around their homes. 
 
Rural women considered the afternoon, particularly the late afternoon to be the time 
at risk for bites. Some also discussed a risk of bites in the morning. Rural men also 
considered the late afternoon and early evening to be a risky time and urban women, 
the evening and night.  
 
2. What are the ways in which you try to prevent mosquito bites when you are 
inside your house? What else could you do, even though you currently don’t? 
Why don’t you do these things?  
Both men and women discussed the use of bednets for the prevention of mosquito 
bites. The rural participants claimed that their communes were sprayed two to three 
times per year whereas some of the urban women sprayed their homes themselves. 
Neither rural men nor women used a ‘cream’ to prevent mosquito bites with some 
women stating that they either had no time to apply it or were concerned about side 
effects however, some of the urban women used this on their children or 
grandchildren. Rural women discussed closing doors and windows to prevent 
mosquito entry to the house with all groups mentioning that door nets were used 
rarely, if at all by either themselves or their communities. Urban women discussed the 
use of rackets and machines to kill mosquitoes. 
 
3. Why do you try to avoid mosquito bites? 
The avoidance of mosquito bites to prevent disease was mentioned by all groups 
however, there was some discrepancy amongst the rural women with some believing 
that mosquitoes could only cause fever and not transmit disease.  
	 185 
4. Do you know of any diseases caused by mosquito bites? Tell me about these 
diseases and how do you get these? (If not discussed, then ask ‘Tell me what 
you know about Japanese Encephalitis and Dengue Fever”) 
Without prompting, those from all groups recognised dengue fever as being 
transmitted by mosquitoes.  However, the rural men considered malaria to be the 
main infectious disease transmitted by mosquito bites, stating that there were many 
cases in their area. JEV was mentioned only within the FGD with rural women. 
 
5. Would you spend time in rice fields e.g. what time of year?   
Both men and women worked in the field or had neighbours who did so. Both men 
and women work in the field during the two farming seasons which the rural 
participants stating that occurs between October and January and the summer 
months. Urban women also discussed growing vegetables all year round.  
6. Which animals are there in your community?  
6a. Do you have any type of contact with each of these animals? If Present, 
which animals do you have contact with and what is the type of contact? 
- e.g.do they live in the house, do you look after any animals  
Both rural women and men discussed keeping dogs, cats, chickens and pigs. Dogs 
and cats were kept by rural participants to protect the house with cats being used to 
catch mice. The presence of rodents around the home environment was raised as an 
issue by all groups. Rural men discussed raising chickens for food. Rural men also 
stated that they kept goats and cattle. In terms of contact, feeding animals was 
common amongst both groups and showering pigs was discussed by rural women. 
Men also discussed slaughtering animals.  
 
7. Which animals do you eat? What do other people in your community eat? 
How often (use counters)? Which of these are eaten raw? 
Both men and women discussed eat pork, chicken, beef and fish. Rural groups also 
ate mice. The rural women stated that they sometimes prepare and eat mice and the 
blood of hedgehogs and ducks, whereas urban women discussed the consumption of 
pork blood puddings by family members. The rural men claimed that although family 
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dogs and cats were not slaughtered for food, the raw meat would be purchased from 
the market on special occasions.  
 
8.  How would you feel if we came to your house to perform a questionnaire? 
9. How would you feel if we took photographs around your house? 
Generally, the men had no problem with the idea of a home visit however, there were 
mixed opinions from the women. Some women were concerned that they lived far 
away and other were embarrassed due to their house being ‘poor’ or ‘ugly’. The 
women stated that during a house visit they would like some advice on how to prevent 
mosquitoes and improve hygiene. 
 
THE RESULTS OF THE QUESTIONNAIRE CONDUCTED DURING THE 
HOME VISIT 
 
The key results from the questionnaire are shown in tables A3.13 to A3.17, appendix 
3.18.  
 
29.6% (n=8) of cases and 33.3% (n=2) of controls worked as farmers. 81.5% (n=22) 
of cases and all of the controls had received some form of education. The majority of 
cases and controls had a monthly household income of up to 10 million Vietnamese 
Dong (VND) (81.5% (n=22) and 66.6%, n=4, respectively). The majority of cases and 
controls shared their bedroom with one other person or no other people (85.2%, n=23 
and 83.3%, n=5, respectively) and 11.1% of cases (n=3) and 16.7% (n=1) of controls 
used a water source which included an unprotected well, river, stream, pond or lake 
(table A3.13, appendix 3.18).  
 
All cases and controls used a simple bed net for mosquito prevention but only one 
case used an insecticide treated bed net. All of the controls and 74.1% (n=20) of 
cases slept under a bed net in the two months prior to conducting the questionnaire 
or the month prior to becoming unwell, respectively. 29.6% of cases compared to 
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100% of controls claimed that indoor residual spraying (IRS) of the house had been 
previously carried out (table A3.14, appendix 3.18).  
 
Five of the cases (18.5%) and none of the controls had contact with a pig in the month 
prior to becoming unwell or the last two months, respectively. 74.1% (n=20) of cases 
and 83.3% (n=5) of controls had seen rats around the house or place of work in the 
month prior to becoming unwell or the last two months, respectively and 66.7% (n=18) 
of cases and 50% (n=3) of controls ate or prepared raw meat, viscera or blood in the 
month before becoming unwell or the last two months (table A3.15, appendix 3.18). 
 
29.6% (n=8) of cases and 50% (n=3) worked in rice fields and 48.1% (n=13) of cases 
and 33.3% (n=2) of controls had walked through grassland in the month before 
becoming becoming unwell or the last two months respectively. 22.2% (n=6) of cases 
and 33.3% (n=2) of controls had travelled outside the province in the month before 
becoming unwell or the last two months respectively (table A3.16, appendix 3.18). 
Only two cases could recall having been vaccinated against JEV and none against               
N. meningitidis or H. influenza. Three cases and one control recalled being vaccinated 
against measles (table A3.17, appendix 3.18). 
There was no evidence for a difference any of the potential risk factors between cases 
and controls with the exception of IRS (p=0.002) (table A3.14, appendix 3.18). 
 
3.4 DISCUSSION 
This pilot case control study conducted at the National Hospital for Tropical Diseases 
in Hanoi aimed to assess the feasibility and acceptability of using a number of 
methods both in terms of study design and data collection to understand the risk 
factors for AES. The results of these were to be used to develop a future, larger case 
control study. The use of electronic data capture at the homes of cases and controls 
worked well. However, despite adequate recruitment of cases, most had a bacterial 
meningitis rather than a viral encephalitis and recruitment of controls was 
unsuccessful. The main outcomes are discussed below for each of the objectives. 
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Use of the WHO case definition for AES 
The target of fifty cases was met without difficulty. This was to be expected given that 
two hundred and forty-seven of patients with AES or meningo-encephalitis from the 
Red River Delta region were admitted to NHTD over the same time period. However, 
the majority of cases had a bacterial meningitis due to S. suis or TBM with recruitment 
of patients with a viral encephalitis posing a challenge. In retrospective 
epidemiological studies, a case definition is imperative to ensure that there is reliability 
in determining the presence of disease and also selecting controls who are 
appropriate (Sharma, 2011). As detailed in chapter one, there are many case 
definitions for encephalitis. However, a number of these are reliant on diagnostic tools 
which may not be available in resource-poor settings. Many countries use the WHO 
definition of AES for surveillance of JE (Heffelfinger et al., 2017). The WHO definition 
is stated as “a person of any age, at any time of year with an acute onset of fever 
(within 10 days of admission to initial hospital/clinic) and either a change in mental 
status (including symptoms such as confusion, disorientation, coma or inability to talk) 
or a new onset of seizures (excluding simple febrile seizures) or other early clinical 
findings including an increase in irritability (in paediatric cases), somnolence or 
abnormal behaviour as well as focal neurological signs” (World Health Organization, 
2016). Despite its use, the sensitivity and specificity in determining laboratory 
confirmed JE was shown to be 65% and 39%, respectively. Adding in features such 
as acute flaccid paralysis and meningism improved this the sensitivity to over 85% 
but reduced the specificity to 26% with acute flaccid paralysis (AFP) and 23% with 
meningism (Solomon et al., 2008). It is therefore possible that this case definition was 
not specific enough for this study. However, had recruitment occurred during the peak 






The procedural aspects of recruitment 
The doctors did not appear to struggle with consenting patients however, 
unfortunately, twelve of the fifty cases did not fulfil the inclusion criteria despite being 
recruited into the study. It is unknown whether these were due to errors with data 
entry. However, the doctors did struggle in determining whether patients with a 
reduced level of consciousness might be eligible and the difficulty in differentiating 
between encephalopathy and encephalitis is already known (Quist-Paulsen et al., 
2019). Unfortunately, the doctors did not routinely complete the feedback forms, 
thereby making it difficult to understand how many patients were screened. 
 
The case report form 
Generally, there little missing data from the CRFs. However, it was evident from the 
case report form that many participants had received treatment and had diagnostics 
undertaken prior to admission to NHTD. Although it was not the purpose of this pilot 
study to determine clinical risk factors, it would be imperative to collect this data from 
the hospital from which the cases were transferred as the CSF results from NHTD 
could indicate a partially treated bacterial meningitis (McGill et al., 2016).  
 
The follow-up after discharge 
Unfortunately, follow-up after discharge was not completed for all participants as the 
nursing staff often found it difficult to make contact. Therefore, this loss to follow-up 
would need to be accounted for in the design of the larger case control study. 
Additionally, it was apparent that the nursing staff struggled with the completion of 
extended GOS. Therefore, either further training or a change to the scoring system 




The procedural aspects of recruitment 
The recruitment of controls using the planned methodology was inadequate. Despite 
support from the staff from OURCU half-way through the recruitment process, it 
remained too difficult to match controls on all criteria required.  
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The study base principle assumes that case and controls are representative of the 
same underlying population, including in time (Wacholder et al., 1992a). When the 
cases and controls are a random sample of those with and without disease within the 
study base, this principle has been met (Wacholder et al., 1992a). As confounding 
can lead to biased results, controls can be matched to cases to help reduce this. For 
example, socioeconomic confounders may be reduced by matching the home of the 
control to the neighbourhood of the case. However, we need to be careful not to 
overmatch, whereby the population are too similar in terms of the exposures being 
studied. This can reduce the precision of the effect size (Wacholder et al., 1992a). 
With regard to the comparable accuracy principle, the degree of measurement errors 
between the cases and controls should be equal (non-differential) (Wacholder et al., 
1992a).  
 
In this study, it was noted that there was a gender imbalance in the relatives caring 
for patients with more females and males whilst cases were predominantly male. 
Additionally, matching on the same province and relatively narrow age ranges as the 
case added to this difficulty. As a result of this, the number of controls recruited was 
far below the number required (twenty-one compared to one-hundred and fifty).  
 
In addition to the methods of selection of controls, the types of controls also need to 
be considered. For example, controls may include population controls, neighbourhood 
controls, hospital controls or relative controls each with their own advantages and 
disadvantages (Wacholder et al., 1992b; Grimes and Schulz, 2005). It was not 
feasible to recruit population controls for this study given the number of local 
permissions required in advance. Therefore, in order to recruit sufficient number of 
controls for the future study, either the matching criteria would need to be changed 
for the relative controls or consider the use of hospital controls. Hospital controls are 
patients admitted to the same hospital as the cases and therefore are considered to 
be from the same secondary base. However, care must be taken if patients live in 
different catchment areas depending on the severity of the disease (Wacholder et al., 
1992b). Additionally, the exposure may be distorted as there may be selective 
inclusion of patients with related diseases (Wacholder, 1995). Despite this, hospital 
controls may be more convenient and provide information which is of comparable 
quality to the cases (Wacholder et al., 1992b).  
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OBJECTIVE 2: TO DETERMINE THE FEASIBILITY OF VISITING 
PARTICIPANTS WITHIN FOUR WEEKS OF HOSPITAL DISCHARGE  
The median time between discharge from NHTD and home visit was 39 days 
indicating that many were seen outside of the four-week period. However, some cases 
were transferred to other hospitals for which the date of discharge was not necessarily 
known and the field staff found it challenging to repeatedly contact the relatives of the 
cases to arrange a time to conduct a home visit and therefore, this process may need 
to be reconsidered in a future study. 
 
OBJECTIVE 3: TO UNDERSTAND THE PRACTICALITY OF UNDERTAKING 
PARTICIPANT QUESTIONNAIRES AND THE ACCEPTABILITY OF 
PHOTOGRAPHING THE LOCAL ENVIRONMENT AND HOUSING DURING 
THE COMMUNITY VISITS  
 
Field staff found that the questionnaire was generally acceptable to the cases and 
families and during the FGDs, with the exception of some concerns about the how the 
staff may perceive their home participants implied that they would be happy to be 
visited. However, the use of a proxy respondent had to be abandoned that this was 
found not to be feasible. As shown in the results of the data, there was little missing 
data, indicated as ‘unknown’. The ODK Collect application also worked well for the 
majority of the time with the exception of a period during which the forms could not be 
sent over Wi-Fi following the installation of a new Secure Sockets Layer (SSL) 
certificate for the server hosted at the University of Liverpool.  
 
A number of electronic data capture (EDC) tools now exist for collecting data during 
such studies (King et al., 2014). EDC tools offer a number of advantages over paper 
data collection both in terms of data quality as in-built validation methods reduce the 
need for mistake to be made during data entry and transcription (Maduka, Akpan and 
Maleghemi, 2017; Meyer et al., 2013). Additionally, the data can be sent to the end 
user in real-time (Zhang et al., 2017b) and finally, the data is more secure as a result 
of the absence of the need to print and transport paper copies of questionnaires (King 
et al., 2013). However, challenges of EDCs including the ability to charge the battery 
of the mobile device and the availability of internet access to send the data are 
acknowledged (Style et al., 2017). The use of electronic data collection in this study 
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allowed for the rapid acquisition of information but also minimised the need for data 
cleaning improving the efficiency of the data management and analysis. The provision 
of GPS coordinates and photos around the home allowed myself, as the lead 
investigator who did not conduct home visits to be able to remotely monitor the visits 
and visualise the living environment. 
 
RECOMMENDATIONS FOR THE FUTURE LARGER CASE-CONTROL 
STUDY 
Following this pilot study, a number of recommendations are made below to 
progress to a future larger case control study to understand risk factors for AES. 
 
CASE RECRUITMENT 
1. To include cases who have ≥5 white cells/μl or more in the CSF. This may help 
to improve the specificity of recruiting those with a CNS infection and also to 
help doctors to decide whether to recruit patients when they are unsure about 
the diagnosis. However, the exclusion of those in whom a lumbar puncture is 
contraindicated may lead to a recruitment bias.  
 
2. To consider excluding patients with TBM or bacterial meningitis based on 
hospital diagnostics. However, this would only be possible at sites where these 
diagnostics are available, potentially excluding more rural hospitals where 
many cases of AES may be seen. Additionally, cases who die before their 
results are available may lead to recruitment bias. 
 
3. To consider recruiting patients only during the summer months e.g. May to 
September. This is the peak season for viral encephalitis and will avoid 
recruiting an excess of patients with bacterial meningitis or TBM during the 
winter months. This will help to improve the cost and efficiency of the study.  
 
 
4. To ensure a greater proportion of cases are children, a paediatric hospital site 




5. To expand the study catchment area to include the whole of northern Vietnam 
and possibly the north-central provinces. The data from chapter two shows 
that many cases of AES come from the border provinces of Son La and Lai 
Chau. However, if house visits are still to be performed, travel to these 
provinces would have to be taken into consideration. This may require the 
employment of additional field staff thereby increasing study costs. 
Alternatively, the questionnaire could be performed in the hospital with GPS 
coordinates of the home of the case obtained using the full address of the 
participants. Home visits could be reserved where spatial clusters of disease 
are found which require further investigation. Prior to undertaking this method, 
it would be useful to compare if there are any discrepancies in results between 
home and hospital conducted questionnaires before moving to this method.  
 
6. Where possible, to employ a study team consisting of one or two study doctors 
or nurses who can recruit across different wards. 
 
CONTROL RECRUITMENT 
1. To amend the matching process for the controls. The age bands for matching 
could be wider; for example, matching those aged 15 years and below and 
above 15 years would be satisfactory to account for differences in aetiologies 
by age. Additionally, instead of matching on province, it may be more efficient 
to match on urban/rural living. The parameters for urban/rural would need to 
be set, most likely depending on population density.  
 
2. To recruit patients without CNS infection rather than relatives as controls. 
Although it is acknowledged that there may be some biases, this primarily 
might reduce the problem of matching on gender and age. These patients may 
also feel more comfortable about participating in a study compared to the 
healthy population. 
 
3. To recruit controls directly from the community using a random selection of 
communes within the study catchment area instead of hospital controls. This 
is a more efficient process as field staff can go from door to door to find an 
appropriate match. This would also avoid the need to follow-up controls until 
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discharge and then find a suitable time frame in which to visit the home. If 
either a blanket permission for the study catchment area and time-frame could 
be provided or permission obtained on the day this may be feasible. However, 
this approach needs to be further explored. 
 
4. To remove the need for a proxy control (used when the questionnaire is 
answered by the relative of a matched case). 
 
 
STUDY DATA COLLECTION 
 
1. To recommend that field staff explain the study and agreement of the 
participant carefully to all family members when visiting the home where 
applicable to avoid any misunderstanding. If there is still disagreement 
arrange the visit at a different time or give the option to the participant to 
withdraw if they feel if would make relatives unhappy. 
 
2. To advise field staff to fully charge the Android after every use and take a 
battery pack with them to the homes. 
 
3. To review the questionnaire and amend the wording of any questions which 
caused confusion or add additional skip patterns where required. 
 
4. To have a centrally managed log system for monitoring follow-up whereby one 
member of staff is responsible for contacting the participants to gain 
information about discharge and arrange home visits. 
 
5. To use a single data collection method and database. As this study used a 
combination of methods, multiple databases with different data dictionaries 
were produced which reduced the efficiency of analysis.  
 
6. To consider conducting home visits within four weeks of cases developing 
symptoms rather than discharge from hospital to account for the possibility of 
long hospital admissions and increased risk of recall bias. It is not necessary 
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for the participant to be at the home during the visit and providing the 
participant has capacity, sections of the question could be conducted whilst 
they remain an in-patient.  
 
CONCLUSION 
Despite its difficulties, this pilot study provided useful information to inform a larger 
case-control study to understand the risk factors for AES in northern Vietnam. 
Primarily, the either the matching criteria of the controls should be amended or the 
use of community controls should be considered; the study catchment area should 
include more rural areas in northern Vietnam; the cases should be recruited after the 
CSF results are available; and a paediatric hospital should be included. Furthermore, 
it may be more efficient to recruit only during the peak season for encephalitis. The 
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THE ROLE OF HUMAN MOBILITY IN PREDICTING THE RISK FACTORS 
FOR AND TRANSMISSION OF PATHOGENS 
The movement of humans can influence both the acquisition and transmission of a 
number of pathogens. Understanding the exposure to environmental pathogens 
through the utilisation of movement data can be beneficial for epidemiological studies 
(Owers et al., 2018) and can help guide strategies for the control of infectious 
diseases (Pindolia et al., 2012). The capture of socio-demographic data can help 
determine whether there are differences between groups of individuals with regard to 
their exposure and hence, potential risk of infection.  
 
A study conducted in Uganda showed that the time mothers and young children spent 
at the shore of Lake Albert was positively associated with the prevalence of 
schistosomiasis, a water-borne parasite which is transmitted via snails (OR=2.1, 
95%CI 1.2-3.7). Amongst young children alone, this association was even higher 
(OR=4.4, 95%CI 1.4-14) (Seto et al., 2012). A study conducted in an urban informal 
settlement in Salvador, Brazil, aimed to identify exposure to environmental sources of 
Leptospira, a spirochete which is transmitted via the urine of an infected mammal. It 
was found that men visited a larger area compared to women over a 24-hour period. 
Moreover, there was significantly higher exposure to locations where there was 
evidence of rodent activity or waste amongst those infected with leptospirosis (Owers 
et al., 2018). In south central Vietnam, a large-scale survey found that undertaking 
regular forest work and sleeping overnight in the forest was associated with an 
increased risk of infection with malaria (OR=1.76, 95%CI 1.05-2.94; and OR=2.86, 
95%CI 1.62-5.07) (Erhart et al., 2005).  
 
As described in previous chapters, cases of AES in Vietnam can be due to a number 
of pathogens. Risk of infections from vector-borne diseases depends on the time at 
which the vectors bite, the number of infected vectors and the time a person spends 
at a location (Stoddard et al., 2009). In children, the most common pathogen causing 
AES in Vietnam is JEV (Tan le et al., 2014). A study conducted in Bali, Indonesia 
found that proximity to rice fields (<100m from the home) was a risk factor for 
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serologically confirmed JE (81% of cases compared to 59% of controls, p=0.0004), 
as well as playing outdoors (55% of cases compared to 41% controls, p=0.028) (Liu 
et al., 2010). DENV is an another cause of AES in Vietnam (Tan le et al., 2014; Phu 
Ly et al., 2015) and a study conducted in Hanoi found that those who lived near an 
open sewer were more likely to have dengue fever or dengue haemorrhagic fever 
(p<0.01) (Toan et al., 2015). Although not a known cause of AES in Vietnam, CNS 
manifestations of scrub typhus have been documented in neighbouring Lao PDR 
(Dittrich et al., 2015). A case control study conducted in South Korea found that cases 
of scrub typhus were more likely to undertake dry field farming (p=0.013) (Kim et al., 
2018), and a case control study conducted in Beijing, China, found that the most 
common risk factors for scrub typhus infections included working in vegetable fields 
and hilly areas (OR=3.7, 95%CI 1.1-11.9 and OR=8.2, 95%CI 1.4-49.5) (Lyu et al., 
2013). Environmental risk factors may also play a part in the acquisition of non-
infectious causes of AES. A case control study conducted in northern India found that 
those who had a litchi orchard within the vicinity of their home were more likely to 
have AES (OR=3.25, 95%CI 2.10-5.00) (Singh et al., 2016). A separate study showed 
that the consumption of litchis was associated with AES (Shrivastava et al., 2017).  
 
 
Increasing travel networks increase the speed and magnitude of the transmission of 
pathogens (Tatem, Rogers and Hay, 2006). This is particularly true of pathogens 
spread by aerosol or droplet as demonstrated by the recent global spread of SARS-
CoV-2 (Wells et al., 2020). Air travel also plays an important role in the international 
spread of influenza A as demonstrated during the 2009 H1N1 pandemic (Kenah et 
al., 2011; Mesle et al., 2019). However, it is thought that short-distance commutes for 
work greatly influence the spread at a regional level, particularly from more to less 
populated areas (Charu et al., 2017; Viboud et al., 2006). For example, the 
seasonality of measles and rubella viruses has been shown to be dependent on 
human mobility at the local level, with epidemics propagating from larger to smaller 
cities (Marguta and Parisi, 2015; Wesolowski et al., 2015a).  
 
In addition to pathogens transmitted by droplet or aerosol, human mobility has also 
been implicated in the spread of pathogens transmitted via alternative routes. Ebola 
virus is primarily contracted following contact with infected bodily fluids (Bausch et al., 
2007). It  is thought that the rapid progression of the 2014-2016 West African epidemic 
of Ebola virus disease was in part due to the effect of the movement of infected people 
from rural to urban areas and also across porous international borders between 
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Guinea, Sierra Leone and Liberia (Coltart et al., 2017). Cholera is a diarrhoeal disease 
caused by the bacterium Vibrio cholerae which transmitted between people via the 
faecal-oral route (Zuckerman, Rombo and Fisch, 2007) and epidemics of cholera may 
be caused by the introduction of the pathogen into previously uninfected areas, 
potentially via asymptomatic shedding by those infected (Mari et al., 2012).  
 
In addition to pathogens which are spread between humans without an intermediate 
host, human mobility is also thought to be responsible for the spread of vector-borne 
diseases (Adams and Kapan, 2009). The Ae. aegypti mosquito generally does not 
travel far (Harrington et al., 2005) and it is thought that the spread of DENV is the 
result of the movement of infected humans between mosquito communities (Adams 
and Kapan, 2009). At a fine spatial scale, it is thought that the movements of humans 
between houses plays an important role in the transmission of the virus (Stoddard et 
al., 2013). At a larger scale, it is thought that the human mobility in combination with 
changes in climate which provide sites conducive to mosquito breeding, can result in 
the spread and introduction of the virus to new locations (Wesolowski et al., 2015b; 
Thapa and Sapkota, 2017; Teurlai et al., 2012).  
 
 
THE COLLECTION OF MOBILITY DATA: GLOBAL-POSITIONING DEVICES 
(GPS) 
Human mobility data can be collected by a variety of methods. At the population level, 
flight data, censuses, household and displacement surveys, mobile phone usage data 
and social media can be used to track movements. However, these have limitations 
in terms of confidentiality agreements and accessibility (Tatem, 2014). Mobile phone 
data may be subject to biases as not all of the population have access to phones or 
the internet (Tatem, 2014; Wesolowski et al., 2012). Additionally, the data  are 
anonymous and do not allow for differentiation of demographics.  
 
At the individual level, the use of personal devices such as Global Positioning 
Systems (GPS) may be used to provide information. In Uganda, the association 
between water contact and schistosomiasis was determined by GPS data. 
Participants wore GPS devices for a period of 3 days to evaluate water contact and 
interpersonal interactions (Seto et al., 2012). In Iquitos, Peru, the use of GPS devices 
to assess human movement patterns in relation to the transmission of DENV was 
shown to be feasible (Vazquez-Prokopec et al., 2009). In Salvador, Brazil, GPS 
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devices were used to track the movements of those living in slum areas and their 
exposure to environments associated with leptospirosis (Owers et al., 2018); and in 
Zambia to ascertain time spent away from the household and in areas at high-risk for 
malaria (Searle et al., 2017).  
 
GPS tracking as a means to understand human mobility may however, raise concerns 
by some populations. In Peru, focus group discussions took place prior to piloting the 
use of the GPS trackers during which participants worried whether their conversations 
would be recorded and also how to look after the unit correctly. During the pilot study 
itself, some participants admitted that they did not use the device for periods of time, 
either because they forgot to wear it, thought the device was not working or that the 
device was due to be exchanged (Paz-Soldan et al., 2010). A similar study was 
performed by Katherine Anders, in southern Vietnam (unpublished). GPS devices 
were attached to 155 paediatric patients who had had clinically suspected dengue 
fever to evaluate their daily activities. Reasons for declining recruitment into the study 
included: a) concern about children damaging the device, b) the need to discuss 
participation with a family member first c) inconvenience e.g. the child lived with 
grandparents or parents didn’t come home until late in the evening or d) the participant 
did not consider themselves to be at risk of mosquito bites.  
 
 
HUMAN CONTACT PATTERNS 
Human contact patterns differ between locations and ages and play a role in the 
acquisition and transmission of pathogens (Prem, Cook and Jit, 2017). Contact 
patterns are particularly important in the spread of pathogens by aerosol or droplets 
which require the close proximity of people for transmission (Leung et al., 2017; 
Gastanaduy et al., 2019). Transmission may be influenced by the age of the contacts 
and underlying immunity with studies looking at both serological and contact data to 
estimate the ability to maintain measles elimination (Funk et al., 2019; Chun et al., 
2020) and the transmission of VZV (Ogunjimi et al., 2009). The age of the contacts 
and impact of school holidays may also influence the seasonality of pathogens such 
as pertussis, measles, VZV and influenza (Eames et al., 2012; Cauchemez et al., 
2008; Rohani, Zhong and King, 2010; Metcalf et al., 2009; Jackson et al., 2014). The 
type and frequency of contact may also be influenced by socio-cultural norms, 
demographics and the living and working environment (Horby et al., 2011) with 
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pathogens such as enterovirus 71 being transmitted within households (Chang et al., 
2002; Hoang et al., 2019a). In addition to pathogens spread by aerosol or droplets, 
contact patterns can also influence the transmission of pathogens spread by body 
secretions such as sexually transmitted infections (Datta, Mercer and Keeling, 2018) 
and Ebola virus disease (Cleaton et al., 2016).  
 
Contact surveys are used globally to understand the demographics of the 
respondents, their types of contact, and location, duration and frequency of each 
contact (Hoang et al., 2019b). Contact diaries have been used to help understand 
these patterns in the context of the spread of infectious diseases in northern Vietnam. 
In Thanh Liem District, Ha Nam province, Vietnam details of physical and non-
physical contact by 865 participants from 264 households in a semi-rural community 
were recorded. A mean of 7.7 different contacts per respondent per day were 
recorded with 91% of physical contacts occurring in the home (Horby et al., 2011). A 
household-based survey amongst urban and rural populations of Guangdong, China 
(n=1821) was performed to ascertain both travel and contact patterns with those aged 
under 20 years having the longest duration of contact (Read et al., 2014). A 
questionnaire administered to participants in a longitudinal cohort study of influenza 
in Hong Kong found that there was an association between the median number of 
contacts or locations and being infected (Kwok et al., 2014). 
 
JUSTIFICATION FOR THE RESEARCH AND QUESTIONS TO BE 
ADDRESSED 
The aetiology of AES in Vietnam includes a number of pathogens for which the risk 
of acquisition and spread can be influenced by human movements and contact 
patterns. These include vector-borne diseases such as JE and dengue; and those 
caused by pathogens spread by aerosols or droplets such as VZV, influenza virus, 
measles virus and enterovirus 71. Additionally, diseases found to cause CNS 
infections in neighbouring Lao PDR such as scrub typhus and leptospirosis for which 
the risk of acquisition may also be dependent on human movements could potentially 
attribute to the aetiology in Vietnam.   
 
The study of daily activities performed in southern Vietnam showed that GPS tracking 
of individuals was feasible. However, there was no evidence to suggest a similar study 
had been conducted in northern Vietnam and whether it would be feasible. 
Additionally, there was scope for building on the contact pattern work conducted by 
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Horby et al. 2011 in Ha Nam province, by analysing the differences between those 
from urban and rural areas, as well as investigating types of food consumed to 
elucidate the potential risk of zoonotic infections such as S. suis (Huong et al., 2014b).  
 
The aims of this study were therefore as follows: 
 
1. To assess the acceptability and feasibility of using GPS devices and contact pattern 
diaries to understand the mobility amongst healthy participants living in Ha Nam 
province, northern Vietnam. 
 
2. To compare the mobility patterns of different groups of participants including adults 
and children from rural and urban areas;  
- at different times of the years 
- during different days of the week 
 
3. To evaluate the time spent in areas deemed to be at risk of mosquito bites 
 
4. To compare the contact and behavioural patterns of adults and children living in 












This study was conducted in collaboration with the NIHE and the PMC in Ha Nam 
province (figure 4.1). Ha Nam province is located just south of Hanoi (figure 5.1) and 
in 2016 had a computed population of 803,700 (General Statistics Office of Viet Nam, 
2018), a mean elevation weighted by population density of 7.38m and a normalised 
difference vegetation index (NDVI) of 0.2 (General Statistics Office of Viet Nam, 2018; 
NOAA: National Centers for Environmental Information, n.d.) The NDVI ranges from 
-1 to +1 where the higher the value, the more biomass of photosynthetically active 
vegetation exists. Negative values refer to non-biomass e.g. clouds, water or snow 
(Helbich, 2019). The NDVI of rice paddy has been shown be a positively related to 
both mosquito density and the number of Japanese encephalitis cases in China (Tian 
et al., 2015) and also positively associated with scrub typhus in Taiwan (Kuo et al., 
2011). However, a negative associated was seen in Taiwan with dengue fever (Huang 
et al., 2018). 
 
In 2016 there were two cases of AES giving an annual incidence of 0.25 cases per 
100,000 population compared to the mean provincial incidence of 1.23 cases per 
100,000 with a range of 0 to 137 cases per province (Ministry of Health Vietnam 
General Department of Preventive Medicine, 2019). However, sentinel site data 
recorded eight cases of JE in Ha Nam in 2016 making it the province (in addition to 
Hai Phong) with the second highest number of cases of JE after Son La (N=10).  
 
Despite the lower incidence of AES compared to other provinces, Ha Nam had 
ongoing collaborations with OUCRU enabling permissions to be obtained to work in 
this area. Obtaining permissions to conduct the study in the border provinces which 
see a higher incidence of AES (chapter 2) was not feasible at this time.  
 
The study was performed in an urban district (Phu Ly) and a rural district (Thanh 
Liem). In Phu Ly, two communes were selected to be used for the study which are 
Tran Hung Dao and Hai Ba Trung and in Thanh Liem, the communes are Thanh Ha 
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and Thanh Binh. The choice of districts and communes were decided in collaboration 
with the Ha Nam PMC. 
 
 
Figure 4.1 Map of the location of Ha Nam province (coloured in red).  
 
FOCUS GROUP DISCUSSIONS 
To gauge the acceptability of conducting this study in the communities in Ha Nam 
province, FGDs took place to explore the attitudes and concerns towards wearing the 
GPS device and being asked questions about their daily activities (appendix 4.1). 
Four FGDs were held in both the urban and rural communes in December 2016, prior 
to the start of the study comprising: a) an urban FGD with eight men b) an urban FGD 
with eight women c) a rural FGD with eight men d) a rural FGD with eight women. 
Participants were selected using a purposive approach with the support of PMC staff, 
and provided informed written consent prior to the start of the FGD (appendix 4.2). 
 
THE SELECTION OF PARTICIPANTS AND CONSENT 
Six adults and six children were randomly selected from each of the four communes 
by study staff members from Ha Nam Preventive Medicine Center (PMC) giving a 
















provide informed written consent; and in the case of children, had a parent or guardian 
who could provide this or if aged 12-15 years could provide assent. Initially informed 
consent was obtained at every visit, but this was later changed to provide consent for 
all future visits. The informed consent /assent form is provided in appendix 4.3 (most 
recent version only).  
 
GPS DEVICES 
During each study period of 72 hours, participants were provided with a GPS device 
(i-gotU GT-120) weighing 20g with dimensions of 44.5x28.5x13mm which they were 
advised to wear on their arm (Stothard et al., 2011). This device has been used in 
previous studies (Seto et al., 2012; Stothard et al., 2011) and as part of the 13DXA 
study performed in southern Vietnam (K Anders, personal communication).  
 
To validate the recordings from the i-gotU devices, GPS coordinates obtained from 
the devices were compared to Garmin etrex 20x devices at four different locations 
with five different devices tested.  The mean latitudinal difference between the Garmin 
device and the iGoTU devices of 4.76x10-5 ºN and longitudinal difference of 4.27x10-
5 ºE.  Using the R statistical software ‘distHaversine’ function from the package 
‘geosphere’ (Hijmans, 2019a), the mean distance between the Garmin GPS 
coordinates and i-gotU devices was 8.99m which was deemed acceptable for this 
study as a difference of 9m would be unlikely to change the outcome regarding 
whether the participant was within an area deemed at risk for mosquito bites.  
 
The devices were also tested by study staff from NIHE and OUCRU to check the 
functionality and settings. Following testing by study staff, it was decided to set the 
device record a latitude and longitude every 2 minutes or every 3 seconds if the 
participant travelled at a speed of 10km/hour or over. This provided a balance 
between the collection of enough GPS locations to sufficiently make inferences about 
the data whilst maintaining sufficient battery power before the device could be 
charged overnight by the participants. To commence recording, the devices are 
required to obtain an initial signal and coordinate before locking the device to prevent 
participants disengaging the system. This procedure was performed at the PMC in 
Phu Ly by staff from NIHE. 
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A 72-hour feasibility study was conducted during weekdays in February 2017 to 
ensure the devices functioned correctly. Following this, the participants wore the GPS 
devices again for seven, 72-hour periods. These included weekdays and weekends 
for each of the months of April 2017, July 2017, September 2017; and weekends only 
in December 2017.  
 
CONTACT PATTERN DIARIES 
Over the same time periods during which the participants wore the GPS devices, the 
study team visited the homes of participants on a daily basis to complete a paper 
contact pattern diary which asked questions about contact with other people, their 
ages, who they were, the type of contact and where the contact happened in addition 
to questions about where they travelled to, activities undertaken at these locations 
and food consumed. These questions were devised to cover multiple risk factors for 
AES of different cause and were in keeping with previous studies (Read et al., 2012). 
Additionally, participants were asked about any problems they had with the device, 
whether they forgot to wear or removed it purposefully (appendix 4.4).  
 
SAMPLE SIZE 
Due to the descriptive nature of this study, a power calculation was not performed. A 
sample size of forty-eight participants was considered to be logistically and financially 
feasible. 
 
DATA MANAGEMENT AND ANALYSIS 
	
QUALITATIVE DATA 
The qualitative data from the FGDs was analysed for each question. Common themes 
were compared between each of the groups including urban men and women and 




QUANTITATIVE DATA: MOVEMENT DATA 
The igotU software (@trip) was used to download data from each of the GPS trackers 
as CSV files. The longitude and latitude coordinates obtained en route from the PMC 
to the participants’ homes were removed and the device number and participant 
identification number were added as covariates. Data from the CSV outputs utilised 
for analysis included the date and time of each GPS recording, the longitude and 
latitude coordinates reported to six decimal places and the distance travelled between 
each coordinate (in metres).  
 
Analyses were performed using R statistical software. Datasets from each of the 
participants were merged, cleaned and managed using the package ‘tidyverse’  
(Wickham, 2017) and Base R (RDocumentation, n.d.-c).  
 
Information about the participants’ age and gender were merged from data from the 
contact diary. Participants aged 18 years and over were considered to be adults; 
those from Hai Ba Trung and Tran Hung Dao were coded as urban participants and 
those from Thanh Ha and Thanh Binh, rural participants. The months of February and 
December were classified as winter; April as spring; July as summer and September 
and October as autumn.  
 
Boxplots were constructed to show the distances covered per participant over the 
study period between urban and rural participants, adults and children, males and 
females, during weekdays and weekends and each of the seasons. The Kruskal 
Wallis test was used to determine the differences between the distances.  
 
The Kruskal Wallis test was used to determine differences in the time spent at each 
coordinate. Maps were constructed of varying time periods however, it was decided 
to show those where participants spent (2 minutes or longer and 6 hours or longer) at 
each coordinate. Two minutes was the standard time between logging GPS 
coordinates when the participant travelling at less than 10km/hr. Spending time at 
locations for less than two minutes was unlikely to be a risk factor for mosquito bites. 
The time spent in locations for six hours or longer might represent a working 
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environment, place of education or home. Maps were produced for each of the groups 
(urban and rural participants, adults and children, male and female participants, 
weekdays and weekends, and each of the seasons). Maps were also produced to 
show the number of participants at each of the coordinates for urban and rural adults 
and urban and rural children. In the latter case, the coordinates were given to four 
decimal places to better differentiate the number of participants at each location.  
 
The distance between the centre of Phu Ly (105.9164, 20.5405) and Thanh Liem 
(105.9390, 20.4368) and each of the coordinates was calculated using the 
distHaversine() function from the package ‘geosphere’. The distHaversine() function 
calculates the distance between two sets of coordinates as the crow flies. The Kruskal 
Wallis test was used to determine the difference between these distances.  
 
QUANTITATIVE DATA: THE NORMALISED DIFFERENCE VEGETATION 
INDEX (NDVI) 
NDVI raster files were obtained from the Copernicus Global Land Service at a 
resolution of 1km and to the nearest two weeks where possible (version 2.2) 
(Copernicus Global Land Service, 2018) to the nearest two weeks where available. 
Buffer zones of 100m were extracted around each coordinate using the R package 
‘raster’ and the function extract() which took the mean of the NDVI. The difference 
between the NDVI values within each buffer zone were compared between each 
group of participants (adults and children, rural and urban participants, males and 
females and at weekdays and weekends) using the Kruskal-Wallis test. The NDVI 
values were then categorised into low (0-0.25), low-medium (0.26-0.50), medium 
(0.51-0.75) and high (>0.75) and the median and range of total time spent over the 
study period was compared between urban and rural participants, adults and children, 
males and females and between different times of the day and the seasons. 
 
QUANTITATIVE DATA: CONTACT PATTERN DATA 
Data from the paper contact pattern diaries was entered into the CliRes database. 
Data was then extracted and read into R as CSV files for analysis.  
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The same participants undertaking the GPS study also participated in a contact 
pattern diary at the same times of the year.  For the purpose of the diary mornings 
were classified as 05:00 hours to 11:59 hours; afternoons as 12:00 hours to 17:59 
hours; evenings as 18:00 hours to 20:59 hours. Monday-Friday were classified as 
weekdays and Saturday and Sunday, weekends. ‘Contacts’ were not given unique 
identifiers.  
 
Data were cleaned for three diaries where the date had been entered incorrectly with 
one excluded as the correct date could not be confirmed. One diary was missing for 
a participant during the summer. Tables showing the total number of non-physical 
contacts defined as face to face and physical contact, defined as skin to skin or touch, 
for each group of participants and the median and ranges of the number of contacts 
per participant over the study period and per day were provided. Statistical differences 
between the numbers of contacts per participant per day were calculated using a 
negative binomial GLM using the R package ‘MASS’ with the identification of the 
participant fitted as a random effect (Venables and Ripley, 2002). As the date of birth 
was incomplete for a number of participants the age in years of the participant was 
calculated as 2017 minus the year of birth.  
 
The median number of contacts per participant by age category were plotted for each 
of the groups including urban and rural participants, males and females and during 
weekdays and weekends, different seasons and times of the day. Negative binomial 
GAM to estimate the number of contacts according to the age of the participant and 
corresponding contact were fitted for each model with the exception of the contact per 
participant per day by time of day which required a Poisson model to allow the model 
to fit. The ages were fitted as smoothed continuous values using the default thin plate 
regression splines. The identification of the participant was fitted as a random effect 
for models comparing the number of contacts per participant, and the identification of 
the participant and the date of the interview as random effects for models comparing 
the number of contacts per participant per day. Plots of models were constructed 
using the function vis.gam() from the package ‘mgcv’ with the corresponding outputs 
including the estimated degrees of freedom, the chi-squared test and the p value. 
vis.gam allows for visualisation of the output of the GAM model using a perspective 
or contour plot (RDocumentation, n.d.-g). 
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Boxplots to show the difference in the numbers of contacts per participant according 
to whether the contact was a family member, friend or other were constructed for 
urban and rural participants, adults and children, males and female and during 
weekdays and weekends. Similarly, boxplots to show the difference in numbers of 
and types of contacts made at home or school/work were produced for adults and 
children. Statistical differences were calculated using negative binomial GAM with the 
participant identification as a random effect. 
 
ETHICS 
The study was approved by OxTREC (reference 42-15), the University of Liverpool 
ethics committee (RETH001072), the University of Liverpool Sponsorship 




THE ACCEPTABILITY, FEASIBILITY AND QUALITY OF THE DATA 
COLLECTION 
 
THE FEASIBILITY STUDY 
During the initial feasibility study conducted during 72 weekday periods in February 
2017 45,825 coordinates were obtained during the mornings, 43,933 during the 
afternoon, 22,751 during the evening and 28,772 during the night. The median time 
between signal recordings was 2.02 minutes. The results showed that for the majority 
of time, the GPS devices were working and recording signals appropriately. 
Additionally, it was suggested that most people were taking the GPS with them during 
their daily activities as the number of recordings was higher during the morning and 





FOCUS GROUP DISCUSSIONS 
 
Knowledge of GPS devices 
Knowledge of GPS devices differed between the groups. Both urban and rural men 
showed an understanding of the concepts of GPS devices explaining that these 
existed within smartphones and could be used to locate positions including of people 
but also to show the road and direction of travel and to track buses. Women showed 
less understanding with some being unaware of the existence of GPS devices and 
others unaware of its utility. 
 
Attitudes towards wearing GPS devices and concerns 
All groups were concerned that the GPS devices may adversely affect their health 
particularly if they were wearing it all day with potential effects on the brain or fertility 
being mentioned. However, some female participants asked whether the device 
would be able to detect diseases or whether it could be of benefit if they were unwell.  
 
Privacy was a particular worry for some participants who required reassurance that 
the devices were unable to record sound. Furthermore, expressed anxieties that the 
devices may be used to ‘spy’ on them and asked about where these were 
manufactured. However, other participants appeared less concerned about privacy, 
stating that they had no worries about the study team knowing their movements which 
were often from the home to the market, school or work. 
 
Many participants thought that the device would be uncomfortable to wear or be 
unsightly and that other people may wonder what it was. Many participants also 
believed that the children would struggle with the device as they would think it was a 
toy. Female participants were concerned that they may break the device, lose it or 
forget to put it on after a shower. Some also mentioned that it would be difficult for 
sellers to wear due to their contact with water. It was suggested that a ‘GPS watch’ 
may be a better option.  
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Attitudes towards participating in the contact pattern diary 
All groups were concerned that staff would not find suitable times to visit their homes 
to complete the diary and some suggested an alternative may be to conduct the 
interview by mobile phone or to leave the diary to complete themselves. They also 
stated that the diary should not be too long. Some urban men suggested that it would 
be more suitable for women participate in the study as they were easier to visit and 
due to their jobs, travelled more. 
 
Despite concerns raised, the groups were happy to take part in the study if it was for 
the benefit of the community. 
 
FEEDBACK FROM THE PARTICIPANTS 
Feedback was obtained on 1,163 occasions with eighty-one (7.0%) reports of 
problems with the GPS device over the study period. There were thirty-seven (3.2%) 
reports of participants forgetting to wear the device. Of these, twenty-one (56.8%) 
reports were from adults and sixteen were from children. There were six (16.2%) 
reports of participants forgetting to wear it for less than one hour, twenty-six (70.3%) 
between one and six hours and fifteen (40.5%) between seven and twenty-four hours. 
There were 1,105 (95%) reports of deliberately removing the device, with ten (0.9%) 
people removing it for less than one hour, 267 (24.2%) removing it from between one 
and six hours; and 809 (73.2%) between seven and twenty-four hours. The main 
reasons for removal of the GPS included charging the device (n=969 (87.7%)), 
bathing or washing (n=763 (69.1%)) or sleeping (n=219 (19.8%)). There were forty-
seven (4.0%) comments that the device was big or heavy and in four (0.3%) occasions 
it was mentioned that friends borrowed the device. 
 
QUALITY OF THE DATA COLLECTION 
After data cleaning, a total of 671,202 longitude and latitude coordinates were 
obtained. Data from two participants during two seasons were removed as the devices 
were lent to friends; data was missing for one participant in July and two in 
September/October; data from an individual season* was removed on eighteen 
occasions where there were spurious coordinates for example, where it was not 
feasible for a participant to travel between the coordinates in the time provided e.g. 
	 213 
was travelling at a speed of 130km/hr or over; and  maps were excluded for one 
participant who did not consent to this.  
* December and February were counted as separate seasons given that the two 72 
hour period could be separated.  
 
MOBILITY PATTERNS 
The participants included in the study included twelve female adults, twelve male 
adults, thirteen female children and eleven male children. 
	
DISTANCES COVERED  
The total distance covered over the study period amongst all participants was 
11977.07km and the median distance covered per participant over the total study 
period was 189.21km (range = 37.26-1429.15km). The median total distance covered 
per participant from an urban area was 179.97 km (range 37.26-896.70km) and from 
a rural area, 223.16 km (range 41.99-1429.15km) with no evidence for a difference 
between the distances (p=0.275). Adult participants travelled a median of 229.91km 
(range 37.27-1429.15km) and children, 153km (range 38.92-449.50km) with no 
strong evidence for a difference between the two (p=0.095). Female participants, 
travelled a median of 193.81km (range 38.92-6345.08km) and male participants 
183.09km (range (37.26-1429.15km) with no evidence for a difference between the 
two (p=0.992).  
 
The median distance covered during weekdays was 122.95km (range 20.50-
782.81km) compared to weekends (59.22km (range 1.5 – 64.34km) with strong 
evidence for a difference between the two (p<0.001) The median total distance 
covered per participant during the spring was 55.06km (range 9.39–343.43km); 
summer, 54.67km (range 0-395.26km)); autumn, 47.53km (range 5.48–528.35km) 
and winter 49.73km (range 10.41-373.76km) with no evidence for a difference 




Figure 4.2 The distances covered per participant over the study period by group of 
participants and between weekdays and weekends and seasons. The upper hinge of 
each box represents to the 75th percentile and the lower hinge, the 25th percentile. 
The bold line located within the box represents the median value. The upper whisker 
is equal to 1.5*the inter-quartile range (IQR) and the lower whisker, 1.5*IQR. The 



























































































Rural adults travelled the most with a median distance covered per participant of 
274.96 km (range 67.03-1429.15km) followed by urban adults (212.83km (range 
37.26-897.70km)); rural children (170.87km (range 41.99-351.77km) and urban 
children (127.36km (range 38.92-449.50km)) but with no evidence for a difference 
between these (p=0.252). On an individual basis, those from all groups covered 
greater distances during the weekdays compared to the weekends. Evidence for a 
difference existed only amongst the children (p=0.003). Urban children travelled a 
median distance of 85.41km (range 38.92-372.64km) per participant during the 
weekdays compared to the weekends (median of 47.76km and range of 1.5-
158.32km) and rural children, 119.52km (range 21.75-206.49km) during weekdays 
compared to weekends (median of 53.41km (range 19.28-145.28km).  
 
THE TIME SPENT AT LOCATIONS 
390,663 unique coordinates were obtained with a median of 7126 unique coordinates 
per participant (range 1641-30689). Unique coordinates are those which have a 
different longitude and latitude as the same coordinate can appear more than once in 
the database. The median time spent at the same coordinate per participant was 2.05 
minutes with a range of 3 seconds to 93 hours.  
 
There was no evidence for a difference in the median time spent at each coordinate 
between urban and rural participants (p=0.342), male and female participants 
(p=0.597) nor during each of the seasons (p=0.05). There was also no difference in 
median time spent at each coordinate at weekdays compared to weekends (p=0.929). 
including when stratified by age (adults, p=0.809 and children, p=0.560). 
 
All groups of participants travelled outside of Ha Nam province during the study 
period.  Using locations participants remained at for 2 minutes or longer, seven 
provinces (Hung Yen, Hai Duong, Bac Ninh, Ha Noi, Ninh Binh, Nam Dinh and Thai 
Binh) outside of Ha Nam were travelled to by adults or those from urban areas 
compared to five by children (Ha Noi, Hoa Binh, Nam Dinh and Thai Binh) and four 
by those from rural areas (Ha Noi, Bac Ninh, Hoa Binh and Thai Binh) (figures 4.3 
and 4.4). Four provinces were travelled to on weekdays, compared to eight provinces 
at weekends (figure 4.5). The participants travelled to four provinces outside of Ha 
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Nam during the spring compared to three in the summer, four in the autumn and three 
in the winter (figure 4.6). One rural child travelled to Quang Nam, during a weekday 
in the winter. However, locations in which participants stayed six hours or longer were 
only within Ha Nam province (figure 4.7).  
 
Figure 4.3 Maps to show median time spent per participant at the same coordinate 
for adults and children. The maps include the neighbouring provinces of Ha Nam with 
Hanoi city and Phu Ly marked. The maps are subset to show those where the median 
time was 2 minutes or 6 hours or longer. The size of the circle and colour indicates 










Figure 4.4 Maps to the median time spent at the same coordinate for rural and urban 
participants. The maps include the neighbouring provinces of Ha Nam with Hanoi city 
and Phu Ly marked. The maps are subset to show those where the median time was 
























Figure 4.5 Maps to show the median time spent at the same coordinate per participant 
for weekdays and weekends. The maps include the neighbouring provinces of Ha 
Nam with Hanoi city and Phu Ly marked. The maps are subset to show those where 
the median time was 2 minutes or 6 hours or longer. The size of the circle and colour 























Figure 4.6 Maps to show the median time spent at the same coordinate per participant 
for each season. The maps include the neighbouring provinces of Ha Nam with Hanoi 
city and Phu Ly marked. The maps are subset to show those where the median time 
was 2 minutes or 6 hours or longer. The size of the circle and colour indicates the 
























Figure 4.7 The places travelled to by more than one participant over the study time 
period, subset by urban and rural adults and urban and rural children. The size and 
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Per individual, urban participants travelled a median distance of 765.97m from the 
centre of Phu Ly with a range of 11.29m-52.43km compared to rural participants who 
travelled a median distance of 6.42km from the centre of Thanh Liem with a range of 
1.68-86.86km with strong evidence for a difference between the two (p<0.001). Per 
participants, adults travelled a median distance of 3.53km from the centre of Phu Ly 
or Thanh Liem with a range of 7.15m–86.86km compared to children who travelled a 
median distance of 3.88km from the centre of Phu Ly or Thanh Liem with a range of 
25.08m-47.88km with no evidence for a difference between the two (p=0.483). Per 
participants, females travelled a median of 2.35km (range 7.15m-52.43km) compared 
to males, 4.73km (range 25.08m-86.86km) with no evidence for a difference between 
the two (p=0.177).    
 
NDVI 
A measurement of the NDVI was available for 359,556 unique coordinates. Per 
participant, the median NDVI within a 100m radius of each recorded coordinate was 
0.93 with a range of 0.12-0.93. Amongst urban participants the median NDVI per 
participant was 0.93 with a range of 0.12 to 0.93, compared to rural participants 
(median=0.69, range = 0.14-0.93) with evidence for a strong difference between the 
two (p<0.001). There was no difference in the NDVI per participant between adults 
and children with a median of 0.93 and a range of 0.12-0.93. The median NDVI 
amongst male participants was 0.93 with a range of 0.14-0.93) and female 
participants 0.93 with a range of 0.12-0.93) with no evidence of a difference between 
the two (p=0.879). The median NDVI at locations during the weekdays was 0.93 with 
a range of 0.12-0.93 and weekends, 0.93 with a range of 0.14-0.93 with no evidence 
of a difference between the two (p=0.018). The median NDVI at locations visited by 
the participants during the morning, afternoon or evening was the same (0.93)  with a 
range of 0.12-0.93).  
 
Across all demographics (urban and rural, male and female and adults and children) 
the most time was spent in areas of NDVI within the highest quartile (>0.75) and in 
general, the shortest amount of time in the lowest NDVI (0-0.25). The exception to 
this is the urban participants who spent the shortest time in the ‘lowest-medium’ NDVI 
(0.26-0.50). In the summer, autumn and winter the most time was spent in the highest 
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NDVI and the spring, the medium-highest (0.51-0.75). Similarly, throughout the day 
the most time was spent in the highest NDVI (tables A4.1-A4.5, appendix 4.5).   
 
CONTACT PATTERNS 
Over the study time period, there were a total of 12,804 non-physical (face to face) 
contacts and 2,911 physical (skin to skin touch) contacts. There was no evidence for 
a difference between the total number of non-physical or physical contacts per 
participant by age category. However, there was strong evidence for a higher number 
of non-physical contacts per participant per day amongst all age groups except those 
aged 13-17 years and 61 years compared to the youngest age group of 0-5 years. 
Those aged 0-5 years were more likely to have a higher number of physical contacts 
per participant per day compared to all age categories except those aged 6-12 years 
and those aged 18-35 years (tables A4.6 and A4.7, appendix 4.5).  
 
There was strong evidence that men were more likely to have a higher number of 
non-physical contacts per participant per day compared to women but a lower number 
of physical contacts (tables A4.8 and A4.9, appendix 4.5). Similarly, there was strong 
evidence that urban participants were more likely to have a higher number of non-
physical contacts compared to rural participants but fewer physical contacts (tables 
A4.10 and A4.11, appendix 4.5).  
 
There was strong evidence for fewer non-physical contacts during weekends. This 
relationship also existed for physical contact but only with respect to the number of 
contacts per participant over the study period and not per participant per day (tables 
A4.12 and A4.13, appendix 4.5). There was strong evidence for a higher number of 
non-physical contacts per participant per day in the spring compared to the summer 
and winter but fewer physical contacts compared to all other seasons (tables A4.14 
and A4.15, appendix 4.5). There was strong evidence for a higher number of non-
physical contacts in the morning compared to the evening however, physical contact 
was greater in the evenings but only with respect to the total number of contacts per 
participant (table A4.16 and A4.17, appendix 4.5). 
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THE NUMBER OF CONTACTS BY AGE OF THE PARTICIPANT AND AGE 
OF THEIR CONTACT (PHYSICAL AND NON-PHYSICAL) 
Data prior to modelling showed that amongst male participants, the most contact was 
seen between children and adults aged 36-60 years. This differed to female 
participants where, with the exception of participants aged 6-12 years, more contact 
was seen amongst adults. In both urban and rural participants, children have the most 
contact with adults aged 36-60 years however, urban participants aged 61 years and 
over also have higher numbers of contacts with those of the same age group. There 
was little difference between ages of participants and contacts at weekdays compared 
to weekends with most contact occurring between participants aged 0-5 years and 
contacts aged 36-60 years and adults with those aged 61 years and older (figure 4.8).  
Negative binomial generalised additive models showed that, amongst urban 
participants, contact was estimated to be highest amongst participants aged 40-50 
years and contacts aged 80 years and older, and participants aged 5 years and under 
and contacts aged around 40 years. Amongst rural participants, contact was 
estimated to be greatest amongst child participants and older contacts e.g. those aged 
over 70 years. Amongst male participants, contact was estimated to be highest 
amongst adult participants and elderly contacts and child participants and contacts 
aged 40-50 years. Amongst female participants, younger adult participants were 
estimated to have more contact with the elderly and child participants with adults aged 
30-40 years. A similar pattern was estimated during weekends and weekdays with 
the highest contact between younger adult participants and elderly contacts and 
younger children and adult contacts aged 30-40 years (figure 4.9). Overall, there was 
strong evidence for differences in the number of contacts between age categories 
within each of the groups with the exception of the male participants which showed 
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Figure 4.8 The median number of contacts per participant over the study period by 
age category shown for urban and rural participants, males and females and during 
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Figure 4.9 Negative binomial GAM of contacts by age group. 
The lighter the colour and the higher number defined by the contour, the greater the 
estimate.  The output of the GAM models is given below in table 4. 
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Table 4.1 The output of the smoothed GAM models. 





Urban 15.75 48.63 <0.001 
Rural 2.01 34.85 <0.001 
Male 6.73 18.48 0.037 
Female 11.16 80.75 <0.001 
Weekday 8.79 71.45 <0.001 
Weekend 10.79 63.6 <0.001 
 
 
There was strong evidence for a higher number of contacts who were family members 
compared to friends amongst all groups of participants (figure 4.10). 
 
Per participant, those from urban compared to rural areas met a higher number of 
contacts at home (p<0.001). A higher number of contacts were met both at home, 
school and work during weekdays compared to weekends (p<0.001). Adults had a 
higher number of non-physical contacts at school or work per participant compared to 
children however, there was no strong evidence for a difference between the two 
(p=0.051). Children had a higher number of physical contacts at school or work with 
strong evidence for a difference between the two (p=0.004).  Children had a higher 
number of both non-physical and physical contacts per participant in the home 
compared to adults but with no evidence of a difference between the two (p=0.77 and 
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Figure 4.10 The number of contacts per participant according to whether the contact 
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Figure 4.11 The number of non-physical compared to physical contacts per participant 




























































































Physical contact at home
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4.4 DISCUSSION  
This study of human movement and contact patterns over a year gives an insight into 
how these factors may affect the risk of acquisition and transmission of a number of 
pathogens causing AES in Ha Nam province, northern Vietnam. This work builds on 
that conducted by Horby et al., 2011 who explored social contacts in Ha Nam through 
the use of diaries in 2007. This is the first known study to use GPS devices to evaluate 
human movement patterns in northern Vietnam.  
 
OBJECTIVE 1: TO ASSESS THE ACCEPTABILITY AND FEASIBILITY OF 
USING GPS DEVICES AND CONTACT PATTERN DIARIES TO 
UNDERSTAND THE MOBILITY AMONGST HEALTHY PARTICIPANTS 
LIVING IN HA NAM PROVINCE, NORTHERN VIETNAM 
Given the novelty of the movement work in this region there was a need to assess the 
acceptability, feasibility and quality of data collection using GPS devices. This was 
not covered by Horby et al., 2011 during their work on social mixing (Horby et al., 
2011). Some initial concerns about the GPS device were highlighted during the FGDs. 
These included privacy; adverse health effects; and whether the device would be 
uncomfortable or may be lost or broken. Some participants were also concerned 
about the time it would take to conduct the contact pattern diary. Despite these 
worries, participants stated they were willing to take part in the study to benefit the 
health of the community. The concerns about the GPS device were not unique to this 
setting. FGDs conducted in Peru to determine the acceptability of wearing a GPS 
device to understand the roles played by humans in the transmission of dengue virus 
found that participants also expressed apprehension about the effect of the GPS 
device on their health, their responsibility for the device and caring for it, and the 
confidentiality of the information and whether the device would audio or video record 
them (Paz-Soldan et al., 2010). However, pre-and post-survey measures to assess 
the acceptability of wearing a GPS device amongst young men who have sex with 
men in New York found that only 8% or less were concerned about losing the GPS, 
their safety or that it would be uncomfortable to wear (Duncan et al., 2016).  
 
In this study where a different cohort participated in the GPS and contact diaries to 
those in the FGDs, there were only 31 out of 1,200 reports of people forgetting to wear 
the device and no devices were lost. Devices were removed on occasion including to 
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charge the device or whilst sleeping or bathing/washing. One device broke during the 
study but was replaced. Other studies have found variable rates of compliance. In 
Peru, 44% of the 126 study participants forgot to wear their device on at least one 
occasion over a study period of 14-30 days (Paz-Soldan et al., 2010) whereas in New 
York, just over 10% of 74 participants forgot to wear the GPS device on a daily basis 
over a period of 7 days (Duncan et al., 2016). 
 
Despite some concerns raised during the FGDs about the length of the contact pattern 
diaries, the suggestion that female participants may be placed to complete these and 
that they may be better conducted over the telephone or by the participants 
themselves rather than the research staff, the return rate for the diaries was good with 
a diary missing for only one participant for one season. During a study conducted at 
a scientific conference in Germany 20% (95%CI 11-34%) of the respondents stated 
that the completion of a contact diary was too much work and only 25% (95%CI 14-
38%) stated that they had difficulty remembering their contacts. However, there was 
improvement with familiarity with the contacts  (Smieszek et al., 2016).    
 
The large numbers of different coordinates obtained over the study period, 
demonstrated that the devices worked well and that participants complied with the 
study by taking the these outside of the house throughout the year. Additionally, the 
maps showed that the participants not only took the devices with them whilst moving 
within their communities but also when they travelled outside of Ha Nam. This showed 
the dedication the participants had towards the study and assumed that there was 
acceptance of wearing the device. The reason for this compliance may have been in 
part due to the quality of the consent process. The participants were assured that the 
device could not record their voices or recognise their contacts; that it was safe and if 
uncomfortable to wear they could put it in their pocket. It is also possible that the 
participants were happy to participate for the benefit of their community as suggested 
during the FGDs. This might be attributed to the collectivist approach often adopted 
in Vietnamese society and cited as a potential reason for the successful response to 
the COVID-19 pandemic (Nguyen, 2020). With nearly 13,000 contacts reported and 
that the majority of diaries being completed, we can assume that the contact pattern 
diaries were also accepted. 
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Although these methods might be deemed acceptable to participants, direct feedback 
was not obtained from PMC staff and their workload cannot be underestimated. The 
data from each GPS device needed to be manually downloaded and cleared on return 
of the device from each participant. The homes of participants also needed to be 
visited on a daily basis. Although it was feasible in this setting, it is unknown whether 
this approach would be transferrable.  
 
OBJECTIVE 2: TO COMPARE THE MOBILITY PATTERNS OF DIFFERENT 
GROUPS OF PARTICIPANTS 
The second objective of this study aimed to compare the mobility patterns between 
healthy adults and children living in rural and urban areas of Ha Nam province during 
different time periods.  There was no evidence for a difference in the overall distances 
covered between the different urban compared to rural participants, men compared 
to women and adults compared to children. On average, rural participants travelled 
further from their commune. This may be due to socio-economic differences but would 
require further research to investigate this including enquiries about the reasons for 
travel. Interestingly, the participants tended to spend shorter amounts of time at the 
same location when travelling outside of Ha Nam. This might suggest that these visits 
do not involve visiting friends or family at home for periods of days.  
 
Compared to other work, a study in Spain showed that women travel shorter distances 
compared to men (Lenormand et al., 2015) yet another in the United States showed 
that gender had less of an impact on human mobility compared to race or ethnicity 
(Luo et al., 2016). 73% of women in Vietnam are estimated to be part of the labour 
force (The World Bank, 2020b). Despite this, women continue to do most of the 
housekeeping and childcare (Vu, et al., 2019). Therefore, travel by women for work 
and family necessities including taking children to school and shopping for groceries 
may contribute to the absence of a difference in overall mobility between the genders. 
Given that children travel as much as adults, this might suggest that people in Ha 
Nam tend to travel as families.  
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Overall, the distances travelled by participants were significantly greater during 
weekdays compared to weekends however, by demographic this difference only 
remained between urban and rural children with rural children travelling further during 
the weekdays, potentially due to school. We did not see any difference in the overall 
distances travelled between the seasons. This is also interesting as it might be 
expected that people travel more during the winter due to the Lunar New Year as is 
seen in neighbouring China (Gibbs et al., 2020) and potentially less in the summer 
due to the very warm climate.  
 
OBJECTIVE 3: TO EVALUATE THE TIME SPENT IN AREAS DEEMED TO 
BE AT RISK OF MOSQUITO BREEDING 
The study participants spent more time over the study period in locations with a higher 
NDVI. This pattern was generally consistent between adults and children, males and 
females and urban and rural participants. The data therefore suggests that 
participants were spending longer periods in areas suitable for mosquito breeding. As 
mosquito breeding and survival is also sensitive to climatic changes (Reisen et al., 
2008; Ciota et al., 2014; Upadhyayula et al., 2012), the time of year in addition to the 
NDVI can influence the likelihood of the population coming into contact with these 
vectors however, no difference was seen between the time spent in areas of different 
NDVIs by the participants. In addition to the changes in climate, different mosquito 
species are active at different times of the day with Cx. tritaeniorhynchus biting in the 
evenings and mornings (Reisen et al., 1976) and Aedes species in during the morning 
and late afternoon (Reinhold, Lazzari and Lahondere, 2018). However, there was no 
difference between the time spent in different areas of NDVI by time of the day. 
 
OBJECTIVE 4: TO COMPARE THE CONTACT AND BEHAVIOURAL 
PATTERNS OF PARTICIPANTS 
The final objective of the study was to assess the relationship between the 
behavioural patterns of healthy people in this study and known risk factors for AES. 
The majority of contact was non-physical e.g. face to face (82%). This proportion was 
higher than that recorded by Horby et al., 2011 in a previous study in Vietnam (56%) 
however, it is possible that the behaviours of the population have changed over time 
with potentially a higher proportion meeting people in the workplace. It is also possible 
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that there were differences between the participants in terms of their socio-economic 
and employment status but given that the sample size for this study was much smaller 
than conducted by Horby et al., 2011 with 48 participants compared to 865, it is 
difficult to draw conclusions about the differences in behaviour. In this study, the 
majority of contacts per participant occurred at home compared to school or work 
which is in keeping with the study by Horby et al., 2011 but also a study conducted in 
a number of European countries (Mossong et al., 2008). The per participant number 
of contacts which occurred at home was higher amongst urban compared to rural 
participants suggesting that the urban participants either lived in households of a 
larger size or had more episodes of contact with the same people within the home. 
This differs from a comment made by authors who conducted a study in China and 
suggested that most urban contacts occur outside the home (Read et al., 2014). 
Additionally, more contacts per participants occurred at home during weekdays 
compared to weekends. This was an unexpected finding as during the weekdays we 
would expect people to spend more time outside of the home, at work or school 
however, whether this is due to unemployment or shift work would need to be 
investigated. Across all groups of participants, contact (physical and non-physical 
combined) occurred more frequently with family members compared to friends. This 
may reflect the importance of the family unit in this setting in Vietnam.  
 
The raw and modelled contact pattern data showed that the contact between children 
and adults was more frequent than between children. Additionally, there was evidence 
of moderate contact between adults. This pattern is similar to that described by Horby 
et al., 2011 who found moderately intense contact between adults aged 20-65 years 
representing the working age group and between children aged 0-5 years and adults 
aged 20-65 years representing contact between children and their parents or 
grandparents. This pattern differed to that seen in studies in the UK and Europe where 
during the school term the highest intensity of contact occurred between children of 
school age and between adults of working age (Eames et al., 2012; Mossong et al., 
2008). However, children were more likely to have physical contact in school 
compared to adults at work. 
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WHAT DOES THIS MEAN FOR RISK OF INFECTION OF PATHOGENS 
CAUSING AES AND TRANSMISSION DYNAMICS? 
There is evidence that people in Ha Nam spend time in areas conducive to the 
breeding of the vectors which transmit pathogens such as JEV, DENV and O. 
tsutsugamushi. If these people become infected in Ha Nam, it is therefore possible 
that they could introduce these pathogens to other areas as a result of their movement 
patterns as it is thought that a large outbreak of dengue fever in Hanoi in 2009 was 
due to the rapid movement of the population between communities (Toan do et al., 
2013). However, this risk would be increased if they spent more time in areas outside 
of their home location.  
 
The adult to child contact in this study suggests that there could be an increased risk 
of pathogens spread by droplets for which adults may not have longstanding immunity 
without vaccination such as influenza (Bahadoran et al., 2016; Eames et al., 2012) or 
measles (He et al., 2013). Our data would suggest that contact within the home, 
between family members would pose the most risk. However, as participants also 
frequently have contact in other locations such as schools and work, the potential for 
transmission to others in these settings should be considered whilst bearing in mind 
the type of contact required for transmission as given that physical contact is more 
likely to happen amongst children in school than adults in the workplace. 
 
STUDY LIMITATIONS 
The logistics required to conduct this study including the cost of the GPS devices 
resulted in a relatively small sample size, with fewer participants compared to similar 
studies (Owers et al., 2018; Seto et al., 2012). Although the devices were shared 
between the participants due to the effect of seasonality on the transmission of a 
number of pathogens, the data had to be collected within limited time periods. Since 
this study, I have explored the use of applications on smartphones which enable 
movement data to be automatically synchronised to a server. However, unfortunately, 
there are two major drawbacks with this: 1) not all participants would necessarily own 
a smartphone and they are very expensive to purchase 2) those which provide 
adequate data security through encryption such as Open Data Kit (Open Data Kit, 
2020) only allow for a limited number of coordinates to be obtained.  
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In addition to the small sample size, this study was only conducted in one semi-rural 
province. As a result, the results cannot be generalised to the wider population of 
Vietnam or beyond. The absence of a difference between NDVI measurements was 
possibly in part due to the resolution of the raster file but also and the absence of 
large differences in vegetation between the rural and urban areas in this study area. 
It is also possible that the characteristics of the population were similar in terms of 
socio-economic status for which data was not collected. This may therefore explain 
why we did not see many differences between these groups in terms of travel 
patterns.  
 
Unlike the studies conducted by Anders in southern Vietnam, and Owers et al., 2018 
in Brazil, this study did not include participants with the disease or, in this case, the 
syndrome. It was not possible to recruit participants who had had AES given that 
many are left with a disability. Not only would this have had practical challenges but 
also there would have been a risk of introducing bias as behaviour pre- and post-AES 
may be different. Furthermore, given the relatively low incidence of AES, participants 
would have to be recruited from geographically diverse areas which may not have 
been logistically possible. However, this meant that I was unable to look at 
correlations between disease or infection status and risk of exposure. Additionally, it 
was unknown whether the participants were having the same contact with a few 
people or multiple different people as contacts were not given unique identifiers and 
the duration of contact was not ascertained. This would therefore limit the ability to 
predict the magnitude and speed at which pathogens may be transmitted.  
 
The study was subject to a degree of responder biases as the contact patterns were 
reliant on participant recall and not validated. A previous study conducted in the USA 
found that there were discrepancies between the data recorded in diaries compared 
to GPS tracking devices (Elgethun et al., 2007). However, to in order to obtain this 
level of information we would need additional consent and more defined recordings 
of the locations in which contact happened. 
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FUTURE CONSIDERATIONS 
It would be recommended to repeat this study in environments where there is a higher 
incidence of AES such in the provinces Lai Chau or Son La. This might also allow us 
to quantify the degree of cross border movement into Lao PDR as discussed in 
chapter two. The study could be repeated in an urban population, perhaps Hanoi, to 
determine the differences in movement and contact patterns. An alternative to the use 
of NDVI could include tasselled cap wetness and brightness (Longbottom et al., 
2017). 
 
The use of different devices to obtain GPS data should be explored. This may improve 
the efficiency of data collection and allow for a greater number of participants over a 
wider geographical area to be recruited. If the acquisition of mobile phone data is not 
feasible, the use of a smaller and more cosmetically acceptable GPS device such as 
sports watch could be considered if budgets allow. The contact pattern diary 
interviews could also be conducted on a daily basis via phone calls instead of home 
visits which would be important if conducting the study in a more rural location. 
 
Finally, healthy participants could be followed-up over time to ascertain whether they 
developed symptoms of AES or became seropositive for example JEV or DENV.  
 
CONCLUSION 
This study provides an initial analysis of the movement and contact patterns of healthy 
people in Ha Nam province to help give some insight into the potential risk factors for 
the acquisition and spread of pathogens causing AES. However, given the small 
sample size and limited geographical area in which the study was conducted, further 
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CHAPTER 5 THE SEROPREVALENCE OF JAPANESE 



























JAPANESE ENCEPHALITIS VIRUS (JEV): THE ENZOOTIC CYCLE 
JEV a flavivirus, occurs in South and South-East Asia (Solomon et al., 2000a) and is 
the commonest cause of acute encephalitis syndrome (AES) in children in Vietnam 
(Le et al., 2010). It is transmitted in an enzootic cycle between infected mosquitoes, 
most commonly the species, Cx. tritaeniorhynchus, and animal reservoirs which act 
as amplifying hosts for the virus including pigs and wild birds (Erlanger et al., 2009); 
humans are dead-end hosts (Solomon et al., 2000a). Cx. tritaeniorhynchus breeds in 
flooded areas such as rice fields (Keiser et al., 2005) but can also occur in urban 
environments (Mansfield et al., 2017; Lindahl et al., 2012b). The density of the 
mosquitoes is influenced by climatic factors including temperature and rainfall (Murty, 
Rao and Arunachalam, 2010; Tian et al., 2015) and potentially, absolute humidity (Xu 
et al., 2014). A positive association between the NDVI of rice paddy and both 
mosquito density and the number of cases of JE has been shown in a study in China 
(Tian et al., 2015). In addition to the enzootic cycle, it has also been proposed that 
the virus can be transmitted between pigs via the oro-nasal secretions under 
experimental conditions (Ricklin et al., 2016; Mansfield et al., 2011).  
 
INFECTION IN PIGS 
It is suggested that most pigs become infected with the pathogen before the age of 
six months (Ruget et al., 2018). However, unlike humans, clinical signs are not seen 
except in pregnant sows, which may abort or give birth to stillborn or infertile piglets 
thereby contributing to economic losses (Salmon, 1984; Lindahl et al., 2012a).  
 
DIFFERENCES IN THE SEROPREVALENCE IN PIGS 
The seroprevalence of JEV in pigs varies by geographic region (Di Francesco et al., 
2018; Yamanaka et al., 2010); the age of the pig (Lindahl et al., 2012a; Di Francesco 
et al., 2018); the season during which testing takes place (Ruget et al., 2018; Lindahl 
et al., 2012a); the type of farm on which the pig was raised (Di Francesco et al., 2018) 
and the method of diagnostic test.    
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STUDIES IN VIETNAM 
A number of studies have been conducted in Vietnam to determine the 
seroprevalence of JEV in pigs. In 1999, three-hundred and fifteen sows which were 
in the second month of gestation or during lactation, were sampled from state-owned 
pig farms in the Mekong Delta, southern Vietnam. The farms were all routinely 
vaccinated against Foot and Mouth Disease and Classical Swine Fever (Lindahl et 
al., 2012a). Sixty percent of pigs were found to be seropositive to JEV using a 
commercial indirect IgG ELISA (Shenzhen Lvshiyuan Biotechnology Co. Ltd., 
Shenzhen, China). The odds of being infected with JEV increased with the age of the 
sow. However, the month of sampling had no influence on the proportion which were 
seropositive, suggesting that JEV transmission occurred year-round (Lindahl et al., 
2012a). A more recent study conducted in Can Tho city, also in the Mekong Delta 
detected anti-JEV IgG antibody in 100 and 97% of female pigs over six months of age 
from urban and rural households, respectively (Lindahl et al., 2013). Samples were 
taken during the rainy season (Lindahl et al., 2013), defined as between July and 
September (Lin et al., 2000). Competitive IgG ELISA and IgM MAC ELISA were used 
to perform serological analyses with specificity validated using Swedish pig sera 
(Lindahl et al., 2013).  
 
In northern Vietnam, sera from six-hundred and forty-one pigs from thirteen provinces 
with an average age of 5.3 months were obtained from a slaughterhouse in Hanoi and 
analysed for the presence of antibodies to flaviviruses using a commercial ELISA Kit 
(ID screen West Nile competition ELISA kit from ID VET, France). 60.4% (n=387) of 
the samples were seropositive of which 97.2% were confirmed by microneutralisation 
tests giving a lower seroprevalence compared to the study conducted by Lindahl et 
al., 2013 in the Mekong Delta but similar to that conducted in 2012. However, the 
predicted seroprevalence was lower amongst pigs born in August to October 
suggesting differences in the seasonality of the circulation of the virus (Ruget et al., 
2018) which was not seen in southern Vietnam (Lindahl et al., 2012a).  
 
A recent study conducted across ten provinces in northern, southern and central 
Vietnam sampled two thousand sera collected from pigs of different age group from 
large-scale farms as part of a swine influenza programme. The samples were tested 
using ELISA (VDProf JE Ab ELISA; Median, Chuncheonsi, Korea) giving a 
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seroprevalence of 74.46% (95%CI 71.84-77.06%) ranging from 60.92% (95%CI 
53.20-68.25%) in Binh Duong to 85.93% (95%CI 79.73-91.36%) in Dong Thap both 
of which are in southern Vietnam (Lee et al., 2019). 
 
STUDIES OUTSIDE VIETNAM 
Studies of JEV seroprevalence in pigs have also been performed outside of Vietnam.  
A study in Cambodia followed fifteen pigs from a farm located in a peri-urban area (Ta 
Khmau Kandal province, in the suburbs of Phnom Penh) with a density of 191.97 
pigs/km2, and the same number from a farm located in a rural area (Kandal province, 
60km from Phnom Penh) with a density 145.69 pigs/km2 (Di Francesco et al., 2018). 
The samples were analysed using an indirect ELISA (Duong et al., 2011; Yang et al., 
2006). Additionally, in the two weeks prior to the date of the pigs’ presumed 
seroconversion, real-time PCR was used to detect JEV RNA. Results from twenty-
nine pigs were available at the end of the study, of which all had seroconverted by the 
age of six months. However, the average age at infection was 98 days in those from 
the peri-urban farm compared to 150 days in those from the rural farm where maternal 
antibodies waned much later. Despite this, the force of infection (the rate at which 
susceptible pigs become infected) was similar in both farms; 0.061 per day (95%CI 
0.034-0.098) in the peri-urban cohort compared to 0.069 per day (95%CI 0.047-0.099) 
in the rural cohort (Di Francesco et al., 2018) which is in keeping with the findings by 
Lindahl et al. 2013 in southern Vietnam. The authors of the work in Cambodia 
therefore suggest that their finding contradicts the known risk factors for JEV 
transmission including proximity to rice paddies which are suitable breeding grounds 
for the mosquito vector (Keiser et al., 2005) and are feeding environments for wild 
aquatic birds (Di Francesco et al., 2018). This led them to hypothesise that other wild 
bird species or domestic animals such as chickens or ducks may act as amplifying 
reservoirs for JEV in peri-urban and rural areas (Di Francesco et al., 2018). 
 
A study conducted in Lao PDR found seroprevalence in pigs at slaughter to be 74.7% 
(95%CI 71.5-77.9%) using a haemagglutination inhibition assay. IgM detected using 
an in-house ELISA from the Armed Forces Research Institute for Medical Sciences 
(AFRIMS), Bangkok, Thailand showed a peak in infection in June and July 
corresponding with the start of the wet season and the filing of rice paddies with water 
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(Conlan et al., 2012). This pattern of seasonality corresponds with that in northern 
Vietnam, albeit with a lower seroprevalence. 
 
In Bangladesh, where pig-rearing is less common for religious reasons, the 
seroprevalence is much lower than that in South-East Asia with a study showing 16% 
and 31% in those less than 12 months of age and aged 12 months or older 
respectively, as confirmed by the presence of anti-JEV IgG antibody using a 
commercial ELISA (GENTAUR BVBA – Genoprice, Belgium) (Khan et al., 2014). A 
discrepancy in seroprevalence was seen in Indonesia with 6% of pigs in Java being 
seropositive as determined by haemagglutination inhibition assay (HAI) compared to 
49% in Bali, Indonesia where the population are predominantly Hindu and the pig 
density is nearly 100 fold higher (Yamanaka et al., 2010). 
 
In addition to the study by Ruget et al., 2018, other studies have compared diagnostics 
for assessing seroprevalence. A study in Cambodia showed that 65.7% pigs tested 
positive by HAI compared to 63.5% by ELISA (Duong et al., 2011). A study in southern 
Nepal compared the use of a competitive ELISA (C-ELISA) with plaque reduction 
neutralisation testing (PRNT) (Pant et al., 2006). A total of sixty-one percent of pigs 
had evidence of antibodies against JEV as detected by C-ELISA. Of those which were 
seropositive, 70% had evidence of JEV antibodies as detected by PRNT (n=84); and 
of those which were seronegative, 39.2% had evidence of JEV antibodies as detected 
by PRNT (n=31) (Pant et al., 2006). Diagnosis of JEV by ELISA can be complicated 
by cross-reactivity between flaviviruses (Mansfield et al., 2011). However, the higher 
specificity of PRNT minimises this problem (Mansfield et al., 2017). 
 
THE ASSOCIATION OF THE SEROPREVALENCE OF JEV IN PIGS AND 
HUMAN INFECTION 
The association between the seroprevalence of JEV in pigs and infection in humans 
remains to be fully determined. In India, a study showed that the highest proportion of 
pigs which seroconverted to JEV occurred during the same month as the peak 
epidemic period of JE in humans (Kalimuddin, Narayan and Choudhary, 1982). 
Additionally, a case-control study from Bali and cross-sectional study from Nepal 
showed that ownership of a pig was associated with serologically confirmed JE in 
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humans (Liu et al., 2010; Rayamajhi et al., 2007). However, living in close proximity 
to pigs was not identified as a risk factor for serologically-confirmed JEV, in a case-
control study in Vietnam (Lowry et al., 1998).  
 
THE CONTROL OF JEV IN PIGS 
Despite the existence of fewer JEV vaccines for livestock compared to humans, in 
order to reduce abortion and so improve livestock production, immunisation using 
either a live-attenuated to inactivated vaccine is recommended (Mansfield et al., 
2011). A compartmental model suggested that the annual vaccination of fifty-percent 
of pigs in Bangladesh will result in an eighty-two percent reduction in the annual 
incidence (Khan et al., 2014) and since 2007, there have been no official notifications 
of outbreaks in the pig population in South Korea, which has used a live-attenuated 
viral strain for a swine vaccination programme for over thirty years (Mansfield et al., 
2011; Nah et al., 2015). However, as a result of maternal antibody, the effectiveness 
of the live-attenuated vaccine is reduced. Additionally, it is expensive to give annual 
vaccinations to newborn pigs when the turnover is high. As a result of this vaccination 
is not commonly used (Erlanger et al., 2009). Furthermore, the effect of vaccination 
on incidence in humans has yet to be established (Khan et al., 2014) particularly, as 
outbreaks of human disease still occurred in the Republic of Korea despite the 
vaccination programmes (Nah et al., 2015; Seo et al., 2013). In addition to 
vaccination, the use of insecticide-treated mosquito nets to cover pigs has been 
shown to reduce the seroconversion rate in both humans and pigs (Dutta et al., 2011).  
 
THE JUSTIFICATION FOR THE RESEARCH AND THE QUESTIONS TO BE 
ADDRESSED 
The other aspects of this thesis have focussed on the epidemiology of JEV in humans. 
However, as described, pigs play a key role in the transmission of the virus. Centre 
de coopération internationale en recherche agronomique pour le développement 
(CIRAD) and the Vietnam National Institute for Veterinary Research (NIVR) in Hanoi 
undertook a surveillance project which included the sampling of blood and nasal 
swabs from pigs for the detection of swine influenza viruses and other respiratory 
pathogens. This included the collection of serum samples from seventy pigs per 
month from Van Phuc slaughterhouse in Hanoi. These samples were kindly made 
available to allow this investigation of the seroprevalence of JEV in pigs in northern 
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Vietnam. The study by Ruget et al. 2018 which also evaluated the seroprevalence in 
this region, had not been published at the time of developing this study and conducting 
the laboratory analysis. However, there are still areas to be researched, including 
whether differences exist in the seroprevalence between provinces and the 
importance of the month of sampling; between familial and industrial farms where the 
former may be in closer proximity to mosquito breeding grounds or other animal 
reservoirs for JEV such as wild birds (Mansfield et al., 2017) and the latter in areas of 
increased number of mosquitoes (Lindahl et al., 2012b); the association with 
environmental factors which are conducive to mosquito breeding and transmission; 
and finally, an association with human cases of acute encephalitis syndrome (AES) 
and JE in space and time.  
  
The aim of this study is to evaluate the epidemiology seroprevalence of JEV in pigs 
in northern Vietnam to potentially guide public health control measures by: 
1. determining if there are differences in the seroprevalence of JEV in pigs 
between provinces and by the month of slaughter in northern Vietnam; 
2. ascertaining if there are differences in the seroprevalence of JEV in pigs from 
familial compared to industrial farms; 
3. evaluating if there is evidence of a correlation between the seroprevalence of 
JEV in pigs and the environmental suitability for Cx. tritaeniorhynchus;  
4. evaluating if there is evidence of a correlation between the incidence of human 




THE COLLECTION OF SAMPLES 
As described, serum samples were provided by CIRAD and NIVR from Van Phuc 
slaughterhouse. Sample collection commenced in May 2013 was still ongoing at the 
time this study was undertaken. The pigs were aged 4-6 months at the time of 
slaughter when the samples were collected. Twenty-five traders operate at the 
slaughterhouse. For each trader their name, contact details, type of farm (familial or 
industrial) and location of farms (province and/or district) were collected. One trader 
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will collect pigs from a number of different farms and therefore potentially reducing 
the accuracy of the data relating to the location of the origin of the pig (personal 
communication, Eugenie Baudon). In Vietnam, there are three types of swine farms; 
familial, company farms and state-owned farms. The familial farms are normally 
owned by household and are small in size, company farms are owned by foreign or 
Vietnamese companies and very large; and state-owned farms keep grandparents 
and great-grandparents of exotic breeds and are also large in size (Baudon et al., 
2017). 
 
THE SAMPLING METHODOLOGY  
Given that this study includes a spatial component, those samples for which there 
was no information detailing the location of operation of the trader were excluded 
leaving a total of 2388 samples for analysis. The number of sera to be sampled was 
stratified by the number of pigs within regions in northern Vietnam using data from the 
General Statistics Office of Vietnam (General Statistics Office of Viet Nam) to prevent 
over-sampling from certain provinces e.g. Hanoi. The regions included the Red River 
Delta (RRD) and two pre-defined regions outside of the RRD with the provinces 
shown in figure 5.1.  In addition to the required sample size of 1565, a further 129 
samples were to be tested to assess the effect of seasonality on JE seroprevalence 
across northern Vietnam. The addition of 129 samples allowed for a minimum of 30 
samples per month from June 2013 to September 2016 to be tested where data on 
location was available (and stratified by pig density to the extent possible with the 
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Figure 5.1 The provinces from which the pigs originated. The provinces in red in the 











It was decided initially to measure seroprevalence of JEV using a commercial indirect 
IgG ELISA (LSY-30008 Shenzhen Porcine Encephalitis Virus, Shenzhen Lyvshiyuan 
Biotechnology Co. Ltd., Shenzhen, China) as this was used previously by NIVR. 
Swedish and Vietnamese researchers have also published results of seroprevalence 
in southern Vietnam using the same kits. The authors stated that based on data from 
the manufacturer, compared to the haemagglutination inhibition test (HI) the ELISA 
had a relative sensitivity of 0.92 and specificity of 0.79 with no cross-reaction to other 
significant pathogens such as Porcine reproductive and respiratory syndrome and 
Porcine Parvovirus (Lindahl et al., 2012a).  
 
Although acute infection is determined by anti-JEV IgM, the titres will wane and other 
studies of seroprevalence in Vietnam used anti-JEV IgG (Lindahl et al., 2013; Lindahl 
et al., 2012a). Despite being potentially less specific then plaque reduction 
neutralization testing (PRNT), the ‘gold standard’ for the serodiagnosis of flaviviruses 
(Mansfield et al., 2017), ELISA is easier to perform because it does not require the 
use of live virus (Maeda and Maeda, 2013). Furthermore, PRNT is not available in 
Hanoi. Other researchers in Vietnam who used ELISA, developed a Bayesian 
Province name Province number 
   Bac Giang 3 
   Bac Ninh 6 
   Ha Nam 21 
   Ha Noi 22 
   Ha Tinh 23 
   Hai Duong 24 
   Hoa Binh 27 
   Hung Yen 28 
   Nam Dinh 37 
   Ninh Binh 39 
   Phu Tho 41 
   Thai Binh 51 
   Thai Nguyen 52 
   Thanh Hoa 53 
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framework to estimate the true prevalence of JE from the apparent prevalence by 
adjusting for the sensitivity and sensitivity. However, there was little difference 
between the two (true prevalence = 74.46%, 95% credible interval: 73.73-86.41 and 
apparent prevalence = 73.45%, 95%CI 71.46-75.37) (Lee et al., 2019).  
 
The ELISAs were performed according to manufacturer’s instructions, using optical 
density cut-offs to determine results as follows: greater than or equal to 0.4 to be 
positive, 0.2-0.4 unclear and less than 0.2, negative (appendix 6.1). However, after 
testing forty-two samples at the beginning of 2017, NIVR staff reported that more 
samples than expected were positive. Additionally, it was noticed that the wells 
continued to change colour after adding stop solution. The staff discussed this 
problem and sent the results to me whilst making amendments to the timings of 
procedures and trying different kits without success. Seventy-one samples previously 
tested using the Shenzhen ELISAs in 2016, were re-tested using the new kits. As 
shown in table 5.1 below there was discrepancy between the results with thirteen of 
the twenty-five samples which were negative in 2016 were positive on retesting in 
2017. 
 
Table 5.1 Comparison of the testing of porcine JEV IgG antibodies using the 










 Samples tested in 2017 
Positive Suspected Negative 




8 0 0 
4 0 3 
13 0 43 
Total 25 0 46 
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I raised the issue with the supplier who felt that the differences may be due to the 
conditions of the storage of the samples and ELISA kits. However, we had no reason 
to suspect these were adverse. 
 
As a result of this, I needed to select a different method of testing. I discussed with 
colleagues in Hanoi the possibility of using HAI however, a colleague based at 
OUCRU HCMC had previously used a competition enzyme-linked immunosorbent 
assay (cELISA) from the Commonwealth Scientific and Industrial Research 
Organisation (CSIRO), Australia for the testing of pig serum for JEV seroprevalence 
and I therefore decided to use this. This cELISA measures all antibodies (IgA, IgG 
and IgM) and is unable to discriminate between these (verbal communication, 
CSIRO). The ELISA plate was initially coated with JEV antigen in coating buffer and 
incubated. The test sera diluted to 1 in 10 was then added in duplicate wells after the 
plate was washed. JEV 989 monoclonal antibody was added to the plates followed 
by incubation and another wash and the additional of anti-mouse (horseradish 
peroxidase) HRPO conjugate. The plate was incubated and washed again before 
adding the tetramethylbenzidine (TMB) substrate, incubating and adding sulphuric 
acid. The plate was then read with a positive result indicating exposure to JEV or a 
closely related flavivirus. Sera with percentage inhibition of greater than 50% were 
classified as positive, less than 40% as negative and 40-50%, suspected positive 
(appendix 5.1).  
 
Due to the known concerns regarding the potential for cross-reactivity between 
flaviviruses and hence, specificity of ELISA, I decided to re-test a subset of serum 
samples by the gold standard method, PRNT  (Mansfield et al., 2017). This is also a 
recommendation by CSIRO who test positive samples for West Nile virus (WNV) and 
Murray-Valley virus. In Hanoi, there was only provision for conducting 
microneutralisation testing and not PRNT. Therefore, I sent one-hundred samples to 
Mahidol University, Center for Vaccine Development, Bangkok under Prof Sutee 
Yoksan to test for JEV using PRNT. Prof Sutee Yoksan was known to me from a 
previous collaboration where his team tested human serum samples for anti-JEV and 
anti-dengue virus. PRNT measures the effect of antibody on virus susceptible cells. 
A plaque is formed when the virus results in an infection. Serial dilutions of the serum 
being tested are used and the number of plaques counted to determine the reduction 
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in virus activity (World Health Organization, 2007a). PRNT was performed at Mahidol 
University according to the local standard operating procedure (SOP) (appendix 5.2). 
In summary, LLC-MK2 cells were inoculated with a serum-virus mixture of ten-fold 
dilutions starting with 1:5 and continuing as required to reach the end point of a fifty 
percent reduction in plaques. The mixture was left to absorb for ninety minutes at 
37°C before adding an overlay medium and incubating at the same temperature in a 
5% CO2 incubator for seven days. After seven days, the number of plaques in each 




All statistical analysis was conducted using R statistical software (versions 3.6.0 and 
3.6.1), (R Core Team, 2019). The data was restructured using the R package 
‘tidyverse’ (Wickham, 2017) with figures constructed using the packages ‘ggplot2’ 
(Wickham, 2016), ‘viridis’  (Garnier, 2018) and ‘ggspatial’ (Dunnington, 2018), ‘sf’ 
(Pebesma, 2018), ‘scales’ (Wickham, 2018) and ‘cowplot’ (Wilke, 2019). 95% 
confidence intervals (CIs) were calculated using the function prop.test().  
 
DESCRIPTIVE ANALYSIS 
The number of samples collected per month was shown as panel of bar charts. The 
number and percentage of the total with 95%CIs of samples collected per province 
were shown in a table with the percentage also demonstrated in a choropleth map. 
Choropleths maps were constructed to show the differences in the percentage of pigs 
from familial and industrial farms; the proportion of land suitable for Cx. 
tritaeniorhynchus, the mean incidence of human cases of AES and JE and the mean 
percentage of vaccination coverage against JE. 
 
UNIVARIATE ANALYSIS 
The seroprevalence of JEV in pigs by the month of slaughter with 95% confidence 
intervals (CIs) was shown as a bar chart and by province, as a table and choropleth 
map. A time series plot of the total seroprevalence over the study period was also 
provided. Differences in seroprevalence were determined using the chi-squared test. 
  251  
	
For the single categorical variable ‘category of farm’, total numbers and percentages 
including 95%CI were given for pigs which were seropositive and seronegative for 
JEV. For the remaining continuous variables, means including standard deviations 
were given.  
 
Logistic regression was performed using the R function glm() used to fit generalised 
linear models (GLM) (RDocumentation, 2020) to compare the relationship between 
the JEV seroprevalence (seropositivity compared to seronegativity) in pigs with each 
of the covariates as below. The R package ‘MASS’ (Venables and Ripley, 2002) was 
used to calculate the odds ratio (OR) with 95%CIs for each of the models.  
 
The residuals of the models were tested for the presence of spatial autocorrelation 
using the Monte-Carlo simulation of Moran’s I as described in chapter two using the 
R package ‘spdep’ (Bivand, Pebesma and Gomez-Rubio, 2013). To allow for 
convergence, one-thousand permutations were included in Monte-Carlo simulation of 
Moran I. If spatial autocorrelation was found to be present, as defined by a p value of 
less than 0.05, the analysis was re-run using a spatio-temporal INLA latent Gaussian 
model of the binomial familial and the specification Besag-York-Mollie (BYM) for the 
spatial random effect. In all model the Random Walk Model of Order1 to account for 
a temporal random effect as described in chapter two using the R package ‘INLA’ 
(Lindgren and Rue, 2015). The fit of the INLA model was defined by the assessment 
of the posterior estimates of the precision for spatial and temporal components. The 
estimates of the INLA model were plotted using the function Efxplot from the R 
package ‘ggregplot’ (Albery, n.d.). 
 
DATA ACQUISITION 
1. The category of farm from which the pigs originated (familial compared to 
industrial) 
This information was obtained directly from the data provided by NIVR. 
 
2. The percentage of area of each province suitable for Cx. tritaeniorhynchus 
A raster file of resolution 5x5km pixels of Cx. tritaeniorhynchus suitability was 
obtained from a paper by Longbottom et al., 2017. The raster is based 
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constructed from a model which includes covariates associated with the 
survival of mosquitoes including land surface temperature (LST) (Gap-filled 
MODIS LST data), Tasselled cap wetness (TCW) and brightness (TCB) (Gap-
filled MODIS satellite data), Shuttle Radar Topography Mission (SRTM) 
elevation and landcover (closed and open shrublands, woody savannas, 
grasslands, permanent wetlands, croplands, urban/built-up areas and 
barren/sparsely populated areas (MODIS land cover product).  
 
The mean percentage of area of suitability for the vector within each province 
(polygon) was extracted as described in chapter two with weighting by human 
population density.  
 
 
3. The incidence of human AES and JE; and JE vaccination coverage 
As described in chapter two, the monthly incidence of human AES was obtained 
from the GDPM (Ministry of Health Vietnam General Department of Preventive 
Medicine, 2019). Populations in each of the provinces were obtained using the R 
packages ‘gso’ (Choisy and Contamin, 2019c) which uses data from the General 
Statistics Office of Vietnam (General Statistics Office of Viet Nam) and merged by 
year using the R package ‘poseid’ (Choisy and Contamin, 2019d). The incidence 
of JE was obtained from sentinel site suspected meningoencephalitis surveillance 
data which was provided by the Expanded Programme on Immunization (EPI), 
World Health Organization (WHO), Hanoi. Cases presenting to the National 
Hospital for Pediatrics in Hanoi with suspected meningoencephalitis with a 
positive anti-JEV IgM as tested by ELISA were diagnosed with JE. Data on JE 
vaccination coverage in humans was included due to its potential for interaction 
with human incidence of JE or AES and was provided by the National Institute of 
Hygiene and Epidemiology (NIHE), Hanoi (National Institute of Hygiene and 
Epidemiology, 2018).  
 
The datasets were merged on province of pig origin and time (month) of 
slaughter/sample collected with the covariates: incidence of human AES, incidence 
of human JE and JE vaccination coverage. The suitability for Cx. tritaeniorhynchus 
was matched on province only as there is no time component. Table 5.2 outlines the 
datasets used. 
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Table 5.2 The datasets used, their unit of time and source. 
Dataset Unit of time Spatial 
unit 
Source Year Resolution 















Time of sample 
collection 
Province of pig 
origin 







suitability for Cx. 
tritaeniorhynchus 
Fixed Provincial Longbottom 




As needed for 
the covariate for 
which it is 
weighted 
Provincial WorldPop 2009 100m 





Monthly Provincial GSO 2013-
2016 
NA 











Given the presence of spatio-temporal autocorrelation in the majority of univariate 
analyses, all multivariate analyses were performed the same INLA methods as 
described for the univariate models.  
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Four multivariate models with an outcome of seroprevalence were constructed using 
the covariates as below. The incidence of human JE and AES were also fitted in 
separate models due to the potential collinearity (we would expect JE cases to be 
included as part of AES surveillance). As the category of farm was available only for 
four-hundred and twenty pigs, models without this variable were required to account 
for the total number of samples. 
 
seroprevalence of JEV in pigs ~ category of farm + environmental suitability for Cx. 
tritaeniorhynchus + incidence of human JE per 100,000 population + percentage of 
coverage of JE vaccination  
 
seroprevalence of JEV in pigs ~ category of farm + environmental suitability for Cx. 
tritaeniorhynchus + incidence of AES per 100,000 population + percentage of 
coverage of JE vaccination 
 
seroprevalence of JEV in pigs ~ environmental suitability for Cx. tritaeniorhynchus + 
incidence of human JE per 100,000 population + percentage of coverage of JE 
vaccination 
 
seroprevalence of JEV in pigs ~ environmental suitability for Cx. tritaeniorhynchus + 
incidence of AES per 100,000 population + percentage of coverage of JE 
vaccination 
 
The estimates of each INLA model were plotted using the function Efxplot from the R 
package ‘ggregplot’ and the Deviance Information Criterion (DIC) and Watanabe-
Akaike information criterion (WAIC) given to assess the models with the best fit 
including those with and without the category of farm. A choropleth map of the 
estimate of seroprevalence was constructed for the model with the best fit. 
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SENSITIVITY AND SPECIFICITY OF THE C-ELISA 
The sensitivity, specificity, positive and negative predictive value of the cELISA were 




The original collection of sera was approved by the Institutional Review Board of the 
University of Hong Kong/Hospital Authority Hong Kong West Cluster (HKU/HA HKW 




DESCRIPTIVE ANALYSIS OF THE COVARIATES 
1398 samples of what were tested. Following the removal of duplicate samples and 
those in which the sample ID did not match the animal ID there were 1391 samples 
for analysis. Of these samples 63.5% (95%CI 60.9-66%, n=883) were seropositive, 
2.7% (1.9-3.7%, n=37) were suspected seropositive and 33.9% (31.4-36.4%, n=471) 
were seronegative. Those which were suspected to be seropositive were removed 
from the analysis leaving a final 1354 samples.  
 
Samples were obtained from pigs from fifteen provinces in northern Vietnam with a 
median of 32 samples per province ranging from five samples in Bac Ninh and Ha 
Tinh to 383 samples in Hanoi (figure 5.2). Eight-hundred and forty samples (62.0%, 
95%CI 59.4-64.6%) samples were from the Red River Delta region. The dates of 
samples ranged from June 2013 to September 2016 with a median number of 35 
samples per month (figure 5.3). The highest percentage of familial farms were seen 
in Ha Nam province (81.6%, 95%CI 71.6-88.8%). The highest percentage of farms 
which were industrial were in Bac Giang, Bac Ninh, Ha Tinh, Hai Duong, Hoa Binh, 
Nam Dinh and Thai Binh (100%) (figure 5.4). The mean proportion of area suitable 
for Cx. tritaeniorhynchus using the raster file from Longbottom et al., 2017 ranged 
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from 0.25 in Hoa Binh to 0.64 in Bac Ninh (figure 5.5). The mean monthly incidence 
per 100,000 population of human cases of AES by province ranged from zero in Bac 
Ninh, Ha Tinh, Hung Yen, Nam Dinh and Thai Nguyen to 0.209 (SD=0.274) in Bac 
Giang (figure 5.6), and the mean monthly incidence per 100,000 population of JE 
ranged from 0.043 (SD=0.015) in Thanh Hoa to 0.302 (SD=0.068) in Hoa Binh (figure 
5.7). 
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Figure 5.5 The mean proportion of area suitable for Cx. tritaeniorhynchus weighted 










Figure 5.6 The mean monthly incidence per 100,000 population of human AES over 





























Weighted by population density
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Figure 5.7 The mean incidence of JE by province. 
 
 
In the years that vaccination against JE was performed, coverage ranged from 
88.97% in Ha Tinh in 2013 to 100% in Ha Noi in 2013.  
 
THE PERCENTAGE OF SEROPOSITIVE SAMPLES BY PROVINCE 
 
The percentage of pigs which were seropositive by province ranged from 30.8, 10.4-
61.1%) in Thai Nguyen to 100% in Bac Ninh (6.3, 100%) (figure 5.8 and table 5.3). 
The percentage of pigs from the Red River Delta which were seropositive was 70.7% 
(95%CI 67.5-73.8%, n=594) compared to other provinces (56.2%, 95%CI 51.8-
60.6%, n=289). There was strong evidence for a difference in seroprevalence 
between provinces from the Red River Delta and other provinces as determined by 
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Table 5.3 Percentage of pigs seropositive for JEV by province.  
 Positive (N=883)  
N (%, 95%CI) 
Total (N=1354) 
p valuea 
Province    
< 0.001 
   Bac Giang 33 (53.2, 40-65.8%) 62  
   Bac Ninh 5 (100.0, 46.3, 100%) 5  
   Ha Nam 231 (76.5, 71.2-81.1%) 302  
   Ha Noi 267 (69.7, 64.8-74.2%) 383  
   Ha Tinh 3 (60.0, 17.0-92.7%) 5  
   Hai Duong 43 (57.3, 45.4-68.5%) 75  
   Hoa Binh 23 (79.3, 59.7-91.3%) 29  
   Hung Yen 25 (78.1, 59.6-90.1%) 32  
   Nam Dinh 13 (61.9, 38.7-81.0%) 21  
   Ninh Binh 6 (66.7, 30.9-91%) 9  
   Phu Tho 76 (45.2, 37.6-53.1%) 168  
   Thai Binh 4 (30.8, 10.4-61.1%) 13  
   Thai Nguyen 9 (33.3, 17.2-54%) 27  
   Thanh Hoa 99 (63.5, 55.3-70.9%) 156  
   Vinh Phuc 46 (68.7, 56-79.1%) 67  
 
 
*The difference in the percentage of samples which were seropositive between 
provinces  
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DIFFERENCES IN THE SEROPREVALENCE OF JEV BY MONTH OF 
SAMPLING 
There was strong evidence for a difference between number of pigs seropositive and 
seronegative at different months of slaughter as determined by the chi-squared test 
(p<0.001). The highest percentage of pigs being seropositive at slaughter was in the 
month of August (85.6% (95%CI 78.2-90.1%)) and the lowest in March (30.9 (95%CI 
19.5-45.0%)) (figure 5.9). There was however, no evidence of an increase or 
decrease in trend over the study period (figure 5.10).  
 
Figure 5.9 The percentage of pigs seropositive at slaughter by month. The error 
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UNIVARIATE AND MULTIVARIATE ANALYSES 
	
The univariate analysis using GLM showed there was no difference in the 
seroprevalence between pigs from an industrial compared to familial farm with no 
evidence of spatial autocorrelation (table A5.1, appendix 5.3). After taking into 
account the temporal autocorrelation, the INLA model showed that those from an 
industrial farm were less likely to be seropositive with a mean posterior value of -0.139 
and the absence of the crossing of zero in the range between the 2.5 and 97.5 
percentile (-0.224- (-0.054) (table A5.2, appendix 5.3 and figure 5.11, below). This 
correlation was also seen in multivariate models 1 and 2 (figure 5.11).  
 
There was strong evidence for a positive correlation between the proportion of land 
suitable for Cx. tritaeniorhynchus and seropositivity (OR=7.15, 95%CI 2.53-20.51) 
with evidence of both spatial autocorrelation (table A5.3, appendix 5.3). The univariate 
INLA model however, did not show any evidence of correlation (estimate = 0.425 (-
0.185-1.063) (table A5.4, appendix 5.3 and figure 5.11). This absence remained in 
multivariate models (figure 5.11). 
 
Incidence of human AES but not incidence of human JE was positively correlated with 
seropositivity in the univariate logistic regression models (OR=3.23, 95%CI (1.61-
7.29) OR=1.53, 95%CI 0.34-7.40) with both analyses showing evidence of spatial 
autocorrelation (tables A5.5 and A5.7, appendix 5.3). There was no correlation with 
the incidence of human JE and the seropositivity of JEV in pigs in the univariate 
multivariate analyses however, the incidence of human AES was negatively 
associated in model 2, and positively associated in model 4 with seropositivity (tables 
A5.6 and A5.18 and tables A5.11-A5.14, appendix 5.3; and figure 5.11).  
 
The univariate logistic regression analysis using GLM showed no evidence of a 
correlation between JE vaccination coverage and seropositivity (OR=1.00, 95%CI 
1.00-1.01) but with evidence of spatial autocorrelation (table A5.9, appendix 5.3). This 
absence of a correlation remained in the INLA univariate and multivariate models 
(tables A5.9 and A5.11-A5.14, appendix 5.3 and figure 5.11).  The DIC and WAIC 
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Figure 5.11 The posterior means of the INLA univariate and multivariate models by 
each covariate with an outcome of number of cases of meningitis. The dot represents 
the posterior mean value and bars represent the 95% credible intervals. The presence 
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Table 5.4 The DIC and WAIC for each multivariate INLA model. 
 
Model DIC WAIC 
1 492.11 493.09 
2 487.96 489.10 
3 1725.07 1729.27 
4 1718.91 1722.81 
 
 
THE COMPARISON BETWEEN C-ELISA AND PRNT 
 
Table 5.5 The correlation between cELISA and PRNT results 
    PRNT 
    Positive Negative 
cELISA 
Positive 22 26 
Negative 8 35 
 Total 30 61 
 
PRNT results were available for ninety-seven samples (for three samples the 
identification codes are incorrect and could not be processed). Compared to PRNT, 
the sensitivity of cELISA was 73.3% (95%CI 53.87.), specificity, 57.4% (95%CI 44.1-










This study examines the seroprevalence of JEV in pigs at six months of age in 
northern Vietnam, the association with environmental risk factors and human 
incidence of AES and JE.  
Over a study period of three years, sixty-four percent of pigs in this region were 
seropositive for JE at six months of age. This shows that despite a reduction in the 
incidence of human AES as detailed in chapter two, there is ongoing transmission of 
JEV between the zoonotic reservoir and mosquitoes.  
 
This percentage of seropositive pigs however, is very similar to that obtained by Ruget 
et al., 2018 in who sampled pigs of a similar age in northern Vietnam. It is however 
lower than that in a study by Lindahl et al., 2013 where 97-100% of pigs were 
seropositive but were from southern Vietnam and of an older age. As pigs get older, 
their chance of being infected would increase. Additionally, in southern Vietnam, JEV 
transmission is likely to occur year-round (Lindahl et al., 2012a) compared to northern 
Vietnam where transmission is seasonal thereby potentially reducing the likelihood of 
exposure to the virus depending on when the pigs were born (Ruget et al., 2018). 
Despite this, the result was however, similar to that obtained by a different study in 
southern Vietnam which sampled older pigs (sows), where 60% were seropositive 
(Lindahl et al., 2012a).  
 
The seroprevalence of JEV in this study was also similar to that of studies conducted 
in some countries outside Vietnam including Lao PDR (74.7%), Nepal (61%) and 
Cambodia (65.7%). However, was higher than that in Bangladesh (16%) and 
Indonesia (6% in Java and 49% in Bali). Given the likelihood that the environment for 
the Cx. tritaeniorhynchus vector is suitable in all of these locations, it is possible that 
the differences in seroprevalence are due to socio-cultural factors. The pig herd in 
Vietnam has been reported to be the largest in Southeast Asia (Lemke, 2008) 
however, although pig rearing does occur in some ethnic minority communities in 
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Bangladesh, for religious reasons, social stigma may be associated with this practice 
(Nahar et al., 2013) and potentially also in Java, Indonesia where the pigs density is 
much lower than in neighbouring Bali.  
 
A difference in seroprevalence was seen between provinces in northern Vietnam in 
this study. This might suggest a variation in the transmission of the virus between 
areas however, as the number of samples tested in some provinces was very small 
e.g. five, this produced very wide confidence intervals. Differences in seroprevalence 
by month of slaughter is likely to be due to the differences in climate in northern 
Vietnam. Northern Vietnam experiences warm and humid summers and cooler 
winters (Thai et al., 2015) which influences the life cycle of Cx. tritaeniorhynchus and 
hence, transmission of the virus (Reisen, Aslamkhan and Basio, 1976; Longbottom et 
al., 2017). This could therefore explain the highest seroprevalence in August 
corresponding with infection in June or July after losing their maternal antibody which 
normally occurs at 4-6 months of age (Scherer, Moyer and Izumi, 1959).  
 
The multivariate analysis showed that pigs from industrial farms were less likely to be 
seropositive for JEV compared to pigs from familial farms in both the univariate and 
multivariate analyses. This might suggest that familial farms were located in areas 
where there was higher transmission of JEV however, without knowing where the 
locations of these farms within the province and hence the proximity to environmental 
areas suitability for Cx. tritaeniorhynchus or whether the pigs in one the familial farms 
spent more time outside or less time under ITNs it is difficult to understand the reasons 
for this. This contrasts with other studies which have shown an association between 
Cx. tritaeniorhynchus and urban areas (Lindahl et al., 2012b) or no difference between 
peri-urban and rural farms (Cappelle et al., 2016).  
 
The covariates including the proportion of land which was suitable for Cx. 
tritaeniorhynchus, the incidence of human cases of JE, and vaccination coverage 
against JE did not show any association with the seropositivity of JEV in pigs in the 
univariate and multivariate INLA models. The association between the incidence of 
JE in humans and the proximity to pigs or the seroprevalence of JEV in pigs, has yet 
to be fully determined with studies showing different results (Kalimuddin, Narayan and 
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Choudhary, 1982; Konno et al., 1966; Liu et al., 2010; Lowry et al., 1998; Rayamajhi 
et al., 2007). It might also suggest that animals other than pigs for example, birds, 
may play a larger role in the transmission of JEV in Vietnam as has been hypothesised 
previously (Lord, Gurley and Pulliam, 2015).   
 
Clinical studies in Vietnam have shown that JE accounts for the highest proportion of 
cases CNS infections in children (Le et al., 2010; Ho Dang Trung et al., 2012). 
Although we do not know the age distribution of the AES surveillance data in our 
study, we might assume that a number of these cases are due to JE as discussed in 
other chapters.  If this is the case, it may account for the positive correlation between 
the seropositivity in pigs and the incidence of human AES seen in one of the 
multivariate models. However, an absence of a correlation between the incidence of 
human JE and seropositivity in pigs may be due to the aggregation of the data into 
provinces hence subjecting the study to ecological fallacy, and the low numbers of 
human cases.  
 
SPECIFICITY AND SENSITIVITY OF THE C-ELISA 
Although not listed as an objective in this study, the results of the cELISA were 
compared to PRNT to validate this test. The low specificity of the cELISA (57%) may 
suggest that there is cross-reactivity with other flaviviruses, a known problem in 
humans (Koraka et al., 2002) but also potentially in pigs (Lindahl et al., 2012a). Other 
flaviviruses which infect pigs may include WNV (Escribano-Romero et al., 2015) and 
MVEV (New South Wales Government, 2016). 
 
STUDY LIMITATIONS AND FUTURE IDEAS 
As the majority of covariates are provided at the provincial level, this study is subject 
to ecological fallacy (Piantadosi, Byar and Green, 1988). The results of the models 
therefore have to be interpreted with some caution as these cannot be applied at the 
individual level. The covariate data was also subjected to assumptions and biases. 
Despite one province being assigned to each sample, traders may collect pigs from 
several provinces (verbal communication, Eugenie Baudon). Furthermore, the human 
surveillance data, particularly that for AES may be subject to reporting biases based 
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on the case definition of AES; and selection bias as those cases which do not present 
to a healthcare centre would be missed as discussed in chapter two. Without the GPS 
coordinates of the farm, it is not possible to establish the proportion of land suitable 
for Cx. tritaeniorhynchus within the range of flight of the mosquitoes. Similarly, without 
the GPS coordinates of the homes of human cases of JE or AES, we cannot deduce 
the distance between humans and pigs. The collection of these would therefore be 
recommended for future studies. 
 
To avoid both the problem of ecological fallacy and some of the potential biases and 
assumptions, a prospective longitudinal study with pigs sampled over serial time 
points might be beneficial. This would allow for the time at which the pigs seroconvert 
to be determined whilst also collecting data on covariates at a smaller unit level. A 
correlation between the timing of pig and human seroconversion may help guide 
public health measures for example, advising unvaccinated people when they should 
avoid close contact with pigs; when it would be most cost-effective to vaccinate pigs; 
or when to use insecticide-treated nets for pig pens. Given that there is still the 
possibility that vector-free transmission of JEV in pigs occurs (Ricklin et al., 2016) a 
correlation between the density of infected mosquitoes and rate of seroconversion 
could also be explored in addition to sampling oro-nasal secretions from pigs in 
northern Vietnam for the presence of the virus.  
 
INLA models are recommended to account for spatio-temporal autocorrelation, 
particularly are these are able to rapidly produce results (Ross, Hooten and Koons, 
2012; Beguin et al., 2012). However, other methods also exist (Dormann et al., 2007) 
which could be explored to optimise the fit of the model. Although not shown in this 
thesis, separate models were constructed including the covariates: normalised 
difference vegetation index (NDVI); mean maximum and minimum temperature; mean 
absolute and relative humidity; mean rainfall; mean hours of sunshine and mean 
elevation. A combination of these covariates accounting for co-linearity were used in 
place of the covariate ‘environmental suitability for Cx. tritaeniorhynchus’. However, 
in the multivariate INLA models, none showed an association with the seropositivity 
with the exception of NDVI which was positively correlated in selected multivariate 
models. An association between climatic variables and seropositivity was not 
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identified however, this may have been due to the similarities in climate between the 
provinces.  
Despite ELISA being a commonly used method for similar studies, the low specificity 
and sensitivity of the cELISA results in difficulties drawing firm conclusions about the 
results. We may be both under-estimating the proportion of pigs which were 
seropositive for JEV or incorrectly attributing the seroprevalence to JEV when another 
pathogen may be involved. Unfortunately, due to time, logistics and finances, it would 
have been very challenging to re-test all samples using PRNT. However, this could 
be considered for future studies and might include testing for other flaviriviruses.  
 
In view of the limitations of this current study, advice regarding public health control 
measures such as changes to vaccination policies against human JE would not be 
recommended. As most pigs are still slaughtered at six months of age, a full cost-
effective analysis should be under-taken prior to considering the implementation of 
vaccination of pigs. 
 
CONCLUSION 
The results of this study are comparable to others within the region and demonstrate 
that there is ongoing transmission of JEV between mosquitoes and pigs despite a 
reduction in human AES over time as shown in chapter two. However, given the low 
specificity and sensitivity of cELISA and the ecological study design, it would be 
recommended to conduct an individual longitudinal study and to use PRNT for testing 
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DISCUSSION 
The aim of this thesis was to understand the epidemiology for, and risk factors 
associated with central nervous system (CNS) infections in Vietnam. The thesis uses 
a variety of methodologies to answer this, exploring zoonotic, entomological and 
socio-demographic risks to account for multiple causes. It commences with a literature 
review of the epidemiology of CNS infections in Vietnam and the surrounding region. 
This provides an understanding of the different aetiologies and their unique and over-
lapping risk factors. The literature review is followed by an ecological study which 
uses national surveillance data for AES, meningitis and a variety of pathogens known 
to cause CNS infections to explore their spatio-temporal patterns and associations 
with environmental, socio-demographic and zoonotic risk factors. However, due to 
ecological fallacy, no conclusions could be made about causation. The second results 
chapter therefore explores the use of a pilot study to understand the feasibility and 
acceptability of conducting a case control study to understand the risk factors for AES 
in northern Vietnam. As the transmission dynamics of many pathogens causing AES 
are influenced both by human mobility and contract patterns, the third results chapter 
looks at both of these factors in a small cohort of the community in Ha Nam province. 
The fourth chapter focusses only on JE and the importance of the zoonotic reservoir 
by looking at associations between seroprevalence in pigs with incidence of AES and 
JE in humans. Whilst using the results to make assumptions about the possible 
aetiologies in those in whom a cause was not identified, suggestions are made about 
how methods could be adapted and expanded to undertake future and possibly larger, 
studies and in some cases, guide public health measures. 
 
THE AETIOLOGY OF CNS INFECTIONS IN VIETNAM  
Despite the economic development and improvements in the health status of the 
population in Vietnam (The World Bank, 2020a; Takashima et al., 2017), CNS 
infections continue to be a burden, particularly in terms of morbidity. In adults, the 
most common cause is S. suis, a bacterium which is associated with the consumption 
of raw pig blood and viscera which often results in a meningitis and can leave patients 
with a hearing impairment (Ho Dang Trung et al., 2012; Wertheim et al., 2009b; van 
Samkar et al., 2015; Huong et al., 2019; Huong et al., 2018). However, in children the 
most common cause is JEV, a flavivirus transmitted by the bite of infected Culex 
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mosquitoes, with pigs and wild birds acting as amplifying hosts (Le et al., 2010; 
Solomon et al., 2000a). JEV remains prevalent despite the implementation of 
vaccination against JEV in the EPI since 1997 (Yen et al., 2010; Yen et al., 2015). 
Other less common causes of CNS infections in Vietnam include the viruses DENV, 
enterovirus, HSV, VZV, measles, mumps, rubella and CMV, and the bacteria S. 
pneumoniae, M. tuberculosis, H. influenza type b and N. meningitidis (Tan le et al., 
2014; Le et al., 2010; Ho Dang Trung et al., 2012; Taylor et al., 2012). In addition to 
the infectious causes, non-infectious causes of encephalitis are starting to be 
identified in Vietnam, including the autoimmune anti-NMDA receptor encephalitis 
(Nguyen Thi Hoang et al., 2017) and possible toxicity from the consumption of lychees 
(Paireau et al., 2012b). However, a number of studies both in Vietnam and on a global 
level have not been able to identify a pathogen in many cases despite extensive 
diagnostics (Tan le et al., 2014; Le et al., 2010; Ho Dang Trung et al., 2012; Taylor et 
al., 2012; Granerod et al., 2010b). The reason for this is likely to be multifactorial. 
Case definitions for AES often have a low specificity which may result in a number of 
patients in whom an infectious agent cannot be found (Granerod et al., 2010b). For 
example, an encephalopathy can often be confused with encephalitis or meningitis 
where the former causes a change in conscious state without inflammation of the 
brain or meninges, due to an infection occurring outside the CNS, a neurological 
disease such as epilepsy or other neurological manifestations such as a stroke or 
psychiatric disorder (Quist-Paulsen et al., 2019). Additionally, the timing of the sample 
can influence the detection of the pathogen with samples taken too early in the course 
of the illness leading to false negative results due to a lower detection rate of viral 
nucleic acid (Davies et al., 2005). Finally, it may not always be possible to identify 
novel pathogens (Granerod et al., 2010b). In Vietnam, it is quite possible that novel 
causes contribute to the undiagnosed CNS infections.  Le et al., 2010 suggested that 
a number of cases of encephalitis of unknown aetiology in children may be due to 
unknown or rarer pathogens such as Banna virus and in separate study of CSF 
samples obtained from patients with CNS infection between 1999 to 2009, a novel 
cyclovirus was detected by PCR (Tan le et al., 2013). A number of studies have been 
performed to try to identify novel pathogens in CNS infections for example by using 
next generation sequencing (Brown, Bharucha and Breuer, 2018) and one of the aim 
of the Vietnam Initiative on Zoonotic Infections (VIZIONS) was to try to understand 
the aetiology of CNS infections of unknown origin using multiple diagnostics (Rabaa 
et al., 2015).  
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in addition to novel pathogens it is also possible that some of the causes of CNS 
infections in Vietnam are due to pathogens which have been identified as common 
causes of CNS infections in neighbouring countries. These include O. tsutsugamushi, 
R. typhi and Leptospira species (Dittrich et al., 2015; Tarantola et al., 2014). Given 
the evidence for the existence of these pathogens in Vietnam (Nadjm et al., 2014; 
Hamaguchi et al., 2015b; Thai et al., 2006; Van et al., 1998) it possible that they 
contribute to the cause of CNS infections too. As well as novel pathogens, emerging 
and re-emerging pathogens such as Nipah virus, CHIKV and ZIKV have either been 
found in humans in Vietnam or in humans or animal reservoirs in the region (Cappelle 
et al., 2020; Quyen et al., 2017; Quan et al., 2018). Although these are not thought to 
be currently contributing to human disease in Vietnam, it would be worthwhile testing 
for these pathogens in those with an CNS infection in whom an aetiology has not be 
found.  
 
FINDINGS FROM THE RESEARCH AND HOW CAN THESE BE 
USED TO DESIGN FUTURE STUDIES 
A number of studies have been conducted in Vietnam looking at the aetiology of CNS 
infections (Tan le et al., 2014, Le et al., 2010, Ho Dang Trung et al., 2012, Taylor et 
al., 2012). Additionally, some have focused on risk factors for particular pathogens 
such as S. suis (Nghia et al., 2011). However, there was a need to understand the 
risk factors for CNS infections as a group whilst also aiming to understand the possible 
aetiology of those in whom a pathogen had not been detected. Despite being an 
ecological study, the results from chapter two can be used to make suggestions about 
the possible causes of CNS infections in Vietnam. There is a clear effect of 
seasonality of AES in northern but not southern Vietnam, with peaks in incidence in 
the summer months. This finding in addition to the positive association with 
temperature and absolute humidity in multivariate models which account for spatial 
and temporal autocorrelation could imply that many cases are caused by diseases 
caused by vectors whose life-cycle is dependent on climate conditions (Reisen et al., 
2008; Tian et al., 2015; Yang et al., 2014; Kuo et al., 2017). Non-vector-borne 
diseases such as influenza and measles also show seasonality however, their 
patterns did not correlate with those of AES whereas peaks of incidence of JE from 
sentinel were seen in the same month as peaks of incidence of AES. The hypothesis 
that many cases are due to vector-borne diseases is further supported by the positive 
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association of incidence of AES with NDVI at a lag of one month where this higher 
density of biomass may provide a suitable habitat for mosquito breeding (Tian et al., 
2015; Longbottom et al., 2017). However, as with all assumptions, further studies 
would be needed to determine whether this is true.  
 
Despite, a national reduction in cases of AES and meningitis over time, increases in 
incidence of CNS infections have been seen in the northern provinces which border 
Lao PDR and those in the central highlands. These are economically poorer provinces 
with a number of ethnic minority groups (Rheinlander et al., 2010; Tuyen, 2015; 
Giang, Wang and Yan, 2014). Many pathogens are associated with poverty in 
Vietnam, particularly those causing respiratory infections (Hoa, Hojer and Persson, 
1997) and enteric diseases (Kelly-Hope et al., 2007) and it is known that uptake of 
vaccination in poorer populations in Vietnam is lower (Kien et al., 2017; Dao et al., 
2016). Accounting for the seasonality and climatic associations it could therefore be 
suggested that a number of cases in these provinces are due to JE. This may be 
attributed to missed vaccination in Vietnamese population or that cases are from Lao 
PDR where the vaccine was implemented more recently (World Health Organization, 
2015b), particularly as it is known at Laotian cross the border to seek medical care 
(Durham, 2017). However, case control or cohort studies with laboratory confirmation 
would be needed to confirm this.  
 
Undertaking a case control study in this setting would require careful planning. The 
pilot study conducted at NHTD revealed a number of challenges and lessons were 
learnt. Firstly, it is important to consider using a case definition for either AES or 
meningitis which is appropriate for the level of healthcare routinely provided. Case 
definitions which are based solely on clinical criteria may be suitable for resource-
limited settings where diagnostics and imaging are not available. However, these are 
often lack specificity and may include CNS manifestations which are not AES or 
meningitis (Granerod et al., 2010b). The results of the pilot study showed that lumbar 
punctures are undertaken in many hospitals in northern Vietnam and also done 
relatively promptly after presentation. Therefore, case definitions for studies of CNS 
infections in Vietnam, should include diagnostics and where possible, imaging, to 
improve specificity. Additionally, the spatio-temporal patterns of incidence should be 
considered in the design, ensuring that recruitment takes place during the season of 
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peak incidence, is geographically representative and that recruitment is sufficiently 
stratified by age.  
 
Home visits were feasible and accepted by the population in the Red River Delta 
however, if the study was to focus on provinces in northwest Vietnam which are at 
higher risk of CNS infections close collaboration with those who have permission to 
visit these communities would be required. Additionally, to overcome the problem of 
finding matched controls in a hospital setting as was demonstrated during the pilot 
study, the recruitment of community controls could be considered but this would need 
advanced planning to obtain permissions from the relevant authorities. Finally, given 
the success of using electronic data capture at the homes of participants, there may 
be a role for using this to collect clinical data, particularly if multiple healthcare settings 
are involved from which paper CRFs cannot easily be returned on a regular basis. 
 
The questionnaire completed at the home of the participants covered a number of 
potential risk factors for AES and was similar to that used in a case control study in 
India (Singh et al., 2016). Despite its length, it was accepted by the participants and 
there were no major problems with completion. Additionally, the results from the FGDs 
with rural participants did not suggest that there were any particular zoonotic or 
entomological risk factors which were missed. Therefore, a similar questionnaire 
could feasibly be implemented for a future study.  
 
Questions about recent travel were included in the questionnaire for the pilot case 
control study however, the results from the GPS devices in chapter four highlight the 
need to address human movement patterns as a risk factor for both acquisition and 
transmission of pathogens causing CNS infections such as DENV (Adams and 
Kapan, 2009; Wesolowski et al., 2015b). Although many participants from Ha Nam 
province spent most of their time within their commune, there was evidence of travel 
to Hanoi and to other regions of Vietnam. Such movement becomes a particularly 
relevant risk factor if there is travel to areas of high incidence of pathogens causing 
CNS infections and may which may help to determine to the aetiology. In addition to 
movement, the results from Ha Nam showed the potential effect of human contact 
patterns in the transmission dynamics of pathogens causing AES such as enterovirus, 
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influenza virus and measles virus (Cauchemez et al., 2008; Eames et al., 2012; 
Metcalf et al., 2009). More in-depth questioning around social contact including the 
age of those with whom contact has occurred should be incorporated into future 
studies. This may also help to determine cause, particularly if others within the 
household are unwell whilst bearing in mind differences in susceptibility to pathogens 
as a result of age or vaccination status. 
 
Despite the recruiting a small cohort of participants in Ha Nam, the study 
demonstrated that the wearing of a GPS device to track movements and completing 
a contact pattern diary over a year was feasible in this setting. It would therefore be 
beneficial to use these methods in provinces where a higher incidence of AES is seen 
such as Son La or Lai Chau in the northwest and where there is cross-border 
movement between Vietnam and Lao PDR. However, a number of factors would need 
to be considered before implementing this. Firstly, the acceptability of undertaking 
such a study would need to be ascertained with a new population. Secondly, if this 
was to be performed on a larger scale, an alternative method for recording the GPS 
coordinates might be considered given the logistics required to download and clean 
the data from each device. More technologically advanced methods such as using 
apps on smartphone might be a possibility. Thirdly, it might be worth exploring 
conducting the contact pattern diary interviews over the telephone with data entered 
by staff directly into an electronic form on a tablet or smartphone. This may be more 
convenient for the participants but would also allow the near real-time access to the 
data. Finally, although this was a study on risk factors for AES infections, these 
methods could equally be applied to populations in this region to understand the 
transmission dynamics of a number pathogens, particularly in outbreak situations 
such as the current pandemic caused by SARS-CoV-2 where understanding 
movement and social contact patterns can influence public health policy (Prem et al., 
2020; Jarvis et al., 2020).    
 
A number of pathogens causing CNS infections have a zoonotic reservoir and 
therefore the utilisation of data from animals can be equally as important as humans. 
The final results chapter analysed serum samples from pigs from northern Vietnam 
and showed that almost two-thirds sample were seropositive to JEV at six months of 
age. Although this study did not demonstrate a positive association between the 
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incidence of JE in humans and seroprevalence of JEV in pigs, the effect of ecological 
fallacy and low numbers of cases of JE may have affected the result as may have the 
poor specificity of the cELISA. However, the evidence of continued infection of the 
zoonotic reservoir suggests that improvements in living standards and subsequent 
reduction of mosquito breeding sites has been insufficient in preventing transmission 
of the virus. Given that risk of living in close proximity to pigs and the acquisition of JE 
in other settings is inconclusive (Liu et al., 2010; Rayamajhi et al., 2007; van den Hurk, 
Ritchie and Mackenzie, 2009; Solomon, 2006) studies to determine the individual risk 
in northern Vietnam would be beneficial. However, the impact of this on public health 
policy is unknown as it is unlikely that populations would change practices around 
keeping livestock and there may be little economic justification for implementing 
vaccination in pigs, particularly when they are often slaughtered at six months of age 
(Erlanger et al., 2009). Control of JE in Vietnam may therefore be better managed 
through revisions of the vaccination policy in children. A study conducted in Ha Tay 
province, northern Vietnam demonstrated that 96.2% of children within the target 
population, received two or more doses of vaccine during a mass JE immunisation 
campaign with a subsequent reduction in incidence of JE. The authors proposed that 
JE vaccine policy should be changed to include children aged 5-9 years in a catch-up 
campaign with a fourth dose given to those who received three doses during the first 
2-3 years of life (Yen et al., 2015). The adoption of a similar system in areas of high 
incidence of AES, such as the provinces bordering Lao PDR should be explored whilst 




This thesis has addressed a number of gaps in the knowledge of the epidemiology of 
CNS infections in Vietnam. However, is has also identified areas where further 
research is needed based on the literature review and results chapters. Table 6.1 
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Table 6.1 Remaining knowledge gaps in the understanding of the epidemiology of 
CNS infections in Vietnam and recommendations for further research. 
Remaining knowledge gaps Recommendations for further 
research 
The true contribution of pathogens 
detected in neighbouring countries but 
not reported as common causes of 
CNS infections in Vietnam. 
To test for pathogens including: O. 
tsutsugamushi, Leptospira species and 
R. typhi in future studies.  
The contribution of JEV to the cases of 
AES reported under the national 
surveillance system 
To conduct a seroprevalence survey of 
JEV amongst cases of AES 
The reasons for continued high 
incidence of AES in certain provinces 
in Vietnam, particularly those in the 
northwest, bordering Lao PDR. 
To conduct studies of the aetiology and 
risk factors for AES in selected 
provinces such as Son La and Lai Chau 
including cross-border movement 
between Vietnam and Lao PDR. 
The impact of human movement 
patterns on the acquisition and 
transmission of pathogens causing 
CNS infections. 
To repeat the human movement study, 
potentially in a range of provinces e.g. 
rural and urban with high and low 
incidence of JE. To follow-up 
participants up over time to determine if 
they seroconvert to pathogens such as 
JEV and DENV (a cohort study).  
The impact of human contact patterns 
on the acquisition and transmission of 
pathogens. 
To repeat the contact pattern study, 
potentially in a range of provinces e.g. 
rural and urban with high and low 
incidence of JE. To follow-up 
participants up over time to determine if 
they seroconvert to pathogens such as 
JEV and DENV (a cohort study).  
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The role of pigs in the risk of human JE 
in Vietnam 
To conduct studies evaluating the time 
of seroconversion of JEV in pigs and 
whether living in close proximity to pigs 
at the time of seroconversion is a risk 
factor for infection with JEV in humans. 
 
CONCLUSION 
This thesis used a data from a number of sources to understand the risk factors for 
CNS infections in Vietnam. JE remains the most common cause in children despite 
implementation of vaccination in the EPI yet in adults, the most common cause is the 
bacterium, S. suis. Surveillance data shows evidence of seasonality of AES in 
northern Vietnam with peaks in the summer months and positive associations of both 
AES and meningitis with temperature and humidity. This might suggest that many 
cases of CNS infections are due to vector-borne diseases, potentially JE. However, 
further studies are required to confirm or refute this suggestion building on the lessons 
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APPENDICES 
APPENDIX 2.1  
 
Supplementary figures and tables for chapter 2 
 
Figure A2.1 Decomposition of time series of the national incidence of AES, meningitis, 
dengue, ILI, S. suis, measles, leptospirosis and HFMD from 1998-2016.  
 
Data: time series of raw data 
Seasonal: seasonal component of the time series 
Trend: trend of the time series 
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Table A2.1 Negative binomial model with an outcome of incidence of AES and time 
fitted as a linear predictor. 
 
 Estimate SE p value Monte-Carlo Moran’s 
I  











Statistic = 0.076 























































































































  337  
	
Table A2.2 Negative binomial model with an outcome of number of cases of AES and 
year fitted as a categorical covariate. 
 
Year Estimate SE p 
value 
Monte Carlo 



















































































Statistic = 0.077 
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Table A2.3 Negative binomial model with an outcome of number of cases of AES and 




Estimate SE p value Monte Carlo 






















































Statistic = 0.074 
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Table A2.4 Negative binomial model with an outcome of number of cases of AES and 





Estimate SE p value Monte Carlo 








































Statistic = 0.072 
p value <0.001 
 
Statistic = 0.072 
p value <0.001 
 
Statistic = 0.072 
p value <0.001 
 
 
Table A2.5 Negative binomial model with an outcome of number of cases of 
meningitis and time fitted as a linear predictor. 
 
 Estimate SE p value Monte-Carlo Moran’s I  
of the residuals 
 








Statistic = 0.067 
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Table A2.6 Negative binomial model with an outcome of number of cases of 
meningitis and year fitted as a categorical covariate. 
 
Year Estimate SE p 
value 
Monte Carlo 



















































































Statistic = 0.066 
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Table A2.7 Negative binomial model with an outcome of number of cases of 




Estimate SE p value Monte Carlo 






















































Statistic = 0.061 
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Table A2.8 Negative binomial model with an outcome of number of cases of 




Estimate SE p value Monte Carlo 








































Statistic = 0.061 
p value <0.001 
 
Statistic = 0.061 
p value <0.001 
 
Statistic = 0.061 
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Table A2.9 Univariate negative binomial generalized additive models with an outcome 
of the number of cases of AES.  
 
Variable Estimate SE p value Monte Carlo 





















Statistic = 0.075, 
p<0.001 
Statistic = 0.072, 
p<0.001 




















Statistic = 0.069, 
p<0.001 
Statistic = 0.069, 
p<0.001 
Statistic = 0.067, 
p<0.001 

















Statistic = 0.072, 
p<0.001 
Statistic = 0.070, 
p<0.001 





















Statistic = 0.071, 
p<0.001 
Statistic = 0.070, 
p<0.001 
Statistic = 0.068, 
p<0.001  























Statistic = 0.078, 
p<0.001 
Statistic = 0.079, 
p<0.001 
Statistic = 0.080, 
p<0.001 























Statistic = 0.080, 
p<0.001 
Statistic = 0.077, 
p<0.001 




















Statistic = 0.077, 
p<0.001 
Statistic = 0.077, 
p<0.001 
Statistic = 0.078, 
p<0.001 
Elevation (weighted by 
population density) 
1.345x10-3 4.433x10-5 <0.001 Statistic = 0.059, 
p<0.001 
Number of pigs per 
100,000 population 
1.814x10-5 7.456x10-7 <0.001 Statistic = 0.064, 
p<0.001 
Poverty rate (%) 2.081x10-2 7.854x10-4 <0.001 Statistic = 0.045, 
p<0.001 











2.547x10-3 3.057x10-4 <0.001 
Statistic = 0.072, 
p<0.001 
Incidence of meningitis 0.975 0.045 <0.001 
Statistic = 0.072, 
p<0.001 
Incidence of dengue -3.147 x10-3 5.92x10-4 <0.001 
Statistic = 0.075, 
p<0.001 
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Incidence of S. suis 1.321 0.369 <0.001 
Statistic = 0.146, 
p<0.001 
Incidence of ILI 1.838x10-3 5.511x10-5 <0.001 
Statistic = 0.057, 
p<0.001 
Incidence of measles 1.12x10-2 2.01x10-3 <0.001 




0.711 0.144 <0.001 
Statistic = 0.077, 
p<0.001 
Incidence of HFMD -1.9x10-2 2.0x10-3 <0.001 
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Table A2.10 Univariate negative binomial generalized additive models with an 
outcome of the number of cases of meningitis.  
 
Variable Estimate SE p value Monte Carlo 

























Statistic = 0.050, p<0.001 
Statistic = 0.050, p<0.001 

























Statistic = 0.049, p<0.001 
Statistic = 0.049, p<0.001 



















Statistic = 0.048, p<0.001 
Statistic = 0.048, p<0.001 
Statistic = 0.049, p<0.001 
Absolute 

















Statistic = 0.050, p<0.001 
Statistic = 0.050, p<0.001 























Statistic = 0.052, p<0.001 
Statistic = 0.052, p<0.001 
Statistic = 0.053, p<0.001 



























Statistic = 0.052, p<0.001 
Statistic = 0.052, p<0.001 


















Statistic = 0.052, p<0.001 
Statistic = 0.053, p<0.001 






1.140x10-3 5.759x10-5 <0.001 Statistic = 0.054, p<0.001 
Number of pigs 
per 100,000 
population 
1.636x10-5 1.047x10-6 <0.001 Statistic = 0.045, p<0.001 














-1.228x10-3 3.667x10-4 <0.001 Statistic = 0.057, p<0.001 
Incidence of 
dengue 
6.197x10-4 6.083x10-4 0.308 Statistic = 0.052, p<0.001 
Incidence of  
S. suis 
1.869 0.610 0.002 Statistic = 0.034, p<0.001 
Incidence of ILI 1.143x10-3 6.694x10-5 <0.001 Statistic = 0.050, p<0.001 
Incidence of 
measles 
0.010 0.003 <0.001 Statistic = 0.052, p<0.001 
Incidence of 
leptospirosis 
-0.064 0.188 0.733 Statistic = 0.052, p<0.001 
Incidence of 
HFMD 
-0.010 0.004 0.009 Statistic = 0.032, p<0.001 
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Table A.211 Multivariate model 1 with an outcome of the number of cases of AES.  
  Mean SD 0.025quant 0.975quant 
(Intercept) -5.105 0.601 -6.279 -3.919 
Max.temp 0.079 0.011 0.057 0.101 
Max.temp.lag_minus1 0.024 0.013 -0.001 0.05 
Max.temp.lag_minus2 -0.018 0.01 -0.039 0.002 
Relative.humidity 0.021 0.006 0.009 0.032 
Relative.humidity.lag_minus1 0.006 0.004 -0.002 0.014 
Relative.humidity.lag_minus2 0.001 0.003 -0.006 0.007 
Rainfall 0 0 0 0.001 
Rainfall.lag_minus1 0 0 0 0.001 
Rainfall.lag_minus2 0 0 0 0 
Rainfall.lag_minus3 0 0 0 0 
Sunshine 0.001 0 0 0.002 
Sunshine.lag_minus1 0.001 0 0 0.002 
Sunshine.lag_minus2 -0.002 0 -0.003 -0.001 
NDVI 0.119 0.122 -0.12 0.359 
NDVI.lag_minus1 0.226 0.115 0.001 0.452 
NDVI.lag_minus2 -0.287 0.114 -0.51 -0.064 
Elevation 0.001 0.001 0 0.002 
Number_of_pigs 0 0 0 0 
Poverty_rate -0.013 0.004 -0.021 -0.006 
Number_hospitals 0.028 0.017 -0.005 0.061 
JE.vaccination 0.003 0.001 0.002 0.004 
     
Size for the nbinomial 
observations (1/overdispersion) 0.48 0.01 0.461 0.501 
Precision for idregion.x (iid 
component) 1.29 0.246 0.873 1.836 
Precision for idregion.x (spatial 
component) 1888.01 1852.812 127.696 6774.671 
Precision for year 36.15 15.566 15.796 75.465 
Precision for month 43.89 22.925 13.611 101.28 
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Table A2.12 Multivariate model 2 with an outcome of the number of cases of AES.  
  Mean SD 0.025quant 0.975quant 
(Intercept) -3.555 0.581 -4.692 -2.411 
Min.temp 0.033 0.007 0.019 0.046 
Min.temp.lag_minus1 0.036 0.007 0.022 0.05 
Min.temp.lag_minus2 -0.008 0.007 -0.022 0.006 
Relative.humidity 0.016 0.006 0.005 0.028 
Relative.humidity.lag_minus1 0.005 0.004 -0.002 0.012 
Relative.humidity.lag_minus2 -0.002 0.003 -0.007 0.004 
Rainfall 0 0 0 0.001 
Rainfall.lag_minus1 0 0 0 0.001 
Rainfall.lag_minus2 0 0 0 0 
Rainfall.lag_minus3 0 0 0 0 
Sunshine 0.003 0 0.002 0.004 
Sunshine.lag_minus1 0.001 0 0 0.002 
Sunshine.lag_minus2 -0.002 0 -0.003 -0.002 
NDVI 0.204 0.121 -0.034 0.443 
NDVI.lag_minus1 0.226 0.115 0 0.451 
NDVI.lag_minus2 -0.333 0.114 -0.557 -0.109 
Elevation 0.001 0.001 0 0.002 
Number_of_pigs 0 0 0 0 
Poverty_rate -0.014 0.004 -0.021 -0.006 
Number_hospitals 0.03 0.017 -0.004 0.063 
JE.vaccination 0.002 0.001 0.001 0.004 
     
Size for the nbinomial 
observations (1/overdispersion) 0.478 0.01 0.459 0.498 
Precision for idregion.x (iid 
component) 1.276 0.24 0.854 1.795 
Precision for idregion.x (spatial 
component) 1890.514 1852.65 128.545 6778.354 
Precision for year 37.587 17.05 16.065 81.103 
Precision for month 27.239 13.92 9.215 62.478 
  350  
	
Table A2.13 Multivariate model 3 with an outcome of the number of cases of AES. 
  Mean SD 0.025quant 0.975quant 
(Intercept) -3.078 0.556 -4.168 -1.986 
Absolute.humidity 0.053 0.009 0.036 0.07 
Absolute.humidity.lag_minus1 0.028 0.011 0.005 0.05 
Absolute.humidity.lag_minus2 -0.017 0.009 -0.035 0 
Relative.humidity 0.005 0.006 -0.007 0.017 
Relative.humidity.lag_minus1 0.004 0.004 -0.005 0.012 
Relative.humidity.lag_minus2 0.001 0.003 -0.005 0.008 
Rainfall 0 0 0 0 
Rainfall.lag_minus1 0 0 0 0 
Rainfall.lag_minus2 0 0 0 0 
Rainfall.lag_minus3 0 0 0 0 
Sunshine 0.002 0 0.001 0.003 
Sunshine.lag_minus1 0.001 0 0 0.002 
Sunshine.lag_minus2 -0.002 0 -0.003 -0.001 
NDVI 0.155 0.121 -0.083 0.394 
NDVI.lag_minus1 0.263 0.115 0.038 0.489 
NDVI.lag_minus2 -0.291 0.114 -0.514 -0.067 
Elevation 0.001 0.001 0 0.002 
Number_of_pigs 0 0 0 0 
Poverty_rate -0.013 0.004 -0.021 -0.005 
Number_hospitals 0.031 0.017 -0.003 0.064 
JE.vaccination 0.003 0.001 0.002 0.004 
     
Size for the nbinomial 
observations (1/overdispersion) 0.48 0.01 0.461 0.5 
Precision for idregion.x (iid 
component) 1.27 0.25 0.863 1.84 
Precision for idregion.x (spatial 
component) 1891.83 1854.05 127.283 6784.46 
Precision for year 36.76 15.76 16.109 76.5 
Precision for month 60.23 32.95 18.554 143.88 
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Table A2.14 Multivariate model 4 with an outcome of the number of cases of AES.  
  Mean SD 0.025quant 0.975quant 
(Intercept) -4.967 0.598 -6.135 -3.788 
Max.temp 0.075 0.011 0.054 0.097 
Max.temp.lag_minus1 0.021 0.013 -0.004 0.046 
Max.temp.lag_minus2 -0.018 0.01 -0.038 0.002 
Relative.humidity 0.02 0.006 0.009 0.031 
Relative.humidity.lag_minus1 0.005 0.004 -0.003 0.014 
Relative.humidity.lag_minus2 0.002 0.003 -0.005 0.008 
Rainfall 0 0 0 0.001 
Rainfall.lag_minus1 0 0 0 0.001 
Rainfall.lag_minus2 0 0 0 0 
Rainfall.lag_minus3 0 0 0 0 
Sunshine 0.001 0 0 0.002 
Sunshine.lag_minus1 0.001 0 0 0.002 
Sunshine.lag_minus2 -0.002 0 -0.003 -0.001 
NDVI 0.103 0.121 -0.135 0.341 
NDVI.lag_minus1 0.21 0.114 -0.014 0.435 
NDVI.lag_minus2 -0.327 0.113 -0.549 -0.104 
Elevation 0.001 0.001 0 0.002 
Number_of_pigs 0 0 0 0 
Poverty_rate -0.013 0.004 -0.021 -0.006 
Number_hospitals 0.031 0.017 -0.003 0.064 
JE.vaccination 0.003 0.001 0.002 0.004 
Incidence_meningitis 0.79 0.089 0.618 0.969 
Incidence_S.suis 2.093 0.618 0.946 3.376 
     
Size for the nbinomial observations 
(1/overdispersion) 0.488 0.01 0.467 0.508 
Precision for idregion.x (iid 
component) 1.302 0.253 0.883 1.875 
Precision for idregion.x (spatial 
component) 1758.788 1798.758 123.423 6493.097 
Precision for year 39.079 16.289 16.996 79.824 
Precision for month 44.552 23.954 14.076 105.399 
  352  
	
Table A2.15 Multivariate model 5 with an outcome of the number of cases of AES. 
 
  Mean SD 0.025quant 0.975quant 
(Intercept) -3.528 0.575 -4.654 -2.396 
Min.temp 0.032 0.007 0.019 0.046 
Min.temp.lag_minus1 0.033 0.007 0.018 0.047 
Min.temp.lag_minus2 -0.008 0.007 -0.022 0.006 
Relative.humidity 0.016 0.006 0.005 0.027 
Relative.humidity.lag_minus1 0.004 0.004 -0.003 0.011 
Relative.humidity.lag_minus2 -0.001 0.003 -0.006 0.005 
Rainfall 0 0 0 0.001 
Rainfall.lag_minus1 0 0 0 0.001 
Rainfall.lag_minus2 0 0 0 0 
Rainfall.lag_minus3 0 0 0 0 
Sunshine 0.003 0 0.002 0.004 
Sunshine.lag_minus1 0.001 0 0 0.002 
Sunshine.lag_minus2 -0.002 0 -0.003 -0.002 
NDVI 0.182 0.121 -0.055 0.419 
NDVI.lag_minus1 0.208 0.114 -0.016 0.433 
NDVI.lag_minus2 -0.374 0.114 -0.597 -0.15 
Elevation 0.001 0.001 0 0.002 
Number_of_pigs 0 0 0 0 
Poverty_rate -0.013 0.004 -0.021 -0.006 
Number_hospitals 0.032 0.017 -0.002 0.065 
JE.vaccination 0.003 0.001 0.002 0.004 
Incidence_meningitis 0.808 0.09 0.634 0.988 
Incidence_S.suis 2.082 0.619 0.934 3.368 
     
Size for the nbinomial 
observations (1/overdispersion) 0.485 0.01 0.466 0.506 
Precision for idregion.x (iid 
component) 1.294 0.244 0.869 1.822 
Precision for idregion.x (spatial 
component) 1763.729 1802.07 124.054 6504.102 
Precision for year 41.894 16.407 16.821 80 
Precision for month 30.184 15.107 9.832 67.737 
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Table A2.16 Multivariate model 6 with an outcome of the number of cases of AES. 
 
  Mean SD 0.025quant 0.975quant 
(Intercept) -3.062 0.551 -4.143 -1.978 
Absolute.humidity 0.052 0.009 0.035 0.069 
Absolute.humidity.lag_minus1 0.023 0.011 0.001 0.046 
Absolute.humidity.lag_minus2 -0.017 0.009 -0.035 0.001 
Relative.humidity 0.005 0.006 -0.007 0.017 
Relative.humidity.lag_minus1 0.004 0.004 -0.005 0.012 
Relative.humidity.lag_minus2 0.002 0.003 -0.004 0.008 
Rainfall 0 0 0 0 
Rainfall.lag_minus1 0 0 0 0 
Rainfall.lag_minus2 0 0 0 0 
Rainfall.lag_minus3 0 0 0 0 
Sunshine 0.002 0 0.001 0.003 
Sunshine.lag_minus1 0.001 0 0 0.002 
Sunshine.lag_minus2 -0.002 0 -0.003 -0.001 
NDVI 0.137 0.121 -0.1 0.374 
NDVI.lag_minus1 0.246 0.114 0.022 0.471 
NDVI.lag_minus2 -0.33 0.113 -0.553 -0.108 
Elevation 0.001 0.001 0 0.002 
Number_of_pigs 0 0 0 0 
Poverty_rate -0.013 0.004 -0.02 -0.005 
Number_hospitals 0.033 0.017 0 0.066 
JE.vaccination 0.003 0.001 0.002 0.004 
Incidence_meningitis 0.791 0.09 0.619 0.97 
Incidence_S.suis 2.115 0.619 0.966 3.4 
     
Size for the nbinomial observations 
(1/overdispersion) 0.487 0.01 0.467 0.508 
Precision for idregion.x (iid 
component) 1.306 0.247 0.866 1.83 
Precision for idregion.x (spatial 
component) 1973.409 1897.418 124.007 6982.787 
Precision for year 40.461 16.311 17.698 80.571 
Precision for month 61.325 34.393 18.626 149.451 
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Table A2.17 Multivariate model 1 with an outcome of the number of cases of 
meningitis. 
  Mean SD 0.025quant 0.975quant 
(Intercept) -3.577 0.695 -4.942 -2.215 
Max.temp 0.05 0.014 0.023 0.076 
Max.temp.lag_minus1 0.061 0.017 0.028 0.095 
Max.temp.lag_minus2 -0.039 0.013 -0.065 -0.013 
Relative.humidity 0.012 0.008 -0.003 0.027 
Relative.humidity.lag_minus1 -0.014 0.006 -0.025 -0.003 
Relative.humidity.lag_minus2 0.006 0.004 -0.003 0.014 
Rainfall 0 0 0 0 
Rainfall.lag_minus1 0 0 0 0 
Rainfall.lag_minus2 0 0 0 0.001 
Rainfall.lag_minus3 0 0 -0.001 0 
Sunshine -0.002 0.001 -0.003 0 
Sunshine.lag_minus1 -0.001 0.001 -0.003 0 
Sunshine.lag_minus2 0.001 0.001 0 0.002 
NDVI 0.24 0.174 -0.101 0.583 
NDVI.lag_minus1 0.076 0.167 -0.251 0.403 
NDVI.lag_minus2 -0.068 0.164 -0.389 0.253 
Elevation 0 0.001 -0.001 0.002 
Number_pigs 0 0 0 0 
Poverty_rate 0.004 0.006 -0.007 0.015 
Number_hospitals -0.01 0.022 -0.055 0.033 
JE.vaccination -0.001 0.001 -0.003 0 
     
Size for the nbinomial 
observations (1/overdispersion) 3.26 x10-1 1.00 x10-2 0.307 3.47 x10-1 
Precision for idregion.x (iid 
component) 1.02 2.18 x10-1 0.653 1.51 
Precision for idregion.x (spatial 
component) 1.86 x103 1.84 x103 129.499 6.71x103 
Precision for year 5.00 1.79 2.217 9.14 
Precision for month 1.70 x10-4 1.74 x104 905.438 6.36 x104 
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Table A2.18 Multivariate model 2 with an outcome of the number of cases of 
meningitis. 
  Mean SD 0.025quant 0.975quant 
(Intercept) -2.748 0.687 -4.095 -1.399 
Min.temp 0.041 0.012 0.019 0.064 
Min.temp.lag_minus1 0.055 0.013 0.03 0.081 
Min.temp.lag_minus2 -0.027 0.01 -0.048 -0.007 
Relative.humidity 0.006 0.008 -0.01 0.021 
Relative.humidity.lag_minus1 -0.01 0.005 -0.02 -0.001 
Relative.humidity.lag_minus2 0.003 0.004 -0.004 0.01 
Rainfall 0 0 0 0 
Rainfall.lag_minus1 0 0 0 0 
Rainfall.lag_minus2 0 0 0 0 
Rainfall.lag_minus3 0 0 -0.001 0 
Sunshine -0.001 0.001 -0.002 0.001 
Sunshine.lag_minus1 0 0.001 -0.002 0.001 
Sunshine.lag_minus2 0 0.001 -0.001 0.001 
NDVI 0.29 0.174 -0.051 0.632 
NDVI.lag_minus1 0.112 0.166 -0.215 0.438 
NDVI.lag_minus2 -0.074 0.164 -0.395 0.248 
Elevation 0 0.001 -0.001 0.002 
Number_pigs 0 0 0 0 
Poverty_rate 0.004 0.006 -0.007 0.015 
Number_hospitals -0.007 0.022 -0.052 0.036 
JE.vaccination -0.002 0.001 -0.003 0 
     
Size for the nbinomial observations 
(1/overdispersion) 3.26 x10-1 1.00 x10-2 0.307 3.47 x10-1 
Precision for idregion.x (iid component) 1.05 2.25 x10-1 0.649 1.53 
Precision for idregion.x (spatial 
component) 2.35 x103 2.41 x103 223.932 8.76 x103 
Precision for year 5.07 1.82 2.244 9.30 
Precision for month 2.19 x104 2.21 x104 1722.147 8.10 x104 
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Table A2.19 Multivariate model 3 with an outcome of the number of cases of 
meningitis. 
 
  Mean SD 0.025quant 0.975quant 
(Intercept) -1.792 0.708 -3.18 -0.403 
Absolute.humidity 0.039 0.012 0.015 0.063 
Absolute.humidity.lag_minus1 0.043 0.017 0.01 0.077 
Absolute.humidity.lag_minus2 -0.026 0.012 -0.049 -0.002 
Relative.humidity -0.005 0.008 -0.021 0.012 
Relative.humidity.lag_minus1 -0.01 0.006 -0.022 0.001 
Relative.humidity.lag_minus2 0.003 0.004 -0.005 0.011 
Rainfall 0 0 -0.001 0 
Rainfall.lag_minus1 0 0 -0.001 0 
Rainfall.lag_minus2 0 0 0 0.001 
Rainfall.lag_minus3 0 0 -0.001 0 
Sunshine -0.001 0.001 -0.002 0 
Sunshine.lag_minus1 -0.001 0.001 -0.002 0.001 
Sunshine.lag_minus2 0 0.001 -0.001 0.002 
NDVI 0.278 0.174 -0.063 0.619 
NDVI.lag_minus1 0.127 0.166 -0.199 0.454 
NDVI.lag_minus2 -0.056 0.164 -0.378 0.266 
Elevation 0 0.001 -0.001 0.002 
Number_pigs 0 0 0 0 
Poverty_rate 0.004 0.006 -0.007 0.015 
Number_hospitals -0.009 0.022 -0.054 0.034 
JE.vaccination -0.001 0.001 -0.003 0 
     
Size for the nbinomial observations 
(1/overdispersion) 3.27 x10
-1 0.01 0.307 3.47 x10-1 
Precision for idregion.x (iid 
component) 1.03 0.22 0.638 1.50 
Precision for idregion.x (spatial 
component) 1.92 x10
3 1873.09 130.52 6.86 x103 
Precision for year 4.89 1.83 2.262 9.35 
Precision for month 1.88 x104 18315.94 1303.893 6.75 x104 
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Table A2.20 Multivariate model 4 with an outcome of the number of cases of 
meningitis. 
 
  Mean SD 0.025quant 0.975quant 
(Intercept) -3.629 0.694 -4.991 -2.269 
Max.temp 0.051 0.014 0.024 0.077 
Max.temp.lag_minus1 0.061 0.017 0.027 0.094 
Max.temp.lag_minus2 -0.04 0.013 -0.066 -0.014 
Relative.humidity 0.013 0.008 -0.002 0.028 
Relative.humidity.lag_minus1 -0.014 0.006 -0.025 -0.003 
Relative.humidity.lag_minus2 0.006 0.004 -0.002 0.015 
Rainfall 0 0 0 0 
Rainfall.lag_minus1 0 0 0 0 
Rainfall.lag_minus2 0 0 0 0.001 
Rainfall.lag_minus3 0 0 -0.001 0 
Sunshine -0.002 0.001 -0.003 0 
Sunshine.lag_minus1 -0.001 0.001 -0.002 0 
Sunshine.lag_minus2 0.001 0.001 0 0.002 
NDVI 0.236 0.174 -0.105 0.578 
NDVI.lag_minus1 0.072 0.166 -0.254 0.399 
NDVI.lag_minus2 -0.073 0.164 -0.394 0.248 
Elevation 0 0.001 -0.001 0.002 
Number_pigs 0 0 0 0 
Poverty_rate 0.004 0.006 -0.007 0.016 
Number_hospitals -0.013 0.022 -0.058 0.03 
JE.vaccination -0.001 0.001 -0.003 0 
Incidence_HFMD -0.013 0.005 -0.022 -0.004 
     
Size for the nbinomial observations 
(1/overdispersion) 3.27 x10
-1 1.00 x10-2 0.307 3.48 x10-1 
Precision for idregion.x (iid 
component) 1.01 2.24 x10
-1 0.65 1.52 
Precision for idregion.x (spatial 
component) 1.92 x10
3 1.87 x103 137.017 6.85 x103 
Precision for year 4.80 1.74 2.171 8.92 
Precision for month 1.80 x104 1.80 x104 1160.942 6.60 x104 
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Table A2.21 Multivariate model 5 with an outcome of the number of cases of meningitis. 
  Mean SD 0.025quant 0.975quant 
(Intercept) -2.797 0.687 -4.145 -1.448 
Min.temp 0.042 0.012 0.019 0.065 
Min.temp.lag_minus1 0.055 0.013 0.03 0.081 
Min.temp.lag_minus2 -0.028 0.01 -0.048 -0.007 
Relative.humidity 0.007 0.008 -0.009 0.022 
Relative.humidity.lag_minus1 -0.01 0.005 -0.02 -0.001 
Relative.humidity.lag_minus2 0.003 0.004 -0.004 0.01 
Rainfall 0 0 0 0 
Rainfall.lag_minus1 0 0 0 0 
Rainfall.lag_minus2 0 0 0 0 
Rainfall.lag_minus3 0 0 -0.001 0 
Sunshine -0.001 0.001 -0.002 0.001 
Sunshine.lag_minus1 0 0.001 -0.001 0.001 
Sunshine.lag_minus2 0 0.001 -0.001 0.001 
NDVI 0.288 0.174 -0.053 0.629 
NDVI.lag_minus1 0.109 0.166 -0.217 0.436 
NDVI.lag_minus2 -0.079 0.164 -0.4 0.243 
Elevation 0 0.001 -0.001 0.002 
Number_pigs 0 0 0 0 
Poverty_rate 0.004 0.006 -0.007 0.015 
Number_hospitals -0.01 0.022 -0.055 0.033 
JE.vaccination -0.001 0.001 -0.003 0 
Incidence_HFMD -0.013 0.005 -0.022 -0.004 
     
Size for the nbinomial observations 
(1/overdispersion) 3.27 x10-1 1.00 x10-2 0.307 3.48 x10-1 
Precision for idregion.x (iid 
component) 1.03 2.24 x10-1 0.662 1.53 
Precision for idregion.x (spatial 
component) 1.90 x103 1.87 x103 129.234 6.82 x103 
Precision for year 4.91 1.77 2.163 9.03 
Precision for month 1.84 x104 1.82 x104 1285.886 6.67 x104 
Table A2.22 Multivariate model 6 with an outcome of the number of cases of meningitis. 




  Mean SD 0.025quant 0.975quant 
(Intercept) -1.849 0.707 -3.234 -0.461 
Absolute.humidity 0.039 0.012 0.015 0.063 
Absolute.humidity.lag_minus1 0.043 0.017 0.01 0.077 
Absolute.humidity.lag_minus2 -0.026 0.012 -0.05 -0.003 
Relative.humidity -0.004 0.008 -0.02 0.013 
Relative.humidity.lag_minus1 -0.01 0.006 -0.022 0.001 
Relative.humidity.lag_minus2 0.003 0.004 -0.005 0.011 
Rainfall 0 0 -0.001 0 
Rainfall.lag_minus1 0 0 -0.001 0 
Rainfall.lag_minus2 0 0 0 0.001 
Rainfall.lag_minus3 0 0 -0.001 0 
Sunshine -0.001 0.001 -0.002 0 
Sunshine.lag_minus1 0 0.001 -0.002 0.001 
Sunshine.lag_minus2 0 0.001 -0.001 0.002 
NDVI 0.274 0.174 -0.066 0.615 
NDVI.lag_minus1 0.125 0.166 -0.201 0.451 
NDVI.lag_minus2 -0.061 0.164 -0.382 0.261 
Elevation 0 0.001 -0.001 0.002 
Number_pigs 0 0 0 0 
Poverty_rate 0.004 0.006 -0.007 0.016 
Number_hospitals -0.011 0.022 -0.056 0.032 
JE.vaccination -0.001 0.001 -0.003 0 
Incidence_HFMD -0.012 0.005 -0.022 -0.003 
     
Size for the nbinomial observations 
(1/overdispersion) 3.27 x10-1 1.00 x10-2 0.308 3.48 x10-1 
Precision for idregion.x (iid 
component) 1.02 2.18 x10-1 0.639 1.49 
Precision for idregion.x (spatial 
component) 2.18 x103 2.10 x103 189.223 7.79 x103 
Precision for year 4.83  1.74 2.159 8.91 
Precision for month 2.08 x104 2.01 x104 1723.643 7.42 x104 
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APPENDIX 3.1 
13HN ICF Cases V4.2 04AUG16 
 
13HN: UNDERSTANDING RISK FACTORS FOR ENCEPHALITIS  
(BRAIN INFLAMMATION)  
 
Information Sheet For Cases 
 
One Copy For Study Records And One Copy To Be Given To The Participant 
 
Please note that you can refer to “I” if consent if being obtained from the participant 
themselves or “your child/relative” if consent is obtained from a representative on 
behalf of the participant 
 
You are being invited to participate in a study looking at risk factors for acute 
encephalitis syndrome, an inflammation of the brain. Approximately 2000 people will 
be part of this study. Please read this information sheet carefully or have someone 
read it to you. Please ask the study staff to explain any information that you are not 
sure about. It is your choice whether to participate in the study and please do not feel 
obliged do so.  If you would like to take part you will be asked to sign or place a 
thumbprint on the last page. You will be given a copy of this form for your personal 
records. 
 
You will be taking part in a practice study before we conduct a larger study. The 
information we collect from you is therefore very important to us as it will help us to 
see if there are any problems and will also be used for our larger study. 
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Why is this study being done?  
Acute Encephalitis Syndrome (AES) is a syndrome of brain inflammation or swelling. 
Patients may die or be left disabled. There are around two thousand cases of AES in 
Viet Nam every year. Although Japanese encephalitis, a virus spread by mosquitoes 
is a common cause of AES in children and Streptococcus suis, a bacteria associated 
with eating or preparing raw pork meat is a common cause in adults, for half of the 
patients or more, we do not know the cause of their AES. However, we do know that 
most of the cases occur during the warmer seasons and therefore we think that 
mosquitoes or other insects are spreading diseases, which cause AES in northern 
Viet Nam.  
 
This study therefore aims to look at the reasons why people might or might not get 
AES including where the person lives and their risks in and around their home and 
work environment and their contact with animals. 
Who is doing this study?  
This study is being performed by a team from: 
The Oxford University Clinical Research Unit (OUCRU) in Ha Noi 
The University of Liverpool, United Kingdom 
The Wellcome Trust Liverpool Glasgow Centre for Global Health Research, United 
Kingdom 
The National Hospital of Tropical Diseases, Ha Noi 
 
What will happen to me in this study and what are the risks?   
You have been chosen to take part because the doctors and nurses think that you 
may have inflammation/swelling of the brain (acute encephalitis syndrome). We would 
like to look at the factors, which may or may not have played a role in you getting this 
syndrome.  
 
With your permission another member of the study team will visit your house within 
the four weeks after you are discharged from hospital. We will ask for your phone 
number so we can contact you to arrange a time. If you are willing, we will also ask 
for a phone number from a relative/friend who may be able to help contact you in case 
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we are unable to. During the visit, we will ask you to answer a questionnaire, which a 
member of the study team will go through with you. This will include questions about 
your background, house, ways in which you prevent mosquito bites and your contact 
with animals and the environment. The study team member will also obtain more 
information by walking around the house and taking photos. He/she will also find the 
location of the house using the mobile phone and plot this on a map, possibly using 
an online programme which is accessible to the public. If you would like more detail, 
please inform us and we can show these questions to you. You are able to refuse to 
answer any questions or restrict access of the study team member to any parts of 
your house and surroundings. 
  
We will also use the results from blood tests and any fluid taken from around your 
spine, which your doctors and nurses have performed as part of your medical care in 
hospital. This is to look for any bacteria, viruses and other infections which might be 
causing your brain inflammation. There are some risks with taking blood and fluid from 
around the spine which your doctor or nurse should explain to you before the 
procedure.  
 
We will then keep your blood and fluid from around the spine in a freezer and test it 
again to look for anything else that might be causing this problem. Because these 
tests will only be done once every couple of months, they will not be useful for your 
care and you will not be given the results of these tests. In the future the sample may 
be tested again to look at your immunity, for any evidence of poisons and to look at 
your genetics. Looking at the genetic testing involves looking at the DNA in your cells. 
This helps us to understand why you became unwell whereas someone else may not 
have. Some of these samples may be sent abroad for testing. You can opt out of this 
part whilst still taking part in the rest of the study. We will also take some information 
from yourself or your medical records about your symptoms any treatment you 
received before you came to hospital and your diagnosis information about your 
discharge from hospital. 
 
We will also collect some information about your from your medical records when you 
arrived at hospital. Additionally, we will ask you to help complete a questionnaire 
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about your health when you go home and 3 months afterwards which is also optional. 
At 3 months time will contact you by telephone. 
 
What will happen to the samples / information taken? 
We will keep your blood and fluid from around the spine in a freezer and test it again 
to look for any other infections. In the future the sample may be tested again to look 
at your immunity, for any evidence of poisons and to look at your genetics. The 
samples will be kept for at least ten years, possibly longer.  
 
The information from the questionnaire will be examined and we will use maps and 
information from around your house to look at other possible risks for AES.  
 
The results will be written as a report or thesis for the University of Liverpool and will 
be published in a journal, which will be made available to the public. The results will 
also be available in Vietnamese through the OUCRU website and the Hospital for 
Tropical Diseases website. The results will also be available for the Ministry of Health 
in Viet Nam. You will not be able to be identified in these results with the exception of 
pictures of your house and the dot on a map to show the location of your house. 
 
The results will also be made available to the public through workshops about AES in 
the community or schools and possibly via the radio or other forms of media. 
 
What is the benefit of participating?   
There is no intended personal benefit to taking part however, the benefit will be to the 
community and people of Viet Nam by help us to understand the risks associated with 
AES. 
You will be reimbursed 100,000 VND for the time spent answering the questionnaire. 
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What happens if I decline participation or change my mind later on? 
You have the right to decline participation or withdraw from the study or any part of 
the study at any time. Please let us know if you wish to do so. You do not need to give 
an explanation for this. You can request for your results to be destroyed at any time. 
There will be no effect to your clinical management. 
  
Can someone else decide to take the patient out of the study?  
The research team doctors can withdraw you from the study, if there is a problem with 
the information collected from you. The Universities and ethics committees can also 
stop the study. 
 
Confidentiality 
You will be given an anonymous code instead of your name, which will be used for 
the questionnaire and the samples of your blood and fluid from around the spine. 
Details linking you to this code will be kept in a separate place. All consent forms will 
be kept in a locked room. Only those who are involved with running the study will have 
access to these documents which will be kept for 3 years and then put on an electronic 
system.  The information from the questionnaire will be recorded on a mobile phone 
and transferred to a computer. However, this information will be kept very securely.  
 
However, it is possible that you may be identified from the location of your house 
which will be shown as a dot on a map and from photos taken around your house 
which with your permission will be used in publications and presentations. Your name 
will not be linked to this information. Your house will be located using Google Earth 
which is an online (and not private database).  
 
Whom do I contact if I have questions or complaints? 
If you have questions about the study you may contact: To be decided 
If you have questions about being in a research study, please contact the Research 
Ethics Board of the NHTD at (phone number) the Clinical Trials Unit at (phone 
number). 
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INFORMED CONSENT FORM FOR CASES 
RISK FACTORS FOR AND SPATIO-TEMPORAL DISTRIBUTION OF CASES OF 
ACUTE ENCEPHALITIS SYNDROME OF SUSPECTED INFECTIOUS 
AETIOLOGY IN THE RED RIVER DELTA REGION, NORTHERN VIET NAM: A 
FEASIBILITY STUDY 
 
• I freely give my permission to join this study. 
• I understand that I have the right to withdraw from the study. I will be given a copy 
of this signed consent form to keep for my reference.  
COMPULSORY FOR STUDY RECRUITMENT 
1. I have read this information sheet or it has been read to me and I 
understand it.  
 
2. I have been able to ask questions about the study.  
3. I understand that my participation in the study is voluntary and I do 
not have to answer questions if I do not wish to do so. 
 
 
4. I am happy for the research assistants to look around my house to 
obtain further information relating the questionnaire. I understand 
that if there is any area of the house or garden I do not wish them to 
look at, this is my decision.  
 
5. I give permission to use results from my investigations in hospital 
(including blood tests and fluid taken from around the spine) for the 
study. I also give permission to use information from my medical 
records. 
 
6. I give permission for the study to store and test the samples of my 
blood and fluid taken from around the spine for infections and other 
possible causes of encephalitis.  I understand that I will not receive 
the results of these tests. 
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7. I understand that can withdraw from the study at any time. If I chose 
to withdraw, I do not need to give a reason and it will not affect me 
in any manner.  
 
8. I understand that I can ask for access to the information I provide or 
have this information destroyed if I wish. 
 
9. I understand that I will be given an anonymous code instead of my 
name which will be used for the questionnaire data.  
 
However, I understand that I may be identifiable from photographs 
taken around my house and the location of my house shown as a 
dot on a map. 
 
 
10. I understand that in order for the study team to locate and use my 
address on a map they will have to use an online programme which 
is accessible to the public. 
 
11. I agree for the questionnaire data collected from me to be used in 
future research publications and presentations without my name. 
 
12.  I agree to take part in the above study.  
OPTIONAL FOR STUDY RECRUITMENT 
13.  I agree for my sample of blood or fluid from around the spine to be 
sent abroad for testing where required. 
 
14. I agree for my sample of blood or fluid from around the spine to be 
used for genetic testing. 
 
15.  I give permission to use photos of my house and surroundings and 
the location of my house on a map, in future presentations and 




Participant ID: 13HN-[__|__]-[__|__|__]     
 Name of participant (Please Print): ________________________ 
By signing/marking my name here, I confirm what is written above (aged 16 
years and above) 










If the participant is under 16 years old or cannot give consent themselves, 


















Full Name of Child 
 
x___________________________ 




I, the undersigned, have fully explained the relevant information of this program to the 
person named above and will provide her/him with a copy of this signed and dated 
informed consent form. 
16.  I am happy to complete a questionnaire relating to my health at 















   
If the person giving consent cannot read the form themselves, a witness must 
be present and sign here: 
I was present throughout the entire informed consent process with the participant.  
This form was read accurately to the volunteer, all questions from the volunteer were 


























APPENDIX 3.2  
13HN ICF CONTROLS V4.2 04AUG16 
 
13HN: UNDERSTANDING RISK FACTORS FOR ENCEPHALITIS  
(BRAIN INFLAMMATION) 
 
Information Sheet For Controls 
 
One Copy For Study Records And One Copy To Be Given To The Participant 
 
Please note that you can refer to “I” if consent if being obtained from the participant 
themselves or “your child/relative” if consent is obtained from a representative on 
behalf of the participant 
 
 
You are being invited to participate in a study looking at risk factors for acute 
encephalitis syndrome, an inflammation of the brain. Approximately 2000 people will 
be part of this study. Please read this information sheet carefully or have someone 
read it to you. Please ask the study staff to explain any information that you are not 
sure about. It is your choice whether to participate in the study and please do not feel 
obliged do so.  If you would like to take part you will be asked to sign or place a 
thumbprint on the last page. You will be given a copy of this form for your personal 
records. 
 
You will be taking part in a practice study before we conduct a larger study. The 
information we collect from you is therefore very important to us as it will help us to 
see if there are any problems and will also be used for our larger study. 
Why is this study being done?  
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Acute Encephalitis Syndrome (AES) is a syndrome of brain inflammation or swelling. 
Patients may die or be left disabled. There are around two thousand cases of AES in 
Viet Nam every year. Although Japanese encephalitis, a virus spread by mosquitoes 
is a common cause of AES in children and Streptococcus suis, a bacteria associated 
with eating or preparing raw pork meat is a common cause in adults, for half of the 
patients or more, we do not know the cause of their AES. However, we do know that 
most of the cases occur during the warmer seasons and therefore we think that 
mosquitoes or other insects are spreading diseases, which cause AES in northern 
Viet Nam.  
 
This study therefore aims to look at the reasons why people might or might not get 
AES including where the person lives and their risks in and around their home and 
work environment and their contact with animals. 
Who is doing this study?  
This study is being performed by a team from: 
The Oxford University Clinical Research Unit (OUCRU) in Ha Noi 
The University of Liverpool, United Kingdom 
The Wellcome Trust Liverpool Glasgow Centre for Global Health Research, United 
Kingdom 
The National Hospital of Tropical Diseases, Ha Noi 
What will happen to me in this study and what are the risks?   
You have been chosen to take part we are looking for healthy people from the 
community who are relatives of patients admitted to the hospital with other infections 
to compare your risk factors to those of patients with AES.  
 
With your permission another member of the study team will visit your house within 
the next four weeks. We will ask for your phone number so we can contact you to 
arrange a time. If you are willing, we will also ask for a phone number from a 
relative/friend who may be able to help contact you in case we are unable to. During 
the visit, we will ask you to answer a questionnaire, which a member of the study team 
will go through with you. This will include questions about your background, house, 
ways in which you prevent mosquito bites and your contact with animals and the 
environment. The study team member will also obtain more information by walking 
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around the house and taking photos. He/she will also find the location of the house 
using the mobile phone and plot this on a map. If you would like more detail, please 
inform us and we can show these questions to you. You are able to refuse to answer 
any questions or restrict access of the study team member to any parts of your house 
and surroundings. 
  
What will happen to the samples / information taken? 
The information from the questionnaire will be examined and we will use maps and 
information from around your house to look at other possible risks for AES.  
 
The results will be written as a report or thesis for the University of Liverpool and will 
be published in a journal, which will be made available to the public. The results will 
also be available in Vietnamese through the OUCRU website and the Hospital for 
Tropical Diseases website. The results will also be available for the Ministry of Health 
in Viet Nam. You will not be able to be identified in these results with the exception of 
pictures of your house and the dot on a map to show the location of your house. 
 
The results will be also be made available to the public through workshops about AES 
in the community or schools and possibly via the radio or other forms of media. 
What is the benefit of participating?   
There is no intended personal benefit to taking part however, the benefit will be to the 
community and people of Viet Nam by help us to understand the risks associated with 
AES. 
 
You will be reimbursed 100,000 VND for the time spent answering the questionnaire. 
What happens if I decline participation or change my mind later on? 
You have the right to decline participation or withdraw from the study or any part of 
the study at any time. Please let us know if you wish to do so. You do not need to give 
an explanation for this. You can request for your results to be destroyed at any time. 
There will be no effect to your management. 
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Can someone else decide to take the patient out of the study?  
The research team doctors can withdraw you from the study, if there is a problem with 
the information collected from you. The Universities and ethics committees can also 
stop the study. 
 
Confidentiality 
Individual information about you will be kept confidential. You will be given an 
anonymous code, which will be used for the questionnaire. Details linking yourself to 
this code will be kept in a separate place. All consent forms will be kept in a locked 
room. Only those who are involved with the study will have access to these documents 
which will be kept for 3 years and then put on an electronic system.  The information 
from the questionnaire will be recorded on a mobile phone and transferred to a 
computer. This information will be kept very securely.  
 
However, it is possible that you may be identified from the location of your house 
which will be shown as a dot on a map and from photos taken around your house 
which with your permission will be used in publications and presentations. Your name 
will not be linked to this information. Your house will be located using Google Earth 
which is an online (and not private database).  
 
Whom do I contact if I have questions or complaints? 
If you have questions about the study you may contact: To be decided 
If you have questions about being in a research study, please contact the Research 




• I freely give my permission to join this study. 
• I understand that I have the right to withdraw from the study. I will be given a copy 
of this signed consent form to keep for my reference.  
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COMPULSORY FOR STUDY RECRUITMENT 
1. I have read this information sheet or it has been read to me 
and I understand it.  
 
2. I have been able to ask questions about the study.  
3. I understand that my participation in the study is voluntary and 
I do not have to answer questions if I do not wish to do so. 
 
 
4. I am happy for the research assistants to look around my 
house to obtain further information relating the questionnaire. I 
understand that if there is any area of the house or garden I do 
not wish them to look at, this is my decision.  
 
5. I understand that can withdraw from the study at any time. If I 
chose to withdraw, I do not need to give a reason and it will not 
affect me in any manner.  
 
6. I understand that I can ask for access to the information I 
provide or have this information destroyed if I wish. 
 
7. I understand that I will be given an anonymous code instead 
of my name which will be used for the questionnaire data.  
 
However, I understand that I may be identifiable from 
photographs taken around my house and the location of my 




8. I understand that in order for the study team to locate and use 
my address on a map they will have to use an online programme 
which is accessible to the public. 
 
9. I agree for the questionnaire data collected from me to be 






















10. I agree to take part in the above study  
OPTIONAL FOR STUDY RECRUITMENT 
2.  I give permission to use photos of my house and 
surroundings and the location of my house on a map, in 
future presentations and publications without my name. 
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Participant ID: 13HN-[__|__]-[__|__|__]      
 
Name of participant (Please Print): ___________________________ 
 















If the participant does not have capacity to consent or is aged under 16 years, 




































If the person giving consent cannot read the form themselves, a witness must 
be present and sign here: 
I was present throughout the entire informed consent process with the participant.  
This form was read accurately to the volunteer, all questions from the volunteer were 















Confirmation of study staff: 
By signing/marking my name here, I confirm that I have fully explained the relevant 
information of this study to the person named above and will provide her/him with a 
copy of this signed and dated informed consent form. 


















APPENDIX 3.3  
OxTREC 42-15 QU HOSPSTAFFCASES v2.0 15MAR16 
	
Risk factors for and spatio-temporal distribution of cases of acute 
encephalitis syndrome of suspected infectious aetiology in the Red River 
Delta region, northern Viet Nam: a feasibility study  
 FEEDBACK QUESTIONNAIRE FOR STUDY STAFF (HOSPITAL CASES) 
 
To be completed at the end of each week 
 
 
Participant ID: 13HN-[__|__]-[__|__|__]      
Date (day-month-year): [__|__]-[__|__|-[__|__|[__|__| 
Week beginning (day-month-year): [__|__]-[__|__|-[__|__|[__|__| 
 
Please list all potential cases of acute encephalitis syndrome who were not 
successfully recruited into the study. Please tick all applicable columns for reasons 
why the participant was not recruited.
 378 
















































1           
2           
3           
4           
5           
6           
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Name of person completing form 
Signature
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APPENDIX 3.4  
	
OxTREC 42-15 QU HOSPSTAFFCASES v2.0 15MAR16 
 
Risk factors for and spatio-temporal distribution of cases of acute encephalitis 
syndrome of suspected infectious aetiology in the Red River Delta region, northern 
VietNam: a feasibility study  
 
 FEEDBACK QUESTIONNAIRE FOR STUDY STAFF (HOSPITAL - CONTROLS) 
 
To be completed at the end of each week 
Participant ID: 13HN-[__|__]-[__|__|__]      
Date (day-month-year): [__|__]-[__|__|-[__|__|[__|__| 
How many patients of potential controls did you see this week? 
How long did it take you to identify a suitable relative of the patient – give shortest 







What were the reasons for unsuccessful recruitment of the relatives  
 Number of patients approached 
No relatives of the matched age 
 
 











Refused to participate 
 
  
Had a past medical history of 
AES 
  
Had a current medical history of 
AES 
  
Lives in the house of someone 
with a current history of AES 
  
Lives in the house of someone 
with a past history of AES 
  
Refused permission for the 
study team to visit their home  
  
Had no method of contact to 




No one available to give 
consent of their behalf (in the 
case of relatives who lack 
capacity) 
  
Already participated in the study 
(or has a family member who 




















APPENDIX 3.5  
13HN OxTREC 42-15 CRF V3.0 05SEP16 
 
1. Patient Information 
1a) Date of birth (dd/mm/yyyy) : __/__/____ 
1b) Date of admission to NHTD (dd/mm/yyyy): __/__/____  
1c) Date of admission to initial hospital (dd/mm/yyyy) : __/__/____  
 
2. Eligibility:  
 
Please indicate ‘unknown’ if the result is not known or at the time of 
consent, the patient specified that he/she did not want this information to 
be used 
 
Inclusion Criteria (essential) 
2a) Is the patient currently living in a province in the Red River Delta region?	(Ha 
Noi, Hai Phong, Bac Ninh, Ha Nam, Hai Duong, Hung Yen, Nam Dinh, Ninh Binh, Thai 
Binh, Vinh Phuc) 
☐   Yes ☐   No                ☐   Unknown   
 
If yes, please specify 
☐   Bac Ninh       ☐   Ha Nam       ☐   Ha Noi           ☐   Hai Duong 
☐   Hai Phong       ☐  Hung Yen    ☐   Nam Dinh      ☐   Ninh Binh 
☐   Thai Binh        ☐   Vinh Phuc 
 
 
2b) Has the patient had a acute onset of fever +/- 10 days of admission to initial 
hospital? 








Inclusion criteria (At least one of c-f) 
2c) Has the patient had a change in mental status (including symptoms 
such as confusion, disorientation, coma, change in behaviour or 
speech)? 
☐   Yes ☐   No                ☐   Unknown   
 
 




2d) Has the patient had a new onset of seizures (excluding simple febrile 
seizures)? 
☐   Yes ☐   No                ☐   Unknown  
  
 
2e) Has the patient had increase in irritability (in children only)? 
☐   Yes ☐   No                ☐   Unknown  ☐ Not applicable 
 
2f) Does the patient have focal neurological signs– (complete for those aged 2 
years and over only)? 
☐   Yes ☐   No                ☐   Unknown  ☐ Not applicable  
 
If yes, please specify (tick all that apply): 
o    Paresis of a limb      o   
Abnormality of vision                
o    Paresis of the side of the face    o   
Abnormality of hearing 
o    Abnormality of speech     o   
Imbalance 




2g) Do you suspect that the patient has an encephalopathy due to a non-
infectious cause other than acute encephalitis syndrome e.g.  brain tumour,  
cerebrovascular accident, electrolyte imbalance? 
☐   Yes ☐   No                ☐   Unknown   
If yes, please specify_______________ 
 
 
2h) Do you suspect that the patient has an encephalopathy due to a infectious 
cause other than acute encephalitis syndrome e.g. sepsis due to pneumonia? 
☐   Yes ☐   No                ☐   Unknown   





2i) Does the patient have post-surgical meningitis/encephalitis? 
☐   Yes ☐   No                ☐   Unknown   
 
 
3. Demographic Information  
3a) Gender at birth    
☐ Male  ☐ Female ☐   Unknown 
 
3b) Date the patient first experienced symptoms (dd/mm/yyyy): __/__/____ 
☐   Unknown  
 
3c) Date the patient first sought medical care for the symptoms (dd/mm/yyyy): 
__/__/____ 
☐   Unknown  
 
4. Antibiotics, antivirals, antifungals and steroids given prior to admission  
Please complete for all medications known otherwise leave blank 
4a) Medication 1 
i. Name: _________________________________ 
ii. Location given 
☐Hospital    ☐Health care centre  ☐Pharmacy 
☐Other (specify): _________________________________
 ☐Unknown 
☐   Unable to answer (participant’s decision) 
iii.  Date commenced (dd/mm/yyyy): __/__/____   ☐Unknown   
☐   Unable to answer (participant’s decision) 
iv. Date stopped  (dd/mm/yyyy):  __/__/____   ☐Unknown 






4b) Medication 2 
i. Name: _________________________________ 
ii. Location given 
☐Hospital    ☐Health care centre  ☐Pharmacy 
☐Other (specify): _________________________________
 ☐Unknown 
☐   Unable to answer (participant’s decision) 
iii.  Date commenced (dd/mm/yyyy): __/__/____   ☐Unknown 
☐   Unable to answer (participant’s decision) 
iv. Date stopped  (dd/mm/yyyy):  __/__/____   ☐Unknown 
☐   Unable to answer (participant’s decision) 
 
 
4c) Medication 3 
i. Name: _________________________________ 
ii. Location given 
☐Hospital    ☐Health care centre  ☐Pharmacy 
☐Other (specify): _________________________________
 ☐Unknown 
iii. Date commenced (dd/mm/yyyy): __/__/____   ☐Unknown 
iv. Date stopped  (dd/mm/yyyy):  __/__/____ ☐Unknown   ☐ Not stopped 
by time of discharge 
 
4d) Medication 4 
i. Name: _________________________________ 
ii. Location given 
☐Hospital    ☐ Health care centre  ☐ Pharmacy 
☐Other (specify): _________________________________ ☐ 
Unknown 
iii. Date commenced (dd/mm/yyyy): __/__/____   ☐ Unknown 
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iv. Date stopped  (dd/mm/yyyy):  __/__/____ ☐ Unknown     ☐ Not 
applicable 
 
4e) Medication 5 
 
i. Name: _________________________________ 
ii. Location given 
☐Hospital    ☐Health care centre  ☐Pharmacy 
☐Other (specify): _________________________________
 ☐Unknown 
iii. Date commenced (dd/mm/yyyy): __/__/____   ☐Unknown 





i. Name: _________________________________ 
ii. Location given 




iii.  Date commenced (dd/mm/yyyy): __/__/____   ☐Unknown 
iv. Date stopped  (dd/mm/yyyy):  __/__/____ ☐Unknown   ☐ Not 
applicable 
 
5. Current History: General  
5a) Admitted to:    




5b) Is the patient known to be HIV positive?  
☐   Yes   ☐   No     
☐   Unknown   ☐   Unable to answer (participant’s decision) 
If yes please give CD4 count ___________ 
☐   Unknown    
 
5c) Past medical history 
Diabetes 
☐   Yes   ☐   No    ☐   Unknown  
Previous meningitis or encephalitis 
☐   Yes   ☐   No    ☐   Unknown  
Family member with a history meningitis or encephalitis 




☐   Yes currently being treated  (specify type e.g. pulmonary, abdominal 
etc) 
_________________ 
☐   Yes previously treated             (specify type e.g. pulmonary, abdominal 
etc) 
_________________ 
☐   Never    
☐   Unknown    
2. Alcohol consumption 
☐   Yes   ☐   No    ☐   Unknown 
 






6) Glasgow Coma Score 
6a). Glasgow Coma Score on admission to initial hospital For adults and children 
≥ 2 years only 
Eyes  ___/4  ☐Unknown   
Verbal  ___/5  ☐Unknown   
Motor   ___/6  ☐Unknown   
Total  ___/15 ☐Unknown   
 
6b) AVPU score on admission to initial hospital  For children < 2 years only 




6c) Glasgow Coma Score on admission to NHTD  For adults and children ≥ 2 
years only 
Eyes  ___/4  ☐Unknown   
Verbal  ___/5  ☐Unknown   
Motor   ___/6  ☐Unknown   
Total  ___/15 ☐Unknown  
  
 
6d) AVPU score on admission  For children < 2 years only 




6e) Was the patient intubated on admission to NHTD? 











7. LABORATORY RESULTS     Please record all sets of results 
 
7a). First lumbar puncture 
i. CSF Sample taken date (dd/mm/yyyy): ____/____/______   ☐   
Unknown 
ii. Location of lumbar puncture  ☐   NHTD   ☐   Other site ☐   Unknown 
iii. CSF cell count 
o Date tests completed (dd/mm/yyyy): ____/____/______                     
☐   Not done/unknown 
o CSF white cell count Result  |__|__|__|__|.|__|__| x cells/μl       
☐   Not done/unknown 
o CSF neutrophils  Result  |__|__| . |__| %        ☐   
Not done/unknown 
o CSF lymphocytes      Result  |__|__| . |__| %                     
☐   Not done/unknown 
o CSF eosinophils      Result  |__|__| . |__| %                     
☐   Not done/unknown 
iv) Biochemistry 
o Date tests completed (dd/mm/yyyy): ____/____/______     ☐   
Not done/unknown 
o CSF Protein Result  |__|__| . |__| g/L   ☐   
Not done/unknown  
o Glucose Result  |__|__| . |__| mmol/L         ☐   
Not done/unknown     
 
v. Gram Stain    
☐   Positive     
☐   Gram positive  ☐   Gram negative  ☐   Fungi
  ☐   Other 
☐   Cocci   ☐   Cocci 
 specify:_________ 
☐   Rods   ☐   Rods 
☐   Negative    
☐   Not done/unknown 
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    vi. Culture    
☐   Positive   
☐   Streptococcus suis  ☐  Streptococcus pneumonia 
   
☐   Neisseria meningitides  ☐   Staphylococcus aureus  
☐   Escherichia coli   ☐  Cryptococcus spp   
☐  Other (specify): 
______________________________________________ 
☐   Negative    
☐   Not done/unknown 
 
7b). Second lumbar puncture 
i. CSF Sample taken date (dd/mm/yyyy): ____/____/______   ☐   
Unknown 
ii. Location of lumbar puncture  ☐   NHTD   ☐   Other site ☐   Unknown 
iii. CSF cell count 
o Date tests completed (dd/mm/yyyy): ____/____/______                     
☐   Not done/unknown 
o CSF white cell count Result  |__|__|__|__|.|__|__| x cells/μl       
☐   Not done/unknown 
o CSF neutrophils  Result  |__|__| . |__| %        ☐   
Not done/unknown 
o CSF lymphocytes      Result  |__|__| . |__| %                     
☐   Not done/unknown 
o CSF eosinophils      Result  |__|__| . |__| %                     
☐   Not done/unknown 
o  
iv) Biochemistry 
o Date tests completed (dd/mm/yyyy): ____/____/______     ☐   
Not done/unknown 
o CSF Protein Result  |__|__| . |__| g/L   ☐   
Not done/unknown  
o Glucose Result  |__|__| . |__| mmol/L         ☐   




v. Gram Stain    
☐   Positive     
☐   Gram positive  ☐   Gram negative  ☐   Fungi
  ☐   Other 
☐   Cocci   ☐   Cocci 
 specify:_________ 
☐   Rods   ☐   Rods 
☐   Negative    
☐   Not done/unknown 
 
    vi. Culture    
☐   Positive   
☐   Streptococcus suis  ☐  Streptococcus pneumonia 
   
☐   Neisseria meningitides  ☐   Staphylococcus aureus  
☐   Escherichia coli   ☐  Cryptococcus spp   
☐  Other (specify): 
______________________________________________ 
☐   Negative    









7c). Third lumbar puncture 
i. CSF Sample taken date (dd/mm/yyyy): ____/____/______   ☐   
Unknown 
ii. Location of lumbar puncture  ☐   NHTD   ☐   Other site ☐   Unknown 
iii. CSF cell count 
o Date tests completed (dd/mm/yyyy): ____/____/______                     
☐   Not done/unknown 
o CSF white cell count Result  |__|__|__|__|.|__|__| x cells/μl       
☐   Not done/unknown 
o CSF neutrophils  Result  |__|__| . |__| %        ☐   
Not done/unknown 
o CSF lymphocytes      Result  |__|__| . |__| %                     
☐   Not done/unknown 
o CSF eosinophils      Result  |__|__| . |__| %                     
☐   Not done/unknown 
o  
iv) Biochemistry 
o Date tests completed (dd/mm/yyyy): ____/____/______     ☐   
Not done/unknown 
o CSF Protein Result  |__|__| . |__| g/L   ☐   
Not done/unknown  
o Glucose Result  |__|__| . |__| mmol/L         ☐   
Not done/unknown      
v. Gram Stain    
☐   Positive     
☐   Gram positive  ☐   Gram negative  ☐   Fungi
  ☐   Other 
☐   Cocci   ☐   Cocci 
 specify:_________ 
☐   Rods   ☐   Rods 
☐   Negative    






    vi. Culture    
☐   Positive   
☐   Streptococcus suis  ☐  Streptococcus pneumonia 
   
☐   Neisseria meningitides  ☐   Staphylococcus aureus  
☐   Escherichia coli   ☐  Cryptococcus spp   
☐  Other (specify): 
______________________________________________ 
☐   Negative    





















8. Pathogen testing 
Pathogen Sample Date of test 
Location 
of test  
   




























































































































Pathogen Sample Date of test 
Location 
of test  
   
Type of test Result 












































































































Pathogen Sample Date of test 
Location 
of test  
   












































































































9. Blood cultures 
9a) First Blood culture 
i. Date sample taken (dd/mm/yyyy): ____/____/______       
 ☐   Not done         ☐   Unknown 
ii. Location of test  ☐   NHTD            ☐   Other site       ☐   Unknown  
 
iii.Pathogen grown  
☐   Streptococcus suis  ☐  Streptococcus pneumonia 
   
☐   Neisseria meningitides  ☐   Staphylococcus aureus  
☐   Escherichia coli   ☐  Cryptococcus spp   
☐  Other (specify): 
______________________________________________ 
☐   Negative    
☐   Unknown 
 
CRF completed by:____________________________________   
___________________________________________ 
Name     
 Signature 
 













10a) Date of discharge or death (dd/mm/yyyy) : __/__/_______  
☐   Unknown 
 
10b) Diagnosis at discharge: 
a. ICD-10 Code 1: |__|__|__| . |__|__| ……………………………………. 
b. ICD-10 Code 2: |__|__|__| . |__|__| ……………………………………. 
c. ICD-10 Code 3: |__|__|__| . |__|__| ……………………………………. 
d. ICD-10 Code 4: |__|__|__| . |__|__| ……………………………………. 
e. ICD-10 Code 5: |__|__|__| . |__|__| ……………………………………. 
f. ICD-10 Code 6: |__|__|__| . |__|__| ……………………………………. 
☐   Unknown 
 
10c) Outcome at discharge (please check only one): 
☐  Discharge to home 
☐  Transferred to another 
hospital
  
☐  Died in hospital 
☐  Discharged to die 
☐  Discharged without permission 
☐  Unknown 
















1. Date of completion (dd/mm/yyyy) : __/__/_______  
2. Relationship of person with child (e.g. mother/aunt): _____________________ 
 
 
Answer each question by ticking the box applicable. 
Ask the parent/guardian the following questions:  
For some of these questions, you ask the parent or caregiver how the child compares with 
how  
they were immediately before the illness (irrespective of length of time in hospital). 
 
1. Speech or communication  
Compared with before the illness, is the child’s speech or communication:   
 The same as before (5) 
 Changed or reduced (3) 
 Not speaking or communicating (2)   
Score______        
  
2. Feeding 
The child’s feeding is:   
 The same as before illness (5) 
 Occasionally needs help (3) 
 Always needs more help (2)                                                                          
Score______                    
 
 
FOR CHILDREN AGED 15 YEARS AND YOUNGER ONLY 
 
LIVERPOOL OUTCOME SCORE AT DISCHARGE   
(TO BE ANSWERED BY THE PARENT 
OR LEGAL GUARDIAN) 
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3. Leaving Alone 
Before the illness, could this child be left alone without coming to harm? 
 No (5)  
If Yes, can this child now be left alone?  
 Yes (5) 
 Yes briefly in familiar environment (3) 
 No (2)                                                                                                                 
Score______  
           
4. Behaviour 
Compared with before the illness do the caregivers think the child’s behaviour is altered? 
 No completely normal (5) 
 Gets angry easily (4) 
 Other behavioural problems (4) 
 Severely abnormal (2)                    
Score_______ 
 
If abnormal give details:          
 
5. Recognition 
Could the child recognise their family members, other than their main carer, before the 
illness? 
 No (5) 
If Yes, can this child now recognise their family members, other than their main carer?  
 Yes (5) 
 Some (3) 
 None (2)                                                                                                               Score 
________ 
   
6. School and working 
Before the illness, was the child at school or working? 
If Yes, do the carers think the child will go back to school or work?   
 Yes (5)  
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 No (3)  
If No, do the carers think the child will still able to do the same tasks at home, follow the  
same routine, or play normally? 
 Yes (5) 
 Not able to (3)          
  
 
7. Epilepsy/ Seizures    
Did the child have any seizures during this illness? 
 No (5) 
If Yes, is the child still having seizures? 
 No seizures and not on anti-epileptic drugs (5) 
 No seizures and on anti-epileptic drugs (4) 
 Yes still having seizures (3) 




Can other children of this age dress themselves? 
 No (5) 
If Yes, can the child dress themselves since their illness?   
 Yes, the same as before illness (5) 
 Occasionally needs extra help (3) 
 Needs more help than before (2)       
Score______ 
 
9. Bladder and Bowel control 
Is urinary and faecal continence: 
 The same as before the illness (5) 
 Occasionally needs more help or occasionally is incontinent (4) 




Does the parent think this child’s hearing is:  
 Normal (5) 
 Reduced in one or both ears (4) 
 Cannot hear at all (3)                                 Score________ 
 
Observation of the child’s abilities 
Answer these questions based on what the caregiver says.  
11. Sitting 
Could the child sit before the illness? 
 No (5)  
If Yes, observe, can this child sit? 
 Yes independently (5) 
 Needs help (3) 




12. Standing up 
Could the child get from sitting to standing before the illness? 
 No (5) 
If Yes, observe, can the child get from sitting to standing? 
 Yes, independently (5) 
 Needs help (3) 








13. Walking  
Could the child walk before the illness?   
 No (5) 
If Yes, observe this child walking 5 metres across room. The child walks:  
 Normally (5) 
 Abnormally, but independently +/- crutches/stick  (3) 
 Not able to walk (2)                  
Score ______ 
 
14. Hands on head 
Put both your hands on your head, and ask the child to copy you. Child is:  
 Too young (5) 
 Normal both hands (5) 
 Abnormal one or both hands (4) 
 Unable one or both hands (3)                                    
Score_______ 
 
15. Picking Up 
Ask child to pick up pea-sized ball of paper or small coin. Child is: 
 Too young (5) 
 Normal pincer grasp both hands (5) 
 Unable one hand (3) 
 Abnormal one hand or both hands (3) 
 Unable both hands (2)                           
Score_______ 
 








The Final Liverpool Outcome Score is the lowest number scored for any question 
single question 
Score interpretation:  
 
5 = Full recovery  
4 = Minor sequelae with no effect, or only minor effects, on physical function; or personality 
change; or on medication. 
3 = Moderate sequelae mildly affecting function, probably compatible with independent living 
2 = Severe sequelae, impairing function sufficient to make patient dependent 
1 = Death 
 
 
Liverpool Outcome Score completed by: 
____________________________                             ____________________________ 
 
Name                                  Signature 
 



















Answer each question. Circle or underline the correct answer, and write the 
score in the column. If the parent/guardian does not wish to answer or does 
not know please indicate this. 
 
1. Date of completion (dd/mm/yyyy) : __/__/_______  
2. Relationship of person with child (e.g. mother/aunt): _____________________ 
 
Ask the parent/guardian the following questions:  
For some of these questions, you ask the parent or caregiver how the child 
compares with how  
they were immediately before the illness (irrespective of length of time in hospital). 
 
1. Speech or communication  
Compared with before the illness, is the child’s speech or communication:   
☐ The same as before (5) 
☐ Changed or reduced (3) 
☐ Not speaking or communicating (2)        
Score ______  
 
2. Feeding 
The child’s feeding is:   
☐ The same as before illness (5) 
☐ Occasionally needs help (3) 
☐ Always needs more help (2)                                                                          
Score______                    
 
 
FOR CHILDREN AGED 15 YEARS AND YOUNGER ONLY 
 
LIVERPOOL OUTCOME SCORE AT 3 MONTHS AFTER DISCHARGE   
(TO BE ANSWERED BY THE PARENT 
OR LEGAL GUARDIAN) 
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3. Leaving Alone 
Before the illness, could this child be left alone without coming to harm? 
☐ No (5)  
If Yes, can this child now be left alone?  
☐ Yes (5) 
☐ Yes briefly in familiar environment (3) 




Compared with before the illness do the caregivers think the child’s behaviour is 
altered? 
☐ No completely normal (5) 
☐ Gets angry easily (4) 
☐ Other behavioural problems (4) 
☐ Severely abnormal (2)                    
Score_______ 
If abnormal give details:          
 
5. Recognition 
Could the child recognise their family members, other than their main carer, before 
the illness? 
☐ No (5) 
If Yes, can this child now recognise their family members, other than their main 
carer?  
☐ Yes (5) 
☐ Some (3) 






6. School and working 
Before the illness, was the child at school or working? 
If Yes, do the carers think the child will go back to school or work?   
☐ Yes (5)  
☐ No (3)  
If No, do the carers think the child will still able to do the same tasks at home, 
follow the  
same routine, or play normally? 
☐ Yes (5) 
☐ Not able to (3)         
   
 
7. Epilepsy/ Seizures    
Did the child have any seizures during this illness? 
☐ No (5) 
If Yes, is the child still having seizures? 
☐ No seizures and not on anti-epileptic drugs (5) 
☐ No seizures and on anti-epileptic drugs (4) 
☐ Yes still having seizures (3) 




Can other children of this age dress themselves? 
☐ No (5) 
If Yes, can the child dress themselves since their illness?   
☐ Yes, the same as before illness (5) 
☐ Occasionally needs extra help (3) 





9. Bladder and Bowel control 
Is urinary and faecal continence: 
☐ The same as before the illness (5) 
☐ Occasionally needs more help or occasionally is incontinent (4) 
☐ Needs more help or is incontinent of bowel or bladder (2)  
 Score ______ 
 
10. Hearing 
Does the parent think this child’s hearing is:  
☐ Normal (5) 
☐ Reduced in one or both ears (4) 
☐ Cannot hear at all (3)                                 
Score________ 
 
Observation of the child’s abilities 
Answer these questions based on what the caregiver says.  
11. Sitting 
Could the child sit before the illness? 
☐ No (5)  
If Yes, observe, can this child sit? 
☐ Yes independently (5) 
☐ Needs help (3) 
☐ Not at all (2)             
Score________ 
 
12. Standing up 
Could the child get from sitting to standing before the illness? 
☐ No (5) 
If Yes, observe, can the child get from sitting to standing? 
☐ Yes, independently (5) 
☐ Needs help (3) 
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☐ Not at all (2)        
Score________ 
 
13. Walking  
Could the child walk before the illness?   
☐ No (5) 
If Yes, observe this child walking 5 metres across room. The child walks:  
☐ Normally (5) 
☐ Abnormally, but independently +/- crutches/stick  (3) 
☐ Not able to walk (2)                  
Score  ______ 
 
14. Hands on head 
Put both your hands on your head, and ask the child to copy you. Child is:  
☐ Too young (5) 
☐ Normal both hands (5) 
☐ Abnormal one or both hands (4) 
☐ Unable one or both hands (3)                                    
Score_______ 
 
15. Picking Up 
Ask child to pick up pea-sized ball of paper or small coin. Child is: 
☐ Too young (5) 
☐ Normal pincer grasp both hands (5) 
☐ Unable one hand (3) 
☐ Abnormal one hand or both hands (3) 
☐ Unable both hands (2)                           
Score_______ 
 




The Final Liverpool Outcome Score is the lowest number scored for any 
question single question 
Score interpretation:  
 
5 = Full recovery  
4 = Minor sequelae with no effect, or only minor effects, on physical function; or 
personality change; or on medication. 
3 = Moderate sequelae mildly affecting function, probably compatible with 
independent living 
2 = Severe sequelae, impairing function sufficient to make patient dependent 
1 = Death 
 
 
Liverpool Outcome Score completed by: 
____________________________                             
____________________________ 
 
Name                                  Signature 
 














1 Death D 
2 Vegetative State VS 
3 Lower severe disability SD- 
4 Upper severe disability SD+ 
5 Lower moderate 
disability 
MD- 
6 Upper moderate 
disability 
MD+ 
7 Lower good recovery GR- 
8 Upper good recovery GR+ 
 
Respondent details 
☐   0 = patient alone 
☐   1 = relative 
☐   2 = patient plus relative 
 
Date of completion (dd/mm/yyyy) : __/__/_______  
 
If relative  
Relationship of person with participant (e.g. spouse/brother): 
_____________________ 
 
FOR ADULTS AGED 16 YEARS AND OVER ONLY 
 
EXTENDED GLASGOW OUTCOME SCALE AT DISCHARGE   
(TO BE ANSWERED BY THE PARENT 




1a) Is the head-injured person able to obey simple commands or say any 
words?  
☐   Yes 
☐   No (VS) 
☐   Don’t know 
☐   Prefer not to answer 
 
Note: anyone who shows the ability to obey even simple commands or utter any 
word or communicate specifically in any other way is no longer considered to be in a 
vegetative state. Eye movements are not reliable evidence of meaningful 
responsiveness.  
Independence at home 
2a) Is the assistance of another person at home essential everyday for some 
activities of daily living? 
☐   Yes 
☐   No (VS)   If no: go to 3 
☐   Don’t know 
☐   Prefer not to answer 
Note: for a NO answer they should be able to look after themselves at home for 24 
hours if necessary, though they need not actually look after themselves. 
Independence includes the ability to plan for and carry out the following activities: 
getting washed, putting on clean clothes without prompting, preparing food for 
themselves, dealing with callers and handling minor domestic crises. The person 
should be able to carry out activities without needing prompting or reminding and 
should be capable of being left alone overnight.  
 
 
2b) Do they need frequent help of someone to be around at home most of the 
time?  
☐   Yes (lower SD) 
☐   No (upper SD) 
☐   Don’t know 
☐   Prefer not to answer 
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Note for a NO answer they should be able to look after themselves at home up to 
eight hours during the day if necessary, though they need not actually look after 
themselves.  
 
2c) Was the patient independent at home before the AES?  
 ☐   Yes  
☐   No  
☐   Don’t know 
☐   Prefer not to answer 
 
Independence outside home 
3a) Are they able to shop without assistance? 
☐   Yes  
☐   No  
☐   Don’t know 
☐   Prefer not to answer 
 
Note, this includes being able to plan what to buy, take care of money themselves 
and behave appropriately in public. They need not normally shop, but must be able 
to do so.  
 
3b) Were they able to shop without assistance before the AES?  
☐   Yes  
☐   No  
☐   Don’t know 
☐   Prefer not to answer 
4a) Are they able to travel locally without assistance?  
☐   Yes  
☐   No (upper SD) 
☐   Don’t know 
☐   Prefer not to answer 
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Note: they may drive or use public transport to get around. Ability to use a taxi is 
sufficient, provided the person can phone for it themselves, and instruct the driver.  
 
4b) Were they able to travel locally without assistance before the injury?  
☐   Yes  
☐   No  
☐   Don’t know 
☐   Prefer not to answer 
 
Work 
5a) Are they currently able to work (or look after others at home) to their 
previous capacity?  
☐   Yes  if yes, go to 6 
☐   No  
☐   Don’t know 
☐   Prefer not to answer 
 
 
5b) How restricted are they? 
☐   Restricted work capacity?  (Upper MD) 
☐   Able to work only in a sheltered workshop or non-competitive job or currently 
unable to work? 
  (Lower MD) 
☐   Don’t know 
☐   Prefer not to answer 
 
5c) Does the level of restriction represent a change in respect to the pre-
trauma situation?  
☐   Yes  
☐   No  
☐   Don’t know 
☐   Prefer not to answer 
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Social and leisure activities 
6a) Are they able to resume regular social and leisure activities outside home?  
☐   Yes     if yes, go to 7 
☐   No  
☐   Don’t know 
☐   Prefer not to answer 
 
Note: they need not have resumed all their previous leisure activities, but should not 
be prevented by physical or mental impairment. If they have stopped the majority of 
activities because of loss of interest or motivation, then this is also considered a 
disability. 
6b) What is the extent of restriction on their social and leisure activities?  
☐   Participates a bit less: at least half as often as before injury  (lower GR) 
☐   Participates much less: less than half as often  (upper MD)  
☐   Unable to participate: rarely, if ever, take part   (lower MD) 
☐   Don’t know 
☐   Prefer not to answer 
 
6c) Does the extent of restriction in regular social and leisure activities 
outside home represent a change compared to before the AES 
☐  Yes   
☐   No  
☐   Don’t know 
☐   Prefer not to answer 
 
Family and friendships 
7a) Has there been family or friendship disruption due to psychological 
problems?  
☐  Yes   
☐   No     if no, go to 8 
☐   Don’t know 
☐   Prefer not to answer 
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Note: typical post-traumatic personality changes are: quick temper, irritability, 
anxiety, insensitivity to others, mood swings, depression and unreasonable or 
childish behaviour. 
 
7b) What has been the extent of the disruption or strain?  
☐  Occasional – less than weekly      (lower GR) 
☐  Frequent – once a week or more, but not tolerable    (upper MD) 
☐   Constant – daily and intolerable     (lower MD) 
☐   Don’t know 
☐   Prefer not to answer 
 
7c) Does the level of disruption or strain represent a change in compared to 
before the AES?  
☐  Yes   
☐   No  
☐   Don’t know 
☐   Prefer not to answer 
Note: if there were some problems before injury, but these have become markedly 
worse since the injury then answer yes to the question 
 
Return to normal life 
8a) Are there any other current problems relating to the AES which affect daily 
life?  
☐  Yes  (lower GR) 
☐   No (upper GR) 
☐   Don’t know 
☐   Prefer not to answer 
Note: for example, memory and concentration problems 
 
8b) If similar problems were present before the AES, have these become 
markedly worse? 
☐  Yes  (lower GR) 
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☐   No (upper GR) 
☐   Don’t know 
☐   Prefer not to answer 
 
9) What is the most important factor in outcome? 
☐  Effects of head injury 
☐   Effects of illness or injury to another part of the body 
☐   A mixture of these 
☐   Don’t know 
☐   Prefer not to answer 
 
The overall rating for the Glasgow Outcome Scale is based on the lowest outcome 
category indicated. Areas in which there has been no change with respect to the 
pre-AES situation are ignored when the overall rating is made. 
 
Glasgow Outcome Scale completed 
by:____________________________________   
___________________________________________ 
Name     
 Signature 
 











1 Death D 
2 Vegetative State VS 
3 Lower severe disability SD- 
4 Upper severe disability SD+ 
5 Lower moderate 
disability 
MD- 
6 Upper moderate 
disability 
MD+ 
7 Lower good recovery GR- 
8 Upper good recovery GR+ 
 
Respondent details 
☐   0 = patient alone 
☐   1 = relative 
☐   2 = patient plus relative 
 
If relative  
Relationship of person with participant (e.g. spouse/brother): 
_____________________ 
 
Date of completion (dd/mm/yyyy) : __/__/_______  
 
FOR ADULTS AGED 16 YEARS AND OVER ONLY 
 
EXTENDED GLASGOW OUTCOME SCALE 3 MONTHS AFTER DISCHARGE   
(TO BE ANSWERED BY THE PARENT 




1a) Is the head-injured person able to obey simple commands or say any 
words?  
☐   Yes 
☐   No (VS) 
☐   Don’t know 
☐   Prefer not to answer 
 
Note: anyone who shows the ability to obey even simple commands or utter any 
word or communicate specifically in any other way is no longer considered to be in a 
vegetative state. Eye movements are not reliable evidence of meaningful 
responsiveness.  
Independence at home 
2a) Is the assistance of another person at home essential everyday for some 
activities of daily living? 
☐   Yes 
☐   No (VS)   If no: go to 3 
☐   Don’t know 
☐   Prefer not to answer 
Note: for a NO answer they should be able to look after themselves at home for 24 
hours if necessary, though they need not actually look after themselves. 
Independence includes the ability to plan for and carry out the following activities: 
getting washed, putting on clean clothes without prompting, preparing food for 
themselves, dealing with callers and handling minor domestic crises. The person 
should be able to carry out activities without needing prompting or reminding and 
should be capable of being left alone overnight.  
 
2b) Do they need frequent help of someone to be around at home most of the 
time?  
☐   Yes (lower SD) 
☐   No (upper SD) 
☐   Don’t know 
☐   Prefer not to answer 
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Note for a NO answer they should be able to look after themselves at home up to 
eight hours during the day if necessary, though they need not actually look after 
themselves.  
 
2c) Was the patient independent at home before the AES?  
 ☐   Yes  
☐   No  
☐   Don’t know 
☐   Prefer not to answer 
 
Independence outside home 
3a) Are they able to shop without assistance? 
☐   Yes  
☐   No  
☐   Don’t know 
☐   Prefer not to answer 
 
Note, this includes being able to plan what to buy, take care of money themselves 
and behave appropriately in public. They need not normally shop, but must be able 
to do so.  
 
3b) Were they able to shop without assistance before the AES?  
☐   Yes  
☐   No  
☐   Don’t know 
☐   Prefer not to answer 
 
4a) Are they able to travel locally without assistance?  
☐   Yes  
☐   No (upper SD) 
☐   Don’t know 
☐   Prefer not to answer 
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Note: they may drive or use public transport to get around. Ability to use a taxi is 
sufficient, provided the person can phone for it themselves, and instruct the driver.  
 
4b) Were they able to travel locally without assistance before the injury?  
☐   Yes  
☐   No  
☐   Don’t know 
☐   Prefer not to answer 
 
Work 
5a) Are they currently able to work (or look after others at home) to their 
previous capacity?  
☐   Yes  if yes, go to 6 
☐   No  
☐   Don’t know 
☐   Prefer not to answer 
 
5b) How restricted are they? 
☐   Restricted work capacity?  (Upper MD) 
☐   Able to work only in a sheltered workshop or non-competitive job or currently 
unable to work? 
  (Lower MD) 
☐   Don’t know 
☐   Prefer not to answer 
 
5c) Does the level of restriction represent a change in respect to the pre-
trauma situation?  
☐   Yes  
☐   No  
☐   Don’t know 
☐   Prefer not to answer 
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Social and leisure activities 
6a) Are they able to resume regular social and leisure activities outside home?  
☐   Yes     if yes, go to 7 
☐   No  
☐   Don’t know 
☐   Prefer not to answer 
 
 
Note: they need not have resumed all their previous leisure activities, but should not 
be prevented by physical or mental impairment. If they have stopped the majority of 
activities because of loss of interest or motivation, then this is also considered a 
disability. 
6b) What is the extent of restriction on their social and leisure activities?  
☐   Participates a bit less: at least half as often as before injury  (lower GR) 
☐   Participates much less: less than half as often  (upper MD)  
☐   Unable to participate: rarely, if ever, take part   (lower MD) 
☐   Don’t know 
☐   Prefer not to answer 
 
6c) Does the extent of restriction in regular social and leisure activities 
outside home represent a change compared to before the AES 
☐  Yes   
☐   No  
☐   Don’t know 









Family and friendships 
7a) Has there been family or friendship disruption due to psychological 
problems?  
☐  Yes   
☐   No     if no, go to 8 
☐   Don’t know 
☐   Prefer not to answer 
 
Note: typical post-traumatic personality changes are: quick temper, irritability, 
anxiety, insensitivity to others, mood swings, depression and unreasonable or 
childish behaviour. 
 
7b) What has been the extent of the disruption or strain?  
☐  Occasional – less than weekly      (lower GR) 
☐  Frequent – once a week or more, but not tolerable    (upper MD) 
☐   Constant – daily and intolerable     (lower MD) 
☐   Don’t know 
☐   Prefer not to answer 
 
7c) Does the level of disruption or strain represent a change in compared to 
before the AES?  
☐  Yes   
☐   No  
☐   Don’t know 
☐   Prefer not to answer 
Note: if there were some problems before injury, but these have become markedly 







Return to normal life 
8a) Are there any other current problems relating to the AES which affect daily 
life?  
☐  Yes  (lower GR) 
☐   No (upper GR) 
☐   Don’t know 
☐   Prefer not to answer 
 
Note: for example, memory and concentration problems 
 
8b) If similar problems were present before the AES, have these become 
markedly worse? 
☐  Yes  (lower GR) 
☐   No (upper GR) 
☐   Don’t know 
☐   Prefer not to answer 
 
9) What is the most important factor in outcome? 
☐  Effects of head injury 
☐   Effects of illness or injury to another part of the body 
☐   A mixture of these 
☐   Don’t know 
☐   Prefer not to answer 
 
The overall rating for the Glasgow Outcome Scale is based on the lowest outcome 
category indicated. Areas in which there has been no change with respect to the 





Glasgow Outcome Scale completed 
by:____________________________________   
___________________________________________ 
Name     
 Signature 
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FOCUS GROUP DISCUSSION 
1. In the area where you live are there places where you think you would be bitten 
by mosquitoes? What time of day? 
 
2. What are the ways in which you try to prevent mosquito bites when you are inside 
your house? What else could you do, even though you currently 
don’t? Why don’t you do these things?  
 
If there is little discussion being generated, prompts including pictures of mosquito 
nets and insect repellent will be shown. 
 
3. Why do you try to avoid mosquito bites? 
 
4. Do you know of any diseases caused by mosquito bites? Tell me about these 
diseases and how do you get these? (If not discussed, then ask ‘Tell me what you 
know about Japanese Encephalitis and Dengue Fever”) 
 
5. Would you spend time in rice fields e.g. what time of year?   
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6. What animals are there in your community?  
 
a. Do you have any type of contact with each of these animals? If yes, which 
animals do you have contact with and what is the type of contact? 
- e.g.do they live in the house, do you look after any animals  
 
7. Which animals do you eat? What do other people in your community eat? How 
often (use counters)? Which of these are eaten raw? 
 
8.  How would you feel if we came to your house to perform a questionnaire? 
 
9. How would you feel if we took photographs around your house? 
 
These participatory rural appraisals (PRA) are known techniques used to facilitate 
community discussion and development (1, 2). 
 
1. Robinson L. Participatory Rural Appraisal: A Brief Introduction. Group Facilitation: 
A Research and Applications Journal. 2002; 4: 45-51.  
 
2. Kumar, S. (2002). Methods for community participation : a complete guide for 
practitioners / Somesh Kumar. London : ITDG, 2002. 
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APPENDIX 3.7  
	
13HN ICF Relatives V4.2 04AUG16 
 
13HN: UNDERSTANDING RISK FACTORS FOR ENCEPHALITIS 
(BRAIN INFLAMMATION) 
 
Information Sheet For Focus Group Discussion (Hospital Relatives) 
 
One Copy For Study Records And One Copy To Be Given To The Participant 
You are being invited to participate in a study looking at risk factors for acute 
encephalitis syndrome, an inflammation of the brain. Approximately 2000 people will 
be part of this study. Please read this information sheet carefully or have someone 
read it to you. Please ask the study staff to explain any information that you are not 
sure about. It is your choice whether to participate in the study and please do not feel 
obliged do so.  If you would like to take part you will be asked to sign or place a 
thumbprint on the last page. You will be given a copy of this form for your personal 
records. 
 
Why is this study being done?  
Acute Encephalitis Syndrome (AES) is a syndrome of brain inflammation or swelling. 
Patients may die or be left disabled. There are around two thousand cases of AES in 
Viet Nam every year. Although Japanese encephalitis, a virus spread by mosquitoes 
is a common cause of AES in children and Streptococcus suis, a bacteria associated 
with eating or preparing raw pork meat is a common cause in adults, for half of the 
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patients or more, we do not know the cause of their AES. However, we do know that 
most of the cases occur during the warmer seasons and therefore we think that 
mosquitoes or other insects are spreading diseases, which cause AES in northern 
Viet Nam.  
 
This study therefore aims to look at the reasons why people might or might not get 
AES including where the person lives and their risks in and around their home and 
work environment and their contact with animals. 
 
Who is doing this study?  
This study is being performed by a team from: 
The Oxford University Clinical Research Unit in Ha Noi 
The University of Liverpool, United Kingdom 
 
The Wellcome Trust Liverpool Glasgow Centre for Global Health Research, United 
Kingdom 
The National Hospital of Tropical Diseases, Ha Noi 
 
What will happen to me in this study and what are the risks?   
You have been chosen to take part because we want to get information from members 
of the community about your daily activities, contact with animals and ways in which 
you prevent mosquito bites. This will help us to design a questionnaire for a larger 
study which will help to understand risks associated with acute encephalitis 
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syndrome. You will then be asked to take part in a group discussion with five other 
members of the same gender in your community. This will take around one hour. 
 
What will happen to the samples / information taken? 
The results of the study will be used to design a questionnaire for a larger study. The 
results will also be written as a report or thesis for the University of Liverpool and will 
be published in a journal, which will be made available to the public. The results will 
also be available in Vietnamese through the OUCRU website and the Hospital for 
Tropical Diseases website. The results will also be available for the Ministry of Health 
in Viet Nam. You will not be able to be identified in these results with the exception of 
pictures of your house and the dot on a map to show the location of your house. 
 
The results will be also be made available to the public through workshops about AES 
in the community or schools and possibly via the radio or other forms of media. 
 
What is the benefit of participating?   
There is no intended personal benefit to taking part however, the benefit will be to the 
community and people of Viet Nam by help us to understand the risks associated with 
AES. 
 





What happens if I decline participation or change my mind later on? 
You have the right to decline participation or withdraw from the study or any part of 
the study at any time. Please let us know if you wish to do so. You do not need to give 
an explanation for this. You can request for your results to be destroyed at any time. 
There will be no effect to your management. 
 
Can someone else decide to take the patient out of the study?  
The research team doctors can withdraw you from the study, if there is a problem with 
the information collected from you. The Universities and ethics committees can also 
stop the study. 
 
Confidentiality 
All conversations will be recorded using a microphone device and later translated by 
the research assistant and kept on a secure database. Information about you will be 
kept confidential and only shared amongst study team members. You will be given an 
anonymous code, which will be used for the answers. Details linking yourself to this 
code will be kept in a separate place. All consent forms and recordings will be kept in 
a locked room. Only those who are involved with the study will have access to these 
documents which will be kept for 3 years and then put on an electronic system.   
The consent forms will be kept in a locked cupboard. 
 
Whom do I contact if I have questions or complaints? 
If you have questions about the study you may contact: To be decided 
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If you have questions about being in a research study, please contact the Research 
Ethics Board of the NHTD at (phone number) the Clinical Trials Unit at (phone 
number) 
 
COMPULSORY FOR STUDY RECRUITMENT 
1. I have read this information sheet or it has been read to me 
and I understand it.  
 
2. I have been able to ask questions about the study. 
 
 
3. I understand that my participation of behalf of my in the study 
is voluntary and I do not have to answer questions if I do not 
wish to do so. 
 
 
4. I understand that my information will be recorded using a 
microphone device. 
 
5. I understand that I can ask for access to the information I 
provide or have this information destroyed if I wish. 
 
6. I understand that I will be given an anonymous code instead 




7. I agree for the data collected from me to be used in future 
research publications and presentations without my name. 
 
8.  I agree to take part in the above study.  
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• I freely give my permission to join this study. 
• I understand that I have the right to withdraw from the study. I will be given a copy 
of this signed consent form to keep for my reference.  
•  
Participant ID: 13HN-[__|__]-[__|__|__]      
Name of participant (Please Print): ________________________ 
 By signing/marking my name here, I confirm what is written above. 













If the person giving consent cannot read the form themselves, a witness must 
be present and sign here: 
I was present throughout the entire informed consent process with the participant.  
This form was read accurately to the volunteer, all questions from the volunteer were 


















Confirmation of study staff: 
By signing/marking my name here, I confirm that I have fully explained the relevant 
information of this study to the person named above and will provide her/him with a 
copy of this signed and dated informed consent form. 






























APPENDIX 3.8  
OxTREC 42-15 Questionnaire for relatives V2.1 10JUN16 
Risk factors for and spatio-temporal distribution of cases of acute encephalitis 
syndrome of suspected infectious aetiology in the Red River Delta region, northern 
Viet Nam: a feasibility study  
 
EPIDEMIOLOGY QUESTIONNAIRE FOR ADULTS (questions can be altered to 
be answered by parents or relatives) 
 
Please note, all questions will be given the option don’t know and prefer not to 
answer where it is felt applicable. 
 
For all string variables where the participant does not know or prefers not to answer 
please type this 
 
Participant Code 
Date of interview 
Start time of interview 
Record the province of the participant’s house 
Record the district of the participant’s house 
 
Record the commune of the participant’s house 
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What is your date of birth? 
 
Use 77 for don’t know and 99 for prefer not to answer 
 











Prefer not to answer 
Please state your other religion 
 













Prefer not to answer 
What is your occupation? 
 
If does not work (e.g. retired, student, housewife) document this 
 
Describe where you work 
(e.g. in the office, in the rice field, in the home) 
 
Describe your typical daily activities at work 
(e.g. working on the computer, ploughing field, cleaning house/washing) 
 









How long have you lived at this address (years)? 
 
Do you have more than one address currently?  
Yes 
No 
         
Where else do you live currently? 
 




Please give the details of previous addresses   
Details for where the participant lived, when and for how long 
 





Specify the other type of ownership of your house? 
 
 440 
How many adults slept in your house last night?  
 
 
How many children slept in your house last night? 
 
 
How many people share your bedroom (on average)?  
 
What is your water source? (select all that apply and specify what the water is 
used for e.g. drinking, bathing, cooking) 





Private protected (covered) well  
Public protected well 
Private unprotected well 
Public unprotected well 
River/stream/pond/lake 





Describe the other water source you use for drinking 
 
How often do you use each of the water sources (part of the year, all year, 
don’t know, (select all that apply) 




Private protected (covered) well  
Public protected well 
Private unprotected well 
Public unprotected well 
River/stream/pond/lake 
Rain water/natural water 
Tanker water 
Other (specify) 









If yes, what type of water treatment do you use? (select all that apply) 
Boiling 
Candle ceramic filters 
Strained through cloth 
Water treatment powder 
Alum 




Describe the other type of water treatment you use 
 
What type of fuel does your household use for cooking or heating the 
house? (select all that apply) 
LP gas 
Biogas 




Coal or charcoal 
Wood 
Straw/shrubs/grass 




Specify the other type of fuel your household uses for cooking or heating 
the house 
 
How often do you use each of the types of fuel for cooking or heating the 













What is your household income per month? 
< 5,000,000 VND 
5,000,000 -10,000,000 VND 




Prefer not to answer 
 




Do you or your household own any of the following? (Select all that apply and 






Bicycle (state number) 
Motorcycle (state number) 















Specify the other form(s) of transport you use 
 
Do you use any of the following methods for prevention of mosquito bites? 
(select all that apply) 
Simple bednet 
Insecticide treated bednet 
Mosquito coils or liquid 
Mosquito repellent on body or clothes 
Other  
 
Specify the other type of mosquito prevention you use 
 
How many simple mosquito bed nets are in your house?  
Use 77 for don’t know  
 
How many insecticide treated mosquito bed nets are in your house? 
Use 77 for don’t know  
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How often do you sleep under a mosquito bed net from June-November? 
(Include any type of bed net) 
Never 
Less frequently that once per week (e.g. one per month) 
Once per week 
2-3 times per week 
4-6 times per week 
Every night 
 
How often do you sleep under a mosquito bed net from December-May?  
(Include any type of bed net) 
Never 
Less frequently that once per week (e.g. one per month) 
Once per week 
2-3 times per week 
4-6 times per week 
Everynight 
 






Cases: Were you sleeping under a bed net in the month prior to becoming 
unwell? 






Cases: Were you sleeping under a bed net treated with insecticide in the 
month prior to becoming unwell? 
Controls: Were you sleeping under a bed net treated with insecticide in the 







Cases: Have you been sleeping inside or outside in the month prior to 
becoming unwell? 
Controls: Have you been sleeping inside or outside in the last two months? 
(Not include whilst in hospital) 
Inside 
Outside 
Sometimes inside, sometimes, outside 
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Cases: How often were you using mosquito repellent on your body or 
clothes in the month before you became unwell? 
Controls: How often were you using mosquito repellent on your body or 
clothes in the last two months? 
Never 
Every day 
2-3 times per week 
Once per week 
Less than once per week 
 
Are there mosquito screens on the doors or windows of your house?  
No 
Yes on all 
Yes on some 
Not applicable (e.g. no doors or window in house)  
 















How long ago was the house painted after spraying with insecticide (e.g. 
days, months)? 
 




What are the ages of these pigs (select all that apply) 
 
Under 6 months of age 
Over 6 months of age 
Don’t know 
Prefer not to answer 
 





Cases: Did you have any contact with or were close to any pigs in the 
month prior to becoming unwell? 




Prefer not to answer 
If yes, describe this contact (e.g. touch, cleaned, stood next to) 
 
What were the ages of these pigs (select all that apply) 
 
Under 6 months of age 
6 months of age and over 
Don’t know 
Prefer not to answer 
 




Cases: Did you have any contact with ducks in the month prior to becoming 
unwell? 




Prefer not to answer  
 
If yes, describe the contact 
 
Cases: Did you have any contact with dogs in the month prior to becoming 
unwell? 
Controls: Did you have any contact with dogs in the last two months? 
Yes 
No 
Prefer not to answer 
 
If yes, describe the contact (e.g. touched, fed, ate) 
 
 
Cases: Did you have any contact with cats in the month prior to becoming 
unwell? 
Controls: Did you have any contact with cats in the last two months? 
Yes 
No 
Prefer not to answer 
 





Cases: Have you seen any rats around your house or place of work in the 
month prior to becoming unwell? 
Controls: Have you seen any rats around your house or place of work in the 





Cases: Have you had any contact with rats in month prior to becoming 
unwell? 
Controls: Have you had any contact with rats in the last two months? 
Yes 
No 
If yes, describe the contact (e.g. touched, fed, ate) 
 
Cases: Have you seen any bats around your house in the month prior to 
becoming unwell? 









Cases: Have you had any contact with bats in the month prior to becoming 
unwell? 




If yes, describe the contact (e.g. touched, fed, ate) 
 
How many buffalo are kept in the house where you are living? 
 
 
How many cows are kept in the house where you are living? 
 
 
How many sheep are kept in the house where you are living? 
 
 
How many goats are kept in the house where you are living? 
 
 




Cases: Have you had any close contact with a sick animal in the month 
before becoming unwell?  





Prefer not to answer 
 
If yes, describe your contact with the sick animal (when (time not date), 
which animal, what contact did you have)? 
 
 
Cases: Have you been bitten by an animal (not including insects) within the 
month before becoming unwell? 
Controls: Have you been bitten by an animal (not including insects) within 
the last two months)? 
Yes  
No 
Prefer not to answer 
 






Cases: Did you drink any raw milk in the month before becoming unwell? 




Prefer not to answer 
 
Cases: Did you milk any animals in the month before becoming unwell? 




Cases: Have you taken part in the slaughter of an animal in the month 
before becoming unwell? 











Cases: Did you eat any raw meat, viscera or blood in the month before 
becoming unwell? 




Prefer not to answer 
If yes, specify the animals 
 
Cases: Did you prepare or touch any raw meat, viscera or blood in the 
month before becoming unwell? 
Controls: Did you prepare or touch any raw meat, viscera or blood in the 
last two months? 
Yes  
No  
Prefer not to answer 
If yes, specify the animals 
 
 
Do you work in any rice fields?  
Yes 
No 











Cases: How many times on average per week did you work in the rice fields 
in the month before you became unwell? 
Controls: How many times on average per week did you work in the rice 






Less than once per week 
 
 
Cases: Did you walk through any rice fields in the evenings in the month 
before you became unwell? 





If yes, how often did you walk through the rice fields on average per week? 
Everyday 
On 5-6 days 
On 3-4 days 
On 1-2 days 








If yes, how often did you walk through the forests or woods on average per 
week? 
Everyday 
On 5-6 days 
On 3-4 days 
On 1-2 days 





Cases: Did you walk through or sit in any grassland in the month before you 
became unwell? 






If yes, how often did you walk through or sit any grassland on average per 
week? 
Everyday 
On 5-6 days  
On 3-4 days 
On 1-2 days 




Cases: Was there any flooding in your area in the month before you became 
unwell? 







Cases: Did you swim, wash, walk through or carry out any other activity in 
any river, stream or lake water in the month before you became unwell?  
Controls: Did you swim, wash, walk through or carry out any other activity 




Prefer not to answer 
 
If yes, describe the activities you carried out, the type of water and how 
frequently this was in more detail 
 
How often do you shower or bathe? 
Daily 
A few times per week 
Weekly 
Less than weekly 
Prefer not to answer 
 










Prefer not to answer 
 
When (time e.g. in days not date) did you last wash the clothes you are 
wearing? 
 
Cases: Did you harvest any fruit in the month before you became unwell? 
Controls: Did you harvest any fruit in the last two months? 
Yes 
No 
Prefer not to answer 
 
If yes, did you harvest any lychees in the month prior to becoming unwell 
(cases)/previous two months (controls)? 
Yes 
No 






Cases: Did you ever sit on the floor of your house without a rug in the 
month before you became unwell? 
Controls: Did you ever sit on the floor of your house without a rug in the 
last two months? 
Yes – always 
Yes - sometimes 
No 
Prefer not to answer 
 
Cases; Did you travel outside of your province in the month before you 
became unwell?  
Controls: Did you travel outside of your province in the last two months? 
Yes 
No 
Prefer not to answer 
 
If yes, which provinces did you travel to and when? 
 
Cases: Did you travel outside of Viet Nam in the month prior to becoming 
unwell? 
Controls: Did you travel outside of Viet Nam in the last two months? 
Yes  
No 
Prefer not to answer 
 
If yes, where and when did you travel? 
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Research assistant to verify JE vaccination card present 
Yes 
No 
Unable to answer (participant’s decision) 
 
End time of interview 
 
VERIFICATION TO BE COMPLETED BY RESEARCH ASSISTANT 
What is the device ID? 
 
Please document the date of completion of the form 
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Document the start time 
 
Please capture the location of the participant’s house using the Samsung 
phone 
 
Record the coordinates of the house using the Garmin GPS 
 





What is the roof of the house made of? 
Tile or slate 
Thatch or straw 
Cement or concrete 
Iron 
Wood and mud 
Other  
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Not applicable as no roof present 
Unable to answer (participant’s choice) 
 
Specify the type of roof present 
 
What are the walls of the house made of? 
Cement 
Tin 
Straw or straw and mud 
Bricks or stones with mud 




Not applicable (no walls present) 
Unable to answer (participant’s decision) 
 








Parquet or polished wood 
Cane/bamboo/palm 




Unable to answer (participant’s decision) 
 
Specify the type of ground present 
 
Where is the place for cooking? 
In the house 




No food cooked in household 
Unable to answer (participant’s decision) 
 
Specify the location where cooking takes place 
What is the drinking water source? (select all that apply) 




Protected (covered) well – specify if drilled or dug/public or private 
River/stream/pond/lake 
Rain water/natural water 






Take a photo of the drinking water sources 
 
What type of toilet is present (circle all that apply)? 
No toilet (use bush or field) 
Bucket toilet 
Public/shared pit toilet (state if traditional or ventilation improved pit toilet) 
Own pit toilet (state if traditional or ventilation improved pit toilet) 
Public/shared flush toilet 
Own flush toilet 
 
Private pit latrine without flush (bucket used) 
Private pit latrine with flush 
Private western style toilet 
 
Other 





Is there a bed net over the participant’s bed? 
Yes 
No 
Unable to answer (participant’s decision) 
 
Are there any abnormal holes in the participant’s bed net? 
Yes 
No 
Unable to answer (participant’s decision) 
 
Take a photo of the bedne 
Unable to answer (participant’s decision) 
 
Are there door or window screens present? 
Yes on all doors and windows 
Yes on some doors and windows 
No 
Unable to answer (participant’s decision) 
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Where is the bed of the participant located? 
 
Are there any pigs living in or next to the house 
Yes 
No 
Unable to answer (participant’s decision) 
 
 
Record the GPS coordinates for the nearest pig pen/house 
 
Unable to answer (participant’s decision) 
 
 













Unable to answer (participant’s decision)  
 
Specify the other animals present and their number 
 
Is there a kitchen garden or garden next to the house? 
Yes 
No 
Unable to answer (participant’s decision) 
 
Are there any water storage containers outside the house?  




Unable to answer (participant’s decision) 
 
Describe the water containers and their number 
 
Are all of the water storage containers covered? 
Yes 
No 
Unable to answer (participant’s decision) 
 
Take a photo of the water storage containers 
 
Are there any bat droppings within a 10m radius of the house? 
Yes 
No 
Unable to answer (participant’s decision) 
 





Is there any evidence of rodent activity within a 10m radius of the house? 





Unable to answer (participant’s decision) 
 
 
Take a photo of the rodent activity 
 





Unable to answer (participant’s decision) 
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Take a photo of the weeds 
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APPENDIX 3.10  
	
The FTD multiplex PCRs were performed in accordance with the manufacturers’ 
guidelines  
1. The pathogen RNA was extracted.  
2. The RNA was transcribed into cDNA by reverse transcription (RT-PCR) using 
sequence-specific primers which bind to the RNA.  
3. The cDNA was amplified in a thermocycler using a programme as follows:  
50 ºC for 15 minutes hold; 94 ºC for 1 minute hold;  
40 cycles of 94 ºC for 8 seconds;  
60ºC for one minute. 
The viral and bacterial meningitis also required a 2-minute hold at 4ºC at the 
end of the process.  
4. If the specific pathogen sequences were present, these were seen as an increase 
in fluorescence from a probe.  
5. The number of cycles of PCR required to see the increase in fluorescence was 
reported as the cycle-threshold (Ct value). The lower the Ct value, the greater the 
amount of nucleic acid present. To validate the assay, the positive and internal 
controls were required to be above a Ct of 33 and the negative control, below the 
threshold.  
6. Brome mosaic virus (BMV) was used as the internal control for the viral meningitis 
PCR and Streptococcus equi (Sequi) as the extraction control (internal control) for the 
bacterial meningitis PCR and tropical fever core.  
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This information is taken from the following SOPs “FTlyo 28-32_64-MANUAL-v3-
2016_10 EN; FTlyo 13-32_64-MANUAL-v1-2017_02 EN and FTD 36-32_64-




























The in-house PCR for S. suis, measles virus, rubella virus and O. tsutsugamushi were 
tested using the generic Real Time-PCR TaqMan assay. Following RT-PCR, the 
cDNA is amplified using different cycles as shown below and the TaqMan probe emits 
fluorescence. The criteria for defining positive S. suis required a cut-off Ct value of 
<40; for and O. tsutugamushi ≤40; for rubella <38 and measles there was no defined 
cut-off. This information was taken from the following SOPs.  
“Realtime PCR for Detection of Streptococcus Suis Serotype 2, Streptococcus 
Pneumoniae, Neisseria Meningitidis, Haemophilus Influenzae Type b; OUCRU-VN; 
TP-TC-EVI-002; Version 02; Effective 7 April 2014” 
 “Measles realtime RTPCR; OUCRU-VN; HN-TP-TF-VI-009; Version 001; Effective 
12 November 2013” 
“Rubella Real-time PCR; OUCRU-VN; HN-TP-TF-VI-013; Version 001; Effective 12 
November 2016” 
“Orientia Tsutsugamushi 47kda Gene-Based Realtime PCR assay using Taqman 
probe; OUCRU-VN; TP-TC-ETR-006; Version 02; Effective 02/06/2014” 
 
S. suis Cycle 1 (1X): Pre-incubation 
95 ºC for 10 min 
Cycle 2 (40-45x): PCR amplification 
Step 1: 95 ºC for 10 seconds 
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Step 2: 58 or 60 ºC (60 ºC in case of VZV) for 30 
seconds  
Step 3: 72 ºC/10 sec, read  
Cycle 3: cool at 40 ºC/30 seconds  
 
Measles virus 1x 15 minutes at 95 ºC 
45x (30 seconds at 94 ºC, 30 seconds at 57ºC, 30 seconds at 
72 ºC with plate read). 
Rubella virus 1x 30 minutes at 50 ºC 
1 x 2 minutes at 90 ºC 
45x (15 seconds at 95 ºC, 30 seconds at 57ºC, 30 seconds at 
72 ºC with plate read). 
 
45x (30 seconds at 94 ºC, 1 minute at 60 ºC) 
Plate read for collecting fluorescence data FAM. 
O. tsutsugamushi * Hold at 50 ºC for 2 minutes 
* Hold at 95 ºC for 2 minutes 
* 45 cycles of the following conditions: 
95 ºC for 15 seconds 
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60 ºC for 30 seconds, acquiring with all channel at the 
end of each cycle 
* Start the run using the 47kDa O. tsutsugamushi template and 
fill the name of the samples in the computer table.  
 
Extraction for PCR used the MagNA pure 96 extraction machine (SOP “NA Extraction 
using MagNA Pure 96 DNA and Viral NA Small Volume Kit, OUCRU-VN; HN-TP-TF-





























The JE Detect MAC-ELISA test for exposure to Japanese Encephalitis Virus 
(JEV) is an ELISA assay system for the detection of IgM antibodies in human 
serum to JEV derived recombinant antigen (JERA).  This test is to aid in the 
diagnosis of recent human exposure to or infection with the Japanese 
Encephalitis Virus (JEV). It is not intended to screen blood or blood 




The JE Detect MAC-ELISA consists of one enzymatically amplified "two-step" 
sandwich type immunoassay. In this assay, NTC, PC, and unknown serum 
samples are diluted with Sample Dilution Buffer, then incubated in microtitration 
wells coated with anti-human IgM antibodies. This is followed by incubation 
with both JEV derived recombinant JERA and Normal Cell Antigen (NCA) 
separately. After incubation and washing, the wells are treated with a JERA-
specific antibody labeled with the enzyme horseradish peroxidase (HRP). After 
a third incubation and washing step, the wells are incubated with the 
tetramethylbenzidine (TMB) substrate. An acidic stopping solution is then 
added and the degree of enzymatic turnover of the substrate is determined by 
absorbance measurement at 450 nanometers. Above a certain threshold, the 
ratio of the absorbencies of the JERA and the control wells accurately 







3. Scope and responsibilities: 
 
Lab technician have responsibility for performing testing following this defined 
procedure 
4. Reference  
 






JEV: Japanese Encephalitis Virus 
JERA: JEV derived recombinant antigen 
NCA: normal cell antigen 
HRP: Horseradish Peroxidase 
mAb: monoclonal antibody 
TMB: tetramethylbenzidine 
NTC:  Negative Control  
PC: Positive control 
ISR: Immune Status Ratio 
 





As the manufacturers have not optimised the kit for testing of CSF, the Laos-
Oxford-Mahosot Wellcome Trust Research Unit (LOMWRU) Standard 
Operating Procedure “Guidelines for DENV diagnosis” will be used. 
CSF should be diluted to 1/10. 
 
7. Materials/Equipments used  




e Store condition 
1 
Anti-Human IgM Coated 
Microtiter Strips 12X8strips 2-8°C 
2 
Sample Dilution Buffer 
for JE Detect IgM 1 bottle of 25ml 2-8°C 
3 
Ready-to-use JE 
Antigen (JERA) for IgM 1 tube  of 3 ml 2-8°C 
4 
Ready-to-use normal 
cell antigen (NCA) for 
IgM 1 tube  of 3 ml 2-8°C 
5 
JE Detect Negative 
Control 1 vial of 30 μL 
Store at 2-8°C until ready to 
use for up to 7 days. For long-
term storage, serum can be 
further aliquoted in a smaller 
volume and stored at –70°C. 
6 
JE Detect IgM Positive 
Control 1 vial of 30 μL 
Store at 2-8 °C until ready to 
use for up to 7 days. For long-
term storage, serum can be 
further aliquoted in a smaller 
volume and stored at –70°C. 




7.2 Other materials and Equipments required 
 
1. 1-10 μL Single-Channel Pipetters, 50-200 μL Single and Multi-Channel 
Pipetters. 
2. ELISA Spectrophotometer capable of absorbance measurement at 450 
nm (ELx808-Biotek) 
3. Plate Washer and Vacuum Pump (in case of using Automated Plate 
Washer) 
4. 37°C Incubator 
5. Biological or High-Grade Water 
6. Polypropylene tubes (falcon) 










Ready to Use Enzyme 
Conjugate-HRP for IgM 1 bottle of 6ml 2-8°C 
9 EnWash 1 bottle of 20 ml 2-8°C 
10 Liquid TMB Substrate 1 bottle of 9 ml 
2-8°C, should be kept in a light 
-protected bottle 
at all times as provided 





Bring all kit reagents and specimens to room temperature (~25°C) 
before use. Thoroughly mix the reagents and samples before use by 
gentle inversion 
2 
Preparation of 1X Wash Buffer: Mix 120 ml 10X wash buffer with 
1080 ml distilled (or deionized) water and rinse out any crystals. 
Swirl until well mixed and all crystals are dissolved. After diluting to 
1X, store at room temperature for up to 4 months. Check for 
contamination prior to use. 
3 
Select the number of coated wells required for the assay. Positive, 
negative controls should be assayed in duplicate for both JERA and 
NCA portions of assay. Unknown serum samples can be assayed 
singly or in duplicate but must be assayed for both JERA and NCA 
portions of assay. Up to 44 or 22 test samples can be tested on one 
96 well plate depending on being assayed singly or in duplicate.  
Place remaining unused wells back quickly into the pouch and stored 
at 2-8°C. Mark the microtitration strips to be used. 
4 
Dilute NTC, PC,CAL and sera to 1/100.  
Using U-bottom plate:  To 10 μL serum add 90 μL of Sample Diluent. 
Take 20 μL of the diluted serum and add 180 μL Sample Diluent. Mix 
well. When using cluster tube: add to 5ul serum add 495 ul of 
Sample Diluent. Mix well. 
  
For CSF: Dilute CSF to 1/10. To 20ul of CSF add 180ul Sample 
Diluent. Mix well. 
5 
Apply the 50 μL/well of 1/100 diluted test sera, PC, NTC to the plate. 
An exemplary arrangement for 44 test serum samples singly is 
shown in 16.1. Cover the plate with parafilm. 
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6 
Incubate the plate at 37 °C for 1hour in an incubator as a single layer 
for even temperature distribution. Do not stack plates on top of each 
other and not use CO2 or other gases. 
7 
After the incubation, wash the plate 6 times with automatic plate 
washer or manually using 1x Wash buffer following the washing 
procedure in 16.2 
8 
Add 50μl /well of JERA into row A-D and 50μl /well of NCA into row 
E-H. An exemplary application for JERA and NCA is shown in 16.3. 
9 Cover the plate with parafilm 
 
10 Incubate the plate at 37 °C for 1 hour in the incubator 
11 After the incubation, wash the plate 6 times  
12 Add 50μl /well of ready to use Enzyme-HRP conjugate 
into all wells by multi-channel pipetter. 
13 Cover the plate with parafilm 
14 Incubate the plate at 37 °C for 1 hour in the incubator in darkness. 
15 After the incubation, wash the plate 6 times  
16 Add 150μl /well of EnWash into all wells  
17 Incubate the plate at room temperature for 5 minutes without any cover 
on the plate. 
18 After the incubation, wash the plate 6 times  
19 Add 75μl /well of Liquid TMB substrate into all wells 
20 Incubate the plate at room temperature in a dark place (or container) 
for 10 minutes without any cover on the plate. 
21 After the incubation, add 50μl /well of Stop solution into all wells  
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22 Within 5 minutes, read the RAW OD 450 value with a Microplate reader 
(ELx808-Biotek). 
 
Step by step of testing instruction. 
 
9. Quality Control 
 
Each kit contains positive and negative control sera. Acceptable Immune 
Status Ratio (ISR) values for these controls are found on specification table 
below. The test is invalid and must be repeated if the ISR value of either the 
controls do not meet the specifications. If the test is invalid, patient results 
cannot be reported.  
 
10. Calculations 
Calculation of the Negative 
Control 
Calculate the mean JE Detect Negative 
Control values with JERA and with the 
Control antigen, then calculate the ISR. 
 
















ISR=      JERA/NCA ratio: 
0.190/0.127=1.50 
 
Calculation of the Positive 
Control 
Calculate the mean JE Detect Positive 
Control values with JERA and with the 
Control antigen, then calculate the ISR. 
 
Obtain following Factors and 
compare to the criteria in 
specific sheet for an indication 
of deterioration of reagents or 
an error in the test procedure 
and the assay must be 
repeated 
Factors include: 
1.Mean JE Detect Negative Control OD in 
JERA 
2.Mean JE Detect IgM Positive Control 
OD in JERA 
3.JE Detect IgM Positive Control Immune 
Status Ratio (ISR) 
4.JE Detect Negative Control Immune 
Status Ratio (ISR) 
Calculation for unknown 
samples analysis 
Calculate the average JERA and NCA 
OD450 of sera, for test samples run in 
singlet, obtain the individual JERA and 
NCA values 




11. Interpretation of results and report 
 
ISR Results Interpretation 
<4.0 Negative No detectable IgM antibody by the ELISA test 
4-6 Equivocal Need confirmatory test 
>6 Positive 
Indicates presence of detectable IgM antibody. 
Recommend supplemental confirmatory testing 
 
 
If a sample is positive for JEV and DENV using both InBios JEV IgM ELISA 
and Panbio dengue IgM capture ELISA, both pathogens should be re-tested 
using eight twofold dilutions (1/20 to 1/2560). The last positive dilution gives the 
titre for the corresponding test. The actual IgM corresponds to the kit that gives 
the highest titre. 
 
 
12. Reporting of results 
Describe the reporting units  
 
13. Reference range and critical value:  
Describe the reference range for the test and the critical value for the rest 
 
14. Limitations: 
1. Since this is an indirect screening method, the presence of false positive 
and negative results must be considered. 
2.  All reactive samples must be evaluated by a confirmatory test. 
3. The reagents supplied in this kit are optimized to measure JERA reactive 
antibody levels in serum 
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4. Serological cross-reactivity across the flavivirus group is common. 
Certain sera from patients infected with Dengue, West Nile, and Saint 
Louis virus may give false positive results. Therefore any JE positive 
sera must be confirmed with other tests. 
5. The assay performance characteristics have not been established for 
visual result determination. 
6. Results from immunosuppressed patients must be interpreted with 
caution. 
7. Assay results should be interpreted only in the context of other laboratory 




1. All human controls and antigen should be handled as potentially infectious 
material at BSL2.  
State safety issue related testing procedure.  
2. Wear protective clothing, eye protection and disposable gloves while 
performing the assay. Wash hands thoroughly afterwards. 
 3. MSDS of entire kit can be found here: Z:\Group 
Folders\Laboratory\Chemical classification\MSDS\Inbios\SDS 4009-01 










16. Supplementary notes 
16.1 Example for Serum Sample Application. 
 
 
16.2 Washing procedure 
A. Automated Plate Washer 
(1) Completely aspirate all wells. 
(2) Fill all wells to rim (300 μL) during wash cycle. 
(3) On completion of six (6) washes, invert plate and tap firmly on 
absorbent paper towel to ensure all Wash Buffer is removed. 
(4) Automated plate washers must be well maintained to ensure 
































Control S#1 S#3 S#5 S#7 S#9 S#11 S#13 S#15 S#17 S#19 S#21 
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efficient washing. Manufacturer’s cleaning instructions should be 
followed at all times. 
B. Manual Washing 
(1) Discard contents of plate in appropriate waste container. 
(2) Fill wells with Wash Buffer using a suitable squeeze bottle. Avoid 
bubbling of Wash Buffer as this may reduce wash efficiency. 
Discard Wash Buffer from wells immediately. 
(3) Refill wells with Wash Buffer and discard immediately. 
(4) Repeat (3) another four times. This will make a total of six (6) 
washes with Wash Buffer. 
(5) After the final wash, discard contents of wells and tap the plate 
on absorbent paper towel to ensure all Wash Buffer is removed. 
 











  1 2 3 4 5 6 7 8 9 10 11 12 
A JERA JERA JERA JERA JERA JERA JERA JERA JERA JERA JERA JERA 
B JERA JERA JERA JERA JERA JERA JERA JERA JERA JERA JERA JERA 
C JERA JERA JERA JERA JERA JERA JERA JERA JERA JERA JERA JERA 
D JERA JERA JERA JERA JERA JERA JERA JERA JERA JERA JERA JERA 
E NCA NCA NCA NCA NCA NCA NCA NCA NCA NCA NCA NCA 
F NCA NCA NCA NCA NCA NCA NCA NCA NCA NCA NCA NCA 
G NCA NCA NCA NCA NCA NCA NCA NCA NCA NCA NCA NCA 
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17. Risk assessment and risk management: 
Describe the risk associated with the test and mitigation plan  
 
The list of subheading is not exhaustive, additional sub heading can be added as 
required for different technical SOPs and some subheadings can be deleted as 
necessary.  
 
18. Related Documents: 
 
Document name Document code 
Panbio Dengue IgM Capture ELISA HN-TP-TF-IM-010          Version 001 
LOMWRU SOP Guidelines for Dengue 
diagnosis 
SER 020-01 
Package insert of Panbio Dengue IgM Capture 
ELISA. 
No. 01PE20/01PE21 
Package insert of JE Detect IgM Antibody 
capture ELISA. Brand InBios 
No : JEMS-1 
Safety data sheet (SDS) of JE Detect™ IgM 
Antibody Capture Elisa kit 
SDS 4009-01 
 






Details of amendment 
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The Panbio Dengue IgM Capture ELISA is for the qualitative detection of IgM 
antibodies to dengue virus antigen in serum, as an aid in the clinical 
laboratory diagnosis of patients with clinical symptoms consistent with dengue 
fever. The kit should be used in conjunction with other dengue serology. 
 
2. Principle: 
Serum antibodies of the IgM class, when present, combine with anti-human 
IgM antibodies attached to the polystyrene surface of the microwell test strips. 
A concentrated pool of Dengue virus 1-4 Antigens is diluted to the correct 
working volume with Antigen Diluent. The antigens are produced using an 
insect cell expression system and immunopurified utilising a specific 
monoclonal antibody. An equal volume of the HRP Conjugated Monoclonal 
Antibody (MAb) is added to the diluted antigen, which allows the formation of 
antigen-MAb complexes. Residual serum is removed from the assay plate by 
washing, and complexed antigen-MAb is added to the assay plate. After 
incubation, the microwells are washed and a colourless substrate system, 
tetramethylbenzidine / hydrogen peroxide (TMB Chromogen) is added. The 
substrate is hydrolysed by the enzyme and the chromogen changes to a blue 
colour. After stopping the reaction with acid, the TMB becomes yellow. Colour 
development is indicative of the presence of anti-dengue IgM antibodies in 







3. Scope and responsibilities: 




Package insert of Panbio Dengue IgM Capture ELISA.Cat. No. 
01PE20/01PE21  
 
Guideline for DENV diagnosis- LOMWRU Standard Operating Procedure. 
Document No: SER 020-01. Created by Audrey Dubot-Peres. Date of original: 




HRP: Horseradish Peroxidase 
MAb: Monoclonal Antibody 
TMB: tetramethylbenzidine 
CSF: Cerebrospinal fluid 
NTC:  Negative Control  
PC: Positive control 
CAL: Calibrator 
 





(*):Icteric or lipaemic sera, or sera exhibiting haemolysis or microbial 
growth should not be used. 
(**): The package insert states “This test should be performed on serum only. 
The use of whole blood, plasma or other specimen matrix has not been 
established”. We will use the Laos-Oxford-Mahosot Wellcome Trust Research 
Unit (LOMWRU) Standard Operating Procedure “Guidelines for DENV 
diagnosis” in which CSF is diluted to 1/10. 
 
6. Materials/Equipments used  






1 Anti-human IgM Coated Microwells  12x8wells 
2 Dengue virus 1-4 Antigens (Recombinant) 1 vial of 150 ul 
3 Wash Buffer (20x) 1 bottle of 60 mL  
4 Sample Diluent  
2 bottles of 50 
mL 
5 Antigen Diluent 1 bottle of 50 mL  
6 
HRP Conjugated Monoclonal Antibody 
Tracer 1 bottle of 7 mL  
7 TMB Chromogen (TMB) 1 bottle of 15 mL 
8 Positive Control 1 vial of 200 ul 
9 Calibrator  1 vial of 400 ul 
10 Negative Control 1 vial of 200 ul 
11 Stop Solution 1 bottle of 15 mL 
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6.2 Additional materials and Equipment 
 
1. Pipette and pipette tips of 5-1000 μl 
2. Deionised water 
3. ELISA reader (ELx808-Biotek) 
4. Timer 
5. Microplate to dilute serum (U-bottom plate, Cat: 3797, Brand: Corning) or 
Cluster tube to dilute serum (Cat: 4418, Brand: Corning). 




1 Equilibrate all reagents to room temperature (20-25 °C) 
2 
Remove the required number of microwells from the foil 
sachet and insert into strip holder. Five microwells are 
required for NTC, PC and CAL in triplicate. Seal unused 
microwells in the foil sachet tightly. 
3 
Dilute NTC, PC, CAL and sera to 1/100.  
Using U-bottom plate:  To 10 μL serum add 90 μL of Sample 
Diluent. Take 20 μL of the diluted serum and add 180 μL 
Sample Diluent. Mix well. When using cluster tube: add to 
5ul serum add 495 ul of Sample Diluent. Mix well.  
For CSF: Dilute CSF to 1/10. Example: To 20ul of CSF add 
180ul Sample Diluent. Mix well. 
4 
Determine the required number of wells for the assay. Dilute 
the antigen 1/250 using the Antigen Diluent and the mixed 
solution will become a pale blue colour (recommended a 
minimum of 10 μL of antigen into 2.5 mL of Antigen Diluent 
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and this is sufficient for up to five strips (40 wells).  The 
remaining unused concentrated antigen is stored back at 2-
8ºC. 
5 
Remove the required volume of diluted antigen and mix with 
an equal volume of MAb Tracer in a clean 15ml falcon tube. 
Gently mix the antigen-MAb Tracer solution and leave at 
room temperature (20-25 ºC) until required. Discard the 
unused diluted antigen. 
6 
Within 10 minutes after mixing the MAb Tracer and diluted 
antigen, pipette 100 μL diluted sera, CSF and Controls into 
their respective microwells of the assay plate 
7 Cover plate and incubate for 1 hour at 37 ºC ±1 ºC. 
8 
Wash six (6) times with diluted Wash Buffer manually or 
using automated plate washer as in washing procedure in 
15.1. 
9 
Mix the antigen-MAb tracer solution before transfer. Pipette 
100 μL of antigen-MAb complexes from the antigen vial to 
the appropriate wells of the assay plate 
10 Cover plate and incubate for 1 hour at 37 ºC ±1 ºC. 
11 
Wash six (6) times with diluted Wash Buffer manually or 
using automated plate washer as in washing procedure in 
15.1. 
12 Pipette 100 μL TMB into each well 
13 
Incubate for 10 minutes at room temperature (20-25 ºC), 
timing from the first addition. A blue colour will develop. 
14 
Pipette 100 μL of Stop Solution into all wells in the same 
sequence and timing as the TMB addition. Mix well. The 
blue colour will change to yellow. 
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15 
Within 30 minutes read the absorbance of each well at a 
wavelength of 450 nm with a reference filter of 600-650 nm 
 
8. Quality Control 
 
Each kit contains Calibrator, Positive and Negative Controls. Acceptable 
values for these are found on the accompanying specification sheet. The 
Negative and Positive Controls are intended to monitor for substantial reagent 
failure.  
The test is invalid and should be repeated if the absorbance readings of either 
the Controls or the Calibrator do not meet the specifications. If the test is 




Obtain the calibration factor value in the specification sheet before 
commencing calculations. 
 
Step   
1 Calculate Cutoff 
Value 
Cut-off Value = [(Absorbance of the 
triplicates of the Calibrator)/3] x (Calibration 
factor) 
2 Calculate index 
value 
Index Value = Sample Absorbance/ Cut-off 
Value 
3 Calculate Panbio 
Units. 




10. Interpretation of results and report 
 
INDEX Panbio Units Result 
<0.9 <9 Negative 
0.9-1.1 9-11 Equivocal 
>1.1 >11 Positive 






No detectable IgM antibody. The result does not rule out 
dengue virus infection. An additional sample should be tested 
in 7-14 days if early infection is suspected. Other dengue 
assays should be performed to rule out acute infection. 
Equivocal  
Equivocal samples should be repeated. Samples that remain 
equivocal after repeat testing should be repeated by an 
alternative method or another sample should be collected. 
Positive 
Presence of detectable IgM antibody. Other dengue serology 
assays should be performed to confirm dengue infection.  
If differentiation between primary and secondary infection is 






11. Reporting of results 
 
Reporting unit is Panbio Unit. 
 
If a sample is positive for JEV and DENV using both InBios JEV IgM ELISA 
and Panbio dengue IgM capture ELISA, both pathogens should be re-tested 
using eight twofold dilutions (from 1/20 to 1/2560). The last positive dilution 
gives the titre for the corresponding test. The actual IgM corresponds to the kit 
that gives the highest titre. 




1. The clinical diagnosis must be interpreted with clinical signs and 
symptoms of the patient. The results from this kit are not by themselves 
diagnostic and should be considered in association with other clinical 
data and patient symptoms. 
 
2. Serological cross-reactivity across the flavivirus group is common (i.e. 
between dengue 1, 2, 3 & 4, Murray Valley encephalitis, Japanese 
encephalitis, Yellow fever and West Nile viruses). These diseases must be 
excluded before confirmation of diagnosis.  
 
3. Heterophilic antibodies are a well-recognised cause of interference in 
immunoassays. These antibodies to animal IgG may cross-react with 
reagent antibodies and generate a false positive signal. This must be 
excluded before confirmation of diagnosis.  
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4. The performance characteristics have not been established for visual 
result determination. 
 
5. This assay employs insect expressed proteins. The cross-reactivity or 




1.  All human controls and antigen should be handled as potentially 
infectious material at BSL2 
 
2. Hazard information for the components under applicable European 
Community (EC) Directives is as per the table below.  





Components Hazard Nature 
Wash buffer 20x Concentrate  
Irritant R36/38, 
R43 
TMB Chromogen (ready for use) Irritant R36/37/38 








Dengue 1-4 Antigen 
Irritant R36/38, 
R43 
Dengue IgM Capture MAb Tracer HRP 
Irritant R36/38, 
R43 
Anti-Human IgM Antibody Coated Microwells 
Not Considered 
Hazardous 
Dengue IgM Capture Positive Control 
Harmful R22, 
R32, R43 
Dengue IgM Capture Calibrator 
Harmful R22, 
R32, R43 




15. Supplementary notes 
15.1Washing procedure 
A. Automated Plate Washer 
(1) Completely aspirate all wells. 
(2) Fill all wells to rim (350 μL) during wash cycle. 
(3) On completion of six (6) washes, invert plate and tap firmly on 
absorbent paper towel to ensure all Wash Buffer is removed. 
(4) Automated plate washers must be well maintained to ensure 
efficient washing. Manufacturer’s cleaning instructions should be 
followed at all times. 
B. Manual Washing 
(1) Discard contents of plate in appropriate waste container. 
(2) Fill wells with Wash Buffer using a suitable squeeze bottle. Avoid 
bubbling of Wash Buffer as this may reduce wash efficiency. 
Discard Wash Buffer from wells immediately. 
(3) Refill wells with Wash Buffer and discard immediately. 
(4) Repeat (3) another four times. This will make a total of six (6) 
washes with Wash Buffer. 
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(5) After the final wash, discard contents of wells and tap the plate on 
absorbent paper towel to ensure all Wash Buffer is removed. 
 
16. Risk assessment and risk management: 
 
Some kit components (PC, NTC, CAL) contain sodium azide, which may 
react with lead or copper plumbing to form highly explosive metal azide 
compounds. When disposing of these reagents through plumbing fixtures, 
flush with a large volume of water to prevent azide build-up in drains. 
 
 
17. Related Documents: 
 
Document name Document code 
Package insert of Panbio Dengue IgM Capture 
ELISA. Brand PanBio. 
 
No. 01PE20/01PE21 
Package insert of JE Detect IgM Antibody 
capture ELISA. Brand InBios 
No : JEMS-1 
JE Detect IgM Antibody capture ELISA HN-TP-TF-IM-011             
version 001 
LOMWRU SOP Guidelines for Dengue 
diagnosis 
SER 020-01 
MSDS sheet for entire Panbio Dengue IgM 
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GROUP DISCUSSION FOR STUDY STAFF (HOSPITAL) 
How did you find the recruitment of cases? 
 
Were there any problems with the recruitment of cases? 
 
If yes, what were these? 
 
How did you find recruitment of controls? 
 
Were there any problems with the recruitment of controls? 
 
If yes, what were there? 
 
How did you find the completion of the CRF? 
 
Did you find any problems with it? 
 
What were the reasons for unsuccessful recruitment of cases? 
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APPENDIX 3.15 
13HN FeedbackField EN V2.0 15MAR16 
 
To be completed for each participant recruited. Please return to CTU, OUCRU 
at the end of every two weeks 
 
1. Participant code   13HN-[__|__]-[__|__|__|__] 
 
2. Date you made contact with the participant by phone   
(dd/mm/yyyy) : __/__/____ 
 
Not applicable as not able to contact the participant      
 
3. Date home visited (dd/mm/yyyy) : __/__/____ 
 
4. Were any of the following problems encountered during the house visit?  
 
House difficult to find 
Participant not at home on arrival        If yes, go to 4a 
Participant/relative did not allow you to enter the house       If yes, go to 4a 
Other (specify)_____________________ 
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4a) When were you next able to return to the house  
[__|__] hours 
[__|__] days 
Not applicable as unable to return to the house 

 
5. How long did it take you to travel to the home of the participant 
[__|__] minutes   
[__|__] hours 
 
6. Did you have to obtain consent from the participant? 
   Yes    No                 
 
7. How long did the questionnaire take to complete? 
 





8. Were there any problems with the ODK system? 
Yes     If yes, go to 8a 
No                   
 
8a) Please specify what these problems were 
 
9. Were there any problems with the Samsung Android? 
 
Yes     If yes, go to 9a 














GROUP DISCUSSION FOR STUDY STAFF (FIELD) 
 
How did you find the travel to the homes of the participants in terms of time 
taken and road conditions? 
If there were any problems, what were these? 
 
 




How easy was it to contact participants to arrange a time to visit their 
homes? 
If there were any problems what were these? 
 
 
Were most participants at home during the time you arranged? 
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How did participants find the questionnaire? 
 
How easy was it for you to perform the questionnaire? Were there any 
problems (including with the mobile technology and question structures)?  
 
 
How did you find recruitment of controls? 
 




How did participants feel about you looking around their houses and taking 
photos? 
 












Rural men Urban women 
House/household 11 5 12 
Lake(s) 7   2 
Water 6 3 6 
Tyres 5     
Chicken(s) 4   3 
Plant(s) 4   1 
Pig(s)/pigsty 3   5 
Standing 3     
Banana 2     
Birds 2     
Garden 2 2 3 
Rubber 2     
Spray 2   1 
Swimming 2     
Trees 4     
Cattle 1   5 
Stools 1   2 
Vegetable(s) 2   5 
Work/workshop 4     
Drainage   3 1 
Tank   3   
Countryside   2   
Pond(s)   2 4 
Rice   2   
Morning 6     
Afternoon 5 2 1 









Rural men Urban women 
Spray(s) 6 3 5 
Season  3   
House/home 2  4 
Net 8 5 10 
Bednet  5  
Cream 2 2 3 
Tank 8   
Water 8   
Bed 6  10 
Children 4   
Family 4 3 1 
Evening 3  1 
Treated 3 2  
Chemical 2  1 
Door/s 4 3 3 
Dung 2   
Racket 1 1 4 
Machine   3 
Electric 1 1 2 





Rural men Urban women 
Disease(s) 4 1  





Rural men Urban women 
Dengue 8 1 6 
Japanese encephalitis 1   
Malaria  8 2 








Rural men Urban women 
December 2   
June 2 1  
October 2   





Rural men Urban women 
Dog 7 2 6 
Chicken 3 6 3 
Mouse/mice 2 10 6 
Goats  4  
Cat(s) 10 3 6 
Cattle  3 2 
Slaughtering  5  
Poultry  2 1 





Rural men Urban women 
Pork/pig 27 7 7 
Blood 10  2 
Chicken 8 1 6 
Pudding 8  2 
Beef 7 2 8 
Fish 9 3 9 
Mice 5 1  
Duck 3   
Hedgehog 2   
Horse 2   
Rat 2   
Goat  7  
Cat  1  
Dog  1  








Rural men Urban women 
Poor 6   
Good 4  3 
Ugly 4   
Clean 3   
Dust 3   
Laugh 3   
Mountainous 3   
City 2   
Hygiene 2   
Uncomfortable 2   
Problem  2  


















Information from the CRF of the cases, the potential numbers of controls 
available matched on different criteria and information from the questionnaire 
conducted during the home visit of the cases and the controls. 
	
Table A3.1 The number and percentage of cases living in each province.  
	
 Total (N=38) 
Province  
Bac Ninh 2 (5.3%) 
Ha Nam 3 (7.9%) 
Hai Duong 4 (10.5%) 
Hai Phong 2 (5.3%) 
Hanoi 10 (26.3%) 
Hung Yen 1 (2.6%) 
Nam Dinh 5 (13.2%) 
Ninh Binh 6 (15.8%) 
Thai Binh 5 (13.2%) 
Van Phuc 0 
 
	
Table A3.2 The neurological inclusion criteria.  
	
	 Total (N=38)	
Change in consciousness level 38 (100%) 
Seizures  10 (26.3%) 
Limb paresis 2 (5.3%) 
Facial paresis 1 (2.6%) 
Speech abnormality 1 (2.6%) 
Hearing abnormality 2 (5.3%) 






Table A3.3 The age and sex of the cases.  
 
 Total  
(N=38) 
Age (years) (median (range)) 60  
(9 - 85, N=29) 
Sex  
   Female 11 (28.9%) 




Table A3.4 Markers and proxy markers of progression of symptoms and severity of 
illness of the cases. 
 Total (N=38) 
Time between first symptoms and first 
seeking medical care (days) (median 
(range)) 
2  
(0 - 7)* 
Ward admitted to  
   ICU 9 (23.7%) 
   Non-ICU ward 29 (76.3%) 
Intubated on admission to NHTD  
   Yes 11 (28.9%) 
   No 27 (71.1%) 
 
* N=3 
Table A3.5 The GCS on admission of the cases. 
 
 To initial hospital To NHTD 
Eyes (median 
(range)) 
4 (2 - 4, N=7) 3 (2 - 4, N=14) 
Verbal (median 
(range)) 
3 (2 - 4, N=7) 3 (1 - 5, N=14) 
Motor (median 
(range) 
4 (4 - 6, N=7) 5 (3 - 6, N=14) 
Total (median 
(range)) 




Table A3.6 The medication taken by the cases prior to admission. 
 Total  
(N=38) 
  
Aciclovir 1 (2.6%) 
Ampicillin 5 (13.2%) 
Ceftriaxone 10 (26.3%) 
Colistin 1 (2.6%) 
Levofloxacin 0 
Linezolid 1 (2.6%) 
Meropenem 2 (5.3%) 
Vancomycin 1 (2.6%) 




Table A3.7 The location of the first lumbar puncture (LP). 
 
 Total  
(N=38) 
Location of first lumbar puncture  
   NHTD 18 (48.6%) 












Table A3.8 The CSF results of first LP. 
 Total 
(N=38) 
White cell count  
(cells/μl) (median (range)) 
310 
(3 - 15634, N=30) 
Neutrophils (%) (median (range)) 70 
(2 - 97) 
Lymphocytes (%) (median (range)) 10 
(1 - 96) 
Eosinophils (%) (median (range)) 6  
(2 -18) 
Neutrophil to lymphocyte ratio (median (range)) 9 
(0 - 89) 
CSF protein (g/L) (median (range)) 1.7 (0.2, 7.3) 
 
 




Length of hospital stay (from initial hospital to 
discharge at NHTD) (days) (median (range)) 
21 
(2 - 64, N=31) 
Outcome  
   Discharge to home 20 (52.6%) 
   Discharged to die 3 (7.9%) 
   Transferred to another hospital 15 (39.5%) 
 
 
Table A3.10 The Glasgow Outcome Scale at discharge of the adult cases. 
 
 Total  
(N=12) 
Time between discharge from NHTD and follow-
up (days) 
 
   Median (Range) 27.0 (4.0-144.0) 
Final score  
   Lower severe disability 5 (41.7%) 
	 522 
   Upper severe disability 4 (33.3%) 
   Lower moderate disability 0 (0.0%) 
   Lower good recovery 2 (16.7%) 
   Upper good recovery 1 (8.3%) 
 
 
Table A3.11 The Glasgow outcome score at three months after discharge of the adult 
cases. 
	 Total  
(N=13)	
Time between discharge from NHTD and follow-up 
(days) 
 
   Median (Range) 108.0 (35.0 - 258.0) 
Final score  
   Lower severe disability 4 (30.8%) 
   Upper severe disability 3 (23.1%) 
   Lower moderate disability 3 (23.1%) 
   Lower good recovery 3 (23.1%) 
































Ratio of potential 
controls to number 
required based on 
province and 
gender/number 
Ratio of potential 
controls to number 
required based on 
province, gender, 
age/number 
Ratio of potential 
controls to number 
required based on 
province, gender, 
age/number and 
living with the 
patient 
  Male  Female     
Bac Ninh 0.44 1.33 0.33 0.17 
Ha Nam 0.42 NA 0 0 
Ha Noi 2 10 1.78 1.72 
Hai Duong 0.25 NA 0.33 0.25 
Hai Phong 1.67 2.33 0.33 0.17 
Hung Yen 1.67 5.67 0 0 
Nam Dinh 0.28 1.5 0.13 0.13 
Ninh Binh 0.33 1.33 0.33 0.17 
Thai Binh 0.33 0.44 0.25 0.25 
Vinh Phuc NA NA NA NA 
	 524 


















Variable Cases (n=27) Controls (n=6) Odds ratio (95% confidence interval)  p value 














































Monthly household income (%) 
<5 million VND 
5-10 million VND 
10-20 million VND 






































































Table A3.14 A comparison of cases with controls by mosquito prevention measures and animal contact. 
Variable Cases (n=27) Controls (n=6) Odds ratio (95% confidence 
interval) 
p value 
Use of mosquito prevention measures 
Simple bed net 
Yes 
No 
Insecticide treated bed net (ITN) 
Yes 
No 
Mosquito coils or liquid 
Yes 
No 






















































Slept under a bed net in the month prior to 
becoming unwell (cases) 

































Indoor residual spraying of the house had 






















Table A3.15 A comparison of the cases with controls by animal contact. 
Variable Cases (n=27) Controls (n=6) Odds ratio (95% confidence interval) p value 
Pig contact in the month prior to becoming unwell (cases)/last 


















Saw rats around the house/place of work in the month prior to 

















Saw bats around the house/place of work in the month prior to 







22 (81.5%)  
















Had close contact with a sick animal in the month prior to 






2 (7.4%)  
24 (88.9%)  
















Slaughtered an animal in the month before becoming unwell 





4 (14.8%)  
23 (85.2%)  
 
 
1 (16.7%)  







Ate or prepared raw meat, viscera or blood in the month before 





18 (66.7%)  
9 (33.3%)  
 
 
3 (50%)  












Table A3.16 A comparison of the cases with controls by environmental exposures and travel. 
Variable Cases (n=27) Controls (n=6) Odds ratio (95% confidence 
interval) 
p value 













Walked through grassland in the month before 

















Flooding in the area in the month before becoming 
























Swum/washed/walked through or carried out any 
other activity in any river/stream/lake in the month 


























Travelled outside of the province in the month before 






















Table A3.17 A comparison of the cases with controls by vaccinations received. 





































8 (29.6%)  
 
 
3 (11.1%)  
18 (66.7%)  
















5 (83.3%)  
 
 
1 (16.7%)  
1 (16.7%)  














































13HNA FGD V2.0 04AUG16 
	
13HNA: Evaluation of the daily activities and contact patterns of healthy adults and 
children in selected rural and urban settings in Ha Nam province, Viet Nam to 
explore potential risk factors for acute encephalitis syndrome 
 
Focus Group Discussion 
 
1. What do you know about GPS devices? 
 
Participants will then be given an introduction to the iGotU GPS device to be used 
for the study including the purpose of the research, how the device works, an 
example of the data collected from the device and a description of the contact 
pattern diary.  
 
2. How would you feel if we asked you to wear one of the GPS devices we will 
use for the study? 
What would your concerns be?  
 
If there is poor discussion generated surrounding this question, the following 
questions will be used as prompts: 
	 530 
2a) Would you be concerned about how to work the device? Why? 
2b) Would you be concerned about losing or breaking the device?  
2c) Would you be concerned about your privacy e.g. what is recorded from the 
device and people from the research team knowing about your activities? 
 
3. How would you feel about a research assistant asking you questions about 
















APPENDIX 4.2  
 
13HNA ICF FGD V2.0 04AUG16 
	
13HNA: Evaluation of daily activities to understand how these relate to encephalitis 
(brain inflammation) 
INFORMED CONSENT -  FOCUS GROUP DISCUSSION 
 
We are conducting a study looking at behavior in relation to risk factors for acute 
encephalitis syndrome, an inflammation of the brain. However, before we perform this 
study we would like to talk about some aspects of it with yourselves as part of a group 
discussion.  Please read this information sheet carefully or have someone read it to 
you. Please ask the study staff to explain any information that you are not sure about. 
It is your choice whether to participate in the study and please do not feel obliged do 
so.  If you would like to take part you will be asked to sign or place a thumbprint on 
the last page. You will be given a copy of this form for your personal records. 
 
Why is this study being done?  
Acute Encephalitis Syndrome (AES) is a syndrome of brain inflammation or swelling. 
Patients may die or be left disabled. There are around two thousand cases of AES in 
Viet Nam every year. Although Japanese encephalitis, a virus spread by mosquitoes 
is a common cause of AES in children and Streptococcus suis, a bacteria associated 
with eating or preparing raw pork meat is a common cause in adults, for half of the 
patients or more, we do not know the cause of their AES. However, we do know that 
most of the cases occur during the warmer seasons and therefore we think that 
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mosquitoes or other insects are spreading diseases, which cause AES in northern 
Viet Nam.  
This study therefore aims to look at the reasons why people might or might not get 
AES including where the person lives and their risks in and around their home and 
work environment and their contact with animals. To collect this information, part of 
this study therefore involves attaching global positioning system (GPS) devices to 
people to look at their movements throughout the day and to ask people to complete 
a diary about their contact with people and animals, where they went and food they 
ate. 
  
Who is doing this study?  
This study is being performed by a team from: 
The Oxford University Clinical Research Unit in Ha Noi 
The University of Liverpool, United Kingdom 
The Wellcome Trust Liverpool Glasgow Centre for Global Health Research, United 
Kingdom 
The National Institute of Hygiene and Epidemiology, Ha Noi 
 
What will happen to me in this study and what are the risks?   
You have been chosen to take part because we want to get information from members 
of the community about your views on wearing the GPS and completing a diary. You 
will be asked to take part in a group discussion with seven other members of the same 




What will happen to the samples / information taken? 
The results of the study will be used to design a questionnaire for a larger study. The 
results will also be written as a report or thesis for the University of Liverpool and will 
be published in a journal, which will be made available to the public. The results will 
also be available in Vietnamese through the OUCRU website and the National 
Institute of Hygiene and Epidemiology website. The results will also be available for 
the Ministry of Health in Viet Nam. You will not be able to be identified in these results 
as you will have a unique code and only your code will appear in the study data, 
results, and publications/reports. 
The results will be also be made available to the public through workshops about AES 
in the community or schools and possibly via the radio or other forms of media. 
 
What is the benefit of participating?   
There is no intended personal benefit to taking part however, the benefit will be to the 
community and people of Viet Nam by helping us to understand the risks associated 
with AES. 
You will be reimbursed 100,000 VND for your time spent and you will be offered light 
refreshments. 
 
What happens if I decline participation or change my mind later on? 
You have the right to decline participation or withdraw from the study at any time. 
Please let us know if you wish to do so. You do not need to give an explanation for 
this. You can request for your results to be destroyed at any time. There will be no 




All conversations will be recorded using a microphone device and later translated by 
the research assistant and kept on a secure database. Information about you will be 
kept confidential and only shared amongst study team members. You will be given an 
anonymous code, which will be used for the answers. Details linking yourself to this 
code will be kept in a separate place. All consent forms and recordings will be kept in a 
locked room. Only those who are involved with the study will have access to these 
documents which will be kept for 3 years and then put on an electronic system. The 
consent forms will be kept in a locked cupboard. 
 
Whom do I contact if I have questions or complaints? 
If you have questions about the study you may contact: To be decided 
If you have questions about being in a research study, please contact the Research 
Ethics Board of the NHTD at (phone number) the Clinical Trials Unit at (phone 
number). 
Thank you for reading this and thinking about joining this project.  Please ask 
the study staff if you have any questions.  If you agree to be in the study please 
sign below (one page per person). 
O I have read this information sheet or it has been read to me and I understand 
it. 
O I have been able to ask questions about the study. 
O I understand that my participation in the study is voluntary and I do not have 
to answer questions if I do not wish to do so 
O I understand that my information will be recorded using a microphone device. 
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O I understand that I can ask for access to the information I provide or have this 
information destroyed if I wish. 
O I agree for the data collected from me to be used in future research 
publications and presentations without my name. 
O I understand that I have the right to withdraw from the study at any time. 
O I agree to take part in the above study. 
 
Participant ID: 13HN-[__|__]-[__|__|__]      
Name of participant (Please Print): ________________________ 













Full Name Date of 
Signature 
 
I, the undersigned, have fully explained the relevant information of this program to the 
person named above and will provide her/him with a copy of this signed and dated 
















If the person giving consent cannot read the form themselves, a witness must be 
present and sign here: 
I was present throughout the entire informed consent process with the participant.  
This form was read accurately to the volunteer, all questions from the volunteer 
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13HNA: Evaluation of daily activities to understand how these relate to encephalitis 
(brain inflammation) 
INFORMED CONSENT -  FOCUS GROUP DISCUSSION 
 
We are conducting a study looking at behavior in relation to risk factors for acute 
encephalitis syndrome, an inflammation of the brain. However, before we perform this 
study we would like to talk about some aspects of it with yourselves as part of a group 
discussion.  Please read this information sheet carefully or have someone read it to 
you. Please ask the study staff to explain any information that you are not sure about. 
It is your choice whether to participate in the study and please do not feel obliged do 
so.  If you would like to take part you will be asked to sign or place a thumbprint on 
the last page. You will be given a copy of this form for your personal records. 
 
Why is this study being done?  
Acute Encephalitis Syndrome (AES) is a syndrome of brain inflammation or swelling. 
Patients may die or be left disabled. There are around two thousand cases of AES in 
Viet Nam every year. Although Japanese encephalitis, a virus spread by mosquitoes 
is a common cause of AES in children and Streptococcus suis, a bacteria associated 
with eating or preparing raw pork meat is a common cause in adults, for half of the 
patients or more, we do not know the cause of their AES. However, we do know that 
most of the cases occur during the warmer seasons and therefore we think that 
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mosquitoes or other insects are spreading diseases, which cause AES in northern 
Viet Nam.  
This study therefore aims to look at the reasons why people might or might not get 
AES including where the person lives and their risks in and around their home and 
work environment and their contact with animals. To collect this information, part of 
this study therefore involves attaching global positioning system (GPS) devices to 
people to look at their movements throughout the day and to ask people to complete 
a diary about their contact with people and animals, where they went and food they 
ate. 
  
Who is doing this study?  
This study is being performed by a team from: 
The Oxford University Clinical Research Unit in Ha Noi 
The University of Liverpool, United Kingdom 
The Wellcome Trust Liverpool Glasgow Centre for Global Health Research, United 
Kingdom 
The National Institute of Hygiene and Epidemiology, Ha Noi 
 
What will happen to me in this study and what are the risks?   
You have been chosen to take part because we want to get information from members 
of the community about your views on wearing the GPS and completing a diary. You 
will be asked to take part in a group discussion with seven other members of the same 




What will happen to the samples / information taken? 
The results of the study will be used to design a questionnaire for a larger study. The 
results will also be written as a report or thesis for the University of Liverpool and will 
be published in a journal, which will be made available to the public. The results will 
also be available in Vietnamese through the OUCRU website and the National 
Institute of Hygiene and Epidemiology website. The results will also be available for 
the Ministry of Health in Viet Nam. You will not be able to be identified in these results 
as you will have a unique code and only your code will appear in the study data, 
results, and publications/reports. 
The results will be also be made available to the public through workshops about AES 
in the community or schools and possibly via the radio or other forms of media. 
 
What is the benefit of participating?   
There is no intended personal benefit to taking part however, the benefit will be to the 
community and people of Viet Nam by helping us to understand the risks associated 
with AES. 
You will be reimbursed 100,000 VND for your time spent and you will be offered light 
refreshments. 
 
What happens if I decline participation or change my mind later on? 
You have the right to decline participation or withdraw from the study at any time. 
Please let us know if you wish to do so. You do not need to give an explanation for 
this. You can request for your results to be destroyed at any time. There will be no 




All conversations will be recorded using a microphone device and later translated by 
the research assistant and kept on a secure database. Information about you will be 
kept confidential and only shared amongst study team members. You will be given an 
anonymous code, which will be used for the answers. Details linking yourself to this 
code will be kept in a separate place. All consent forms and recordings will be kept in a 
locked room. Only those who are involved with the study will have access to these 
documents which will be kept for 3 years and then put on an electronic system. The 
consent forms will be kept in a locked cupboard. 
 
Whom do I contact if I have questions or complaints? 
If you have questions about the study you may contact: To be decided 
If you have questions about being in a research study, please contact the Research 
Ethics Board of the NHTD at (phone number) the Clinical Trials Unit at (phone 
number). 
Thank you for reading this and thinking about joining this project.  Please ask 
the study staff if you have any questions.  If you agree to be in the study please 
sign below (one page per person). 
O I have read this information sheet or it has been read to me and I understand 
it. 
O I have been able to ask questions about the study. 
O I understand that my participation in the study is voluntary and I do not have 
to answer questions if I do not wish to do so 
O I understand that my information will be recorded using a microphone device. 
	 541 
O I understand that I can ask for access to the information I provide or have this 
information destroyed if I wish. 
O I agree for the data collected from me to be used in future research 
publications and presentations without my name. 
O I understand that I have the right to withdraw from the study at any time. 
O I agree to take part in the above study. 
 
Participant ID: 13HN-[__|__]-[__|__|__]      
Name of participant (Please Print): ________________________ 













Full Name Date of 
Signature 
 
I, the undersigned, have fully explained the relevant information of this program to the 
person named above and will provide her/him with a copy of this signed and dated 
















If the person giving consent cannot read the form themselves, a witness must be 
present and sign here: 
I was present throughout the entire informed consent process with the participant.  
This form was read accurately to the volunteer, all questions from the volunteer 
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13HNA CPD V2.1 017OCT16 
Please complete this diary for the 3 days the participants wear the GPS. If the participants feel uncomfortable with anything they do not have to 
include this. 
GENERAL INFORMATION: 
District of Participant’s house  
Commune of Participant’s house  
GPS coordinates of participant’s house (using Garmin eTrex GPS)  
4. Date of birth of the participant (in dd/mm/yyyy) – if not known state ‘not 
known’ or put in mm/yyyy etc.  
 




DIARIES: (Please refer the coding numbers underneath to complete the form. If there are multiple answers please list all) 
 
 Who did 
you/your child 
have contact 
with? (list each 
person in the 
boxes  below)1 
What was 
the type of 
contact?2 
What was 

























Date of interview: 
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 Who did 
you/your child 
have contact 
with? (list each 
person in the 
boxes  below)1 
What was 
the type of 
contact?2 
What was 
























Start time of 
interview: 
__ __:__ __ 
 






        
        
        
        
Evening 
(after 6 
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 Who did 
you/your child 
have contact 
with? (list each 
person in the 
boxes  below)1 
What was 
the type of 
contact?2 
What was 
























__ __:__ __ pm until 
bedtime) 
        
        
        
Day 2: 
Date of interview: 
__ __/__ __/__ __ 
Morning 
(wake up 
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 Who did 
you/your child 
have contact 
with? (list each 
person in the 
boxes  below)1 
What was 
the type of 
contact?2 
What was 

























Start time of 
interview: 
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 Who did 
you/your child 
have contact 
with? (list each 
person in the 
boxes  below)1 
What was 
the type of 
contact?2 
What was 
























End time of 
interview: 
__ __:__ __ 
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 Who did 
you/your child 
have contact 
with? (list each 
person in the 
boxes  below)1 
What was 
the type of 
contact?2 
What was 

























Date of interview: 
__ __/__ __/__ __ 
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 Who did 
you/your child 
have contact 
with? (list each 
person in the 
boxes  below)1 
What was 
the type of 
contact?2 
What was 
























__ __:__ __ 
 
End time of 
interview: 
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 Who did 
you/your child 
have contact 
with? (list each 
person in the 
boxes  below)1 
What was 
the type of 
contact?2 
What was 





























        
        
        
        
 
1. (1) Family members      (2) Friend    (3) Other  (777) Don’t know  (999) Prefer not to answer 
2. (1) Face to face conversation  (2) Skin to skin touch  (777) Don’t know  (999) Prefer not to answer 
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3. (777) Don’t know (999) Prefer not to answer 
4. (1) Home (2) Work (3) School (4) Other (777) Don’t know (999) Prefer not to answe 
 Day 1 Day 2 Day 3 
1. Did you/your child have any 




  Prefer not to answer 




  Prefer not to answer 




  Prefer not to answer 
If yes, what were these 
problems? 
2. During the day did you/your 




  Prefer not to answer 
  Yes 
  No 
  Prefer not to answer 
  Yes 
  No 
  Prefer not to answer 
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2a. If yes, for how long did 
you/your child forget to wear 
it? 
  Less than one hour 
  Between one and six hours 
  Between 7 and 24 hours 
  More than 24 hours 
  Don’t know 
  Prefer not to answer 
  Less than one hour 
  Between one and six hours 
  Between 7 and 24 hours 
  More than 24 hours 
  Don’t know 
  Prefer not to answer 
  Less than one hour 
  Between one and six hours 
  Between 7 and 24 hours 
  More than 24 hours 
  Don’t know 
  Prefer not to answer 
3. Did you/your child remove it 




  Prefer not to answer 
  Yes 
  No 
  Prefer not to answer 
  Yes 
  No 
  Prefer not to answer 
3a. If yes, for how long did 
you/your child remove it? 
  Less than one hour 
  Between one and six hours 
  Between 7 and 24 hours 
  More than 24 hours 
  Less than one hour 
  Between one and six hours 
  Between 7 and 24 hours 
  More than 24 hours 
  Less than one hour 
  Between one and six hours 
  Between 7 and 24 hours 
  More than 24 hours 
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  Don’t know 
  Prefer not to answer 
  Don’t know 
  Prefer not to answer 
  Don’t know 
  Prefer not to answer 





   
Do you have any other 















Tables from chapter four. 
Table A4.1 Time spent in each of the NDVI quartiles per participant comparing urban 




















         1.5 days 
(4.8 minutes 
– 7.2 days) 
3.4 hours 
(19.1 minutes – 
4.0 days) 
6.28 hours 
(4.1 minutes – 
10.9 hours) 
12 days 
(3.0 - 23.5 
days) 
Rural 
         5.1 minutes 
(2.7 minutes – 11.1 
minutes) 
        4.9 days 
(1.1 – 7.8 days) 
6.0 days 
(2.3 – 10.2 days) 
9.0 days 



























       1.4 hours  
(2.7 minutes – 
7.2 days) 
       3.0 days  
(19.1 hours – 7.8 
days) 
         5.4 days  
(41.0 minutes – 
10.2 days) 
       10.5 days  




        2.4 days  
(4.8 minutes – 
2.9 days) 
     3.6 days 
(51.5 minutes – 
6.5 days) 
         5.8 days 
(4.1 minutes – 9.7 
days) 
        9.2 days  













           (0-0.25) 
 
(median (range)) 


















48.9 minutes (2.7 
minutes – 2.9 
days) 
 
3.6 days (1.3 
hours - 7.4 days) 
 










2.5 hours (8.1 
minutes – 7.2 
days) 
 
3.2 days (19.1 
minutes – 7.8 
days) 
 
5.8 days (41.0 
minutes – 9.7 
days) 
 
9.0 days (3.4 















































3.9 hours  
(1.4 minutes – 4.1 
days) 
 
2.1 hours  
(2.4 minutes – 
3.8 days) 
 
5.8 days  
(2.8 hours - 
8.1 days) 
 
5.1 days  
(1.4 hours - 
6.0 days)  
Summer 
 
5.4 minutes  
(5.4 - 5.4 minutes) 
 
2.3 minutes (21 




4.4 minutes  
(4.1 minutes – 
4.8 minutes) 
 
6.0 days  
(24.1 hours 
– 6.7 days) 
Autumn 
 
2.5 minutes (6 
seconds – 8.0 
minutes) 
 
13.3 hours  
(51.5 minutes – 
4.0 days) 
 




3.2 days  
(2.0 minutes 
– 7.0 days) 
Winter 
 
16.7 hours  
(3.1 minutes – 3.3 
days) 
 
2.7 days  
(54 seconds – 
4.9 days) 
 
36.1 minutes  
(20.8 – 51.3 
minutes) 
 
3.0 days  
(17.5 hours 












































10.9 hours (2.3 
minutes – 32.8 
hours) 
 
21.0 hours (18 
seconds – 53.7 
hours) 
 
1.7 days (15.7 








7.1 hours (1.7 
minutes – 2.5 
days) 
 
18.0 hours (4.5 
minutes – 1.8 
days) 
 
1.3 days (43.5 
minutes – 2.6 
days) 
 





5.0 hours (2.3 







15.0 hours (1.9 
minutes – 26.9 
hours) 
 
1.1 days (6.0 















Table A4.6 The number of non-physical contacts by age category. 
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Number of contacts 
per participant over 













0-5 6 1306 
205 
(188 – 269) 
- 8 (1-21) - 
6-12 14 3917 
279.5 
(91 -398) 
0.139 13 (1-30) <0.001 
13-17 4 897 
217.5 
(129 -333) 
0.895 10 (1-22) 0.686 
18-35 8 2474 
302 
(127-451) 
0.061 14 (1-30) <0.001 
36-60 12 3257 
270.5 
(85-514) 
0.205 11 (1-28) <0.001 
61 and 
over 4 953 
215 
(187-336) 










Table A4.7 The number of physical contacts by age category. 
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Number of contacts 
per participant over 
the study period 
Number of 
contacts per 









0-5 6 311 42.5 (2-127) - 5.5 (1-17) - 
6-12 14 1173 84 (3-229) 0.234 4 (1-24) 0.086 
13-17 4 253 51 (42-109) 0.709 3 (1-13) <0.001 
18-35 8 465 70 (3-147) 0.590 5 (1-30) 0.075 
36-60 12 629 59 (14-132) 0.651 4 (1-28) <0.001 
61 and 




















Non-physical contact (face to face) 





Number of contacts per 






















Table A4.9 Number of physical contacts by gender. 
 
Physical contact (touch) 





Number of contacts 
per participant over 











Female 24 1633 63 (2-179) - 4 (1-24) - 
Male 24 1278 51 (3-229) 0.934 3 (1-20) 0.019 
 




Non-physical contact (face to face) 






Number of contacts 
per participant over 
the study period 
Number of 
contacts per 









Urban 24 6974 273 (156-514) - 13 (1-30) - 
Rural 24 5830 237.5 (85-410) 0.080 10 (1-30) <0.001 
 
 
Table A4.11 The number of physical contacts by urban and rural participants. 
 
 
Physical contact (touch) 






Number of contacts 
per participant over 
the study period 
Number of 
contacts per 









Urban 24 1553 65 (3-127) - 3 (1-15) - 









Non-physical contact (face to face) 





Number of contacts 
per participant over 




















Weekends 48 4047 
79 
(20- 154) 





















Physical contact (touch) 






















Weekdays 48 1961 37 (2-166) - 4 (1-24) - 
















Table A4.14 The number of non-physical contacts by season. 
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Non-physical contact (face to face) 






Number of contacts 
per participant over 













Spring 48 3713 75 (19-170) - 12 (1-30) - 
Summer 45 2622 56 (3-125) 0.009 11 (1-24) <0.001 
Autumn 48 3397 69.5 (7-130) 0.405 12 (1-24) 0.056 

















Physical contact (touch) 






Number of contacts 
per participant over 













Spring 48 346 14 (2-31) - 3 (1-9) - 
Summer 45 1044 22.5 (1-74) <0.001 5 (1-20) <0.001 
Autumn 48 592 13 (1-88) 0.139 3 (1-24) <0.001 
















Non-physical contact (face to face) 






















Morning 48 4917 
96.5  
(31-207) 
- 4 (1-10) - 
Afternoon 48 4653 
92.5  
(32-196) 
0.499 4 (1-10) 0.006 
Evening 48 3234 64.5 
(180125) 









Table A4.17 Number of physical contacts by time of the day. 
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Physical contact (touch) 






Number of contacts 
per participant over 













Morning 48 963 17.5 (1-99) - 2 (1-10) - 
Afternoon 48 920 21 (2-77) 0.476 2 (1-10) 0.399 


















A summary of the JEV cELISA Methods from CSIRO 
	
1. The ELISA plate is coated with JEV antigen.  
2. The test and control sera are diluted to 1/10. 
3. The plate is washed. 
2. The diluted sera are added to each well.  
3. JEV 989 monoclonal antibody is added to the wells. 
4. The anti-mouse horseradish peroxidase (HRPO) conjugate is diluted to 1/400. 
5. The plate is washed. 
6. The diluted anti-mouse HRPO conjugate is added to the wells. 
7. The plate is washed. 
8. The tetramethylbenzidine (TMB) substrate is added to the wells followed by 
sulphuric acid. 
9. Sera with percentage inhibition of greater than 50% are classified as positive, less 























These procedures describe the method for determination of neutralizing 
antibodies against Japanese Encephalitis viruses in test sera, including sera from 
vaccination and infections. 
 
Neutralization tests conducted in cell culture may be applied in two ways to the 
laboratory diagnosis of viral infections.  First, virus strains isolated from the 
patient may be identified by demonstrating the ability of known, specific immune 
serum to neutralize the infective capacity of the virus, i.e., to prevent a CPE, 
plaque formation, or other manifestations of infection in cell cultures.  Secondly, 
infections, and vaccinations may be diagnosed by demonstrating a significant 
increase in neutralizing antibody for a given virus between acute- and 
convalescent- phase serum specimens collected from the patient. 
 
In cell culture systems, serum specimens are generally assayed for neutralizing 
antibody content by testing serial dilutions of serum against a standard dose 
(usually 100 TCID50) of the virus.  This is referred to as the constant virus-
varying serum technique, and it is more useful for demonstrating significant 
increases in neutralizing antibody than is the constant serum-varying virus 
procedure in which undiluted serum is tested against serial dilutions of virus.  In 
Standard Operating Procedure 
SOP 
Center for Vaccine Development 
Mahidol University 
SOP No. : 63 
Effective Date: 11 
Jul 2012 
 
Title: Plaque Reduction Neutralization Test for JE Viruses in LLC-MK2 Cells 






Reviewer: Sutee Yoksan, 
M.D.,Ph.D. 
Director, CVD   
Approved by: Sutee Yoksan, 
M.D.Ph.D. 
 Director, CVD    
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the constant virus-varying serum system the antibody titer is expressed as the 
highest serum dilution, which neutralizes the test dose of virus. 
 
2.  SPECIMEN COLLECTION / TREATMENT 
 
3.  EQUIPMENT / REAGENTS 
a.  Equipment 
i. Pipettes, sterile, multi-PK, 1 ml 
ii. Pipettes, sterile, 5 ml 
iii. Pipettes, sterile, 10 ml 
iv. 6-well Cluster Plates 
v. Biosafety Cabinet (Laminar flow hood) 
vi. 37°C, 5% CO2 Incubator 
vii. 13 ´ 100 mm Sterile Glass Tubes, capped Pyrex 
viii. 12 ´ 75 mm Sterile Polyethylene tube, capped. 
Falcon/Cat. 2063 
ix. 37°C water bath 
x. 56°C water bath 
xi. Light Box 
xii. Vortex mixer 




LLC-MK2 cells (ATCC) 
ii. Virus Diluent : MEM + 10% heat-inactivate Fetal Bovine Serum 
(FBS) + Pen-Step 300 units, adjust pH to 7.4-7.8 with 7.5% 
NaHCO3 
PBS, pH 7.5 with 20% heat-inactivated Fetal Bovine Serum 
iii. Reference viruses: (Vaccine strain) 
Japanese encephalitis JEV (Beij) 
iv. Standard positive sera :  




JE (Beij) 830 
 
Normal Human serum control (Donor) PRNT titer < 1:10 
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v. Test sera, heat-inactivated 56°C [54°C to 58°C], 30 minutes 
vi. Growth medium for LLC-MK2 cells: 
Fetal Bovine Serum     
 100 ml 
(heat-inactivated at 56°C [54°C to 58°C], 30 minutes) 
L-glutamine      
 5.0 ml 
Penicillin-Streptomycin mixture   
 5.0 ml 
(10,000 units/ml of Penicillin G, and 10,000 ug/ml 
of streptomycin sulfate in 0.85% saline) 
M-199 to      
 500 ml 
 
Adjust pH to 7.4 ± 0.1 with 7.5% Sodium bicarbonate 
vii. Overlayer medium 
100  ml MEM (2 X) 
10 ml Ñ FCS 
1 ml L-glutamine 
2 ml P & S 
50 ml 3.0% CMC 
3 ml Neutral Red 
 
4.  CALIBRATION 
 
5.  QUALITY CONTROL 
The number of plaques in each assay plate is critical to avoid the “plaque 
overlap  phenomenon.”  Generally, between 40-60 plaques in a 6 well plate. 
In each assay, checked titration of virus control must be done.  This helps to 
check or confirm the number of plaques in serum/plasma-virus mixtures.  Each 
assay has duplicate virus control in each plate.   
At least two replication wells should be included for all test serum/plasma for 
reliability. 
 
6.  PROCEDURES 
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a. Assay in LLC-MK2 Cells 
i. Preparation of LLC-MK2 cells: seed in a 6 well plate, 4 ml of 
1.0 ´ 105 cells per well, cells will form monolayer in 6-8 days at 
35°C [33°C to 37°C] in 5% CO2 incubator. 
ii. Preparation of serum dilution (prepare in advance) 
 
1. In an ice-bath, prepare ten fold dilutions of the test sera 
with the virus diluent as follow. 
 
					    Tube 1  Tube 2   Tube 3     
Diluent ml        0.4     0.9     0.9   
Test Serum ml       0.1 mix                 0.1 mix     0.1  mix   
Dilution        1:5       1:50                 1:500 	 	
 
Start with 1:5 and continue on the dilution required to 
encompass the expected 50% plaques reduction end 
point (3dilutions are standard) 
 
2. Transfer 0.3 ml each of each dilution to new tube. For 
virus control, place 0.3 ml each of virus diluent into each 
extra empty tubes (for JE).  Store at -20°C (-25°C to -
15°C).   The diluted samples should be used within 7-
10 days. 
 
iii. Serum-virus mixtures: 
1. Bring the diluted sera from storage (6.1.2.2), place in an 
ice-bath then add an equal volume (0.3 ml) of the virus 
suspension, diluted to contain approximately 50 pfu/0.2 
ml (for 6 well plate) to each tube.  For virus control add 
0.3 ml each. 
2. Shake rack of tubes thoroughly then incubate in 37°C 
water bath for one hour. 
3. Place rack of tubes in an ice-bath, the virus-serum 
mixture and virus control are ready to be inoculated on 
cells.  
 
iv. Inoculation of serum-virus mixture onto LLC-MK2 cells 
1. Discard all growth medium of LLC-ML2 in 6 well plates 
(or Flask) 
2. Inoculate 0.2 ml of each virus-serum mixture on to a 
well of cell sheet of prepared LLC-MK2 monolayer, 2 
wells per dilution. 2 wells each for virus control. 
3. Let absorption for 90 min at 37°C with continuous 
rocking to distribute the fluid. 
4. Discard excess of serum-virus mixture. 
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5. Add 4.0 ml of overlay medium into each well.  Incubate 
plates 37°C [33°C to 37°C] in 5% CO2 atmosphere 
incubator, 7 days JE 











7.  RESULTS REPORTING AND INTERPRETATION 
Determination of plaque neutralizing titer (PRNT50): The neutralizing 
activity of a test   serum is determined by its ability to reduce the number of 
virus plaques as to compare to the number seen in control cultures.  A 
reduction of plaque count of 50% is taken as the neutralizing end point.  This 
can be done by plotting the percentage of plaques observed at each dilution 
of test sera on probability x 2 cycle logarithmic paper or using SPSS Program.  
The 50% end point is that dilution at which the line of best fit (by visual 
inspection) crosses the 50% probit line. 
 
8.  PROCEDURAL NOTES 
Any changes, suggestions, or recommendations for the SOP should be sent 
to Director, CVD. 
 
9.  LIMITATIONS/INTERFERENCES 
If the number of control plaques do not match with the check titration of control, 
or the number of control plaques is not in the range, the test should not be 
accepted. 
  
10.  REFERENCES 
Russell, P.K. Nisalak, A., Sukhavachana, P., and Vivona, S., 1967.  A plaque 
reduction test for dengue neutralizing antibodies.  J. Immunol. 99: 285-290. 
 




Table A5.1 Univariate logistic regression using a GLM to compare the type of farm 




(N (%, 95%CI)) 
Seronegative  








Moran I for 
spatial 
autocorrelation 





































Table A5.2 Univariate logistic regression using an INLA model comparing the type of 
farm from which the pig originated with the seroprevalence of JEV with month fitted 
as a random effect. 
 
Variable Mean posterior 
estimate 
SD  2.5 percentile  97.5 percentile 










Table A5.3 Univariate logistic regression using GLM to compare the environmental 

































Table A5.4 Univariate logistic regression using as an INLA model to compare the 
environmental suitability for Cx. tritaeniorhynchus with seroprevalence with province 
and month fitted as random effects. 
 
Variable Mean posterior 
estimate 
SD  2.5 percentile  97.5 percentile 












Table A5.5 Univariate logistic regression using GLM to compare the incidence of 






























Statistic = 0.012 
p = 0.001 
	
	
Table A5.6 Univariate logistic regression using an INLA model to compare the 
incidence of AES with the seroprevalence of JEV in pigs with province and month 
fitted as random effects. 
 
Variable Mean posterior 
estimate 
SD  2.5 percentile  97.5 percentile 



























Table A5.7 Univariate logistic regression using GLM to compare the incidence of 






































Table A5.8 Univariate logistic regression using an INLA model to compare the 
incidence of human JE with the seroprevalence of JEV in pigs with province and 
month fitted as random effects. 
	
	
Variable Mean posterior 
estimate 
SD  2.5 percentile  97.5 percentile 








Table A5.9 Univariate logistic regression using GLM to compare vaccination 


































Table 5.10 Univariate logistic regression using INLA to compare vaccination coverage 
against JE with the seroprevalence of JEV in pigs including province and month fitted 
as random effects. 
 
Variable Mean posterior 
estimate 






























Table A5.11 The output of multivariate model 1 with an outcome of seropositivity of 
JEV in pigs. 
 
  Mean SD 0.025quant 0.975quant 
 580 
(Intercept) 1.927 0.195 1.541 2.309 
FarmIndustrial -0.16 0.048 -0.256 -0.067 
Environmental.suitability 0.135 0.269 -0.347 0.711 
JE -0.571 0.397 -1.354 0.204 
JE.vaccination -0.003 0.002 -0.007 0.001 
     
Precision for the logistic 
observations 2.31 0.099 2.12 2.51 
Precision for idregion (iid 
component) 1361.19 1560.28 44.64 5506.76 
Precision for the logistic 
observations 1808.83 1821.115 117.95 6642.56 












Table A5.11 The output of multivariate model 2 with an outcome of seropositivity of 
JEV in pigs. 
  Mean SD 0.025quant 0.975quant 
(Intercept) 1.927 0.195 1.539 2.309 
FarmIndustrial -0.144 0.048 -0.241 -0.051 
 581 
Environmental.suitability 0.013 0.284 -0.482 0.677 
AES -0.015 0.007 -0.028 -0.002 
JE.vaccination -0.002 0.002 -0.006 0.001 
     
Precision for the logistic 
observations 2.33 0.103 2.12 2.52 
Precision for idregion (iid 
component) 18.28 9.61 6.5 43.04 
Precision for the logistic 
observations 898.01 1088.969 13.75 3878.47 













Table A5.12 The output of multivariate model 3 with an outcome of seropositivity of 
JEV in pigs. 
  Mean SD 0.025quant 0.975quant 
(Intercept) 1.48 0.153 1.168 1.778 
Environmental.suitability 0.395 0.307 -0.205 1.019 
 582 
JE -0.215 0.237 -0.685 0.247 
JE.vaccination 0 0 -0.001 0 
     
Precision for the logistic 
observations 2.13 0.049 2.04 2.23 
Precision for idregion (iid 
component) 124.75 80.286 29.79 330.78 
Precision for the logistic 
observations 1962.2 1888.564 127.07 6950.66 
Precision for month 50.76 26.59 17.66 118.88 
 
 
Table A5.13 The output of multivariate model 3 with an outcome of seropositivity of 
JEV in pigs. 
  Mean SD 0.025quant 0.975quant 
(Intercept) 1.436 0.148 1.132 1.723 
Environmental.suitability 0.47 0.299 -0.112 1.083 
AES 0.008 0.003 0.003 0.013 
JE.vaccination 0 0 -0.001 0 
     
Precision for the logistic 
observations 2.14 0.049 2.04 2.23 
Precision for idregion (iid 
component) 140.57 102.703 34.6 411.27 
Precision for the logistic 
observations 1828.13 1825.579 128.81 6634.56 
Precision for month 53.56 27.122 18.81 122.34 
 
	
	
